Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23424.Total Lipids in VLDL,AGRP,Agouti-related protein,42754,0.256974424949453,0.00477273685517369,0.247619860713313,0.266328989185594,0
NMR metabolomics,X23424.Total Lipids in VLDL,CCN1,CCN family member 1,42569,0.348563203898476,0.00684022778815183,0.335156357433698,0.361970050363254,0
NMR metabolomics,X23424.Total Lipids in VLDL,LDLR,Low-density lipoprotein receptor,42644,0.389384451387728,0.00396576365071798,0.381611554632321,0.397157348143135,0
NMR metabolomics,X23424.Total Lipids in VLDL,MFGE8,Lactadherin,42611,0.203547833063947,0.00407130621367694,0.19556807288514,0.211527593242754,0
NMR metabolomics,X23424.Total Lipids in VLDL,NPY,Pro-neuropeptide Y,42721,0.318368342819165,0.00594747743029354,0.30671128705579,0.330025398582541,0
NMR metabolomics,X23424.Total Lipids in VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,42611,0.171678253281984,0.00302900451968343,0.165741404423405,0.177615102140564,0
NMR metabolomics,X23424.Total Lipids in VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,40483,0.276421942641091,0.00721287560512702,0.262284706455042,0.29055917882714,3.38480786520559e-302
NMR metabolomics,X23424.Total Lipids in VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,40532,0.0804007108069585,0.00212805689808078,0.0762297192867201,0.0845717023271968,2.53076807662732e-294
NMR metabolomics,X23424.Total Lipids in VLDL,CES1,Liver carboxylesterase 1,42661,0.290959560127833,0.00783541674693424,0.275602143303842,0.306316976951824,1.9080570939919e-287
NMR metabolomics,X23424.Total Lipids in VLDL,LPL,Lipoprotein lipase,42636,-0.162588658556617,0.00452370241149017,-0.171455115283138,-0.153722201830096,3.38718585897679e-270
NMR metabolomics,X23424.Total Lipids in VLDL,GHR,Growth hormone receptor,40283,0.0987052088955642,0.00273347011722166,0.0933476074658097,0.104062810325319,4.70260797438294e-270
NMR metabolomics,X23424.Total Lipids in VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42689,0.145530596181097,0.00410516469494646,0.137484473379002,0.153576718983192,2.76622376492162e-263
NMR metabolomics,X23424.Total Lipids in VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,42721,0.111260441716278,0.00319219757070838,0.105003734477689,0.117517148954866,5.88032408819504e-255
NMR metabolomics,X23424.Total Lipids in VLDL,F7,Coagulation factor VII,42671,0.104853656211459,0.00301847536615074,0.0989374444938035,0.110769867929114,2.66958313481005e-253
NMR metabolomics,X23424.Total Lipids in VLDL,FURIN,Furin,42679,0.110027203423907,0.00317484377718442,0.103804509620625,0.116249897227188,3.51962993099183e-252
NMR metabolomics,X23424.Total Lipids in VLDL,TFPI,Tissue factor pathway inhibitor,42618,0.102589700552142,0.00301808910734646,0.0966742459017426,0.108505155202541,5.07345357426483e-243
NMR metabolomics,X23424.Total Lipids in VLDL,CCL27,C-C motif chemokine 27,42636,0.192160141867589,0.00575497370000752,0.180880393415574,0.203439890319604,6.49982251310431e-235
NMR metabolomics,X23424.Total Lipids in VLDL,NRP1,Neuropilin-1,42705,-0.0898751130432235,0.00271529149176268,-0.0951970843670783,-0.0845531417193686,4.46047167293316e-231
NMR metabolomics,X23424.Total Lipids in VLDL,CCL23,C-C motif chemokine 23,42676,0.135142684315127,0.00410234138155117,0.127102095207287,0.143183273422968,5.6288858269568e-229
NMR metabolomics,X23424.Total Lipids in VLDL,GCG,Pro-glucagon,42346,0.402511129032481,0.0123600814371511,0.378285369415665,0.426736888649297,8.57870434156723e-224
NMR metabolomics,X23424.Total Lipids in VLDL,PROC,Vitamin K-dependent protein C,42663,0.0799017263378001,0.00245822785284642,0.0750835997462211,0.0847198529293791,3.49782485273105e-223
NMR metabolomics,X23424.Total Lipids in VLDL,PTH,Parathyroid hormone,40182,0.260104985847499,0.00797881856459881,0.244466501460886,0.275743470234113,1.34706472954943e-222
NMR metabolomics,X23424.Total Lipids in VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42721,0.109462377400917,0.00337393170459906,0.102849471259903,0.116075283541931,1.9839758357466e-222
NMR metabolomics,X23424.Total Lipids in VLDL,SMAD1,Mothers against decapentaplegic homolog 1,42346,0.256227457546375,0.00795121317507435,0.240643079723229,0.27181183536952,2.36378946623771e-219
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJB1,DnaJ homolog subfamily B member 1,42587,0.272036303965377,0.008461203548841,0.255452345009649,0.288620262921105,1.54426969492005e-218
NMR metabolomics,X23424.Total Lipids in VLDL,IGSF9,Protein turtle homolog A,40511,0.258870223665215,0.00809250896644821,0.243008906090977,0.274731541239454,4.89554277902507e-215
NMR metabolomics,X23424.Total Lipids in VLDL,APCS,Serum amyloid P-component,40419,0.104619223887485,0.00334230227004959,0.0980683114381877,0.111170136336782,2.78143872260474e-206
NMR metabolomics,X23424.Total Lipids in VLDL,RARRES2,Retinoic acid receptor responder protein 2,42705,0.143532381864321,0.00461495877459959,0.134487062666106,0.152577701062536,3.58262578899171e-205
NMR metabolomics,X23424.Total Lipids in VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,42587,0.239153990774604,0.00779320933348058,0.223879300480982,0.254428681068226,6.40022847443949e-200
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA5,Plasma serine protease inhibitor,40387,0.0941269836548207,0.00308925945422219,0.0880720351245452,0.100181932185096,5.85543638679207e-196
NMR metabolomics,X23424.Total Lipids in VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,42587,0.311422289316405,0.010261227391557,0.291310283628953,0.331534295003857,1.00013089761498e-195
NMR metabolomics,X23424.Total Lipids in VLDL,PLA2G10,Group 10 secretory phospholipase A2,42495,-0.175876332002286,0.0058028161347153,-0.187249851626328,-0.164502812378244,3.50553814970976e-195
NMR metabolomics,X23424.Total Lipids in VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,42477,0.445489659112317,0.0147520648578618,0.416575611990908,0.474403706233726,8.14591919953092e-194
NMR metabolomics,X23424.Total Lipids in VLDL,SLC39A5,Zinc transporter ZIP5,42594,0.158597680397481,0.00530238516171978,0.14820500548051,0.168990355314451,2.39904302578951e-190
NMR metabolomics,X23424.Total Lipids in VLDL,ADIPOQ,Adiponectin,40539,-0.20340833433551,0.00678670743423668,-0.216710280906614,-0.190106387764406,5.20623978454443e-190
NMR metabolomics,X23424.Total Lipids in VLDL,INHBC,Inhibin beta C chain,42611,0.117341056732206,0.00404456943363364,0.109413700642285,0.125268412822128,1.52748759189837e-179
NMR metabolomics,X23424.Total Lipids in VLDL,CD4,T-cell surface glycoprotein CD4,42570,0.0883444217421314,0.00306081494328131,0.0823452244533,0.0943436190309628,9.20653483002731e-178
NMR metabolomics,X23424.Total Lipids in VLDL,CNTN3,Contactin-3,42611,0.0880514058354984,0.00308030119207473,0.0820140154990319,0.0940887961719648,1.64380651194524e-174
NMR metabolomics,X23424.Total Lipids in VLDL,TTR,Transthyretin,40424,0.0711158763154932,0.00248726313791791,0.0662408405651741,0.0759909120658123,1.27564828065852e-173
NMR metabolomics,X23424.Total Lipids in VLDL,CFP,Properdin,40539,0.0623302163297384,0.00219807645453745,0.058021986478845,0.0666384461806318,5.82211164944049e-171
NMR metabolomics,X23424.Total Lipids in VLDL,SNCA,Alpha-synuclein,40283,0.320896085794523,0.0113212827813594,0.298706371543059,0.343085800045987,1.08641277206595e-170
NMR metabolomics,X23424.Total Lipids in VLDL,DSG2,Desmoglein-2,42611,-0.0758244169746666,0.0026906833469032,-0.0810981563345969,-0.0705506776147364,8.52608480677694e-170
NMR metabolomics,X23424.Total Lipids in VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,42587,0.192755713618637,0.0068807989245789,0.179269347726462,0.206242079510811,7.30503431366763e-168
NMR metabolomics,X23424.Total Lipids in VLDL,CHMP6,Charged multivesicular body protein 6,40511,0.15448668663061,0.00551148262834951,0.143684180679045,0.165289192582175,3.32583551123876e-167
NMR metabolomics,X23424.Total Lipids in VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,42586,0.0523394064436712,0.00187381613842648,0.0486667268123553,0.0560120860749871,6.3316416692653e-167
NMR metabolomics,X23424.Total Lipids in VLDL,GUSB,Beta-glucuronidase,42711,0.1669541633398,0.00599641598396282,0.155201188011233,0.178707138668367,6.12668637352338e-166
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL6,C-X-C motif chemokine 6,42754,0.210101810637545,0.00756408562569875,0.195276202811176,0.224927418463915,3.38141374195361e-165
NMR metabolomics,X23424.Total Lipids in VLDL,GPR37,Prosaposin receptor GPR37,42357,0.185607161321694,0.00674978450618339,0.172377583689575,0.198836738953814,6.61680256156829e-162
NMR metabolomics,X23424.Total Lipids in VLDL,BCHE,Cholinesterase,40346,0.075729191361838,0.00274999387313756,0.0703392033704884,0.0811191793531876,1.45168217775768e-161
NMR metabolomics,X23424.Total Lipids in VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,42238,0.053644322379644,0.00195573546508905,0.0498110808680694,0.0574775638912185,4.36247868070358e-161
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA4,Kallistatin,40342,0.0647923099822091,0.00238102134731589,0.06012550814147,0.0694591118229482,6.30664182861508e-158
NMR metabolomics,X23424.Total Lipids in VLDL,PAMR1,Inactive serine protease PAMR1,42611,0.0715948708070065,0.00264939278631581,0.0664020609458275,0.0767876806681854,1.18672215382152e-156
NMR metabolomics,X23424.Total Lipids in VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42711,0.138529927771722,0.00512853528436902,0.128477998614358,0.148581856929085,1.48942749714684e-156
NMR metabolomics,X23424.Total Lipids in VLDL,PRAP1,Proline-rich acidic protein 1,40527,0.110764043503712,0.00410007957980793,0.102727887527289,0.118800199480136,7.93665195181822e-156
NMR metabolomics,X23424.Total Lipids in VLDL,C9,Complement component C9,40532,-0.141061432764633,0.00524204600721092,-0.151335842938767,-0.1307870225905,1.14785205085171e-154
NMR metabolomics,X23424.Total Lipids in VLDL,P4HB,Protein disulfide-isomerase,42563,0.100902213396807,0.00378843321344274,0.0934768842984594,0.108327542495155,2.47673181684686e-152
NMR metabolomics,X23424.Total Lipids in VLDL,TMPRSS15,Enteropeptidase,42587,0.240579293900525,0.00904000125162254,0.222860891447344,0.258297696353705,4.20579443465193e-152
NMR metabolomics,X23424.Total Lipids in VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42495,0.190061520498446,0.0072206443999489,0.175909057474546,0.204213983522346,6.76030513234564e-149
NMR metabolomics,X23424.Total Lipids in VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,42346,0.153371323151034,0.00585509845622702,0.141895330176829,0.164847316125239,1.79797059706014e-147
NMR metabolomics,X23424.Total Lipids in VLDL,CRIP2,Cysteine-rich protein 2,42495,0.0951763920134829,0.00363423046286612,0.0880533003062653,0.1022994837207,1.88299653996404e-147
NMR metabolomics,X23424.Total Lipids in VLDL,ERP44,Endoplasmic reticulum resident protein 44,42569,0.065763672682422,0.00252902282533086,0.0608067879447735,0.0707205574200705,1.8029282478498e-145
NMR metabolomics,X23424.Total Lipids in VLDL,PLTP,Phospholipid transfer protein,42752,-0.0920495218621652,0.00355633727497572,-0.0990199429211176,-0.0850791008032128,3.18212161201966e-144
NMR metabolomics,X23424.Total Lipids in VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,42357,0.208256563588945,0.00805513963184934,0.19246848991052,0.22404463726737,8.28797081092623e-144
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,42771,-0.157395020328664,0.00615615639926419,-0.169461086871222,-0.145328953786106,7.42944314151423e-141
NMR metabolomics,X23424.Total Lipids in VLDL,FLI1,Friend leukemia integration 1 transcription factor,42346,0.278532209826625,0.0108904475315541,0.257186932664779,0.299877486988471,7.62633300087718e-141
NMR metabolomics,X23424.Total Lipids in VLDL,AGR3,Anterior gradient protein 3,42326,0.151685297776638,0.0059414824383563,0.140039992197459,0.163330603355816,2.36553350097016e-140
NMR metabolomics,X23424.Total Lipids in VLDL,SYAP1,Synapse-associated protein 1,40283,0.144929175949581,0.00566520677367501,0.133825370673178,0.156032981225984,2.6804044079884e-140
NMR metabolomics,X23424.Total Lipids in VLDL,NUMB,Protein numb homolog,40199,0.207715505448455,0.00813645464047095,0.191768054353132,0.223662956543778,1.04124570787468e-139
NMR metabolomics,X23424.Total Lipids in VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42613,0.285944040583773,0.0112785733780078,0.263838036762877,0.308050044404668,1.48596151560154e-138
NMR metabolomics,X23424.Total Lipids in VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,42679,0.0831147839375753,0.00328233638789353,0.076681404617304,0.0895481632578466,3.04028973362553e-138
NMR metabolomics,X23424.Total Lipids in VLDL,CPM,Carboxypeptidase M,42655,0.0839729338761238,0.00335225403074789,0.077402515975858,0.0905433517763897,2.16618793157619e-135
NMR metabolomics,X23424.Total Lipids in VLDL,SNAPIN,SNARE-associated protein Snapin,40482,0.142839888433391,0.00569984899896484,0.13166818439542,0.154011592471362,6.31085088952991e-135
NMR metabolomics,X23424.Total Lipids in VLDL,CFH,Complement factor H,39956,0.0568502049147954,0.00226782517891943,0.0524052675641133,0.0612951422654775,7.79444219426264e-135
NMR metabolomics,X23424.Total Lipids in VLDL,LATS1,Serine/threonine-protein kinase LATS1,40199,0.209542975615959,0.00836222291887042,0.193153018694973,0.225932932536945,8.16099270280788e-135
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPTL2,Angiopoietin-related protein 2,42640,0.0995060066097038,0.00398635897141712,0.0916927430257263,0.107319270193681,1.796287122281e-134
NMR metabolomics,X23424.Total Lipids in VLDL,SMAD2,Mothers against decapentaplegic homolog 2,40451,0.171362172162596,0.00685571719627549,0.157924966457896,0.184799377867296,3.00542114469235e-134
NMR metabolomics,X23424.Total Lipids in VLDL,LAT2,Linker for activation of T-cells family member 2,42587,0.304480119098505,0.0122360144198847,0.280497530835531,0.328462707361479,1.17785501542927e-133
NMR metabolomics,X23424.Total Lipids in VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40449,0.340970842724547,0.0136976013118859,0.314123544153251,0.367818141295844,3.42956666159444e-133
NMR metabolomics,X23424.Total Lipids in VLDL,ENO3,Beta-enolase,40223,0.145570858191993,0.00584914112813763,0.134106541580844,0.157035174803143,4.56219854012207e-133
NMR metabolomics,X23424.Total Lipids in VLDL,KLKB1,Plasma kallikrein,40293,0.0604289242516812,0.00244750688822847,0.0556318107507534,0.065226037752609,4.52485652108127e-131
NMR metabolomics,X23424.Total Lipids in VLDL,AFM,Afamin,40539,0.0488038828924729,0.00198021788558328,0.0449226558367297,0.0526851099482162,1.07859939542279e-130
NMR metabolomics,X23424.Total Lipids in VLDL,PLAT,Tissue-type plasminogen activator,42760,0.123210040406182,0.00502001887727931,0.113370803406715,0.13304927740565,3.41431133616851e-130
NMR metabolomics,X23424.Total Lipids in VLDL,CFI,Complement factor I,40539,0.0468357504061917,0.00194543298006129,0.0430227017652716,0.0506487990471119,6.06798761265624e-125
NMR metabolomics,X23424.Total Lipids in VLDL,SORT1,Sortilin,42613,0.0882701753882555,0.00367484594782938,0.0810674773305099,0.0954728734460011,7.27684236200921e-125
NMR metabolomics,X23424.Total Lipids in VLDL,KDR,Vascular endothelial growth factor receptor 2,42679,0.0586585984684382,0.00245884828641282,0.053839255827069,0.0634779411098073,3.0725766586198e-123
NMR metabolomics,X23424.Total Lipids in VLDL,CREG1,Protein CREG1,42445,0.0914043083163597,0.00383874374552583,0.083880370575129,0.0989282460575903,9.5489309669152e-123
NMR metabolomics,X23424.Total Lipids in VLDL,DTYMK,Thymidylate kinase,40511,0.160494972179067,0.00674910669394928,0.147266723058926,0.173723221299208,5.11566435312532e-122
NMR metabolomics,X23424.Total Lipids in VLDL,FGF21,Fibroblast growth factor 21,42689,0.276759724808959,0.0116693473143044,0.253887804072923,0.299631645544996,7.40214230718352e-122
NMR metabolomics,X23424.Total Lipids in VLDL,GSTA3,Glutathione S-transferase A3,42346,0.179671199606291,0.00759996402871159,0.164775270110016,0.194567129102565,4.7962096668523e-121
NMR metabolomics,X23424.Total Lipids in VLDL,ATRN,"Attractin, Isoform 2",40539,0.0394263367761023,0.00166804348070338,0.0361569715539237,0.0426957019982809,1.30623743261709e-120
NMR metabolomics,X23424.Total Lipids in VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42689,-0.0879551298346501,0.00373793369245546,-0.0952814798718628,-0.0806287797974374,5.11753869299558e-120
NMR metabolomics,X23424.Total Lipids in VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,42346,0.15823287003219,0.00675991527420162,0.144983436094755,0.171482303969625,9.4318965372159e-119
NMR metabolomics,X23424.Total Lipids in VLDL,NOMO1,Nodal modulator 1,42611,0.053857554225284,0.0023053716580122,0.0493390257755801,0.058376082674988,2.37333240795084e-118
NMR metabolomics,X23424.Total Lipids in VLDL,EEF1D,Elongation factor 1-delta,40511,0.211807334472445,0.00908567421723499,0.193999413006664,0.229615255938226,1.90037797456997e-117
NMR metabolomics,X23424.Total Lipids in VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,42760,0.0447381893539606,0.00192427256328686,0.0409666151299183,0.0485097635780028,2.79036222307923e-117
NMR metabolomics,X23424.Total Lipids in VLDL,SNAP29,Synaptosomal-associated protein 29,42679,0.210965478443829,0.00907414212117925,0.193180159886317,0.22875079700134,2.89843222357221e-117
NMR metabolomics,X23424.Total Lipids in VLDL,GRP,Gastrin-releasing peptide,40223,0.129610901672002,0.00558548428401855,0.118663352475325,0.140558450868678,2.41767122399577e-116
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,42689,0.0732509629609171,0.00316365256528833,0.0670502039329519,0.0794517219888822,2.42268529584816e-116
NMR metabolomics,X23424.Total Lipids in VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,42679,0.0542816501444599,0.00235105240766967,0.0496735874254274,0.0588897128634925,1.05085988796554e-115
NMR metabolomics,X23424.Total Lipids in VLDL,NAA80,N-alpha-acetyltransferase 80,40182,0.27733858927613,0.0119856930288979,0.25384663093949,0.30083054761277,1.06190263473945e-115
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,42770,-0.274682659196198,0.0119905680875863,-0.298184172647868,-0.251181145744529,5.50401564861643e-114
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL13,C-X-C motif chemokine 13,42711,0.142713001035604,0.00625022649687989,0.130462557101719,0.154963444969489,2.9387954676285e-113
NMR metabolomics,X23424.Total Lipids in VLDL,YES1,Tyrosine-protein kinase Yes,42587,0.256761848508863,0.0112814890646622,0.234650129942125,0.278873567075601,1.55250507040463e-112
NMR metabolomics,X23424.Total Lipids in VLDL,MASP1,Mannan-binding lectin serine protease 1,42476,0.0532719652841232,0.00234216764375619,0.0486813167023611,0.0578626138658854,2.23775865174947e-112
NMR metabolomics,X23424.Total Lipids in VLDL,IL16,Pro-interleukin-16,42754,0.0933429832907298,0.00412141261924272,0.085265014557014,0.101420952024446,1.67682619814796e-111
NMR metabolomics,X23424.Total Lipids in VLDL,MTSS1,Protein MTSS 1,40449,0.2520736944343,0.0111114945892799,0.230295165039311,0.273852223829288,1.90738289928952e-111
NMR metabolomics,X23424.Total Lipids in VLDL,FYB1,FYN-binding protein 1,42590,0.207184093352881,0.00915389351483775,0.189242462063799,0.225125724641963,2.45537287814713e-111
NMR metabolomics,X23424.Total Lipids in VLDL,GLA,Alpha-galactosidase A,40267,0.0840522910202885,0.003711368423117,0.0767780089109792,0.0913265731295978,4.83010958936345e-111
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42587,0.0982321989088201,0.00434707272007321,0.0897119363774766,0.106752461440164,5.40668160970781e-111
NMR metabolomics,X23424.Total Lipids in VLDL,SKAP1,Src kinase-associated phosphoprotein 1,42476,0.16613513532514,0.00735407442742519,0.151721149447387,0.180549121202893,6.46584885960809e-111
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42754,0.0575744960033546,0.00255054737233069,0.0525754231535865,0.0625735688531228,8.60486037217824e-111
NMR metabolomics,X23424.Total Lipids in VLDL,TJAP1,Tight junction-associated protein 1,42679,0.18495395764407,0.00819918840028623,0.168883548379509,0.201024366908631,1.24521209690684e-110
NMR metabolomics,X23424.Total Lipids in VLDL,MAPK9,Mitogen-activated protein kinase 9,42594,0.0947695293149715,0.00420767640599021,0.0865224835592307,0.103016575070712,2.72087914948704e-110
NMR metabolomics,X23424.Total Lipids in VLDL,PROS1,Vitamin K-dependent protein S,40539,0.0588042976973267,0.00260768347768605,0.053693238081062,0.0639153573135914,3.44249425541201e-110
NMR metabolomics,X23424.Total Lipids in VLDL,MYH9,Myosin-9,40527,0.255974368372562,0.011406713960628,0.233617209009731,0.278331527735392,3.694005825535e-109
NMR metabolomics,X23424.Total Lipids in VLDL,SARG,Specifically androgen-regulated gene protein,40456,0.242531993410272,0.0108149293715277,0.221334731842078,0.263729254978466,5.27547232516701e-109
NMR metabolomics,X23424.Total Lipids in VLDL,AP1G2,AP-1 complex subunit gamma-like 2,40451,0.17609861950831,0.0078654004873167,0.160682434553169,0.191514804463451,1.16236005479112e-108
NMR metabolomics,X23424.Total Lipids in VLDL,ABL1,Tyrosine-protein kinase ABL1,42587,0.148660070903858,0.0066588819412805,0.135608662298949,0.161711479508768,1.98257121808488e-108
NMR metabolomics,X23424.Total Lipids in VLDL,SERPIND1,Heparin cofactor 2,40516,0.0625412082821386,0.0028028509476845,0.057047620424677,0.0680347961396003,5.70624811353263e-108
NMR metabolomics,X23424.Total Lipids in VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,42475,0.197250805499175,0.00887686946539886,0.179852141346994,0.214649469651357,1.94154936170479e-107
NMR metabolomics,X23424.Total Lipids in VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",40223,0.126862128372068,0.00569991366803356,0.115690297582722,0.138033959161414,2.1937489863119e-107
NMR metabolomics,X23424.Total Lipids in VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42594,0.213629572195858,0.00962113365937281,0.194772150223488,0.232486994168229,2.66458931521229e-107
NMR metabolomics,X23424.Total Lipids in VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,40283,0.0479131297946657,0.0021567499022755,0.0436858999862058,0.0521403596031257,5.15815003432093e-107
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINF1,Pigment epithelium-derived factor,40351,0.058970651999465,0.00266274302819002,0.0537516756642125,0.0641896283347174,2.16394334966521e-106
NMR metabolomics,X23424.Total Lipids in VLDL,CDHR5,Cadherin-related family member 5,42636,0.0854817767161758,0.00386843538509535,0.0778996433613889,0.0930639100709627,2.59650804696308e-106
NMR metabolomics,X23424.Total Lipids in VLDL,F10,Coagulation factor X,40532,0.0625969126526467,0.00283028498345395,0.0570495540850769,0.0681442712202164,3.7542790393003e-106
NMR metabolomics,X23424.Total Lipids in VLDL,KYNU,Kynureninase,42754,0.0978809619439295,0.00443972368622508,0.0891791035189283,0.106582820368931,7.37306969996484e-106
NMR metabolomics,X23424.Total Lipids in VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,40116,0.149305972744872,0.00676076259164544,0.136054878065247,0.162557067424497,9.07145159598609e-106
NMR metabolomics,X23424.Total Lipids in VLDL,CCL16,C-C motif chemokine 16,42794,0.11403163695859,0.00521679984842875,0.10380670925567,0.124256564661511,3.96072350672535e-104
NMR metabolomics,X23424.Total Lipids in VLDL,BPIFB1,BPI fold-containing family B member 1,42573,-0.136401988695754,0.00624410623006056,-0.148640436906673,-0.124163540484835,5.64584036148554e-104
NMR metabolomics,X23424.Total Lipids in VLDL,F9,Coagulation factor IX,42663,0.0392889112575444,0.00180308681123063,0.0357548611075323,0.0428229614075564,1.75922561519588e-103
NMR metabolomics,X23424.Total Lipids in VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,42357,0.120556277518386,0.00553224604994534,0.109713075260493,0.131399479776279,1.86097004528797e-103
NMR metabolomics,X23424.Total Lipids in VLDL,MXRA8,Matrix remodeling-associated protein 8,40283,-0.0678680720306252,0.00311220751451362,-0.0739679987590719,-0.0617681453021785,2.88794461278801e-103
NMR metabolomics,X23424.Total Lipids in VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40483,0.0868294277408919,0.00398273563841177,0.0790232658896048,0.0946355895921789,2.98058591875559e-103
NMR metabolomics,X23424.Total Lipids in VLDL,NOS3,"Nitric oxide synthase, endothelial",42311,0.119118337602178,0.00547227881649918,0.108392671121839,0.129844004082516,3.12782407545642e-103
NMR metabolomics,X23424.Total Lipids in VLDL,ASGR1,Asialoglycoprotein receptor 1,42495,0.0661541869633137,0.00305184092376152,0.0601725787527412,0.0721357951738863,1.9925691214949e-102
NMR metabolomics,X23424.Total Lipids in VLDL,FCN2,Ficolin-2,42597,0.0882892495628924,0.00410501892550005,0.0802434124689123,0.0963350866568725,6.64744784750841e-101
NMR metabolomics,X23424.Total Lipids in VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,40302,0.240026778063602,0.0111524165405272,0.218168041644169,0.261885514483036,1.07673666499061e-100
NMR metabolomics,X23424.Total Lipids in VLDL,STAB2,Stabilin-2,40527,0.0602316701902569,0.00280207665894701,0.0547395999387208,0.0657237404417931,1.72036850964005e-100
NMR metabolomics,X23424.Total Lipids in VLDL,FGFR2,Fibroblast growth factor receptor 2,42679,0.0478703132909458,0.00223666588816938,0.0434864481501339,0.0522541784317578,5.77550925677911e-100
NMR metabolomics,X23424.Total Lipids in VLDL,HJV,Hemojuvelin,40482,0.0941423234576327,0.00440319557086741,0.0855120601387326,0.102772586776533,1.87777854380454e-99
NMR metabolomics,X23424.Total Lipids in VLDL,ACY1,Aminoacylase-1,42636,0.12892276451775,0.0060404498031415,0.117083482903592,0.140762046131907,1.99625999920254e-99
NMR metabolomics,X23424.Total Lipids in VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42587,0.206256625258366,0.00967501317105032,0.187293599443108,0.225219651073625,3.37579129030079e-99
NMR metabolomics,X23424.Total Lipids in VLDL,DPY30,Protein dpy-30 homolog,42651,0.128289727531892,0.00602260019820876,0.116485431143403,0.140094023920382,4.72225863550642e-99
NMR metabolomics,X23424.Total Lipids in VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42587,0.0845059503625025,0.00397978513906873,0.0767055714899278,0.0923063292350772,1.93634625672808e-98
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJA2,DnaJ homolog subfamily A member 2,42721,0.171781810602148,0.0080969114373084,0.155911864185024,0.187651757019273,2.70958381602408e-98
NMR metabolomics,X23424.Total Lipids in VLDL,SHBG,Sex hormone-binding globulin,40532,-0.106578038217658,0.00504703454793351,-0.116470225931608,-0.0966858505037082,4.06246953325458e-97
NMR metabolomics,X23424.Total Lipids in VLDL,CKB,Creatine kinase B-type,40527,-0.127387681207825,0.00603399912141516,-0.139214319485798,-0.115561042929851,4.53481938065214e-97
NMR metabolomics,X23424.Total Lipids in VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,42443,0.102141259809585,0.00484551271890085,0.0926440548805394,0.111638464738631,4.76567045281397e-97
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,40223,0.177234837030676,0.00839665615564266,0.160777390965616,0.193692283095735,5.5041255156601e-97
NMR metabolomics,X23424.Total Lipids in VLDL,CES3,Carboxylesterase 3,42587,0.148420242215756,0.00704417586528191,0.134613657519804,0.162226826911709,5.5838352220609e-97
NMR metabolomics,X23424.Total Lipids in VLDL,AXIN1,Axin-1,42594,0.199042025574679,0.00945536274022921,0.180509514603829,0.217574536545528,8.2542675153763e-97
NMR metabolomics,X23424.Total Lipids in VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42495,0.112373501674666,0.00534095247767075,0.101905234818431,0.122841768530901,1.05481127622144e-96
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINF2,Alpha-2-antiplasmin,40317,0.0284845911872619,0.00135392171786043,0.0258309046202554,0.0311382777542683,2.16461807719479e-96
NMR metabolomics,X23424.Total Lipids in VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40482,0.203878955752918,0.00970318200552316,0.184860719022093,0.222897192483744,3.52136866229346e-96
NMR metabolomics,X23424.Total Lipids in VLDL,YTHDF3,YTH domain-containing family protein 3,42370,0.177847949487236,0.00847732385352581,0.161232394734325,0.194463504240146,3.75860383302887e-96
NMR metabolomics,X23424.Total Lipids in VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40449,0.0636145641330028,0.00303290374570898,0.0576700727914133,0.0695590554745924,7.50121292543316e-96
NMR metabolomics,X23424.Total Lipids in VLDL,MLN,Promotilin,42594,0.186015249635586,0.00888722457338248,0.168596289471756,0.203434209799415,9.52315008582817e-96
NMR metabolomics,X23424.Total Lipids in VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40465,0.168397279995922,0.00803784476709718,0.152643104252412,0.184151455739433,1.21786718012957e-95
NMR metabolomics,X23424.Total Lipids in VLDL,BECN1,Beclin-1,40223,0.125322626323115,0.00598437463500215,0.113593252038511,0.137052000607719,1.59434760959348e-95
NMR metabolomics,X23424.Total Lipids in VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,42794,-0.0713608637793327,0.00341543831835285,-0.0780551228833042,-0.0646666046753611,1.91963126887287e-95
NMR metabolomics,X23424.Total Lipids in VLDL,TXLNA,Alpha-taxilin,42495,0.183037819192443,0.00876721632475519,0.165854075195923,0.200221563188964,2.86919186755099e-95
NMR metabolomics,X23424.Total Lipids in VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,42594,0.220277383512661,0.0105681712788875,0.199563767806041,0.24099099921928,5.57518171427838e-95
NMR metabolomics,X23424.Total Lipids in VLDL,MTSS2,Protein MTSS 2,40451,0.204881892466064,0.00983809003865083,0.185599235990308,0.22416454894182,1.52576366294468e-94
NMR metabolomics,X23424.Total Lipids in VLDL,GSTA1,Glutathione S-transferase A1,42611,0.171112520661201,0.00823418096596548,0.154973525967909,0.187251515354493,1.97140710994568e-94
NMR metabolomics,X23424.Total Lipids in VLDL,HEG1,Protein HEG homolog 1,40283,0.0560852231974716,0.00269645953200238,0.0508001625147469,0.0613702838801963,2.72034870876352e-94
NMR metabolomics,X23424.Total Lipids in VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,40283,0.172894070089335,0.00831394061174787,0.15659874649031,0.189189393688361,2.9415430540994e-94
NMR metabolomics,X23424.Total Lipids in VLDL,STC1,Stanniocalcin-1,42711,0.0938877862164413,0.00452323899035571,0.0850222377953441,0.102753334637538,3.12081098224952e-94
NMR metabolomics,X23424.Total Lipids in VLDL,SELPLG,P-selectin glycoprotein ligand 1,42594,0.0571719705246571,0.00275454594350691,0.0517730604753836,0.0625708805739307,3.29505558835228e-94
NMR metabolomics,X23424.Total Lipids in VLDL,CD300LG,CMRF35-like molecule 9,42611,-0.0796854347284321,0.00385238519977807,-0.0872361097199972,-0.0721347597368671,1.36388146845218e-93
NMR metabolomics,X23424.Total Lipids in VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,42733,0.0651538189828053,0.00315089167698179,0.058978071295921,0.0713295666696896,1.51800589835673e-93
NMR metabolomics,X23424.Total Lipids in VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42582,0.0560400293876054,0.00271002990082149,0.0507283707819953,0.0613516879932156,1.5480577719309e-93
NMR metabolomics,X23424.Total Lipids in VLDL,GH1,Somatotropin,42613,-0.353845361984671,0.0171781667363912,-0.387514568787998,-0.320176155181345,7.67058397570067e-93
NMR metabolomics,X23424.Total Lipids in VLDL,S100A4,Protein S100-A4,42679,0.116384572500859,0.00569359708136659,0.10522512222138,0.127544022780337,1.73798377072799e-91
NMR metabolomics,X23424.Total Lipids in VLDL,EHBP1,EH domain-binding protein 1,40511,0.151825796367715,0.00741650048133077,0.137289455424307,0.166362137311124,1.74115780759898e-91
NMR metabolomics,X23424.Total Lipids in VLDL,KAZN,Kazrin,40449,0.21258272166479,0.0104073974948001,0.192184222574981,0.232981220754598,4.34487587105496e-91
NMR metabolomics,X23424.Total Lipids in VLDL,ARF6,ADP-ribosylation factor 6,40449,0.21848975763536,0.0107015536538403,0.197514712473833,0.239464802796887,5.23876706484131e-91
NMR metabolomics,X23424.Total Lipids in VLDL,LEFTY2,Left-right determination factor 2,42689,0.101875473345055,0.00500603726986862,0.0920636402961124,0.111687306393997,1.04960213149944e-90
NMR metabolomics,X23424.Total Lipids in VLDL,DCTN1,Dynactin subunit 1,42721,0.131338869918741,0.00646483244895195,0.118667798318795,0.144009941518687,2.06672580593638e-90
NMR metabolomics,X23424.Total Lipids in VLDL,UPB1,Beta-ureidopropionase,40511,0.182910985167572,0.00899352111507947,0.165283683782017,0.200538286553128,2.41344091734546e-90
NMR metabolomics,X23424.Total Lipids in VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,42346,0.146076600117962,0.00720370119771737,0.131957345770436,0.160195854465488,4.76049878559325e-90
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40511,0.0598203547808953,0.00295541219353462,0.0540277468815674,0.0656129626802232,1.62362037013858e-89
NMR metabolomics,X23424.Total Lipids in VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,42346,0.133426704360944,0.00660069044275667,0.120489351093141,0.146364057628747,1.67567946074836e-89
NMR metabolomics,X23424.Total Lipids in VLDL,F11R,Junctional adhesion molecule A,42611,0.112170973372484,0.00555465684546261,0.101283845955378,0.123058100789591,2.33740125431648e-89
NMR metabolomics,X23424.Total Lipids in VLDL,ISM1,Isthmin-1,42594,0.0778103276749448,0.00385699657966931,0.070250614378793,0.0853700409710967,3.49053952233253e-89
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL17,C-X-C motif chemokine 17,42754,0.0820011435736254,0.00406829833934376,0.0740272788285117,0.0899750083187392,4.76793890386964e-89
NMR metabolomics,X23424.Total Lipids in VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,40483,0.216257089620576,0.0107161326895375,0.195253469549082,0.237260709692069,5.33949390351539e-89
NMR metabolomics,X23424.Total Lipids in VLDL,CCL22,C-C motif chemokine 22,42509,0.10689987018942,0.0053103802468056,0.0964915249056808,0.117308215473159,8.33880919471532e-89
NMR metabolomics,X23424.Total Lipids in VLDL,AP3S2,AP-3 complex subunit sigma-2,40483,0.0957897363776193,0.00475777443779177,0.0864644984795474,0.105114974275691,1.34086672942467e-88
NMR metabolomics,X23424.Total Lipids in VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,42448,0.0440506123709567,0.00219202845603314,0.0397542365971318,0.0483469881447817,1.6616505918079e-88
NMR metabolomics,X23424.Total Lipids in VLDL,FN1,Fibronectin,40539,0.0536567534543751,0.00267007217544449,0.0484234119905038,0.0588900949182463,2.74525568668038e-88
NMR metabolomics,X23424.Total Lipids in VLDL,TARBP2,RISC-loading complex subunit TARBP2,42311,0.156416617407006,0.0078079876773705,0.14111296155936,0.171720273254652,5.85201177308564e-88
NMR metabolomics,X23424.Total Lipids in VLDL,RBP5,Retinol-binding protein 5,42587,0.111903403025949,0.00558745078801974,0.10095199948143,0.122854806570468,6.10047869869386e-88
NMR metabolomics,X23424.Total Lipids in VLDL,PDGFC,Platelet-derived growth factor C,42346,0.0572782610172324,0.00285990550696647,0.0516728462235782,0.0628836758108867,6.38422871511861e-88
NMR metabolomics,X23424.Total Lipids in VLDL,CD2AP,CD2-associated protein,42636,0.12728175337941,0.00636498590333406,0.114806381008875,0.139757125749945,1.09252227097422e-87
NMR metabolomics,X23424.Total Lipids in VLDL,EPHA1,Ephrin type-A receptor 1,42658,0.0660930360090943,0.00330588003000621,0.0596135111502822,0.0725725608679065,1.18945743492205e-87
NMR metabolomics,X23424.Total Lipids in VLDL,BTD,Biotinidase,40539,0.0413040648213799,0.00206345422519973,0.0372596945399884,0.0453484351027713,1.26464967235161e-87
NMR metabolomics,X23424.Total Lipids in VLDL,PDLIM7,PDZ and LIM domain protein 7,42676,0.246826097147329,0.0123521541497497,0.222615875013819,0.271036319280838,1.44328700149715e-87
NMR metabolomics,X23424.Total Lipids in VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,40223,0.144821178901741,0.00723977687947095,0.130631216217978,0.159011141585504,1.80684716591627e-87
NMR metabolomics,X23424.Total Lipids in VLDL,PAXX,Protein PAXX,40283,0.0908732947620657,0.00454686193977837,0.0819614453601001,0.0997851441640313,2.49269934149218e-87
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPTL3,Angiopoietin-related protein 3,42652,0.0714472720888166,0.00358183345279947,0.0644268785213296,0.0784676656563035,2.88180059863887e-87
NMR metabolomics,X23424.Total Lipids in VLDL,CD63,CD63 antigen,42475,0.101905875003903,0.00511623357437848,0.0918780571981214,0.111933692809685,5.25172027439095e-87
NMR metabolomics,X23424.Total Lipids in VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,40483,0.0738739017143345,0.00370577729035981,0.0666105782252293,0.0811372252034397,6.30135252054716e-87
NMR metabolomics,X23424.Total Lipids in VLDL,IGSF8,Immunoglobulin superfamily member 8,42636,0.0611100624146477,0.00307111589054062,0.0550906752691881,0.0671294495601073,7.45189182390326e-87
NMR metabolomics,X23424.Total Lipids in VLDL,NFX1,Transcriptional repressor NF-X1,40116,0.13550787222338,0.00680731096856119,0.122165542725,0.14885020172176,1.22306097467548e-86
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,42594,0.205708387065532,0.0103671521569146,0.185388768837979,0.226028005293084,2.221899330617e-86
NMR metabolomics,X23424.Total Lipids in VLDL,COL4A1,Collagen alpha-1(IV) chain,42636,-0.0794298078802249,0.00400329243727354,-0.0872762610572811,-0.0715833547031688,2.25437302475381e-86
NMR metabolomics,X23424.Total Lipids in VLDL,SOST,Sclerostin,42613,0.0773628423058567,0.00390363322796973,0.0697117211790361,0.0850139634326774,3.52907325808709e-86
NMR metabolomics,X23424.Total Lipids in VLDL,CEP85,Centrosomal protein of 85 kDa,42346,0.126836083655864,0.00640326228766661,0.114285689572037,0.13938647773969,4.53887262808578e-86
NMR metabolomics,X23424.Total Lipids in VLDL,DAB2,Disabled homolog 2,42721,0.215909602372528,0.010915370542131,0.194515476109951,0.237303728635105,7.16150738435104e-86
NMR metabolomics,X23424.Total Lipids in VLDL,YOD1,Ubiquitin thioesterase OTU1,40116,0.125647305508477,0.00635441004050598,0.113192661829086,0.138101949187869,1.57105670040586e-85
NMR metabolomics,X23424.Total Lipids in VLDL,TIMP4,Metalloproteinase inhibitor 4,42611,-0.0816037468100747,0.00414306343970895,-0.0897241511519042,-0.0734833424682451,3.67327237282908e-85
NMR metabolomics,X23424.Total Lipids in VLDL,APOC1,Apolipoprotein C-I,40516,0.0729543177963552,0.00370230918083669,0.0656977918019152,0.0802108437907951,5.14007954001763e-85
NMR metabolomics,X23424.Total Lipids in VLDL,ATG16L1,Autophagy-related protein 16-1,40449,0.166209128489283,0.00844210526734567,0.149662602165285,0.18275565481328,7.24332509113383e-85
NMR metabolomics,X23424.Total Lipids in VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",40408,0.214231769793013,0.0108870714087085,0.192893109831944,0.235570429754081,8.95096974925909e-85
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1R9B,Neurabin-2,42754,0.184083880164978,0.00937010853298413,0.165718467440329,0.202449292889626,9.42065443050667e-85
NMR metabolomics,X23424.Total Lipids in VLDL,ERBIN,Erbin,42587,0.200173513609772,0.0101941072014185,0.180193063494992,0.220153963724552,1.17172163964533e-84
NMR metabolomics,X23424.Total Lipids in VLDL,CPB2,Carboxypeptidase B2,40516,0.0436649371404167,0.00222646014816435,0.0393010752500146,0.0480287990308188,3.04033453139196e-84
NMR metabolomics,X23424.Total Lipids in VLDL,IKBKG,NF-kappa-B essential modulator,42594,0.177886541375555,0.00910705125562451,0.160036720914531,0.195736361836579,8.41608897980689e-84
NMR metabolomics,X23424.Total Lipids in VLDL,EIF4B,Eukaryotic translation initiation factor 4B,42495,0.112320724235197,0.00576199684184885,0.101027210425173,0.123614238045221,1.81812250674881e-83
NMR metabolomics,X23424.Total Lipids in VLDL,CDHR2,Cadherin-related family member 2,42587,0.137879944059525,0.00707497769285115,0.124012987781537,0.151746900337513,1.96264643996824e-83
NMR metabolomics,X23424.Total Lipids in VLDL,TNIP1,TNFAIP3-interacting protein 1,40483,0.17258350380026,0.00887451240484454,0.155189459486765,0.189977548113756,6.94836047950886e-83
NMR metabolomics,X23424.Total Lipids in VLDL,RAB11FIP3,Rab11 family-interacting protein 3,40511,0.207606648804522,0.010678588660184,0.186676615030562,0.228536682578483,7.67950911577658e-83
NMR metabolomics,X23424.Total Lipids in VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42587,0.0652406260197131,0.00336350186321792,0.058648162367806,0.0718330896716203,1.11768488176057e-82
NMR metabolomics,X23424.Total Lipids in VLDL,PLXNA4,Plexin-A4,42594,0.159224452997215,0.00820909321562028,0.1431346302946,0.175314275699831,1.12743981769273e-82
NMR metabolomics,X23424.Total Lipids in VLDL,FAM20A,Pseudokinase FAM20A,40511,0.0550072253166117,0.00283290044026231,0.0494547404536976,0.0605597101795259,1.20989158363908e-82
NMR metabolomics,X23424.Total Lipids in VLDL,CANT1,Soluble calcium-activated nucleotidase 1,42580,0.0397513979944799,0.00205559409413509,0.0357224335699751,0.0437803624189847,3.37802267630561e-82
NMR metabolomics,X23424.Total Lipids in VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,40462,0.165132418752959,0.00856902300004591,0.148337133672869,0.181927703833049,1.91510827335585e-81
NMR metabolomics,X23424.Total Lipids in VLDL,TPD52L2,Tumor protein D54,40283,0.206536616330768,0.0107239441884894,0.185517685721329,0.227555546940207,2.48845611506201e-81
NMR metabolomics,X23424.Total Lipids in VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,40116,0.142009143348731,0.00737733416049405,0.127549568394163,0.156468718303299,3.13959127743203e-81
NMR metabolomics,X23424.Total Lipids in VLDL,CEP20,Centrosomal protein 20,42346,0.143924558787243,0.00749346733948294,0.129237362801856,0.158611754772629,4.18184891787002e-81
NMR metabolomics,X23424.Total Lipids in VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,42346,0.0953412864950428,0.00496702260791442,0.0856059221835306,0.105076650806555,5.21741410135117e-81
NMR metabolomics,X23424.Total Lipids in VLDL,DKK1,Dickkopf-related protein 1,42711,0.112698396679421,0.00588049269093785,0.101172631005182,0.124224162353659,8.56248735587901e-81
NMR metabolomics,X23424.Total Lipids in VLDL,ADH1B,All-trans-retinol dehydrogenase,40283,0.142914889934678,0.00745417914404898,0.128304698812342,0.157525081057014,1.25882813790004e-80
NMR metabolomics,X23424.Total Lipids in VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,42370,0.130402684154358,0.00682273152015463,0.117030130374855,0.143775237933861,2.39863344890536e-80
NMR metabolomics,X23424.Total Lipids in VLDL,NPPC,C-type natriuretic peptide,42594,0.0962598410806401,0.00503717330557573,0.0863869814017116,0.106132700759569,2.43834301141687e-80
NMR metabolomics,X23424.Total Lipids in VLDL,SLA2,Src-like-adapter 2,40482,0.198187751032996,0.010385094431156,0.17783296594793,0.218542536118061,6.19787543916109e-80
NMR metabolomics,X23424.Total Lipids in VLDL,NCS1,Neuronal calcium sensor 1,42721,0.0552564661627251,0.00290249584804911,0.0495675743005488,0.0609453580249013,9.16755673315217e-80
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL10,C-X-C motif chemokine 10,42676,0.129127937332215,0.00678316916381612,0.115832925771136,0.142422948893295,9.42191802410574e-80
NMR metabolomics,X23424.Total Lipids in VLDL,STAT5B,Signal transducer and activator of transcription 5B,42587,0.260634729809336,0.0137044380420049,0.233774031247006,0.287495428371665,1.34334898035655e-79
NMR metabolomics,X23424.Total Lipids in VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40449,0.0560043062043988,0.00294249424948073,0.0502370174754166,0.061771594933381,1.60445965197278e-79
NMR metabolomics,X23424.Total Lipids in VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40482,0.15922002052722,0.0083718741301368,0.142811147232152,0.175628893822288,2.08020470561472e-79
NMR metabolomics,X23424.Total Lipids in VLDL,MINK1,Misshapen-like kinase 1,40483,0.176297463668673,0.00928010647354531,0.158108454980524,0.194486472356822,3.07020225393041e-79
NMR metabolomics,X23424.Total Lipids in VLDL,BCR,Breakpoint cluster region protein,42594,0.173095007403809,0.0091283869136866,0.155203369052983,0.190986645754635,3.78960664493977e-79
NMR metabolomics,X23424.Total Lipids in VLDL,NCK2,Cytoplasmic protein NCK2,42676,0.198466358787471,0.0104672728168887,0.177950504066369,0.218982213508572,3.84992651916489e-79
NMR metabolomics,X23424.Total Lipids in VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42636,-0.219683008206019,0.0115908307875768,-0.24240103654967,-0.196964979862369,4.45283560749932e-79
NMR metabolomics,X23424.Total Lipids in VLDL,TCTN3,Tectonic-3,40511,0.0570181057311515,0.00300915122305764,0.0511201693339586,0.0629160421283445,7.54237662535179e-79
NMR metabolomics,X23424.Total Lipids in VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,40223,0.194248210925953,0.010260397848941,0.174137831142029,0.214358590709877,1.0955080208597e-78
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC1B,C-type lectin domain family 1 member B,42711,0.179936920989154,0.00954202225687099,0.161234557365687,0.198639284612621,2.58170630597576e-78
NMR metabolomics,X23424.Total Lipids in VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,40511,0.126869511616173,0.00671993602273484,0.113698437011613,0.140040586220734,2.66542004557213e-78
NMR metabolomics,X23424.Total Lipids in VLDL,RLN2,Prorelaxin H2,40257,0.0945414559372834,0.00500992166649667,0.08472200947095,0.104360902403617,3.32850186982511e-78
NMR metabolomics,X23424.Total Lipids in VLDL,PAK4,Serine/threonine-protein kinase PAK 4,42311,0.114581789404533,0.00608739820865552,0.102650488915568,0.126513089893498,5.22196101061889e-78
NMR metabolomics,X23424.Total Lipids in VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,40451,0.214079438238121,0.0113719176114614,0.191790479719656,0.236368396756585,7.31494505005623e-78
NMR metabolomics,X23424.Total Lipids in VLDL,CD6,T-cell differentiation antigen CD6,42746,0.0995855294741945,0.00529742846936705,0.0892025696742351,0.109968489274154,7.52653507649245e-78
NMR metabolomics,X23424.Total Lipids in VLDL,OTUD7B,OTU domain-containing protein 7B,40482,0.116622315905759,0.00620071036103179,0.104468923598136,0.128775708213381,9.97841369020817e-78
NMR metabolomics,X23424.Total Lipids in VLDL,SUGP1,SURP and G-patch domain-containing protein 1,40449,0.0749351081899833,0.00400414586722545,0.0670869822902215,0.0827832340897452,5.53862048314157e-77
NMR metabolomics,X23424.Total Lipids in VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42754,0.18331626623165,0.009823373041884,0.164062455069557,0.202570077393742,9.3378544818977e-77
NMR metabolomics,X23424.Total Lipids in VLDL,ELN,Elastin,40511,0.0687775860757641,0.00368305018322117,0.0615588077166506,0.0759963644348776,1.136075708815e-76
NMR metabolomics,X23424.Total Lipids in VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,42594,0.207681059126152,0.0111368891653659,0.185852756362035,0.229509361890269,1.21919469645431e-76
NMR metabolomics,X23424.Total Lipids in VLDL,IL1RN,Interleukin-1 receptor antagonist protein,42585,0.101587499486108,0.00545901370552979,0.0908878326232698,0.112287166348947,2.47947869906204e-76
NMR metabolomics,X23424.Total Lipids in VLDL,SORD,Sorbitol dehydrogenase,42658,0.124712239968133,0.00670493854737053,0.111570560415287,0.137853919520979,2.89012172275757e-76
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42679,0.177980227400091,0.00957440512956438,0.159214393346145,0.196746061454038,3.51104753902479e-76
NMR metabolomics,X23424.Total Lipids in VLDL,FOXO1,Forkhead box protein O1,42594,0.157854867081304,0.00850589684244131,0.141183309270119,0.174526424892489,6.2362495811192e-76
NMR metabolomics,X23424.Total Lipids in VLDL,HBEGF,Proheparin-binding EGF-like growth factor,42674,0.135275467886926,0.00729143712258588,0.120984251126658,0.149566684647194,6.82034308880995e-76
NMR metabolomics,X23424.Total Lipids in VLDL,SMAD5,Mothers against decapentaplegic homolog 5,42587,0.0373235636859579,0.00201351325087986,0.0333770777142334,0.0412700496576824,9.26200411872547e-76
NMR metabolomics,X23424.Total Lipids in VLDL,SEMA3F,Semaphorin-3F,42636,0.0503772331633478,0.0027241558642591,0.0450378876694,0.0557165786572957,2.02932002415849e-75
NMR metabolomics,X23424.Total Lipids in VLDL,PCBP2,Poly(rC)-binding protein 2,40482,0.13356141116,0.00721381745018972,0.119422328957628,0.147700493362372,2.0464802170013e-75
NMR metabolomics,X23424.Total Lipids in VLDL,GHRL,Appetite-regulating hormone,42636,0.15753491108448,0.00853204838531595,0.140812096249261,0.174257725919699,3.42027876150976e-75
NMR metabolomics,X23424.Total Lipids in VLDL,IL18R1,Interleukin-18 receptor 1,42754,0.0610984245613723,0.00331395638445885,0.054603070047833,0.0675937790749117,5.48726449451627e-75
NMR metabolomics,X23424.Total Lipids in VLDL,EZR,Ezrin,42711,0.0441609583570292,0.00239617127697434,0.0394644626541595,0.0488574540598989,6.2556027072575e-75
NMR metabolomics,X23424.Total Lipids in VLDL,DOK2,Docking protein 2,42636,0.221814090886811,0.0120477219709451,0.198200555823759,0.245427625949863,8.83420393456943e-75
NMR metabolomics,X23424.Total Lipids in VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,40223,0.137649181792185,0.00746623883213792,0.123015353681195,0.152283009903175,8.89192402509259e-75
NMR metabolomics,X23424.Total Lipids in VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40483,0.12771240729104,0.00692996971696799,0.114129666645783,0.141295147936297,9.54812182805392e-75
NMR metabolomics,X23424.Total Lipids in VLDL,VEGFC,Vascular endothelial growth factor C,42679,0.102291336517182,0.00556947675401035,0.0913751620793217,0.113207510955042,1.96742860854272e-74
NMR metabolomics,X23424.Total Lipids in VLDL,CMIP,C-Maf-inducing protein,40451,0.152478026777414,0.00829802297498447,0.136213901746444,0.168742151808384,2.52007576016954e-74
NMR metabolomics,X23424.Total Lipids in VLDL,SRPK2,SRSF protein kinase 2,42594,0.153118446681887,0.00836023046648969,0.136732394967568,0.169504498396207,5.00602903609166e-74
NMR metabolomics,X23424.Total Lipids in VLDL,KHK,Ketohexokinase,40223,0.115352307397035,0.00629726821594689,0.103009661693779,0.127694953100291,7.38637774186462e-74
NMR metabolomics,X23424.Total Lipids in VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42657,0.188645368078834,0.0103230563329024,0.168412177666345,0.208878558491323,1.03162689810052e-73
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40449,0.199120205060955,0.0109008010653946,0.177754634972782,0.220485775149129,1.75226906913664e-73
NMR metabolomics,X23424.Total Lipids in VLDL,CTBS,Di-N-acetylchitobiase,40383,0.0489188064199358,0.00269092459674818,0.0436445942103094,0.0541930186295623,8.38259631254604e-73
NMR metabolomics,X23424.Total Lipids in VLDL,PLIN1,Perilipin-1,42311,0.0636460296191013,0.00350725116678338,0.0567718173322058,0.0705202419059967,1.0488042333852e-72
NMR metabolomics,X23424.Total Lipids in VLDL,NUCB2,Nucleobindin-2,42683,0.0673009186137268,0.00370986128898203,0.060029590487322,0.0745722467401315,1.10173652160774e-72
NMR metabolomics,X23424.Total Lipids in VLDL,BACH1,Transcription regulator protein BACH1,42594,0.132775282090648,0.00732722634974219,0.118413918445154,0.147136645736143,1.59966674706488e-72
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,40483,0.163465936701952,0.00901433924344996,0.14579783178479,0.181134041619114,1.82630623783583e-72
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL5,C-X-C motif chemokine 5,42605,0.20512996287816,0.0113617172193782,0.182860997128179,0.227398928628141,5.16982025325768e-72
NMR metabolomics,X23424.Total Lipids in VLDL,CRELD2,Protein disulfide isomerase CRELD2,42654,0.0937968978110562,0.00520107978932032,0.0836027814239884,0.103991014198124,7.35743987550609e-72
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJB6,DnaJ homolog subfamily B member 6,40183,0.15145968767903,0.00838954072571317,0.135016187856633,0.167903187501428,8.0522148791922e-72
NMR metabolomics,X23424.Total Lipids in VLDL,PON3,Serum paraoxonase/lactonase 3,42676,-0.0514990368311162,0.00285857851957561,-0.0571018507294844,-0.045896222932748,1.01692571443757e-71
NMR metabolomics,X23424.Total Lipids in VLDL,SELP,P-selectin,42689,0.100946634183876,0.00561512546591923,0.0899409882706743,0.111952280097078,1.98285920009875e-71
NMR metabolomics,X23424.Total Lipids in VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,42250,0.0996853002924465,0.00554413290298088,0.088818799802604,0.110551800782289,2.01477102188708e-71
NMR metabolomics,X23424.Total Lipids in VLDL,AAMDC,Mth938 domain-containing protein,40223,0.0960385354397572,0.00533785905901251,0.0855763316840926,0.106500739195422,2.34842325036963e-71
NMR metabolomics,X23424.Total Lipids in VLDL,TANK,TRAF family member-associated NF-kappa-B activator,42370,0.125066617426208,0.00696102511005411,0.111423008210502,0.138710226641915,2.51572720017511e-71
NMR metabolomics,X23424.Total Lipids in VLDL,USO1,General vesicular transport factor p115,42587,0.161819639062989,0.00901730261253402,0.144145725942422,0.179493552183555,3.54252759920821e-71
NMR metabolomics,X23424.Total Lipids in VLDL,SNAP23,Synaptosomal-associated protein 23,42636,0.155705098418792,0.00868522646832259,0.138682054540879,0.172728142296704,4.81683098363024e-71
NMR metabolomics,X23424.Total Lipids in VLDL,RGCC,Regulator of cell cycle RGCC,40482,0.135671170814509,0.00755932030279304,0.120854903021035,0.150487438607984,4.85205564270822e-71
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42679,0.0664155152906558,0.00370769856567418,0.0591484261019345,0.0736826044793772,6.19944999460563e-71
NMR metabolomics,X23424.Total Lipids in VLDL,PHACTR2,Phosphatase and actin regulator 2,40482,0.203496476623367,0.0113641610519257,0.181222720961592,0.225770232285141,9.88041149730582e-71
NMR metabolomics,X23424.Total Lipids in VLDL,CLUL1,Clusterin-like protein 1,42621,-0.0806035022903878,0.00451142888612118,-0.0894459029071853,-0.0717611016735903,1.40832960756903e-70
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINH1,Serpin H1,40302,0.231512168899356,0.0129430959645105,0.206143700808915,0.256880636989796,1.45013764807217e-70
NMR metabolomics,X23424.Total Lipids in VLDL,F13B,Coagulation factor XIII B chain,40479,0.0464241731995257,0.00260634996828946,0.0413157272616784,0.0515326191373731,5.16654676055856e-70
NMR metabolomics,X23424.Total Lipids in VLDL,HCLS1,Hematopoietic lineage cell-specific protein,42754,0.098081639251402,0.00552351952130919,0.087255540989636,0.108907737513168,9.34330068197019e-70
NMR metabolomics,X23424.Total Lipids in VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,42476,0.19799908756357,0.0111622217462154,0.176121132940988,0.219877042186153,1.34436116897213e-69
NMR metabolomics,X23424.Total Lipids in VLDL,TOP2B,DNA topoisomerase 2-beta,40199,0.141935052553338,0.00799283116207701,0.126269103475667,0.157601001631009,1.39623997669368e-69
NMR metabolomics,X23424.Total Lipids in VLDL,ASAH2,Neutral ceramidase,42495,0.095470762768978,0.00538757621730538,0.0849111133830595,0.106030412154897,1.8262762285598e-69
NMR metabolomics,X23424.Total Lipids in VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42495,0.168560305153385,0.00951626750194457,0.149908420849573,0.187212189457196,2.08684361882686e-69
NMR metabolomics,X23424.Total Lipids in VLDL,PON2,Serum paraoxonase/arylesterase 2,42357,0.0622564845075665,0.00351726820344858,0.0553626388288073,0.0691503301863257,2.64730032532656e-69
NMR metabolomics,X23424.Total Lipids in VLDL,PDCD5,Programmed cell death protein 5,42711,0.101764582634574,0.00577891907462894,0.0904379012483015,0.113091264020847,1.21173865382758e-68
NMR metabolomics,X23424.Total Lipids in VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42587,0.135417641991077,0.0076902286290429,0.120344793878153,0.150490490104001,1.24354661886032e-68
NMR metabolomics,X23424.Total Lipids in VLDL,PPY,Pancreatic prohormone,42600,0.183384324771659,0.0104161684908412,0.16296863452961,0.203800015013708,1.31457235498238e-68
NMR metabolomics,X23424.Total Lipids in VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42570,0.18541154088148,0.0105445038489719,0.164744313337495,0.206078768425465,1.9297192431036e-68
NMR metabolomics,X23424.Total Lipids in VLDL,RABEP1,Rab GTPase-binding effector protein 1,40283,0.137945020943444,0.00783954055704595,0.122579521451634,0.153310520435254,2.23463027979532e-68
NMR metabolomics,X23424.Total Lipids in VLDL,GIT1,ARF GTPase-activating protein GIT1,40199,0.170878426194994,0.00972572438397465,0.151816006402403,0.189940845987584,3.56687539283987e-68
NMR metabolomics,X23424.Total Lipids in VLDL,AKT1S1,Proline-rich AKT1 substrate 1,42311,0.117127720387674,0.00668607841954855,0.104023006685359,0.130232434089989,6.17032572430114e-68
NMR metabolomics,X23424.Total Lipids in VLDL,TGFB1,Transforming growth factor beta-1 proprotein,42746,0.0669454353793872,0.00382522551060862,0.0594479933785943,0.0744428773801801,7.82516282659992e-68
NMR metabolomics,X23424.Total Lipids in VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40449,0.180438720679497,0.0103059279332053,0.160239101930414,0.200638339428579,9.75937275932996e-68
NMR metabolomics,X23424.Total Lipids in VLDL,METAP2,Methionine aminopeptidase 2,42689,0.100045068369884,0.00572147658233051,0.0888309742685165,0.111259162471252,1.02230960356913e-67
NMR metabolomics,X23424.Total Lipids in VLDL,C1S,Complement C1s subcomponent,40539,0.0366024477844881,0.00209436337610775,0.0324974955673169,0.0407074000016593,1.64797609524671e-67
NMR metabolomics,X23424.Total Lipids in VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",40223,0.120390589559942,0.00689189111958988,0.106882482965545,0.133898696154338,2.00713955958334e-67
NMR metabolomics,X23424.Total Lipids in VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,40449,0.158297133404361,0.00906495468119402,0.140529822229221,0.176064444579501,2.13021310775165e-67
NMR metabolomics,X23424.Total Lipids in VLDL,CEP43,Centrosomal protein 43,42255,0.120800217383489,0.00692983466422199,0.107217741441614,0.134382693325364,2.72416749096642e-67
NMR metabolomics,X23424.Total Lipids in VLDL,GAS6,Growth arrest-specific protein 6,42718,-0.0444338426022594,0.00254969414071932,-0.0494312431180693,-0.0394364420864496,2.786483145785e-67
NMR metabolomics,X23424.Total Lipids in VLDL,MAMDC4,Apical endosomal glycoprotein,40451,0.0963826593639805,0.00552594800952826,0.0855518012653051,0.107213517462656,3.03097367601629e-67
NMR metabolomics,X23424.Total Lipids in VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40451,0.124864876704998,0.00716875372700156,0.110814119400075,0.138915634009921,4.55314107328366e-67
NMR metabolomics,X23424.Total Lipids in VLDL,SNX15,Sorting nexin-15,40283,0.0947301708959114,0.00544945474729763,0.0840492395912081,0.105411102200615,8.43492292350624e-67
NMR metabolomics,X23424.Total Lipids in VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40511,0.135809977668247,0.00781639799990398,0.120489837588435,0.151130117748059,9.34629577521577e-67
NMR metabolomics,X23424.Total Lipids in VLDL,AP3B1,AP-3 complex subunit beta-1,40449,0.133289911124683,0.00767478022478283,0.118247341884109,0.148332480365258,1.07752302830045e-66
NMR metabolomics,X23424.Total Lipids in VLDL,PLSCR3,Phospholipid scramblase 3,40457,0.101044090157379,0.00582152307056935,0.0896339049390627,0.112454275375695,1.28094796238441e-66
NMR metabolomics,X23424.Total Lipids in VLDL,STAMBP,STAM-binding protein,42476,0.110103531321882,0.00635270599013534,0.0976522275812163,0.122554835062547,1.46017907484805e-66
NMR metabolomics,X23424.Total Lipids in VLDL,SCLY,Selenocysteine lyase,42674,0.0812398734177509,0.00469807387871992,0.0720316486154599,0.090448098220042,2.79218188961436e-66
NMR metabolomics,X23424.Total Lipids in VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,42346,0.112034771097981,0.00647872017637352,0.0993364795522892,0.124733062643673,2.87956924161189e-66
NMR metabolomics,X23424.Total Lipids in VLDL,CCL17,C-C motif chemokine 17,42604,0.159044183562079,0.00920527861180875,0.141001837482934,0.177086529641225,3.61147812663015e-66
NMR metabolomics,X23424.Total Lipids in VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,42357,0.160160053526531,0.00928790041968238,0.141955768703953,0.178364338349108,6.57178679802061e-66
NMR metabolomics,X23424.Total Lipids in VLDL,OPHN1,Oligophrenin-1,40483,0.185148375662425,0.0107277265320851,0.164122031659538,0.206174719665312,6.7056295830822e-66
NMR metabolomics,X23424.Total Lipids in VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,40302,0.182368519941922,0.0105706372580298,0.161650070916184,0.203086968967661,7.7184317259099e-66
NMR metabolomics,X23424.Total Lipids in VLDL,SH2B3,SH2B adapter protein 3,42346,0.168115870266018,0.00977561705745559,0.148955660833405,0.187276079698631,1.44327500268063e-65
NMR metabolomics,X23424.Total Lipids in VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,42346,0.108487757819407,0.00631238004306399,0.0961154929350017,0.120860022703813,1.73648824215414e-65
NMR metabolomics,X23424.Total Lipids in VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,40283,0.122410784482173,0.00712691696327113,0.108442027234162,0.136379541730185,2.8058776887004e-65
NMR metabolomics,X23424.Total Lipids in VLDL,CTSD,Cathepsin D,41747,0.0727560362666142,0.00424298432607517,0.0644397869875069,0.0810722855457216,3.62462522102449e-65
NMR metabolomics,X23424.Total Lipids in VLDL,DNMBP,Dynamin-binding protein,42495,0.10328888510882,0.00603032277514833,0.0914694524695296,0.115108317748111,4.54876763926062e-65
NMR metabolomics,X23424.Total Lipids in VLDL,OXT,Oxytocin-neurophysin 1,42711,0.238238196311139,0.0139114183076118,0.210971816428219,0.265504576194058,4.65537485406363e-65
NMR metabolomics,X23424.Total Lipids in VLDL,HGF,Hepatocyte growth factor,42754,0.0598591530337829,0.00350307131467304,0.0529931332570238,0.0667251728105421,8.73524050321831e-65
NMR metabolomics,X23424.Total Lipids in VLDL,STK11,Serine/threonine-protein kinase STK11,42357,0.124172805004157,0.00726768944370255,0.1099281336945,0.138417476313814,9.4659238328728e-65
NMR metabolomics,X23424.Total Lipids in VLDL,NPL,N-acetylneuraminate lyase,40511,0.078360130113588,0.00458266636015315,0.0693781040476878,0.0873421561794881,9.74799536960903e-65
NMR metabolomics,X23424.Total Lipids in VLDL,IL1R2,Interleukin-1 receptor type 2,42600,0.0341278487868202,0.00200216490591489,0.0302036055712271,0.0380520920024134,1.80192691983588e-64
NMR metabolomics,X23424.Total Lipids in VLDL,APOM,Apolipoprotein M,42663,0.0484178391263613,0.00284144372474166,0.0428486094258677,0.053987068826855,1.96483608667225e-64
NMR metabolomics,X23424.Total Lipids in VLDL,AGRN,Agrin,42676,0.0622784678771573,0.00365841647336327,0.0551079715893653,0.0694489641649493,2.58705541389095e-64
NMR metabolomics,X23424.Total Lipids in VLDL,BID,BH3-interacting domain death agonist,42594,0.11489674834812,0.00675348832528268,0.101659911230566,0.128133585465674,3.10665498311789e-64
NMR metabolomics,X23424.Total Lipids in VLDL,IST1,IST1 homolog,40375,0.168786007180044,0.00991316428772221,0.149356205176108,0.188215809183979,3.35847847436664e-64
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM5,Tripartite motif-containing protein 5,42594,0.145733249888345,0.00857005286397874,0.128935946274947,0.162530553501743,3.55128802573356e-64
NMR metabolomics,X23424.Total Lipids in VLDL,NAGK,N-acetyl-D-glucosamine kinase,40209,0.0953478587184045,0.00560145290373079,0.0843690110270922,0.106326706409717,3.71858003770494e-64
NMR metabolomics,X23424.Total Lipids in VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,42587,0.144253006608517,0.00848501824017776,0.127622370857769,0.160883642359266,3.80186245794296e-64
NMR metabolomics,X23424.Total Lipids in VLDL,SYTL4,Synaptotagmin-like protein 4,40511,0.126143286905326,0.00741249784641652,0.11161479112635,0.140671782684303,3.80417111782736e-64
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGAP45,Rho GTPase-activating protein 45,40283,0.140752830323988,0.00827019064520787,0.124543256659381,0.156962403988596,3.84105511283125e-64
NMR metabolomics,X23424.Total Lipids in VLDL,NIT2,Omega-amidase NIT2,40462,0.124778797577825,0.00734151962619835,0.110389419110476,0.139168176045174,5.4677306285037e-64
NMR metabolomics,X23424.Total Lipids in VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,40283,0.0849064926481378,0.0049950971875152,0.075116102160608,0.0946968831356676,5.47693034627127e-64
NMR metabolomics,X23424.Total Lipids in VLDL,FETUB,Fetuin-B,42663,0.0548529662105441,0.00323380261451112,0.0485147130861023,0.0611912193349859,7.16881287212777e-64
NMR metabolomics,X23424.Total Lipids in VLDL,AZI2,5-azacytidine-induced protein 2,40482,0.0938703872712151,0.00552998645957544,0.0830316138104473,0.104709160731983,7.79399390399744e-64
NMR metabolomics,X23424.Total Lipids in VLDL,LSP1,Lymphocyte-specific protein 1,42594,0.067839408902109,0.00400110911577963,0.0599972350351809,0.075681582769037,8.1482546346298e-64
NMR metabolomics,X23424.Total Lipids in VLDL,LAT,Linker for activation of T-cells family member 1,42754,0.128238696911891,0.00756589452727838,0.113409543638425,0.143067850185357,8.78350072214173e-64
NMR metabolomics,X23424.Total Lipids in VLDL,CMC1,COX assembly mitochondrial protein homolog,40511,0.154146222342657,0.0090915160574444,0.136326850870066,0.171965593815248,1.07852362580531e-63
NMR metabolomics,X23424.Total Lipids in VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,42346,0.106550293075397,0.00629628233292731,0.0942095797028594,0.118891006447934,1.43758203332827e-63
NMR metabolomics,X23424.Total Lipids in VLDL,OGFR,Opioid growth factor receptor,42587,0.0552868783467945,0.00327007234287201,0.0488775365547654,0.0616962201388237,1.81871079964332e-63
NMR metabolomics,X23424.Total Lipids in VLDL,HEXIM1,Protein HEXIM1,42594,0.136945168373153,0.00810253283795971,0.121064204010752,0.152826132735554,1.98789083223549e-63
NMR metabolomics,X23424.Total Lipids in VLDL,GMPR,GMP reductase 1,42754,0.0838769149373759,0.00496537059107796,0.0741447885788631,0.0936090412958887,2.27368091421221e-63
NMR metabolomics,X23424.Total Lipids in VLDL,CSNK2A1,Casein kinase II subunit alpha,40482,-0.0762573383852362,0.00451266742093347,-0.0851021665302658,-0.0674125102402066,2.75988396699584e-63
NMR metabolomics,X23424.Total Lipids in VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,42611,0.0395902873666035,0.00234589726502742,0.0349923287271498,0.0441882460060573,3.01090840444007e-63
NMR metabolomics,X23424.Total Lipids in VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,40483,0.107812874095375,0.00638952708149125,0.0952894010156521,0.120336347175098,4.18043699599441e-63
NMR metabolomics,X23424.Total Lipids in VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42587,0.0642765190548203,0.00381378446461938,0.0568015015041663,0.0717515366054743,4.3946034220427e-63
NMR metabolomics,X23424.Total Lipids in VLDL,GGT1,Glutathione hydrolase 1 proenzyme,42590,0.0851264356711319,0.00506170789822931,0.0752054881906024,0.0950473831516613,7.97066644519301e-63
NMR metabolomics,X23424.Total Lipids in VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40449,0.150243619730185,0.00892702305092876,0.132746654550365,0.167740584910006,8.56556303208639e-63
NMR metabolomics,X23424.Total Lipids in VLDL,CIRBP,Cold-inducible RNA-binding protein,40449,0.160423642849893,0.00954109081309236,0.141723104856232,0.179124180843554,1.11900962054004e-62
NMR metabolomics,X23424.Total Lipids in VLDL,MITD1,MIT domain-containing protein 1,42495,0.161646353586859,0.00962492300139344,0.142781504504128,0.18051120266959,1.18087070198743e-62
NMR metabolomics,X23424.Total Lipids in VLDL,PSIP1,PC4 and SFRS1-interacting protein,42594,0.108685462701283,0.0064722701148656,0.0959998132761466,0.12137111212642,1.20898857997632e-62
NMR metabolomics,X23424.Total Lipids in VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40511,0.106616918125476,0.00635488569614919,0.0941613421610236,0.119072494089928,2.03071679102905e-62
NMR metabolomics,X23424.Total Lipids in VLDL,SKAP2,Src kinase-associated phosphoprotein 2,42676,0.17514193214092,0.010459049291924,0.154642195528749,0.195641668753091,2.59995449487465e-62
NMR metabolomics,X23424.Total Lipids in VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,42583,0.0555735478847041,0.00331887696238705,0.0490685490384255,0.0620785467309827,2.66103765741027e-62
NMR metabolomics,X23424.Total Lipids in VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,42357,0.158346991573218,0.00947462759042115,0.139776721495993,0.176917261650444,4.61133708928024e-62
NMR metabolomics,X23424.Total Lipids in VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40482,0.133621492161163,0.00798992945607832,0.11796123042725,0.149281753895077,4.89859280880094e-62
NMR metabolomics,X23424.Total Lipids in VLDL,FAM13A,Protein FAM13A,40449,0.112757630035538,0.00676456346416372,0.0994990856457772,0.126016174425299,1.20738573766938e-61
NMR metabolomics,X23424.Total Lipids in VLDL,ST13,Hsc70-interacting protein,40283,0.0945290040227877,0.0056707108524827,0.0834144107519216,0.105643597293654,1.22148272093259e-61
NMR metabolomics,X23424.Total Lipids in VLDL,CDH2,Cadherin-2,42636,0.0595063588717474,0.00357466140699893,0.0525000225140296,0.0665126952294653,1.32135522766577e-61
NMR metabolomics,X23424.Total Lipids in VLDL,NSFL1C,NSFL1 cofactor p47,42711,0.108431957015465,0.00651728040750964,0.0956580874167458,0.121205826614184,1.52179239936732e-61
NMR metabolomics,X23424.Total Lipids in VLDL,TBCC,Tubulin-specific chaperone C,42495,0.134140165216852,0.00806293741860334,0.11833680787639,0.149943522557315,1.58142270757302e-61
NMR metabolomics,X23424.Total Lipids in VLDL,CRKL,Crk-like protein,42636,0.174705539713491,0.0105031240902125,0.154119416496674,0.195291662930307,1.63558308498504e-61
NMR metabolomics,X23424.Total Lipids in VLDL,DBNL,Drebrin-like protein,42676,0.152726368537314,0.00919985916487501,0.134694644574159,0.170758092500469,2.78069453312129e-61
NMR metabolomics,X23424.Total Lipids in VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40482,0.12919929340539,0.00777871210440271,0.113953017680761,0.144445569130019,3.17025228479753e-61
NMR metabolomics,X23424.Total Lipids in VLDL,CCN2,CCN family member 2,42624,0.0919534000653831,0.00554206465290653,0.0810909533456863,0.10281584678508,3.24023375441645e-61
NMR metabolomics,X23424.Total Lipids in VLDL,SEC31A,Protein transport protein Sec31A,40223,0.127956916524866,0.00771277152646077,0.112839884333003,0.143073948716729,4.49288003908575e-61
NMR metabolomics,X23424.Total Lipids in VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40511,0.123732202686552,0.00746905929512132,0.109092846468114,0.13837155890499,6.38865678493905e-61
NMR metabolomics,X23424.Total Lipids in VLDL,BRAP,BRCA1-associated protein,40342,0.181404267163928,0.0109504098889474,0.159941463781591,0.202867070546265,6.54661253007233e-61
NMR metabolomics,X23424.Total Lipids in VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42594,0.166226434854381,0.0100956941621191,0.146438874296627,0.186013995412134,2.5546051352922e-60
NMR metabolomics,X23424.Total Lipids in VLDL,MYDGF,Myeloid-derived growth factor,40511,0.16269504200523,0.00987277440294632,0.143344404175455,0.182045679835005,2.60524974517431e-60
NMR metabolomics,X23424.Total Lipids in VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,40199,0.147402548824952,0.0089537475455325,0.129853203635709,0.164951894014196,3.55631832800878e-60
NMR metabolomics,X23424.Total Lipids in VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,42587,0.190169008284657,0.0115961453531498,0.167440563392484,0.212897453176831,7.40091975391392e-60
NMR metabolomics,X23424.Total Lipids in VLDL,APOA2,Apolipoprotein A-II,40532,-0.0812025473646463,0.00495778831826761,-0.0909198124684508,-0.0714852822608418,1.30821170180593e-59
NMR metabolomics,X23424.Total Lipids in VLDL,CCL13,C-C motif chemokine 13,42734,0.113783573334852,0.00695411980165569,0.100153498523607,0.127413648146097,1.3308790170424e-59
NMR metabolomics,X23424.Total Lipids in VLDL,FKBPL,FK506-binding protein-like,40449,0.0963637973858737,0.00588905035825097,0.0848212586837018,0.107906336088046,1.69888393930847e-59
NMR metabolomics,X23424.Total Lipids in VLDL,LYN,Tyrosine-protein kinase Lyn,42587,0.137746439531167,0.00843089346933533,0.12122188833127,0.154270990731064,1.97799904551212e-59
NMR metabolomics,X23424.Total Lipids in VLDL,ARSB,Arylsulfatase B,42587,0.0903180606770878,0.00552835655898362,0.07948248182148,0.101153639532696,2.01205335126696e-59
NMR metabolomics,X23424.Total Lipids in VLDL,LBR,Delta(14)-sterol reductase LBR,42711,0.109180687171405,0.00668991140431204,0.0960684608189537,0.122292913523857,2.61428479284002e-59
NMR metabolomics,X23424.Total Lipids in VLDL,IDUA,Alpha-L-iduronidase,42721,0.0761360559929787,0.00466568402595606,0.0669913153021049,0.0852807966838526,2.69248330441062e-59
NMR metabolomics,X23424.Total Lipids in VLDL,RTN4R,Reticulon-4 receptor,42721,0.056587358259601,0.00346776043224334,0.0497905478124041,0.0633841687067979,2.70016311262546e-59
NMR metabolomics,X23424.Total Lipids in VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,42311,0.0839335547339451,0.00515088178822547,0.0738378264290232,0.094029283038867,4.07442002875654e-59
NMR metabolomics,X23424.Total Lipids in VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40482,0.176224168971089,0.0108134121568446,0.155029881143674,0.197418456798505,4.89722811414385e-59
NMR metabolomics,X23424.Total Lipids in VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,40451,0.0850758047415716,0.00522350872586567,0.0748377276388749,0.0953138818442684,5.74356583311334e-59
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL3,C-X-C motif chemokine 3,42620,0.152158287691417,0.00936508684911234,0.133802717467157,0.170513857915677,8.47060405893561e-59
NMR metabolomics,X23424.Total Lipids in VLDL,THOP1,Thimet oligopeptidase,42571,0.0504323917864991,0.00310593326413773,0.0443447625887892,0.0565200209842091,9.97953939297637e-59
NMR metabolomics,X23424.Total Lipids in VLDL,TRAF2,TNF receptor-associated factor 2,42594,0.113347693018761,0.00698667210455028,0.0996538156938429,0.12704157034368,1.24576684878808e-58
NMR metabolomics,X23424.Total Lipids in VLDL,CES2,Cocaine esterase,42587,0.0895711317104685,0.00552413378483332,0.0787438294921952,0.100398433928742,1.43705717832521e-58
NMR metabolomics,X23424.Total Lipids in VLDL,KLK10,Kallikrein-10,42636,0.0663797657803178,0.00409400400406484,0.0583555179323507,0.0744040136282849,1.44450367877043e-58
NMR metabolomics,X23424.Total Lipids in VLDL,EREG,Proepiregulin,42476,0.131274313320559,0.00810623812204375,0.115386086601354,0.147162540039765,2.00696800747926e-58
NMR metabolomics,X23424.Total Lipids in VLDL,DAG1,Dystroglycan,42676,0.0745624774992236,0.00461055546716492,0.0655257887835803,0.0835991662148668,2.8012721561045e-58
NMR metabolomics,X23424.Total Lipids in VLDL,CD99L2,CD99 antigen-like protein 2,42611,0.0395138211478255,0.00244427032206303,0.034723051316582,0.044304590979069,3.11198376808535e-58
NMR metabolomics,X23424.Total Lipids in VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,42346,0.070982276289522,0.00439073103395894,0.0623764434629625,0.0795881091160816,3.16629533210861e-58
NMR metabolomics,X23424.Total Lipids in VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42587,0.0721863951276756,0.00446569623127405,0.0634336305143785,0.0809391597409727,3.18170267968206e-58
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINE1,Plasminogen activator inhibitor 1,42794,0.107255408859764,0.00664162638201031,0.0942378211510242,0.120272996568505,4.00618077057919e-58
NMR metabolomics,X23424.Total Lipids in VLDL,TBC1D23,TBC1 domain family member 23,42587,0.145190068347157,0.00899145547713932,0.127566815611964,0.162813321082351,4.17534287480235e-58
NMR metabolomics,X23424.Total Lipids in VLDL,CCL5,C-C motif chemokine 5,42689,0.161662268335364,0.0100134547803274,0.142035896965922,0.181288639704806,4.34209575410096e-58
NMR metabolomics,X23424.Total Lipids in VLDL,PDLIM5,PDZ and LIM domain protein 5,40482,0.189402744228161,0.0117353191342143,0.166401518725101,0.212403969731221,5.97738098805617e-58
NMR metabolomics,X23424.Total Lipids in VLDL,SH3GLB2,Endophilin-B2,40483,0.108262092558723,0.00670982596967432,0.0951108336581617,0.121413351459285,6.43724345758696e-58
NMR metabolomics,X23424.Total Lipids in VLDL,FGF19,Fibroblast growth factor 19,42676,0.125816197525546,0.00780972576447508,0.110509135027175,0.141123260023917,7.49688998247164e-58
NMR metabolomics,X23424.Total Lipids in VLDL,COMMD1,COMM domain-containing protein 1,40223,0.0980605682152969,0.00608053719042232,0.0861427153220692,0.109978421108525,7.55080122845022e-58
NMR metabolomics,X23424.Total Lipids in VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42569,0.12390984614246,0.00769473588607599,0.108828163805751,0.138991528479169,8.45946185891307e-58
NMR metabolomics,X23424.Total Lipids in VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40482,0.106759878170348,0.00662764153043332,0.0937697007706986,0.119750055569997,9.80348487946956e-58
NMR metabolomics,X23424.Total Lipids in VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,40302,0.0855223989930629,0.00531148882958754,0.0751118808870713,0.0959329170990545,1.11897598008535e-57
NMR metabolomics,X23424.Total Lipids in VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,40449,0.0962887663769564,0.00598421871586686,0.0845596976938573,0.108017835060055,1.30478842943581e-57
NMR metabolomics,X23424.Total Lipids in VLDL,GLB1,Beta-galactosidase,42495,0.0669802859144364,0.00417028030248196,0.0588065365215718,0.0751540353073011,1.65273054036359e-57
NMR metabolomics,X23424.Total Lipids in VLDL,CNST,Consortin,42636,0.175041665145225,0.0109019670512548,0.153673809724766,0.196409520565684,1.77615057101516e-57
NMR metabolomics,X23424.Total Lipids in VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,40277,0.0751738658813292,0.00468044091877677,0.0660002016805267,0.0843475300821316,2.11412018870216e-57
NMR metabolomics,X23424.Total Lipids in VLDL,TAX1BP1,Tax1-binding protein 1,40483,0.102104149304483,0.0063589747205538,0.0896405588521971,0.114567739756768,2.21228178787825e-57
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,42594,0.127125228114089,0.00792657000760229,0.111589150899188,0.142661305328989,2.37377425613288e-57
NMR metabolomics,X23424.Total Lipids in VLDL,CRELD1,Protein disulfide isomerase CRELD1,40283,0.0611591782604002,0.00381002538584692,0.0536915285041403,0.0686268280166602,2.43833289148283e-57
NMR metabolomics,X23424.Total Lipids in VLDL,PSME1,Proteasome activator complex subunit 1,42480,0.059969530245054,0.00374140394780551,0.0526363785073552,0.0673026819827528,2.77554912056936e-57
NMR metabolomics,X23424.Total Lipids in VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,40482,0.108133499893253,0.00674832391913574,0.0949067850117471,0.121360214774759,3.71652075291012e-57
NMR metabolomics,X23424.Total Lipids in VLDL,NIT1,Deaminated glutathione amidase,40223,0.0766013281545553,0.00478239240213534,0.06722783904637,0.0859748172627406,4.24930207256285e-57
NMR metabolomics,X23424.Total Lipids in VLDL,MMP10,Stromelysin-2,42608,-0.0947570156462134,0.00592361887063771,-0.106367308632663,-0.0831467226597634,4.5548488973057e-57
NMR metabolomics,X23424.Total Lipids in VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,40030,0.053825065755271,0.00336411978577658,0.0472313909751489,0.0604187405353931,5.75069004058561e-57
NMR metabolomics,X23424.Total Lipids in VLDL,VWA1,von Willebrand factor A domain-containing protein 1,42689,0.066284563385554,0.00415264391295202,0.058145381316168,0.0744237454549399,7.77957873788827e-57
NMR metabolomics,X23424.Total Lipids in VLDL,SFRP4,Secreted frizzled-related protein 4,40283,0.0648476153320625,0.00406123867197789,0.0568875875349859,0.0728076431291392,9.22766505461944e-57
NMR metabolomics,X23424.Total Lipids in VLDL,GIGYF2,GRB10-interacting GYF protein 2,40482,0.120659667237006,0.00756539277279499,0.105831497402328,0.135487837071684,1.20320317030049e-56
NMR metabolomics,X23424.Total Lipids in VLDL,DCXR,L-xylulose reductase,42679,0.0842612963216107,0.00528857867360025,0.0738956821213542,0.0946269105218672,1.23435082385414e-56
NMR metabolomics,X23424.Total Lipids in VLDL,TIMP3,Metalloproteinase inhibitor 3,42676,0.20846363072884,0.0130960060606897,0.182795458849888,0.234131802607792,1.55220915613373e-56
NMR metabolomics,X23424.Total Lipids in VLDL,CDC27,Cell division cycle protein 27 homolog,42346,0.0962903284929328,0.00605977676917006,0.0844131660253595,0.108167490960506,2.47965344916838e-56
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40451,0.131250634123048,0.00825566364121225,0.115069533386272,0.147431734859824,2.66602255668488e-56
NMR metabolomics,X23424.Total Lipids in VLDL,STAT2,Signal transducer and activator of transcription 2,40199,0.121680324293366,0.00765531685140183,0.106675903264619,0.136684745322114,2.90094222343411e-56
NMR metabolomics,X23424.Total Lipids in VLDL,APPL2,DCC-interacting protein 13-beta,40283,0.177395354195937,0.0111614193306474,0.155518972307868,0.199271736084006,2.92682377315733e-56
NMR metabolomics,X23424.Total Lipids in VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",40267,0.135686131927194,0.00854013124318842,0.118947474690544,0.152424789163843,3.19837433741988e-56
NMR metabolomics,X23424.Total Lipids in VLDL,GOLGA3,Golgin subfamily A member 3,40482,0.125115414514057,0.00788080598255578,0.109669034788247,0.140561794239866,3.76016970420321e-56
NMR metabolomics,X23424.Total Lipids in VLDL,GPC5,Glypican-5,42495,0.0900546144423612,0.00568024475574102,0.0789213347211088,0.101187894163614,4.30142218970795e-56
NMR metabolomics,X23424.Total Lipids in VLDL,CNPY4,Protein canopy homolog 4,42587,0.117897583847456,0.00743859106055487,0.103317945368769,0.132477222326144,4.58150238701272e-56
NMR metabolomics,X23424.Total Lipids in VLDL,GASK1A,Golgi-associated kinase 1A,40116,0.0692718784123084,0.00436660497640624,0.0607133326585522,0.0778304241660646,4.74336273271785e-56
NMR metabolomics,X23424.Total Lipids in VLDL,TWF2,Twinfilin-2,40527,0.132382734337578,0.0083496776573814,0.11601736612911,0.148748102546045,5.19824013190934e-56
NMR metabolomics,X23424.Total Lipids in VLDL,BAG4,BAG family molecular chaperone regulator 4,40199,0.0780303894916671,0.00493559571084229,0.0683566218984162,0.087704157084918,1.09139468782424e-55
NMR metabolomics,X23424.Total Lipids in VLDL,FABP5,Fatty acid-binding protein 5,42678,0.107512651113549,0.00681015904059449,0.0941647393939837,0.120860562833114,1.20177892644089e-55
NMR metabolomics,X23424.Total Lipids in VLDL,PCDH9,Protocadherin-9,40449,0.0548834863212163,0.0034771090286356,0.0480683526250905,0.0616986200173421,1.57164714214417e-55
NMR metabolomics,X23424.Total Lipids in VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,42594,0.0620288233603755,0.00393463912479534,0.0543169306757767,0.0697407160449744,1.71180530937942e-55
NMR metabolomics,X23424.Total Lipids in VLDL,AMBP,Protein AMBP,42706,0.033269881011729,0.0021109038983455,0.0291325093709718,0.0374072526524862,1.80012350765055e-55
NMR metabolomics,X23424.Total Lipids in VLDL,PDGFB,Platelet-derived growth factor subunit B,42676,0.135422892854939,0.00859340263024964,0.11857982369965,0.152265962010229,1.86236740530883e-55
NMR metabolomics,X23424.Total Lipids in VLDL,DDHD2,Phospholipase DDHD2,40482,0.104000138143453,0.0065954440184792,0.0910730678672341,0.116927208419673,1.99816131552751e-55
NMR metabolomics,X23424.Total Lipids in VLDL,NHLRC3,NHL repeat-containing protein 3,40013,0.0512548198305054,0.00325018229049895,0.0448844625411274,0.0576251771198833,2.07395407403655e-55
NMR metabolomics,X23424.Total Lipids in VLDL,HS1BP3,HCLS1-binding protein 3,40223,0.140413599989663,0.00891359807560462,0.122942947761478,0.157884252217848,2.63081357388559e-55
NMR metabolomics,X23424.Total Lipids in VLDL,SPART,Spartin,40283,0.121380379323672,0.00770735037211447,0.106273972594328,0.136486786053016,2.78192911191095e-55
NMR metabolomics,X23424.Total Lipids in VLDL,IGBP1,Immunoglobulin-binding protein 1,40482,0.0966376107150039,0.00613735348533166,0.0846083978837539,0.108666823546254,2.83815410519933e-55
NMR metabolomics,X23424.Total Lipids in VLDL,VAMP8,Vesicle-associated membrane protein 8,40199,0.139598913434193,0.0088655390898775,0.122222456818033,0.156975370050353,2.91767519080891e-55
NMR metabolomics,X23424.Total Lipids in VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,40116,0.0982296731440961,0.00623872946094352,0.0860017634006468,0.110457582887545,2.99869385348343e-55
NMR metabolomics,X23424.Total Lipids in VLDL,MTDH,Protein LYRIC,40199,0.148569402314985,0.00945333203035928,0.13004087153548,0.167097933094489,4.64850930451132e-55
NMR metabolomics,X23424.Total Lipids in VLDL,EGLN1,Egl nine homolog 1,42594,0.0876488549097142,0.0055863585763364,0.0766995921000948,0.0985981177193335,5.47636652910509e-55
NMR metabolomics,X23424.Total Lipids in VLDL,UBXN1,UBX domain-containing protein 1,40283,0.107973554661649,0.00688255938798284,0.0944837382612028,0.121463371062095,7.09607872646299e-55
NMR metabolomics,X23424.Total Lipids in VLDL,PYY,Peptide YY,40116,0.162316958373051,0.0103463278884665,0.142038155711657,0.182595761034446,7.20150559983931e-55
NMR metabolomics,X23424.Total Lipids in VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42594,0.112421077954849,0.00717352909268537,0.0983609609331855,0.126481194976512,7.24980994497243e-55
NMR metabolomics,X23424.Total Lipids in VLDL,MVK,Mevalonate kinase,42370,0.126168102531886,0.00805111412808814,0.110387918840833,0.141948286222938,7.47576246902411e-55
NMR metabolomics,X23424.Total Lipids in VLDL,NT5E,5'-nucleotidase,42679,0.0893599604217596,0.0057043233404484,0.0781794866744807,0.100540434169038,7.94170403906183e-55
NMR metabolomics,X23424.Total Lipids in VLDL,NUDT5,ADP-sugar pyrophosphatase,42611,0.0796708651034625,0.00508571431089503,0.0697028650541082,0.0896388651528167,7.94725895017113e-55
NMR metabolomics,X23424.Total Lipids in VLDL,AMN,Protein amnionless,42370,0.0743269572989954,0.00474767272456455,0.0650215187588488,0.0836323958391419,9.48763669775053e-55
NMR metabolomics,X23424.Total Lipids in VLDL,PXN,Paxillin,42311,0.0806432121192525,0.00515201060386618,0.0705452713356748,0.0907411529028302,9.93904956329583e-55
NMR metabolomics,X23424.Total Lipids in VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",42676,0.172346217956034,0.011020653325893,0.150745737437284,0.193946698474785,1.20187343433831e-54
NMR metabolomics,X23424.Total Lipids in VLDL,GORASP2,Golgi reassembly-stacking protein 2,40449,0.0740356661641837,0.00473154442721613,0.0647618390868401,0.0833094932415273,1.30275173506719e-54
NMR metabolomics,X23424.Total Lipids in VLDL,RILPL2,RILP-like protein 2,40511,0.152518603885213,0.00975151088026488,0.133405642559894,0.171631565210532,1.43473768550971e-54
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42636,0.0435240727025123,0.00278646642450383,0.0380625985104848,0.0489855468945398,1.60774514188023e-54
NMR metabolomics,X23424.Total Lipids in VLDL,STIP1,Stress-induced-phosphoprotein 1,42586,0.101630822350097,0.00650642626092979,0.0888782268786747,0.114383417821519,1.60786005540781e-54
NMR metabolomics,X23424.Total Lipids in VLDL,GMPR2,GMP reductase 2,40283,0.105892884358741,0.00677737040726055,0.0926092383605107,0.119176530356972,1.88475433104479e-54
NMR metabolomics,X23424.Total Lipids in VLDL,SH2D1A,SH2 domain-containing protein 1A,42594,0.0907689917167581,0.00581867440547132,0.0793643898820344,0.102173593551482,2.20192618739124e-54
NMR metabolomics,X23424.Total Lipids in VLDL,PLXNB3,Plexin-B3,42597,0.0734233813905728,0.00471137433436876,0.06418908769521,0.0826576750859356,2.78609298482233e-54
NMR metabolomics,X23424.Total Lipids in VLDL,RAB27B,Ras-related protein Rab-27B,40511,0.129238947397374,0.00829281509730871,0.112985029806649,0.145492864988099,3.39152003260359e-54
NMR metabolomics,X23424.Total Lipids in VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,42346,0.121163781201701,0.0077810526512098,0.10591291800533,0.136414644398072,3.45350042839787e-54
NMR metabolomics,X23424.Total Lipids in VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42587,0.137465995515629,0.00883192248768173,0.120155427439772,0.154776563591485,3.76824471072119e-54
NMR metabolomics,X23424.Total Lipids in VLDL,SRP14,Signal recognition particle 14 kDa protein,42587,0.0926638182420519,0.00596476049349979,0.0809728876747923,0.104354748809311,5.92076923570331e-54
NMR metabolomics,X23424.Total Lipids in VLDL,THPO,Thrombopoietin,42357,0.0609891422209354,0.00392739936582471,0.053291439463919,0.0686868449779519,6.62023457447989e-54
NMR metabolomics,X23424.Total Lipids in VLDL,ATXN2L,Ataxin-2-like protein,40482,0.0753789048331374,0.00485941718097958,0.0658544471584174,0.0849033625078574,1.03096580833727e-53
NMR metabolomics,X23424.Total Lipids in VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42679,0.111959890850282,0.00722496662788099,0.0977989562596354,0.126120825440929,1.06709503405113e-53
NMR metabolomics,X23424.Total Lipids in VLDL,CASC3,Protein CASC3,40182,0.0655042109468661,0.0042259590470463,0.0572213312146554,0.0737870906790769,1.27101658373115e-53
NMR metabolomics,X23424.Total Lipids in VLDL,SUSD1,Sushi domain-containing protein 1,42357,0.0767925750704915,0.00496217132779819,0.067066719268007,0.0865184308729759,1.50089980930333e-53
NMR metabolomics,X23424.Total Lipids in VLDL,AHSG,Alpha-2-HS-glycoprotein,40532,0.0423565782482612,0.00273801556773052,0.0369900677355094,0.0477230887610131,1.9473118257194e-53
NMR metabolomics,X23424.Total Lipids in VLDL,IGSF3,Immunoglobulin superfamily member 3,42587,0.0563638984810389,0.00364862540880461,0.0492125926797818,0.0635152042822959,2.2454679710754e-53
NMR metabolomics,X23424.Total Lipids in VLDL,LEP,Leptin,42636,0.103249876778657,0.00668450870450471,0.090148239717828,0.116351513839486,2.30048786983802e-53
NMR metabolomics,X23424.Total Lipids in VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40449,0.226633959665818,0.0146605050230267,0.197899369820685,0.25536854951095,2.32293049008146e-53
NMR metabolomics,X23424.Total Lipids in VLDL,QDPR,Dihydropteridine reductase,42581,0.0660368077577407,0.00427615135946044,0.0576555510931982,0.0744180644222831,2.42195232553326e-53
NMR metabolomics,X23424.Total Lipids in VLDL,RBM17,Splicing factor 45,40482,0.11873839387892,0.00768658467532303,0.103672687915287,0.133804099842553,2.74916991313147e-53
NMR metabolomics,X23424.Total Lipids in VLDL,GTPBP2,GTP-binding protein 2,40182,0.125469292656778,0.00813057751067665,0.109533360735852,0.141405224577704,3.60866371781146e-53
NMR metabolomics,X23424.Total Lipids in VLDL,TIA1,Nucleolysin TIA-1 isoform p40,42190,0.186680883582489,0.0121452762800442,0.162876142073602,0.210485625091375,7.5075173192805e-53
NMR metabolomics,X23424.Total Lipids in VLDL,DOK1,Docking protein 1,40483,0.21012388715804,0.0136722263138393,0.183326323582915,0.236921450733165,9.07541480426768e-53
NMR metabolomics,X23424.Total Lipids in VLDL,SIAE,Sialate O-acetylesterase,42646,0.0708786321301974,0.00461745508401481,0.0618284201655283,0.0799288440948664,9.88401282165904e-53
NMR metabolomics,X23424.Total Lipids in VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,42346,0.130435116150847,0.0085012258245958,0.113772713534639,0.147097518767055,1.1256330447982e-52
NMR metabolomics,X23424.Total Lipids in VLDL,DLK1,Protein delta homolog 1,42794,0.0850095265696989,0.00554936262067281,0.0741327758331801,0.0958862773062176,1.57140941012034e-52
NMR metabolomics,X23424.Total Lipids in VLDL,OGA,Protein O-GlcNAcase,40449,0.108080429509543,0.00705144998580459,0.0942595875373659,0.12190127148172,1.69818105962346e-52
NMR metabolomics,X23424.Total Lipids in VLDL,GOLM2,Protein GOLM2,42711,0.0356139137970034,0.0023258217198205,0.0310553032261553,0.0401725243678516,1.74143886520326e-52
NMR metabolomics,X23424.Total Lipids in VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40451,0.0588957352136444,0.00384645483487931,0.0513566837372809,0.0664347866900078,2.15141554264995e-52
NMR metabolomics,X23424.Total Lipids in VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42794,0.0450917381115306,0.00295075605938839,0.0393082562351293,0.0508752199879318,2.76345834042105e-52
NMR metabolomics,X23424.Total Lipids in VLDL,RWDD1,RWD domain-containing protein 1,42711,0.096614816878825,0.006328283274451,0.084211381660901,0.109018252096749,3.44796192067603e-52
NMR metabolomics,X23424.Total Lipids in VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40451,0.0737983749522894,0.00483001554889145,0.0643315444764622,0.0832652054281166,3.51241874687227e-52
NMR metabolomics,X23424.Total Lipids in VLDL,TP53,Cellular tumor antigen p53,42346,0.0662367209822256,0.00433880811046622,0.0577326570857118,0.0747407848787394,3.59972818958469e-52
NMR metabolomics,X23424.Total Lipids in VLDL,RTBDN,Retbindin,42587,0.0460115045659981,0.0030146104905313,0.0401028680045568,0.0519201411274395,3.7131568500809e-52
NMR metabolomics,X23424.Total Lipids in VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",40223,0.0395372590555517,0.00259470616953874,0.0344516349632558,0.0446228831478477,6.70556417539037e-52
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS8,Galectin-8,42711,0.091610471064761,0.0060236151873252,0.0798041852976036,0.103416756831918,8.32501979477516e-52
NMR metabolomics,X23424.Total Lipids in VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,42311,0.0441506333142008,0.00290327896471895,0.0384602065433517,0.04984106008505,8.7573081275641e-52
NMR metabolomics,X23424.Total Lipids in VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,40283,0.0884601903618348,0.00581766424734491,0.0770575684370388,0.0998628122866308,1.07923704339884e-51
NMR metabolomics,X23424.Total Lipids in VLDL,WASHC3,WASH complex subunit 3,40483,0.114575760717883,0.00753707453481135,0.0998030946296529,0.129348426806113,1.11911289714603e-51
NMR metabolomics,X23424.Total Lipids in VLDL,HYOU1,Hypoxia up-regulated protein 1,42794,0.0353632651684724,0.00233142622936292,0.0307936697589211,0.0399328605780237,1.51854256204809e-51
NMR metabolomics,X23424.Total Lipids in VLDL,DGKA,Diacylglycerol kinase alpha,40199,0.0835074917949657,0.00551417014422565,0.0726997183122834,0.094315265277648,2.71862385224084e-51
NMR metabolomics,X23424.Total Lipids in VLDL,MPHOSPH8,M-phase phosphoprotein 8,42357,0.114746914507575,0.00758360009470678,0.0998830583219499,0.1296107706932,2.73246228917902e-51
NMR metabolomics,X23424.Total Lipids in VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,42370,0.0848773398902243,0.00561948674491656,0.0738631458701879,0.0958915339102608,4.07350415792919e-51
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA11,Annexin A11,42570,0.101406920317145,0.00671722590056338,0.0882411575520409,0.114572683082249,4.49379039424488e-51
NMR metabolomics,X23424.Total Lipids in VLDL,CD36,Platelet glycoprotein 4,40199,0.0682755215003061,0.00452028396283026,0.0594157649331588,0.0771352780674535,4.92328705563807e-51
NMR metabolomics,X23424.Total Lipids in VLDL,MEP1A,Meprin A subunit alpha,40449,0.110264871626803,0.00731116820400995,0.0959349819469433,0.124594761306662,6.70770742582964e-51
NMR metabolomics,X23424.Total Lipids in VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,42594,0.157386024358734,0.0104548004519454,0.136894615472921,0.177877433244547,8.458924355957e-51
NMR metabolomics,X23424.Total Lipids in VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42711,-0.0716290764327791,0.00475976043644825,-0.0809582068882177,-0.0622999459773405,9.04628039109802e-51
NMR metabolomics,X23424.Total Lipids in VLDL,HSPA1A,Heat shock 70 kDa protein 1A,42658,0.105948878802464,0.00704318491044994,0.0921442363779816,0.119753521226945,9.9459154539844e-51
NMR metabolomics,X23424.Total Lipids in VLDL,COL18A1,Collagen alpha-1(XVIII) chain,42692,0.0367891261464205,0.00244641139542465,0.0319941598113882,0.0415840924814528,1.06487348798826e-50
NMR metabolomics,X23424.Total Lipids in VLDL,IL1RL2,Interleukin-1 receptor-like 2,42370,0.0584435183512242,0.00389617199009885,0.0508070212506305,0.066080015451818,1.90723174348673e-50
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,40451,0.132423046974803,0.00882445650495385,0.115127112225094,0.149718981724513,2.04693252985367e-50
NMR metabolomics,X23424.Total Lipids in VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42587,0.0664304815149393,0.00443417747053975,0.0577394936726814,0.0751214693571972,2.48014487750905e-50
NMR metabolomics,X23424.Total Lipids in VLDL,DLG4,Disks large homolog 4,40483,0.105716249577662,0.00705621794002015,0.0918860624152226,0.119546436740102,2.92429393997192e-50
NMR metabolomics,X23424.Total Lipids in VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,42370,0.0905110617203663,0.00605459578668325,0.0786440539784671,0.102378069462265,4.0602419895468e-50
NMR metabolomics,X23424.Total Lipids in VLDL,IFNLR1,Interferon lambda receptor 1,42594,0.0549019629739923,0.00367512563210237,0.0476987167350716,0.0621052092129129,4.65731740805839e-50
NMR metabolomics,X23424.Total Lipids in VLDL,MME,Neprilysin,42587,0.12214608818313,0.00818668175339277,0.10610019194648,0.13819198441978,6.13969659428482e-50
NMR metabolomics,X23424.Total Lipids in VLDL,PRKG1,cGMP-dependent protein kinase 1,40283,0.186913474105241,0.0125302644058632,0.16235415586975,0.211472792340733,7.76880717082533e-50
NMR metabolomics,X23424.Total Lipids in VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,40169,0.0739913553863714,0.00496323463801509,0.0642634154958618,0.083719295276881,8.97726826223774e-50
NMR metabolomics,X23424.Total Lipids in VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,40417,0.0653477052599611,0.00438572138418586,0.0567516913469568,0.0739437191729654,9.82134410802531e-50
NMR metabolomics,X23424.Total Lipids in VLDL,ITGA5,Integrin alpha-5,42611,0.0375966430499533,0.00252578793330023,0.0326460987006848,0.0425471873992217,1.0260212329883e-49
NMR metabolomics,X23424.Total Lipids in VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,42587,0.0842054570818515,0.00565809909466631,0.0731155828563055,0.0952953313073974,1.07131517513843e-49
NMR metabolomics,X23424.Total Lipids in VLDL,FOXJ3,Forkhead box protein J3,40199,0.0656766584082014,0.0044121343011616,0.0570288751779247,0.0743244416384782,1.24365374446468e-49
NMR metabolomics,X23424.Total Lipids in VLDL,MAVS,Mitochondrial antiviral-signaling protein,42346,0.135879330595975,0.00913624288588541,0.117972294539639,0.15378636665231,1.25657941026483e-49
NMR metabolomics,X23424.Total Lipids in VLDL,NUDC,Nuclear migration protein nudC,42754,0.0928265748718824,0.00624425742566096,0.0805878303175869,0.105065319426178,1.34783714653267e-49
NMR metabolomics,X23424.Total Lipids in VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42611,0.0911615889273934,0.00613389930315644,0.0791391462932068,0.10318403156158,1.44258423729482e-49
NMR metabolomics,X23424.Total Lipids in VLDL,FLT4,Vascular endothelial growth factor receptor 3,42679,0.049428916828108,0.00332799119113334,0.0429060540934867,0.0559517795627294,1.64989455813667e-49
NMR metabolomics,X23424.Total Lipids in VLDL,ICA1,Islet cell autoantigen 1,42370,0.117552409748714,0.00792419320190855,0.102020991072973,0.133083828424455,2.18904215263438e-49
NMR metabolomics,X23424.Total Lipids in VLDL,MFAP5,Microfibrillar-associated protein 5,42794,0.0615285653131609,0.00415135656101025,0.0533919064535809,0.069665224172741,2.58627855029358e-49
NMR metabolomics,X23424.Total Lipids in VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",42459,0.0623017187843148,0.00420566633816641,0.0540586127615087,0.070544824807121,2.95357307372063e-49
NMR metabolomics,X23424.Total Lipids in VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",42611,0.113954294676143,0.00769450563834285,0.0988730636249913,0.129035525727295,3.09689283147809e-49
NMR metabolomics,X23424.Total Lipids in VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,42346,0.112667498366913,0.00761332315249964,0.0977453849880137,0.127589611745812,3.70831203159851e-49
NMR metabolomics,X23424.Total Lipids in VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,40451,0.0627648091300443,0.00424487052197289,0.0544448629069774,0.0710847553531112,5.19033987895359e-49
NMR metabolomics,X23424.Total Lipids in VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40449,0.0772043085863116,0.00522580191063983,0.0669617368414575,0.0874468803311657,6.21514587174259e-49
NMR metabolomics,X23424.Total Lipids in VLDL,COCH,Cochlin,40511,0.0698905308031855,0.00473394281797787,0.0606120028799489,0.0791690587264221,7.14521275305537e-49
NMR metabolomics,X23424.Total Lipids in VLDL,CRHBP,Corticotropin-releasing factor-binding protein,42618,0.0407229925509873,0.00276321868683668,0.0353070839247874,0.0461389011771872,8.89815580316819e-49
NMR metabolomics,X23424.Total Lipids in VLDL,ADD1,Alpha-adducin,40283,0.105679619993399,0.00717099794801839,0.0916244640152827,0.119734775971515,1.07454188727256e-48
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40482,0.119551400232273,0.00811754184932636,0.103641018207593,0.135461782256952,1.21181294789071e-48
NMR metabolomics,X23424.Total Lipids in VLDL,KIFBP,KIF-binding protein,42587,0.120736553949177,0.00821857701533425,0.104628142999122,0.136844964899232,1.76209594286025e-48
NMR metabolomics,X23424.Total Lipids in VLDL,GYS1,"Glycogen [starch] synthase, muscle",42357,0.136620622293632,0.00929924640411921,0.118394099341559,0.154847145245706,1.76572993963773e-48
NMR metabolomics,X23424.Total Lipids in VLDL,CTSO,Cathepsin O,42754,0.0455477122619281,0.00310168409530135,0.0394684114351375,0.0516270130887188,1.89832414085652e-48
NMR metabolomics,X23424.Total Lipids in VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,40223,0.0473773359907012,0.00322344137655528,0.0410593908926529,0.0536952810887496,1.91164701310779e-48
NMR metabolomics,X23424.Total Lipids in VLDL,NEXN,Nexilin,40532,0.102130049553247,0.00695143556177477,0.0885052358521682,0.115754863254325,2.02146222943387e-48
NMR metabolomics,X23424.Total Lipids in VLDL,ALDH1A1,Retinal dehydrogenase 1,42611,0.0793339718107728,0.00540576489603208,0.0687386726145499,0.0899292710069956,2.18361476365825e-48
NMR metabolomics,X23424.Total Lipids in VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42651,0.0861358801146023,0.00588198211314106,0.0746071951728458,0.0976645650563587,3.45289179880809e-48
NMR metabolomics,X23424.Total Lipids in VLDL,MGLL,Monoglyceride lipase,42654,0.126460121382497,0.00863664655945498,0.109532294125965,0.143387948639029,3.54092082305125e-48
NMR metabolomics,X23424.Total Lipids in VLDL,AP2B1,AP-2 complex subunit beta,40182,0.0713986134114481,0.00487555588562928,0.0618425238756147,0.0809547029472815,4.1617648442722e-48
NMR metabolomics,X23424.Total Lipids in VLDL,SELE,E-selectin,42794,0.0748675470418181,0.00511934645600138,0.0648336279880554,0.0849014660955808,4.54420966949508e-48
NMR metabolomics,X23424.Total Lipids in VLDL,CHMP1A,Charged multivesicular body protein 1a,42495,0.116326816704478,0.00795574758839126,0.100733551431231,0.131920081977725,4.81432488801141e-48
NMR metabolomics,X23424.Total Lipids in VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42611,0.0667095539944155,0.00456303925738356,0.0577659970499438,0.0756531109388873,4.93277203455427e-48
NMR metabolomics,X23424.Total Lipids in VLDL,CETN3,Centrin-3,40449,0.111636951448736,0.00763323049977814,0.0966758196691706,0.126598083228301,5.34796728015504e-48
NMR metabolomics,X23424.Total Lipids in VLDL,LPP,Lipoma-preferred partner,40116,0.0971444096999484,0.00664151218302701,0.0841270458212155,0.110161773578681,5.37807607421527e-48
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC4A,C-type lectin domain family 4 member A,42594,-0.0519243029348914,0.00355501338287065,-0.0588921291653178,-0.0449564767044649,6.01099242213696e-48
NMR metabolomics,X23424.Total Lipids in VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,40302,0.0968268974457976,0.00663643437168459,0.0838194860772958,0.109834308814299,8.96072754301231e-48
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1R2,Protein phosphatase inhibitor 2,42636,0.115306772565978,0.00792143145953676,0.0997807669052855,0.13083277822667,1.22645701179838e-47
NMR metabolomics,X23424.Total Lipids in VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42636,0.12159720351517,0.00835558500062442,0.105220256913946,0.137974150116394,1.28982630759585e-47
NMR metabolomics,X23424.Total Lipids in VLDL,KRT5,"Keratin, type II cytoskeletal 5",42311,0.0755158136587534,0.00518875312076789,0.0653458575420483,0.0856857697754584,1.29868429878607e-47
NMR metabolomics,X23424.Total Lipids in VLDL,CRADD,Death domain-containing protein CRADD,42476,0.10959666288492,0.00754824416651609,0.0948021043185487,0.124391221451292,2.10298522423336e-47
NMR metabolomics,X23424.Total Lipids in VLDL,YJU2,Splicing factor YJU2,40451,0.0474809202743445,0.00327269557105974,0.0410664369550674,0.0538954035936215,2.86756620094578e-47
NMR metabolomics,X23424.Total Lipids in VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40483,0.141902745627441,0.0097918902017475,0.122710640832016,0.161094850422866,3.61228336003978e-47
NMR metabolomics,X23424.Total Lipids in VLDL,F2,Prothrombin,40539,0.0217653044447614,0.00150405533334971,0.018817355991396,0.0247132528981268,4.83808521551446e-47
NMR metabolomics,X23424.Total Lipids in VLDL,SEMA4D,Semaphorin-4D,42711,0.043582042642955,0.00301457012529688,0.0376734851973731,0.0494906000885369,5.06733905997279e-47
NMR metabolomics,X23424.Total Lipids in VLDL,MAX,Protein max,42311,0.152651398277873,0.0105585701915671,0.131956600702402,0.173346195853345,5.15909233849816e-47
NMR metabolomics,X23424.Total Lipids in VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",42679,0.0882142895551582,0.00610594844915283,0.0762466305948186,0.100181948515498,5.8459191957711e-47
NMR metabolomics,X23424.Total Lipids in VLDL,AMOT,Angiomotin,40283,0.0564238027423051,0.00391280862261887,0.0487546978419721,0.0640929076426381,1.01977501722357e-46
NMR metabolomics,X23424.Total Lipids in VLDL,YWHAQ,14-3-3 protein theta,40283,0.106493507084009,0.00740740277517013,0.0919749976446751,0.121012016523342,1.89549046829642e-46
NMR metabolomics,X23424.Total Lipids in VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,40283,0.122171548403308,0.00850334038185132,0.105505001254879,0.138838095551736,2.15819375354069e-46
NMR metabolomics,X23424.Total Lipids in VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,40283,0.0904764045180685,0.00630087526488566,0.0781266889988926,0.102826120037244,2.42196056553097e-46
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM40,E3 ubiquitin ligase TRIM40,40182,0.104000793649481,0.00724498710428072,0.0898006189250908,0.118200968373871,2.60295421020192e-46
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42754,0.0407589096576818,0.00284666556088682,0.0351794451583437,0.04633837415702,3.65855801619458e-46
NMR metabolomics,X23424.Total Lipids in VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,40182,0.100422099314758,0.00700980508299394,0.0866828813520903,0.114161317277427,3.91823995548259e-46
NMR metabolomics,X23424.Total Lipids in VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,42346,0.14159000561175,0.00989369038629385,0.122198372454614,0.160981638768886,4.13604472524284e-46
NMR metabolomics,X23424.Total Lipids in VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,40199,0.0821011258957952,0.00574490108446003,0.0708411197702535,0.0933611320213368,6.39581347165658e-46
NMR metabolomics,X23424.Total Lipids in VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42654,0.122244883691762,0.00856278946173596,0.105461816346759,0.139027951036764,6.65087771833969e-46
NMR metabolomics,X23424.Total Lipids in VLDL,ELOA,Elongin-A,42587,0.077094174067529,0.00540204222498531,0.0665061713065578,0.0876821768285002,7.16405121065352e-46
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM24,Transcription intermediary factor 1-alpha,40287,0.0933365078405855,0.00654591224660013,0.0805065198372493,0.106166495843922,1.00177676253837e-45
NMR metabolomics,X23424.Total Lipids in VLDL,ATXN3,Ataxin-3,40483,0.0894506413749487,0.00627951298437544,0.0771427959255728,0.101758486824325,1.19903183104432e-45
NMR metabolomics,X23424.Total Lipids in VLDL,RNASE4,Ribonuclease 4,40169,0.0420322240765597,0.00295435944213856,0.0362416795699681,0.0478227685831513,1.57641688682288e-45
NMR metabolomics,X23424.Total Lipids in VLDL,SPRY2,Protein sprouty homolog 2,42370,0.131817757411905,0.00927499383997962,0.113638769485545,0.149996745338265,1.66958839913268e-45
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42594,0.0865142736431349,0.0060907194971948,0.0745764634286331,0.0984520838576367,1.84177176605406e-45
NMR metabolomics,X23424.Total Lipids in VLDL,TXNDC5,Thioredoxin domain-containing protein 5,42711,0.0956793310741076,0.00673866924585136,0.082471539352239,0.108887122795976,1.98330905958262e-45
NMR metabolomics,X23424.Total Lipids in VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,42346,0.0731607841431558,0.00515523305317331,0.0630565273589361,0.0832650409273755,2.23370715165222e-45
NMR metabolomics,X23424.Total Lipids in VLDL,TMED8,Protein TMED8,40449,0.146094278387169,0.0102902870986375,0.125925315673839,0.166263241100498,2.34339708207356e-45
NMR metabolomics,X23424.Total Lipids in VLDL,EHD3,EH domain-containing protein 3,40223,0.167945091838061,0.0118419733696608,0.144734824033526,0.191155359642596,2.94893428416674e-45
NMR metabolomics,X23424.Total Lipids in VLDL,SMAD3,Mothers against decapentaplegic homolog 3,40451,0.0738836392756131,0.00521256694337792,0.0636670080665924,0.0841002704846338,3.24080398361225e-45
NMR metabolomics,X23424.Total Lipids in VLDL,CACYBP,Calcyclin-binding protein,40267,0.145640417309757,0.0102822651314578,0.125487177652099,0.165793656967414,3.77727553356922e-45
NMR metabolomics,X23424.Total Lipids in VLDL,DFFA,DNA fragmentation factor subunit alpha,42754,0.095245619291454,0.00673275875650118,0.0820494121287117,0.108441826454196,4.10231793110629e-45
NMR metabolomics,X23424.Total Lipids in VLDL,FUOM,Fucose mutarotase,40283,0.0904325837209563,0.00638923524958752,0.0779096826317648,0.102955484810148,4.35872946149083e-45
NMR metabolomics,X23424.Total Lipids in VLDL,FUS,RNA-binding protein FUS,42336,0.0567946267964404,0.00401564718762322,0.0489239583086989,0.0646652952841819,4.39526173717589e-45
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGAP25,Rho GTPase-activating protein 25,42346,0.0846917647088068,0.00599387236798081,0.0729437748675644,0.0964397545500491,5.31409073087952e-45
NMR metabolomics,X23424.Total Lipids in VLDL,GRAP2,GRB2-related adapter protein 2,42636,0.180489457927146,0.0127904205322538,0.155420233683929,0.205558682170364,6.76534100873112e-45
NMR metabolomics,X23424.Total Lipids in VLDL,TALDO1,Transaldolase,40499,0.0627148963308171,0.00444791655737178,0.0539969798783684,0.0714328127832658,9.10953487601563e-45
NMR metabolomics,X23424.Total Lipids in VLDL,OTUD6B,Deubiquitinase OTUD6B,40449,0.0831797263096999,0.00590331609879072,0.0716092267560701,0.0947502258633297,1.04369487619975e-44
NMR metabolomics,X23424.Total Lipids in VLDL,IMPACT,Protein IMPACT,40483,0.0796332415307619,0.00565379953654054,0.0685517944391424,0.0907146886223813,1.12270706207186e-44
NMR metabolomics,X23424.Total Lipids in VLDL,TDRKH,Tudor and KH domain-containing protein,42311,0.119893592230005,0.00852613707904709,0.103182363555073,0.136604820904937,1.37217887321569e-44
NMR metabolomics,X23424.Total Lipids in VLDL,GLOD4,Glyoxalase domain-containing protein 4,42602,0.049461645035151,0.00351939215099656,0.0425636364191977,0.0563596536511043,1.50650688063751e-44
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,40482,0.131968524544907,0.00939222276208741,0.113559767931216,0.150377281158599,1.80274362513731e-44
NMR metabolomics,X23424.Total Lipids in VLDL,CD226,CD226 antigen,40199,0.0601501916362551,0.00428534457898697,0.0517509162614407,0.0685494670110696,2.25532999040481e-44
NMR metabolomics,X23424.Total Lipids in VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,42346,0.119457603838019,0.00851971202341253,0.10275896827213,0.136156239403908,2.40728687778162e-44
NMR metabolomics,X23424.Total Lipids in VLDL,ERP29,Endoplasmic reticulum resident protein 29,40283,0.167270834303595,0.0119334034340003,0.143881363572954,0.190660305034236,2.92429652517996e-44
NMR metabolomics,X23424.Total Lipids in VLDL,RRAS,Ras-related protein R-Ras,40182,0.183276356002114,0.0130769285388745,0.15764557606592,0.208907135938308,3.02105459055711e-44
NMR metabolomics,X23424.Total Lipids in VLDL,CD244,Natural killer cell receptor 2B4,42754,0.0387581670540288,0.00276793596987216,0.0333330125530794,0.0441833215549783,3.05605216225745e-44
NMR metabolomics,X23424.Total Lipids in VLDL,FGL1,Fibrinogen-like protein 1,40532,-0.0929688900925518,0.00664673991669832,-0.10599650032928,-0.0799412798558231,4.33885262505654e-44
NMR metabolomics,X23424.Total Lipids in VLDL,NACC1,Nucleus accumbens-associated protein 1,40451,0.0779433492854841,0.00557245044985173,0.0670213464037747,0.0888653521671935,4.3574014371443e-44
NMR metabolomics,X23424.Total Lipids in VLDL,CD207,C-type lectin domain family 4 member K,42365,0.0561591243857921,0.00401910458810084,0.0482816793931144,0.0640365693784697,4.69563647898635e-44
NMR metabolomics,X23424.Total Lipids in VLDL,VASP,Vasodilator-stimulated phosphoprotein,40532,0.101681772003156,0.0072746247080031,0.0874235075754701,0.115940036430842,4.95037934257482e-44
NMR metabolomics,X23424.Total Lipids in VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42495,0.0614764147427096,0.00440334969521625,0.0528458493400857,0.0701069801453334,5.48670616352836e-44
NMR metabolomics,X23424.Total Lipids in VLDL,KRT18,"Keratin, type I cytoskeletal 18",42587,0.113557571883742,0.00813825785865934,0.0976065864807694,0.129508557286714,6.0765151304875e-44
NMR metabolomics,X23424.Total Lipids in VLDL,NUB1,NEDD8 ultimate buster 1,42594,0.116826799566834,0.0083760463846452,0.100409748652929,0.133243850480739,6.58326636337984e-44
NMR metabolomics,X23424.Total Lipids in VLDL,VNN1,Pantetheinase,40532,0.10254241496113,0.00735480082292048,0.0881270053482059,0.116957824574054,8.06180092216881e-44
NMR metabolomics,X23424.Total Lipids in VLDL,UROD,Uroporphyrinogen decarboxylase,40283,0.096819862395458,0.00695250373697269,0.0831929550709916,0.110446769719924,1.02837555982357e-43
NMR metabolomics,X23424.Total Lipids in VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",40302,0.0688783284760153,0.00496134131112859,0.0591540995062033,0.0786025574458274,1.85105012364957e-43
NMR metabolomics,X23424.Total Lipids in VLDL,IL7,Interleukin-7,42594,0.0888245577908527,0.0064070913334854,0.0762666587772213,0.101382456804484,2.10167869385419e-43
NMR metabolomics,X23424.Total Lipids in VLDL,TADA3,Transcriptional adapter 3,40451,0.0553679824909375,0.00399125263370638,0.047545127328873,0.063190837653002,2.11954250496088e-43
NMR metabolomics,X23424.Total Lipids in VLDL,CCL3,C-C motif chemokine 3,42594,0.0805200042273218,0.00580986674035425,0.0691326654162274,0.0919073430384161,2.229352060088e-43
NMR metabolomics,X23424.Total Lipids in VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42495,0.10903441822914,0.0078757476441153,0.0935979528466737,0.124470883611606,2.7475228129801e-43
NMR metabolomics,X23424.Total Lipids in VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,40482,0.118728960794356,0.00857112193850264,0.101929561794891,0.135528359793821,2.78621595476839e-43
NMR metabolomics,X23424.Total Lipids in VLDL,CTF1,Cardiotrophin-1,42357,0.117147877727639,0.0084694219321307,0.100547810740663,0.133747944714616,3.28299286627087e-43
NMR metabolomics,X23424.Total Lipids in VLDL,PARP1,Poly [ADP-ribose] polymerase 1,42594,0.0812690011022915,0.00587613569637587,0.0697517751373948,0.0927862270671882,3.31124119148457e-43
NMR metabolomics,X23424.Total Lipids in VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,42295,0.0801658386943247,0.00580081394410078,0.0687962433638872,0.0915354340247622,3.88774694241776e-43
NMR metabolomics,X23424.Total Lipids in VLDL,FAM172A,Cotranscriptional regulator FAM172A,40223,0.0851141210085262,0.00615488074178843,0.0730505547546208,0.0971776872624315,3.9148733470152e-43
NMR metabolomics,X23424.Total Lipids in VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,42620,0.078849932856489,0.00571053305560949,0.0676572880674944,0.0900425776454836,4.50299742588655e-43
NMR metabolomics,X23424.Total Lipids in VLDL,TBCB,Tubulin-folding cofactor B,42495,0.13841818422255,0.010041503853658,0.11873683666938,0.158099531775719,6.22289280395658e-43
NMR metabolomics,X23424.Total Lipids in VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",40209,0.11100742837049,0.00805686152016317,0.0952159797909704,0.12679887695001,7.82726563069944e-43
NMR metabolomics,X23424.Total Lipids in VLDL,DNM3,Dynamin-3,40482,0.0762643341992435,0.00554195795386695,0.0654020966096642,0.0871265717888227,9.63986335670527e-43
NMR metabolomics,X23424.Total Lipids in VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,42311,0.15361953423897,0.0111715550153198,0.131723286408943,0.175515782068997,9.94222164736986e-43
NMR metabolomics,X23424.Total Lipids in VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,42620,0.0681658913360388,0.00496806380761425,0.0584284862731149,0.0779032963989628,1.47552929730047e-42
NMR metabolomics,X23424.Total Lipids in VLDL,KLK13,Kallikrein-13,42381,0.0638301981672849,0.00465939359010239,0.0546977867306842,0.0729626096038856,2.00157493601851e-42
NMR metabolomics,X23424.Total Lipids in VLDL,PGF,Placenta growth factor,42754,0.0368238505741474,0.00268884748455794,0.0315537095044138,0.0420939916438809,2.08133734914357e-42
NMR metabolomics,X23424.Total Lipids in VLDL,ORM1,Alpha-1-acid glycoprotein 1,40483,0.027814979342668,0.00203235849760539,0.0238315566873614,0.0317984019979746,2.67433369146214e-42
NMR metabolomics,X23424.Total Lipids in VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",40283,0.143032313999264,0.0104528456898399,0.122544736447178,0.16351989155135,2.80427337476566e-42
NMR metabolomics,X23424.Total Lipids in VLDL,SNCG,Gamma-synuclein,42495,0.0950268479826873,0.00696412455392578,0.0813771638569927,0.108676532108382,4.14087193612985e-42
NMR metabolomics,X23424.Total Lipids in VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,42311,0.100655579317667,0.00737813404809588,0.0861944365833989,0.115116722051935,4.33867439017711e-42
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPTL7,Angiopoietin-related protein 7,42721,0.0501312467287705,0.00367683573886352,0.042924648680598,0.057337844776943,4.74401887354586e-42
NMR metabolomics,X23424.Total Lipids in VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42594,0.131219946739311,0.00963255086619261,0.112340147041574,0.150099746437049,5.5969857814702e-42
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJB2,DnaJ homolog subfamily B member 2,40283,0.0740731534420932,0.00543525178254631,0.0634200599483024,0.0847262469358839,5.91605997135216e-42
NMR metabolomics,X23424.Total Lipids in VLDL,VAV3,Guanine nucleotide exchange factor VAV3,40136,0.136217364358579,0.00999706592325877,0.116623115148991,0.155811613568166,6.18632659737391e-42
NMR metabolomics,X23424.Total Lipids in VLDL,PMVK,Phosphomevalonate kinase,42303,0.148291452151903,0.0108977183298842,0.12693192422533,0.169650980078476,6.94926630952375e-42
NMR metabolomics,X23424.Total Lipids in VLDL,MAP2,Microtubule-associated protein 2,40483,0.0638950446660184,0.00469384257686712,0.0546951132153589,0.073094976116678,7.21640082253612e-42
NMR metabolomics,X23424.Total Lipids in VLDL,FIS1,Mitochondrial fission 1 protein,42624,0.103236904794873,0.00759112343257513,0.0883583028670258,0.11811550672272,7.60992491221051e-42
NMR metabolomics,X23424.Total Lipids in VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",42346,0.111986239340172,0.00823530182849933,0.0958450477563138,0.128127430924031,7.85612582182418e-42
NMR metabolomics,X23424.Total Lipids in VLDL,RFC4,Replication factor C subunit 4,40451,0.0290480200699923,0.00213498426328097,0.0248634509139616,0.033232589226023,7.92434614340091e-42
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINB9,Serpin B9,42495,0.0451159415123033,0.00332045244030273,0.0386078547293099,0.0516240282952966,9.04960381857966e-42
NMR metabolomics,X23424.Total Lipids in VLDL,LRRC59,Leucine-rich repeat-containing protein 59,40511,0.0666675264930444,0.00490982077195579,0.057044277780011,0.0762907752060777,1.13972306074538e-41
NMR metabolomics,X23424.Total Lipids in VLDL,GET3,ATPase GET3,40511,0.0741715549369817,0.00546411673465078,0.0634618861370662,0.0848812237368973,1.20430941301151e-41
NMR metabolomics,X23424.Total Lipids in VLDL,FOXO3,Forkhead box protein O3,42346,0.129922822295145,0.00958377561167828,0.111138622096255,0.148707022494034,1.37865191681486e-41
NMR metabolomics,X23424.Total Lipids in VLDL,ACE2,Angiotensin-converting enzyme 2,42357,0.0734578477892032,0.00542052979381385,0.062833609393328,0.0840820861850783,1.4688414127326e-41
NMR metabolomics,X23424.Total Lipids in VLDL,SPON2,Spondin-2,42562,-0.0491010513632334,0.00362681796328056,-0.0562096145712633,-0.0419924881552035,1.74278525055092e-41
NMR metabolomics,X23424.Total Lipids in VLDL,ATP6AP2,Renin receptor,42346,0.055112786992817,0.00408029101590805,0.0471154166016372,0.0631101573839967,2.6773918411546e-41
NMR metabolomics,X23424.Total Lipids in VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,42307,0.106207535462584,0.0078641260043884,0.090793848493983,0.121621222431186,2.74611812509004e-41
NMR metabolomics,X23424.Total Lipids in VLDL,GZMA,Granzyme A,42754,0.0484412914455512,0.00359185500551599,0.0414012556347399,0.0554813272563625,3.46386938625875e-41
NMR metabolomics,X23424.Total Lipids in VLDL,MOCS2,Molybdopterin synthase catalytic subunit,40283,0.0901027033843046,0.00667769595695652,0.0770144193086698,0.103190987459939,3.62660822269943e-41
NMR metabolomics,X23424.Total Lipids in VLDL,MCAM,Cell surface glycoprotein MUC18,42689,-0.0457420249748734,0.00339583480798347,-0.052397861198521,-0.0390861887512258,4.32516943224551e-41
NMR metabolomics,X23424.Total Lipids in VLDL,PF4,Platelet factor 4,40463,0.133451092947256,0.00992135121042915,0.114005244574815,0.152896941319697,6.28914516158215e-41
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS9,Galectin-9,42620,0.043690768602127,0.00325593487704036,0.0373091362431279,0.0500724009611261,8.59242209612485e-41
NMR metabolomics,X23424.Total Lipids in VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40482,0.0656427424584857,0.00489423796367162,0.0560500360496894,0.0752354488672821,1.04999323732062e-40
NMR metabolomics,X23424.Total Lipids in VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,40283,0.0495403351310371,0.00369906215295783,0.0422901733112397,0.0567904969508344,1.37866137150978e-40
NMR metabolomics,X23424.Total Lipids in VLDL,CCT5,T-complex protein 1 subunit epsilon,42346,0.0620497300124328,0.00463953429273016,0.0529562427986817,0.071143217226184,1.57544801371277e-40
NMR metabolomics,X23424.Total Lipids in VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42594,0.133600021660923,0.00999263822415404,0.114014450741581,0.153185592580265,1.64906203359889e-40
NMR metabolomics,X23424.Total Lipids in VLDL,GPI,Glucose-6-phosphate isomerase,40532,0.0633974834179246,0.00474048067739132,0.0541061412902376,0.0726888255456116,1.74630776110504e-40
NMR metabolomics,X23424.Total Lipids in VLDL,SUGT1,Protein SGT1 homolog,42346,0.10789579827573,0.00808434041558954,0.0920504910611744,0.123741105490285,2.2790947293225e-40
NMR metabolomics,X23424.Total Lipids in VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42587,0.037431892580534,0.0028048564614427,0.0319343739161063,0.0429294112449617,2.28123374531851e-40
NMR metabolomics,X23424.Total Lipids in VLDL,CASP10,Caspase-10,42311,0.0962947302798048,0.00721838989198296,0.0821466860915182,0.110442774468091,2.47392587324041e-40
NMR metabolomics,X23424.Total Lipids in VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,42192,0.115504573321754,0.00866212358910442,0.0985268110871095,0.132482335556399,2.68432474780969e-40
NMR metabolomics,X23424.Total Lipids in VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,42346,0.0782274019433277,0.00586797206535189,0.066726176695238,0.0897286271914173,2.7803202362069e-40
NMR metabolomics,X23424.Total Lipids in VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39940,0.143354489260617,0.010745323223939,0.122293655741697,0.164415322779538,2.7893708975489e-40
NMR metabolomics,X23424.Total Lipids in VLDL,DIABLO,"Diablo homolog, mitochondrial",42603,0.146102103237116,0.0109718042380524,0.124597366930533,0.167606839543698,3.35651519899832e-40
NMR metabolomics,X23424.Total Lipids in VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40482,0.0638726931243529,0.00479473866802329,0.0544750053350272,0.0732703809136785,3.49272878709941e-40
NMR metabolomics,X23424.Total Lipids in VLDL,THTPA,Thiamine-triphosphatase,40436,0.1182102909316,0.00887507043889138,0.100815152871373,0.135605428991827,3.59854889259425e-40
NMR metabolomics,X23424.Total Lipids in VLDL,A1BG,Alpha-1B-glycoprotein,40539,0.0229109537831901,0.00172064186686903,0.0195384957241268,0.0262834118422534,3.770170530022e-40
NMR metabolomics,X23424.Total Lipids in VLDL,EIF4E,Eukaryotic translation initiation factor 4E,40199,0.121267791145938,0.00911226076195023,0.103407760052515,0.13912782223936,4.23144056835823e-40
NMR metabolomics,X23424.Total Lipids in VLDL,MESD,LRP chaperone MESD,42611,0.161327802425577,0.0121338164730236,0.137545522138451,0.185110082712703,4.39415221390777e-40
NMR metabolomics,X23424.Total Lipids in VLDL,TSC22D1,TSC22 domain family protein 1,40482,0.0875600214186181,0.00658183956324805,0.0746596158746519,0.100460426962584,4.43591967017104e-40
NMR metabolomics,X23424.Total Lipids in VLDL,STXBP1,Syntaxin-binding protein 1,40482,0.103096899136587,0.00775242337167964,0.087902149328095,0.118291648945079,4.71341586087794e-40
NMR metabolomics,X23424.Total Lipids in VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40511,0.120034208062934,0.00902621845095551,0.102342819899061,0.137725596226807,4.72210532644585e-40
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJB14,DnaJ homolog subfamily B member 14,40449,0.085036029606807,0.00639562753219624,0.0725005996437024,0.0975714595699116,4.89405434840312e-40
NMR metabolomics,X23424.Total Lipids in VLDL,GGCT,Gamma-glutamylcyclotransferase,40500,0.0639652588285883,0.00481561781255507,0.0545266479159804,0.0734038697411963,5.79568979505496e-40
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINE2,Glia-derived nexin,40511,0.0860339919480677,0.00649034513764144,0.0733129154782905,0.0987550684178449,8.27876448098785e-40
NMR metabolomics,X23424.Total Lipids in VLDL,CASP7,Caspase-7,40483,0.111600770537197,0.00843769906714141,0.0950628803656003,0.128138660708795,1.21678633671666e-39
NMR metabolomics,X23424.Total Lipids in VLDL,CCL7,C-C motif chemokine 7,42594,0.0790114953940901,0.00597992492905557,0.0672908425331412,0.090732148255039,1.30924274057949e-39
NMR metabolomics,X23424.Total Lipids in VLDL,BIN2,Bridging integrator 2,42611,0.120381674159495,0.00911325117567689,0.102519701855168,0.138243646463821,1.36564389315199e-39
NMR metabolomics,X23424.Total Lipids in VLDL,EGF,Pro-epidermal growth factor,42597,0.136737952511543,0.0103524486750135,0.116447153108517,0.15702875191457,1.38900529949428e-39
NMR metabolomics,X23424.Total Lipids in VLDL,HSPB1,Heat shock protein beta-1,42448,0.0901970187596991,0.00682927606250245,0.0768116376771943,0.103582399842204,1.41380437413872e-39
NMR metabolomics,X23424.Total Lipids in VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42587,0.071063744215184,0.00538085053839063,0.0605172771599384,0.0816102112704296,1.41691187654343e-39
NMR metabolomics,X23424.Total Lipids in VLDL,MPI,Mannose-6-phosphate isomerase,42587,0.112226624492477,0.00851710330113988,0.0955331020222432,0.128920146962712,2.10342896081553e-39
NMR metabolomics,X23424.Total Lipids in VLDL,FMNL1,Formin-like protein 1,42311,0.0823281211578434,0.00625127198476113,0.0700756280677115,0.0945806142479752,2.32623007327399e-39
NMR metabolomics,X23424.Total Lipids in VLDL,MUC13,Mucin-13,42311,0.0695013387104808,0.00527888290117831,0.0591547282241713,0.0798479491967903,2.44792002106386e-39
NMR metabolomics,X23424.Total Lipids in VLDL,CIAPIN1,Anamorsin,42679,0.0823054064747366,0.00625413503825559,0.0700473017997556,0.0945635111497176,2.59862089357949e-39
NMR metabolomics,X23424.Total Lipids in VLDL,TP53I3,Quinone oxidoreductase PIG3,40058,0.0707187994787334,0.00537258018661329,0.0601885423129713,0.0812490566444954,2.86408678362486e-39
NMR metabolomics,X23424.Total Lipids in VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,42370,0.0613836983332121,0.00466700221599204,0.0522363739898677,0.0705310226765565,2.90171016754199e-39
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINB1,Leukocyte elastase inhibitor,42569,0.117612382110088,0.00894845305650811,0.100073414119332,0.135151350100844,3.25242991589364e-39
NMR metabolomics,X23424.Total Lipids in VLDL,MIF,Macrophage migration inhibitory factor,42586,0.0897169064393702,0.00683205025545036,0.0763260879386875,0.103107724940053,3.77868517731254e-39
NMR metabolomics,X23424.Total Lipids in VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42495,0.12359458914088,0.00942562033964871,0.105120373275168,0.142068805006591,4.86773223612425e-39
NMR metabolomics,X23424.Total Lipids in VLDL,ATOX1,Copper transport protein ATOX1,42679,0.0919455749625733,0.00702126682995632,0.0781838919758589,0.105707257949288,6.05290391886116e-39
NMR metabolomics,X23424.Total Lipids in VLDL,PARK7,Parkinson disease protein 7,42611,0.068442717404583,0.00522975175795418,0.0581924039589928,0.0786930308501732,6.74483789114664e-39
NMR metabolomics,X23424.Total Lipids in VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,42636,0.0881824946322031,0.00674147327170031,0.0749692070196705,0.101395782244736,7.34003063952661e-39
NMR metabolomics,X23424.Total Lipids in VLDL,SPARC,SPARC,42679,0.0923380826860933,0.0070645686746584,0.0784915280837628,0.106184637288424,8.34420777036235e-39
NMR metabolomics,X23424.Total Lipids in VLDL,CASP2,Caspase-2,42594,0.0887636526114911,0.0067962092810382,0.0754430824206563,0.102084222802326,9.51196999192735e-39
NMR metabolomics,X23424.Total Lipids in VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40511,0.0960692070590497,0.00736011396774484,0.0816433836822698,0.11049503043583,1.16620122388847e-38
NMR metabolomics,X23424.Total Lipids in VLDL,BPIFB2,BPI fold-containing family B member 2,40473,0.0909822432064035,0.00697135224236986,0.0773183928113585,0.104646093601448,1.19630052737673e-38
NMR metabolomics,X23424.Total Lipids in VLDL,CD22,B-cell receptor CD22,42754,0.0575014189619959,0.00440967864341284,0.0488584488209068,0.0661443891030851,1.23988947639665e-38
NMR metabolomics,X23424.Total Lipids in VLDL,CERT,Ceramide transfer protein,42311,0.0804233086528483,0.00617124247923959,0.0683276733935387,0.0925189439121579,1.39771865094501e-38
NMR metabolomics,X23424.Total Lipids in VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,42656,0.122493552522319,0.00940418282810296,0.104061354179237,0.140925750865401,1.49950595291615e-38
NMR metabolomics,X23424.Total Lipids in VLDL,PENK,Proenkephalin-A,40283,0.0432113048993176,0.00331743878993035,0.0367091248710541,0.0497134849275811,1.67845275857573e-38
NMR metabolomics,X23424.Total Lipids in VLDL,SCGB3A2,Secretoglobin family 3A member 2,42654,-0.114302769676675,0.00879474230139414,-0.131540464587407,-0.0970650747659421,2.1735538903873e-38
NMR metabolomics,X23424.Total Lipids in VLDL,JPT2,Jupiter microtubule associated homolog 2,40449,0.114163880600755,0.00877873627013394,0.0969575575112927,0.131370203690218,2.17723519119255e-38
NMR metabolomics,X23424.Total Lipids in VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,42346,0.0852684391980252,0.00656671717838037,0.0723976735283996,0.0981392048676507,2.56156814727539e-38
NMR metabolomics,X23424.Total Lipids in VLDL,BAG6,Large proline-rich protein BAG6,42357,0.0466464913758144,0.00359346888476333,0.0396032923616783,0.0536896903899505,2.69708369800043e-38
NMR metabolomics,X23424.Total Lipids in VLDL,MICALL2,MICAL-like protein 2,40182,0.0901907095006858,0.00695913991988305,0.0765507952577151,0.103830623743657,3.92117897919996e-38
NMR metabolomics,X23424.Total Lipids in VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,40449,0.0689673460050425,0.00532385207635178,0.058532595935393,0.079402096074692,4.15199072453768e-38
NMR metabolomics,X23424.Total Lipids in VLDL,COMT,Catechol O-methyltransferase,42214,0.10852234423514,0.00838340511369748,0.0920908702122928,0.124953818257987,4.31284344795723e-38
NMR metabolomics,X23424.Total Lipids in VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,40283,0.0784885419603416,0.00606105117037744,0.0666088816664018,0.0903682022542814,4.45408185588302e-38
NMR metabolomics,X23424.Total Lipids in VLDL,BCL2L1,Bcl-2-like protein 1,40483,0.129512779635593,0.0100078384074223,0.109897416357045,0.14912814291414,4.91383228747637e-38
NMR metabolomics,X23424.Total Lipids in VLDL,ESYT2,Extended synaptotagmin-2,40483,0.107521429762252,0.0083091147942306,0.0912355647655603,0.123807294758944,4.97442895768539e-38
NMR metabolomics,X23424.Total Lipids in VLDL,LACTB2,Endoribonuclease LACTB2,42636,0.0849027665430205,0.00656525231439433,0.0720348720068076,0.0977706610792333,4.99669877789469e-38
NMR metabolomics,X23424.Total Lipids in VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,40223,0.119697240321568,0.00925724497381217,0.101553040172897,0.13784144047024,5.74207954645285e-38
NMR metabolomics,X23424.Total Lipids in VLDL,ATG4A,Cysteine protease ATG4A,42346,0.0768374959317551,0.00594634072544249,0.0651826681098878,0.0884923237536224,5.77084302811553e-38
NMR metabolomics,X23424.Total Lipids in VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,40283,0.112364260835007,0.00869960176061007,0.0953130413842113,0.129415480285803,6.85434938069232e-38
NMR metabolomics,X23424.Total Lipids in VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,40302,0.0963974455670008,0.00746819033994436,0.0817597925007099,0.111035098633292,7.6128737535428e-38
NMR metabolomics,X23424.Total Lipids in VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,42711,0.0600470341381959,0.00465826461221481,0.0509168354982548,0.0691772327781369,8.50823876097536e-38
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINB6,Serpin B6,42679,0.0752563597172993,0.00583983832738054,0.0638102765956334,0.0867024428389651,8.93308236479161e-38
NMR metabolomics,X23424.Total Lipids in VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40511,0.0792073026576427,0.00615141889626374,0.0671505216209657,0.0912640836943196,1.12530915986779e-37
NMR metabolomics,X23424.Total Lipids in VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,42711,0.0844215639105207,0.00656998842292846,0.0715443866015809,0.0972987412194605,1.43473258983163e-37
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINC1,Antithrombin-III,40516,0.0191335325910997,0.00149086289738563,0.0162114413122239,0.0220556238699756,1.93136718053892e-37
NMR metabolomics,X23424.Total Lipids in VLDL,CDNF,Cerebral dopamine neurotrophic factor,42587,0.0436290830812266,0.00340446639997386,0.0369563289372779,0.0503018372251754,2.23309531537277e-37
NMR metabolomics,X23424.Total Lipids in VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42638,0.0335686970153221,0.00261954214056702,0.0284343944198107,0.0387029996108334,2.24392900182199e-37
NMR metabolomics,X23424.Total Lipids in VLDL,CCL8,C-C motif chemokine 8,42706,0.0783168558723346,0.00611177661405553,0.0663377737087857,0.0902959380358834,2.25630479741842e-37
NMR metabolomics,X23424.Total Lipids in VLDL,VEGFA,Vascular endothelial growth factor A,42716,0.0757567469588748,0.00591526129616888,0.0641628348183838,0.0873506590993658,2.46859482181462e-37
NMR metabolomics,X23424.Total Lipids in VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40511,0.116754854085554,0.00911928341803331,0.0988810585862089,0.1346286495849,2.85730564330558e-37
NMR metabolomics,X23424.Total Lipids in VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42594,0.116987867711193,0.00914661235838162,0.0990605074887646,0.134915227933621,3.06683688336603e-37
NMR metabolomics,X23424.Total Lipids in VLDL,DCTD,Deoxycytidylate deaminase,40283,0.121426545632573,0.00949697002747181,0.102812484378729,0.140040606886418,3.59969215706004e-37
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC4G,C-type lectin domain family 4 member G,42594,0.0427751774221931,0.00335193603182586,0.0362053827998144,0.0493449720445718,4.42998062336112e-37
NMR metabolomics,X23424.Total Lipids in VLDL,SULT2A1,Bile salt sulfotransferase,42594,0.0722694709612433,0.00567366273856615,0.0611490919936536,0.0833898499288329,5.97626654563002e-37
NMR metabolomics,X23424.Total Lipids in VLDL,MCEMP1,Mast cell-expressed membrane protein 1,40199,0.11733503865835,0.00921251762427761,0.0992785041147654,0.135391573201934,6.75063717482462e-37
NMR metabolomics,X23424.Total Lipids in VLDL,PDIA4,Protein disulfide-isomerase A4,40527,0.0770397377691762,0.00605291638248341,0.0651760216595087,0.0889034538788437,7.41316309081159e-37
NMR metabolomics,X23424.Total Lipids in VLDL,FST,Follistatin,42654,0.063182386465467,0.00496970490005712,0.0534417648613551,0.072923008069579,8.09937714046203e-37
NMR metabolomics,X23424.Total Lipids in VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,40223,0.0979815669514362,0.00771172975763753,0.0828665766264667,0.113096557276406,9.96223726996499e-37
NMR metabolomics,X23424.Total Lipids in VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42587,0.119301076390336,0.00939694925463011,0.100883055851261,0.137719096929411,1.01637381742798e-36
NMR metabolomics,X23424.Total Lipids in VLDL,TBC1D5,TBC1 domain family member 5,42594,0.100513455749339,0.00792072419421232,0.0849888363286833,0.116038075169996,1.09316125829642e-36
NMR metabolomics,X23424.Total Lipids in VLDL,CCL11,Eotaxin,42754,0.0470630930487312,0.00371139785779875,0.0397887532474457,0.0543374328500168,1.22133049637939e-36
NMR metabolomics,X23424.Total Lipids in VLDL,CETN2,Centrin-2,42311,0.0860906084387645,0.00679115735710734,0.0727799400188341,0.0994012768586948,1.30234645943861e-36
NMR metabolomics,X23424.Total Lipids in VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42667,0.141979926327359,0.0112037176662684,0.120020639701473,0.163939212953246,1.35709471406361e-36
NMR metabolomics,X23424.Total Lipids in VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40451,0.137839636982575,0.0108742818260398,0.116526044603537,0.159153229361613,1.43216398895143e-36
NMR metabolomics,X23424.Total Lipids in VLDL,GMFG,Glia maturation factor gamma,40511,0.0915490278154598,0.00722361464932272,0.0773907431027873,0.105707312528132,1.46734962842094e-36
NMR metabolomics,X23424.Total Lipids in VLDL,F11,Coagulation factor XI,40383,0.0386643668884776,0.00305282357229593,0.0326808326867776,0.0446479010901777,1.64253462936798e-36
NMR metabolomics,X23424.Total Lipids in VLDL,PLG,Plasminogen,40285,0.0274904401416238,0.00217125695646869,0.0232347765069452,0.0317461037763024,1.73687812791469e-36
NMR metabolomics,X23424.Total Lipids in VLDL,CD69,Early activation antigen CD69,42585,0.1116334986383,0.00882617979936911,0.0943341862315368,0.128932811045064,1.85449394412097e-36
NMR metabolomics,X23424.Total Lipids in VLDL,RILP,Rab-interacting lysosomal protein,42674,0.0760352587136187,0.00601290944039262,0.0642499562104492,0.0878205612167882,1.91159701682904e-36
NMR metabolomics,X23424.Total Lipids in VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,40223,0.0627478530845032,0.00496296755516147,0.0530204366763867,0.0724752694926197,2.18021586513959e-36
NMR metabolomics,X23424.Total Lipids in VLDL,F12,Coagulation factor XII,40539,0.0531312869644153,0.00420354659827018,0.0448923356318057,0.0613702382970248,2.24406594051281e-36
NMR metabolomics,X23424.Total Lipids in VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,42370,0.0678789173118348,0.00537555373683261,0.0573428319876429,0.0784150026360267,2.42292043248929e-36
NMR metabolomics,X23424.Total Lipids in VLDL,DYNLT1,Dynein light chain Tctex-type 1,40182,0.102888233562566,0.00814806985655451,0.0869180166437187,0.118858450481412,2.66659945539863e-36
NMR metabolomics,X23424.Total Lipids in VLDL,IL18,Interleukin-18,42566,0.0592100445021099,0.00469210258334478,0.0500135234387542,0.0684065655654657,2.6683773272449e-36
NMR metabolomics,X23424.Total Lipids in VLDL,TXNDC9,Thioredoxin domain-containing protein 9,40483,0.0671790538532548,0.00532348985680374,0.0567450137339194,0.0776130939725901,2.90099411136204e-36
NMR metabolomics,X23424.Total Lipids in VLDL,SDC4,Syndecan-4,42636,0.0600420049235636,0.00476542658160478,0.0507017688236182,0.069382241023509,3.40269267691083e-36
NMR metabolomics,X23424.Total Lipids in VLDL,STK24,Serine/threonine-protein kinase 24,42311,0.0781694537975406,0.00620858318120259,0.0660006307623835,0.0903382768326977,3.85084817073876e-36
NMR metabolomics,X23424.Total Lipids in VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,42711,0.040260372286893,0.00319846601321825,0.0339913789009853,0.0465293656728008,3.94936492732059e-36
NMR metabolomics,X23424.Total Lipids in VLDL,RASSF2,Ras association domain-containing protein 2,42346,0.0722410739443937,0.00574338669342025,0.06098403602529,0.0834981118634974,4.49226445603808e-36
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA3,Annexin A3,42681,0.0881905578622849,0.00701448757208304,0.0744421622210021,0.101938953503568,4.7558969776306e-36
NMR metabolomics,X23424.Total Lipids in VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,42611,0.0720375482463922,0.00573020683104953,0.0608063428575351,0.0832687536352493,4.83254295897086e-36
NMR metabolomics,X23424.Total Lipids in VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,40451,0.119143395098266,0.00950814776509402,0.100507425478682,0.137779364717851,8.78871815125435e-36
NMR metabolomics,X23424.Total Lipids in VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,40199,0.0634695928051532,0.00506484980796936,0.0535424871815332,0.0733966984287731,8.81919579784562e-36
NMR metabolomics,X23424.Total Lipids in VLDL,RAB33A,Ras-related protein Rab-33A,40116,0.0830979687095807,0.00664319861210818,0.0700772994298486,0.0961186379893127,1.17351964217053e-35
NMR metabolomics,X23424.Total Lipids in VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,40223,0.0925012160185017,0.00741195395713848,0.0779737862625103,0.107028645774493,1.66650382510396e-35
NMR metabolomics,X23424.Total Lipids in VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42676,0.148224207193207,0.0118963871381074,0.124907288402516,0.171541125983897,1.94304105285903e-35
NMR metabolomics,X23424.Total Lipids in VLDL,HMOX2,Heme oxygenase 2,42311,0.0575359608567272,0.00462028225677132,0.0484802076334554,0.066591714079999,2.13724015842232e-35
NMR metabolomics,X23424.Total Lipids in VLDL,STX4,Syntaxin-4,42587,0.0746165429076139,0.00600258142649554,0.0628514833116827,0.0863816025035452,2.78568611637399e-35
NMR metabolomics,X23424.Total Lipids in VLDL,APOL1,Apolipoprotein L1,40532,0.0732136924307887,0.00589323368645539,0.0616629544053361,0.0847644304562412,3.30754599384467e-35
NMR metabolomics,X23424.Total Lipids in VLDL,TTF2,Transcription termination factor 2,40182,0.0615318480471565,0.00495591536592174,0.0518182539299499,0.0712454421643631,3.68916365593961e-35
NMR metabolomics,X23424.Total Lipids in VLDL,CASP3,Caspase-3,42794,0.108453341206667,0.00875640546078911,0.0912907865035205,0.125615895909814,4.83138331880102e-35
NMR metabolomics,X23424.Total Lipids in VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",40481,0.0496501540579194,0.00401641687226586,0.0417779769882783,0.0575223311275605,7.07004158706222e-35
NMR metabolomics,X23424.Total Lipids in VLDL,HPSE,Heparanase,40408,0.117186491972661,0.00948129164212172,0.0986031603541021,0.135769823591219,7.27386246501664e-35
NMR metabolomics,X23424.Total Lipids in VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,40199,0.0998368501076859,0.00807879044191271,0.084002420841537,0.115671279373835,7.51568086239764e-35
NMR metabolomics,X23424.Total Lipids in VLDL,KLB,Beta-klotho,42311,-0.0933121805080167,0.00755711114517785,-0.108124118352565,-0.0785002426634681,7.83464143989374e-35
NMR metabolomics,X23424.Total Lipids in VLDL,KITLG,Kit ligand,42636,-0.0468895865998356,0.00379878032618524,-0.0543351960391586,-0.0394439771605125,8.16911875033087e-35
NMR metabolomics,X23424.Total Lipids in VLDL,AKT2,RAC-beta serine/threonine-protein kinase,40482,0.156593419632478,0.0127014366129921,0.131698603871014,0.181488235393943,1.05960226993199e-34
NMR metabolomics,X23424.Total Lipids in VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42654,0.0941873305561402,0.00764694382893582,0.079199320651426,0.109175340460854,1.12794053296002e-34
NMR metabolomics,X23424.Total Lipids in VLDL,SEPTIN9,Septin-9,42587,0.0354666364658831,0.00287984246417804,0.0298221452360941,0.041111127695672,1.1514952735805e-34
NMR metabolomics,X23424.Total Lipids in VLDL,APOE,Apolipoprotein E,40539,0.0908141308602194,0.00737427031522167,0.0763605610423849,0.105267700678054,1.25130314852954e-34
NMR metabolomics,X23424.Total Lipids in VLDL,RP2,Protein XRP2,42587,0.0521581850763354,0.00424315027340631,0.043841610540459,0.0604747596122118,1.52894455495395e-34
NMR metabolomics,X23424.Total Lipids in VLDL,PLA2G4A,Cytosolic phospholipase A2,42676,0.107422112006087,0.00874358573212425,0.0902846839711233,0.12455954004105,1.65096655071225e-34
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS1,Galectin-1,42636,0.0435760236293093,0.00354736693593429,0.0366231844348781,0.0505288628237405,1.68924098799044e-34
NMR metabolomics,X23424.Total Lipids in VLDL,NUDT16,U8 snoRNA-decapping enzyme,40429,0.107466981591958,0.00874870561989269,0.0903195185769681,0.124614444606947,1.84179153610565e-34
NMR metabolomics,X23424.Total Lipids in VLDL,PPBP,Platelet basic protein,40471,0.104533042618007,0.00851386797578637,0.0878458613854662,0.121220223850549,1.9727388715216e-34
NMR metabolomics,X23424.Total Lipids in VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,42676,0.0488655258911889,0.00398340299810039,0.0410580560149121,0.0566729957674657,2.07071897098619e-34
NMR metabolomics,X23424.Total Lipids in VLDL,PKD2,Polycystin-2,40116,0.0724865826122178,0.00590711682246694,0.0609086336401826,0.084064531584253,2.18141491301489e-34
NMR metabolomics,X23424.Total Lipids in VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",42357,0.114383174681727,0.00932741138487316,0.0961014483673759,0.132664900996079,2.20083780372611e-34
NMR metabolomics,X23424.Total Lipids in VLDL,REEP4,Receptor expression-enhancing protein 4,40482,0.0768168371005351,0.00626264871039518,0.0645420456281605,0.0890916285729097,2.28522432254085e-34
NMR metabolomics,X23424.Total Lipids in VLDL,CALCA,Calcitonin,42476,0.0785294537919154,0.006408852346145,0.0659681031934713,0.0910908043903596,2.47213060328588e-34
NMR metabolomics,X23424.Total Lipids in VLDL,WDR46,WD repeat-containing protein 46,40451,0.0445477090738365,0.00363821744853208,0.0374168028747136,0.0516786152729594,2.97270471491596e-34
NMR metabolomics,X23424.Total Lipids in VLDL,CRYBB1,Beta-crystallin B1,40511,0.0789204625578842,0.00645542828623439,0.0662678231168648,0.0915731019989036,3.73221238031408e-34
NMR metabolomics,X23424.Total Lipids in VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,40116,0.0824218839626269,0.00674301190694578,0.0692055806250131,0.0956381873002406,3.89899525845163e-34
NMR metabolomics,X23424.Total Lipids in VLDL,NRGN,Neurogranin,40532,0.112190321355986,0.00918050156939665,0.0941965382799682,0.130184104432003,3.95942841173561e-34
NMR metabolomics,X23424.Total Lipids in VLDL,CDC37,Hsp90 co-chaperone Cdc37,42679,0.102831134953239,0.00842440183098195,0.0863193073645144,0.119342962541964,4.34998263895915e-34
NMR metabolomics,X23424.Total Lipids in VLDL,LARP1,La-related protein 1,40451,0.0755734884902132,0.0061938359789908,0.0634335699713913,0.0877134070090352,5.00928900409795e-34
NMR metabolomics,X23424.Total Lipids in VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,42618,0.0643437917134499,0.00529418244373108,0.053967194123737,0.0747203893031629,8.25398977260754e-34
NMR metabolomics,X23424.Total Lipids in VLDL,MYO9B,Unconventional myosin-IXb,42370,0.0811120086098652,0.00667511089820594,0.0680287912493816,0.0941952259703489,8.54872232885045e-34
NMR metabolomics,X23424.Total Lipids in VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42673,-0.0399527598043982,0.00328823477961151,-0.0463976999724367,-0.0335078196363596,8.59302430037429e-34
NMR metabolomics,X23424.Total Lipids in VLDL,GP1BB,Platelet glycoprotein Ib beta chain,40116,0.0849143992107752,0.00699692926175325,0.0712004178577388,0.0986283805638115,1.12161635038144e-33
NMR metabolomics,X23424.Total Lipids in VLDL,RNASEH2A,Ribonuclease H2 subunit A,40482,0.058882447570257,0.00485248257441797,0.0493715817243978,0.0683933134161163,1.12328290715088e-33
NMR metabolomics,X23424.Total Lipids in VLDL,CTSZ,Cathepsin Z,42648,0.0395287614630082,0.00326034762333872,0.0331384801212643,0.0459190428047521,1.1791772182144e-33
NMR metabolomics,X23424.Total Lipids in VLDL,JAM3,Junctional adhesion molecule C,40283,0.0622108022477798,0.00513407584584313,0.0521480135899273,0.0722735909056324,1.3949190580195e-33
NMR metabolomics,X23424.Total Lipids in VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,40539,-0.0328206881334394,0.00271055303420596,-0.0381333720804831,-0.0275080041863957,1.53304723617593e-33
NMR metabolomics,X23424.Total Lipids in VLDL,PRSS2,Trypsin-2,42689,0.0683612817247801,0.00565090275104229,0.0572855123327372,0.079437051116823,1.62490818599802e-33
NMR metabolomics,X23424.Total Lipids in VLDL,CD5,T-cell surface glycoprotein CD5,42706,0.0441339404953927,0.00365066480111257,0.036978637485212,0.0512892435055733,1.79097225197876e-33
NMR metabolomics,X23424.Total Lipids in VLDL,CCS,Copper chaperone for superoxide dismutase,42495,0.0581513133485997,0.00481322123843584,0.0487173997212655,0.067585226975934,1.97744492139655e-33
NMR metabolomics,X23424.Total Lipids in VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40511,0.118603827375497,0.00983677844334506,0.099323741626541,0.137883913124454,2.84209227696228e-33
NMR metabolomics,X23424.Total Lipids in VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,42346,0.0636782638014233,0.00528381784160158,0.0533219808318842,0.0740345467709624,2.84906428307302e-33
NMR metabolomics,X23424.Total Lipids in VLDL,DXO,Decapping and exoribonuclease protein,40483,0.0556175506690136,0.00462030756524658,0.0465617478411303,0.0646733534968969,3.5960691272404e-33
NMR metabolomics,X23424.Total Lipids in VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,42297,0.0689633677232128,0.0057351122617723,0.0577225476901391,0.0802041877562865,3.93436989914937e-33
NMR metabolomics,X23424.Total Lipids in VLDL,NPPB,Natriuretic peptides B,42357,-0.172451025935328,0.0143416958650941,-0.200560749830912,-0.144341302039743,3.94192331330288e-33
NMR metabolomics,X23424.Total Lipids in VLDL,PQBP1,Polyglutamine-binding protein 1,42346,0.0692442028440449,0.005763332969283,0.0579480702242502,0.0805403354638396,4.43618110757663e-33
NMR metabolomics,X23424.Total Lipids in VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,42346,0.0807077491961114,0.00672457823437291,0.0675275758567405,0.0938879225354823,5.16418185479381e-33
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,40223,0.0556008895975288,0.00463062499050695,0.0465248646161352,0.0646769145789224,5.22892859451709e-33
NMR metabolomics,X23424.Total Lipids in VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40451,0.0417837133247274,0.00348023131831702,0.0349624599408261,0.0486049667086288,5.25380680268379e-33
NMR metabolomics,X23424.Total Lipids in VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,40223,0.123771808109478,0.0103096476951508,0.103564898626983,0.143978717591974,5.34088211712497e-33
NMR metabolomics,X23424.Total Lipids in VLDL,IL32,Interleukin-32,42594,-0.0537991475528703,0.00448546893875159,-0.0625906666728235,-0.0450076284329172,5.62812744154204e-33
NMR metabolomics,X23424.Total Lipids in VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40449,0.0775314481379801,0.00647161538258238,0.0648470819881186,0.0902158142878416,7.14540115396107e-33
NMR metabolomics,X23424.Total Lipids in VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,40116,0.0832213711230283,0.00695198202139584,0.0695954863610925,0.0968472558849642,8.09801217536378e-33
NMR metabolomics,X23424.Total Lipids in VLDL,TMEM106A,Transmembrane protein 106A,40451,0.084826680487671,0.00708788305958821,0.0709344296908781,0.0987189312844639,8.28006822631391e-33
NMR metabolomics,X23424.Total Lipids in VLDL,RBKS,Ribokinase,42317,0.0601341878896,0.00503184358255054,0.0502717744678009,0.0699966013113991,9.51706867825319e-33
NMR metabolomics,X23424.Total Lipids in VLDL,ACYP1,Acylphosphatase-1,40250,0.079189894181082,0.00663028648488914,0.0661945326706993,0.0921852556914647,1.11285741448579e-32
NMR metabolomics,X23424.Total Lipids in VLDL,FNDC1,Fibronectin type III domain-containing protein 1,40483,0.0570564407308791,0.00477955859919892,0.0476885058764492,0.0664243755853089,1.18467791445557e-32
NMR metabolomics,X23424.Total Lipids in VLDL,PDGFA,Platelet-derived growth factor subunit A,42794,0.0863820106101443,0.00724551178205631,0.072180807517314,0.100583213702975,1.31902511526924e-32
NMR metabolomics,X23424.Total Lipids in VLDL,CEBPB,CCAAT/enhancer-binding protein beta,42357,0.0458886982369911,0.00384981482231469,0.0383430611852543,0.0534343352887278,1.37440125156088e-32
NMR metabolomics,X23424.Total Lipids in VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,40116,0.0833758128549664,0.00699121488983932,0.0696730316708813,0.0970785940390515,1.38329319997147e-32
NMR metabolomics,X23424.Total Lipids in VLDL,PKN3,Serine/threonine-protein kinase N3,40302,0.0903715571212798,0.0075790344612361,0.0755166495772571,0.105226464665303,1.40407420418741e-32
NMR metabolomics,X23424.Total Lipids in VLDL,SWAP70,Switch-associated protein 70,40449,0.0430135875839409,0.00361357586034338,0.0359309788976679,0.050096196270214,1.78068227639714e-32
NMR metabolomics,X23424.Total Lipids in VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40482,0.119360908283449,0.0100361439229971,0.0996900661943747,0.139031750372523,2.00711272114931e-32
NMR metabolomics,X23424.Total Lipids in VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42721,0.0736803430837688,0.00620308786193894,0.0615222908743685,0.0858383952931691,2.23050368023346e-32
NMR metabolomics,X23424.Total Lipids in VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,40182,0.0732936833365584,0.00616877462436426,0.0612028850728044,0.0853844816003123,2.33282266283824e-32
NMR metabolomics,X23424.Total Lipids in VLDL,BMP6,Bone morphogenetic protein 6,42342,0.0486420156466703,0.0041048031014845,0.0405966015677607,0.05668742972558,3.13819854838584e-32
NMR metabolomics,X23424.Total Lipids in VLDL,TBCA,Tubulin-specific chaperone A,40283,0.101507251432926,0.00856854347330547,0.0847129062252474,0.118301596640605,3.50676759075458e-32
NMR metabolomics,X23424.Total Lipids in VLDL,SMTN,Smoothelin,40460,0.110344998654116,0.00933479832635261,0.0920487939344654,0.128641203373768,4.71134466563389e-32
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJC9,DnaJ homolog subfamily C member 9,40449,0.0915347003106926,0.0077642427223493,0.0763167845748879,0.106752616046497,6.82784143406994e-32
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,42357,0.130287079059546,0.0110589695932584,0.108611498656759,0.151962659462332,7.06021338537575e-32
NMR metabolomics,X23424.Total Lipids in VLDL,ZNRD2,Protein ZNRD2,40449,0.0831661371781822,0.00705740730745079,0.0693336188555787,0.0969986555007858,7.24260888703071e-32
NMR metabolomics,X23424.Total Lipids in VLDL,C3,Complement C3,39989,0.0561360582424761,0.00477065147436745,0.0467855813527159,0.0654865351322363,9.02920346302736e-32
NMR metabolomics,X23424.Total Lipids in VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,40283,0.0357175525826956,0.00303671302599017,0.0297655950517549,0.0416695101136364,9.46662522523114e-32
NMR metabolomics,X23424.Total Lipids in VLDL,STX8,Syntaxin-8,42594,0.0568259122357926,0.00483747642223445,0.0473444584482131,0.0663073660233721,1.04642603724692e-31
NMR metabolomics,X23424.Total Lipids in VLDL,CD274,Programmed cell death 1 ligand 1,42495,0.0416450328531157,0.00355021008826394,0.0346866210801184,0.048603444626113,1.27585224003265e-31
NMR metabolomics,X23424.Total Lipids in VLDL,C19orf12,Protein C19orf12,42311,0.0752893962446046,0.0064376266091513,0.062671648090668,0.0879071443985411,1.9314825977499e-31
NMR metabolomics,X23424.Total Lipids in VLDL,DBN1,Drebrin,40199,0.059256615144492,0.00506626913777371,0.0493267276344555,0.0691865026545284,2.04207560709811e-31
NMR metabolomics,X23424.Total Lipids in VLDL,BAG3,BAG family molecular chaperone regulator 3,42475,0.0480830770106823,0.00411509591051286,0.040017489026077,0.0561486649952875,2.17716730351203e-31
NMR metabolomics,X23424.Total Lipids in VLDL,CCL2,C-C motif chemokine 2,42475,0.0629501301218013,0.00539064103492536,0.0523844736933476,0.073515786550255,2.35899382476466e-31
NMR metabolomics,X23424.Total Lipids in VLDL,CST3,Cystatin-C,42659,0.0357054178972733,0.00305806454634244,0.0297116113864421,0.0416992244081045,2.39879811520651e-31
NMR metabolomics,X23424.Total Lipids in VLDL,PRSS8,Prostasin,42568,0.0494720389604875,0.00424588246661246,0.0411501093259271,0.0577939685950479,3.18058225137365e-31
NMR metabolomics,X23424.Total Lipids in VLDL,CHRDL2,Chordin-like protein 2,42636,0.0556795443374234,0.00478319998940827,0.0463044723581832,0.0650546163166636,3.61276927323789e-31
NMR metabolomics,X23424.Total Lipids in VLDL,PPP3R1,Calcineurin subunit B type 1,42495,0.0472108064888251,0.00405609554557468,0.0392608592194987,0.0551607537581515,3.67573251316962e-31
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC3B,Tetranectin,40269,0.0248333652518144,0.00213364140678243,0.0206514280945208,0.0290153024091079,3.96300896013921e-31
NMR metabolomics,X23424.Total Lipids in VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42594,0.095786912767984,0.0082345628544259,0.0796471695733093,0.111926655962659,3.98444533619675e-31
NMR metabolomics,X23424.Total Lipids in VLDL,BLNK,B-cell linker protein,40199,0.0481864630848571,0.00414082454376466,0.0400704469790784,0.0563024791906359,4.06817589211327e-31
NMR metabolomics,X23424.Total Lipids in VLDL,PNMA1,Paraneoplastic antigen Ma1,40223,0.0656616006926897,0.0056545929814502,0.0545785984490473,0.0767446029363321,5.41759147427782e-31
NMR metabolomics,X23424.Total Lipids in VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,40290,0.0520999518470099,0.00448873261252089,0.043302035926469,0.0608978677675509,5.74233712814008e-31
NMR metabolomics,X23424.Total Lipids in VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40511,0.0472249262108126,0.00407079494941273,0.0392461681099637,0.0552036843116616,6.09983677320811e-31
NMR metabolomics,X23424.Total Lipids in VLDL,DBI,Acyl-CoA-binding protein,42562,0.0894164667243451,0.00771786887221636,0.074289443734801,0.104543489713889,6.84413680500785e-31
NMR metabolomics,X23424.Total Lipids in VLDL,CEP170,Centrosomal protein of 170 kDa,40223,0.0906361052163236,0.0078200827060905,0.0753087431123862,0.105963467320261,6.97694303717787e-31
NMR metabolomics,X23424.Total Lipids in VLDL,GNAS,Neuroendocrine secretory protein 55,40482,0.100886184831451,0.0087075625289835,0.0838193622746436,0.117953007388259,7.24913985264667e-31
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42495,0.0674538265802534,0.00583161571142506,0.0560238597858602,0.0788837933746465,8.51008685165733e-31
NMR metabolomics,X23424.Total Lipids in VLDL,ESM1,Endothelial cell-specific molecule 1,42618,-0.0402066087709913,0.00347929515701222,-0.0470260272787352,-0.0333871902632473,9.62629727839995e-31
NMR metabolomics,X23424.Total Lipids in VLDL,GIPC3,PDZ domain-containing protein GIPC3,40449,0.113618263424192,0.00983774976855628,0.0943362738778222,0.132900252970563,1.10914581793929e-30
NMR metabolomics,X23424.Total Lipids in VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,42346,0.0862694053630868,0.00747576069882062,0.0716169143933984,0.100921896332775,1.16647218681449e-30
NMR metabolomics,X23424.Total Lipids in VLDL,HPGDS,Hematopoietic prostaglandin D synthase,42346,0.0448311803767464,0.00388863241823834,0.0372094608369992,0.0524528999164935,1.32542091981334e-30
NMR metabolomics,X23424.Total Lipids in VLDL,ITGA2,Integrin alpha-2,40283,0.0407797276925628,0.00353868182854999,0.0338439113086048,0.0477155440765208,1.49060415007797e-30
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,40283,0.0446977602179782,0.00388259119015203,0.0370878814852802,0.0523076389506762,1.70335082702658e-30
NMR metabolomics,X23424.Total Lipids in VLDL,CD1C,T-cell surface glycoprotein CD1c,42679,0.0293313448196308,0.00255312029433975,0.0243272290427249,0.0343354605965367,2.08897630322662e-30
NMR metabolomics,X23424.Total Lipids in VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42594,0.138891219541431,0.0120919690729391,0.11519096015847,0.162591478924392,2.1465601469512e-30
NMR metabolomics,X23424.Total Lipids in VLDL,GDF2,Growth/differentiation factor 2,42636,0.0416382935679024,0.00363194167109575,0.0345196878925547,0.0487568992432501,2.75119591873816e-30
NMR metabolomics,X23424.Total Lipids in VLDL,F2R,Proteinase-activated receptor 1,42654,0.0646852502257244,0.00565427911981773,0.0536028631508817,0.0757676373005672,3.6351295155889e-30
NMR metabolomics,X23424.Total Lipids in VLDL,ERMAP,Erythroid membrane-associated protein,40199,0.0519260244447277,0.00453989658061869,0.043027827146715,0.0608242217427403,4.00820342736933e-30
NMR metabolomics,X23424.Total Lipids in VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,42794,-0.0381431872088829,0.00333796724593577,-0.044685603010917,-0.0316007714068488,4.20169241764465e-30
NMR metabolomics,X23424.Total Lipids in VLDL,BOLA2_BOLA2B,BolA-like protein 2,40223,0.0627369680562407,0.0054918760008703,0.0519728910945349,0.0735010450179465,4.70282071480273e-30
NMR metabolomics,X23424.Total Lipids in VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42594,0.0708078620501485,0.00620274510521867,0.0586504816439199,0.0829652424563771,4.81270964467485e-30
NMR metabolomics,X23424.Total Lipids in VLDL,INPP1,Inositol polyphosphate 1-phosphatase,42587,0.0610814057809049,0.00535161240015563,0.0505922454765998,0.0715705660852099,4.92011695144885e-30
NMR metabolomics,X23424.Total Lipids in VLDL,C1R,Complement C1r subcomponent,40539,0.022469074167647,0.00197285917284766,0.0186022701888656,0.0263358781464284,6.88575084120955e-30
NMR metabolomics,X23424.Total Lipids in VLDL,CDC26,Anaphase-promoting complex subunit CDC26,40428,0.0797435046647331,0.00700386931340904,0.0660159208104514,0.0934710885190149,7.18732788569502e-30
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPT1,Angiopoietin-1,42554,0.096415995977017,0.00847326053010438,0.0798084053380124,0.113023586616022,7.31382201311244e-30
NMR metabolomics,X23424.Total Lipids in VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,42794,0.0454938138352551,0.00399835591182739,0.0376570362480734,0.0533305914224368,7.33339632315129e-30
NMR metabolomics,X23424.Total Lipids in VLDL,ANG,Angiogenin,42618,0.0385954883479708,0.00339562280060289,0.0319400676587892,0.0452509090371525,8.42625761409705e-30
NMR metabolomics,X23424.Total Lipids in VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40449,0.120312509437759,0.010581792525931,0.0995721960869339,0.141052822788583,8.5975976448287e-30
NMR metabolomics,X23424.Total Lipids in VLDL,FEN1,Flap endonuclease 1,42346,0.073292344256509,0.00644929744652199,0.0606517212613259,0.0859329672516921,8.66105672306546e-30
NMR metabolomics,X23424.Total Lipids in VLDL,GGACT,Gamma-glutamylaminecyclotransferase,40511,0.0808236050405483,0.00711134764206538,0.0668853636621001,0.0947618464189964,9.01084972414834e-30
NMR metabolomics,X23424.Total Lipids in VLDL,CCL4,C-C motif chemokine 4,42642,0.0783961932742755,0.00692096156322458,0.0648311086103554,0.0919612779381957,1.30821732341067e-29
NMR metabolomics,X23424.Total Lipids in VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,40527,0.0590298795287091,0.00521854400950912,0.0488015332700713,0.069258225787347,1.65536327625308e-29
NMR metabolomics,X23424.Total Lipids in VLDL,AIF1,Allograft inflammatory factor 1,42346,0.0595874462089674,0.0052734391514914,0.0492515054720442,0.0699233869458905,1.80328031198681e-29
NMR metabolomics,X23424.Total Lipids in VLDL,TSNAX,Translin-associated protein X,40116,0.0452874162231156,0.00400596388354477,0.0374357270113679,0.0531391054348634,1.80675179805827e-29
NMR metabolomics,X23424.Total Lipids in VLDL,ABHD14B,Protein ABHD14B,42460,0.0652333580115445,0.00577418611255028,0.0539159532309459,0.076550762792143,1.8421960091805e-29
NMR metabolomics,X23424.Total Lipids in VLDL,RAD23B,UV excision repair protein RAD23 homolog B,42346,0.0533958447141348,0.0047279977347374,0.0441289691540495,0.0626627202742201,1.92946429879832e-29
NMR metabolomics,X23424.Total Lipids in VLDL,AK2,"Adenylate kinase 2, mitochondrial",40483,0.120511727378778,0.0106752304503225,0.0995882756961459,0.14143517906141,2.1392782253465e-29
NMR metabolomics,X23424.Total Lipids in VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42711,0.0657265593824902,0.00582518068689804,0.0543092052361701,0.0771439135288104,2.15040482375033e-29
NMR metabolomics,X23424.Total Lipids in VLDL,DTNB,Dystrobrevin beta,40430,0.0489147650405779,0.0043337314352537,0.0404206514274807,0.0574088786536752,2.18982408709985e-29
NMR metabolomics,X23424.Total Lipids in VLDL,CPB1,Carboxypeptidase B,42794,0.0692942074831117,0.00614379869068313,0.0572523620493728,0.0813360529168506,2.25693312549736e-29
NMR metabolomics,X23424.Total Lipids in VLDL,SLMAP,Sarcolemmal membrane-associated protein,40449,0.0942923710529849,0.00835722663791759,0.0779122068426664,0.110672535263303,2.29564529466844e-29
NMR metabolomics,X23424.Total Lipids in VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,42636,0.0427701546957749,0.00379399141226718,0.0353339315277313,0.0502063778638186,2.41208500449922e-29
NMR metabolomics,X23424.Total Lipids in VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,42311,0.0725102946886087,0.00644479449781012,0.0598784974729008,0.0851420919043165,3.11695659235194e-29
NMR metabolomics,X23424.Total Lipids in VLDL,C2,Complement C2,42663,0.0260296804364971,0.00232044303191675,0.0214816120939403,0.0305777487790539,4.49931782791052e-29
NMR metabolomics,X23424.Total Lipids in VLDL,POMC,Pro-opiomelanocortin,40223,0.079369905147341,0.00710258192163656,0.0654488445809334,0.0932909657137487,7.73741491676292e-29
NMR metabolomics,X23424.Total Lipids in VLDL,MRI1,Methylthioribose-1-phosphate isomerase,40182,0.0777693817927127,0.00696969387720091,0.0641087817933989,0.0914299817920265,9.31705680977111e-29
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL1,Growth-regulated alpha protein,42607,0.107760637083777,0.00966529397025796,0.0888166609020713,0.126704613265482,9.66026646482011e-29
NMR metabolomics,X23424.Total Lipids in VLDL,NBN,Nibrin,42370,0.0604699018358285,0.00542396282240869,0.0498389347039074,0.0711008689677495,9.77332346778509e-29
NMR metabolomics,X23424.Total Lipids in VLDL,CEMIP2,Cell surface hyaluronidase,40199,0.0389619310957995,0.00349538605362934,0.032110974430686,0.045812887760913,1.05870948397156e-28
NMR metabolomics,X23424.Total Lipids in VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,40199,0.0612957047065833,0.00550141617191287,0.0505129290096341,0.0720784804035325,1.11755352248554e-28
NMR metabolomics,X23424.Total Lipids in VLDL,HAO1,Hydroxyacid oxidase 1,42721,0.140859874375689,0.0126503710423052,0.116065147132771,0.165654601618607,1.13108814731428e-28
NMR metabolomics,X23424.Total Lipids in VLDL,CPA1,Carboxypeptidase A1,42794,0.0703446961016786,0.00632526847378142,0.0579471698930671,0.0827422223102902,1.31398563886033e-28
NMR metabolomics,X23424.Total Lipids in VLDL,MATN2,Matrilin-2,42638,0.033315372877634,0.00299815006613885,0.0274389987480018,0.0391917470072661,1.46076733026179e-28
NMR metabolomics,X23424.Total Lipids in VLDL,FABP4,"Fatty acid-binding protein, adipocyte",42794,0.0574771616195345,0.00518995763323159,0.0473048446584006,0.0676494785806684,2.20101573757189e-28
NMR metabolomics,X23424.Total Lipids in VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",42754,0.073983701911078,0.00668435674030795,0.0608823627000744,0.0870850411220816,2.36707638116834e-28
NMR metabolomics,X23424.Total Lipids in VLDL,IL17RB,Interleukin-17 receptor B,42416,-0.0599482551654595,0.00541714321312432,-0.0705658558631832,-0.0493306544677358,2.43156261796836e-28
NMR metabolomics,X23424.Total Lipids in VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,42570,0.097174122638209,0.00878198305889741,0.0799614358427701,0.114386809433648,2.45672851605932e-28
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42638,0.0355873842562071,0.00322368922009267,0.0292689533848255,0.0419058151275887,3.26297202784905e-28
NMR metabolomics,X23424.Total Lipids in VLDL,IFT20,Intraflagellar transport protein 20 homolog,40182,0.0480987791432281,0.00435564401821681,0.0395617168675231,0.056635841418933,3.33912755074431e-28
NMR metabolomics,X23424.Total Lipids in VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42587,0.0380189664249656,0.0034457488924651,0.031265298595734,0.0447726342541972,3.48015543395881e-28
NMR metabolomics,X23424.Total Lipids in VLDL,FADD,FAS-associated death domain protein,42636,0.0842201484050414,0.00763347935898112,0.0692585288614384,0.0991817679486444,3.49930677756435e-28
NMR metabolomics,X23424.Total Lipids in VLDL,LBP,Lipopolysaccharide-binding protein,42689,-0.0655886989969729,0.00595462002587535,-0.0772597542476886,-0.0539176437462572,4.27315056114567e-28
NMR metabolomics,X23424.Total Lipids in VLDL,BAP18,Chromatin complexes subunit BAP18,40483,0.0754671594335071,0.00686451769767937,0.0620127047460555,0.0889216141209586,5.67350009706212e-28
NMR metabolomics,X23424.Total Lipids in VLDL,GP5,Platelet glycoprotein V,40283,0.040257397519227,0.00366420148112747,0.0330755626162172,0.0474392324222369,6.17040931226529e-28
NMR metabolomics,X23424.Total Lipids in VLDL,PSMG3,Proteasome assembly chaperone 3,42594,0.0568818683096134,0.00518409684248042,0.0467210384983518,0.067042698120875,6.8195929051507e-28
NMR metabolomics,X23424.Total Lipids in VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",40223,0.0492613937048524,0.00448896685599659,0.0404630186670991,0.0580597687426057,7.1111120202896e-28
NMR metabolomics,X23424.Total Lipids in VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,42664,0.131645831566962,0.0120052711481789,0.108115500116531,0.155176163017393,7.32958239944398e-28
NMR metabolomics,X23424.Total Lipids in VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,40223,0.0586417104164701,0.00534981554546852,0.0481560719473518,0.0691273488855884,8.14736843062888e-28
NMR metabolomics,X23424.Total Lipids in VLDL,BLMH,Bleomycin hydrolase,42794,0.0346211015494691,0.00317001044695258,0.028407881073442,0.0408343220254962,1.1858013418195e-27
NMR metabolomics,X23424.Total Lipids in VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,42706,0.0733522785902885,0.00671842551420397,0.0601841645824487,0.0865203925981283,1.23235194390161e-27
NMR metabolomics,X23424.Total Lipids in VLDL,KLF4,Krueppel-like factor 4,40136,0.0443939922315206,0.00407190821517321,0.0364130521297811,0.0523749323332601,1.55325999369685e-27
NMR metabolomics,X23424.Total Lipids in VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42636,0.0695499199904653,0.0063860778365566,0.0570332074308143,0.0820666325501162,1.66003069663662e-27
NMR metabolomics,X23424.Total Lipids in VLDL,NFAT5,Nuclear factor of activated T-cells 5,40199,0.0954545528573596,0.0087761807118672,0.0782532386620999,0.112655867052619,2.05535186330435e-27
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42794,0.0259986001952056,0.00239184787404433,0.0213105783620787,0.0306866220283325,2.0840184181261e-27
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,40511,0.0313506569264422,0.00288387477089703,0.025698262375484,0.0370030514774004,2.16334939357824e-27
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42579,0.0270232835355376,0.0024868356137058,0.0221490857326742,0.031897481338401,2.16521929121732e-27
NMR metabolomics,X23424.Total Lipids in VLDL,SOD1,Superoxide dismutase [Cu-Zn],42365,0.052738126139931,0.00485998723637793,0.0432125511566303,0.0622637011232317,2.55994357756666e-27
NMR metabolomics,X23424.Total Lipids in VLDL,HNMT,Histamine N-methyltransferase,42439,0.0527288499815471,0.00487004719182955,0.0431835574855612,0.062274142477533,3.32674474240609e-27
NMR metabolomics,X23424.Total Lipids in VLDL,MZT1,Mitotic-spindle organizing protein 1,42346,0.0566058260831833,0.00522846533468012,0.0463580340272103,0.0668536181391564,3.35836225472095e-27
NMR metabolomics,X23424.Total Lipids in VLDL,DCTN6,Dynactin subunit 6,42311,0.0785903751676887,0.00726476472799292,0.0643514363008226,0.0928293140345548,3.68235403616642e-27
NMR metabolomics,X23424.Total Lipids in VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,40451,0.0623112449347351,0.00576005858040928,0.051021530117133,0.0736009597523373,3.85390662296173e-27
NMR metabolomics,X23424.Total Lipids in VLDL,GP6,Platelet glycoprotein VI,42590,0.095173488929041,0.00880316039883698,0.0779192945473205,0.112427683310761,3.9388638861846e-27
NMR metabolomics,X23424.Total Lipids in VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,40483,0.0354046155245567,0.00327395038818209,0.0289876727637198,0.0418215582853936,4.01090470904746e-27
NMR metabolomics,X23424.Total Lipids in VLDL,SCRN1,Secernin-1,42594,0.060514885399459,0.00559891408212906,0.0495410137984861,0.071488757000432,4.06662960824233e-27
NMR metabolomics,X23424.Total Lipids in VLDL,RAB2B,Ras-related protein Rab-2B,40451,0.0662462106788737,0.00613405351425534,0.0542234657909332,0.0782689555668141,4.68339087391415e-27
NMR metabolomics,X23424.Total Lipids in VLDL,CCL24,C-C motif chemokine 24,42654,0.0904873996668946,0.00838400268289574,0.074054754408419,0.10692004492537,4.80005902800347e-27
NMR metabolomics,X23424.Total Lipids in VLDL,RAB10,Ras-related protein Rab-10,40511,0.058505286342689,0.00541980030533298,0.0478824777442363,0.0691280949411416,4.93546733782617e-27
NMR metabolomics,X23424.Total Lipids in VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,40185,0.0304780105600913,0.00282678746672271,0.0249375071253148,0.0360185139948678,5.72015384135612e-27
NMR metabolomics,X23424.Total Lipids in VLDL,APP,Amyloid-beta precursor protein,42592,0.0724162808442227,0.00672468233675151,0.0592359034641898,0.0855966582242557,6.23351358898837e-27
NMR metabolomics,X23424.Total Lipids in VLDL,GDNF,Glial cell line-derived neurotrophic factor,42311,0.0417077103474629,0.00387377476343583,0.0341151118111287,0.0493003088837972,6.40674670776854e-27
NMR metabolomics,X23424.Total Lipids in VLDL,SH3BP1,SH3 domain-binding protein 1,40449,0.0522022814960937,0.00484975439289232,0.0426967628860247,0.0617078001061626,6.8881839966783e-27
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42495,0.0638422857456422,0.0059468761529391,0.0521864084858816,0.0754981630054028,8.93273513478688e-27
NMR metabolomics,X23424.Total Lipids in VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,42676,-0.0225437487551664,0.0021019462262754,-0.0266635633586662,-0.0184239341516666,9.93809589723245e-27
NMR metabolomics,X23424.Total Lipids in VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,42346,0.0655360815187226,0.00611106544157147,0.0535583932532425,0.0775137697842027,1.01089692070122e-26
NMR metabolomics,X23424.Total Lipids in VLDL,IL10RB,Interleukin-10 receptor subunit beta,42676,0.0327067805419052,0.00305001378289133,0.0267287535274381,0.0386848075563722,1.01201306933755e-26
NMR metabolomics,X23424.Total Lipids in VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40482,0.0726668767735168,0.00677697524422682,0.0593840052948322,0.0859497482522014,1.0716371952139e-26
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJC21,DnaJ homolog subfamily C member 21,40483,0.0415915125055707,0.00388421642509081,0.0339784483123927,0.0492045766987487,1.25526757354066e-26
NMR metabolomics,X23424.Total Lipids in VLDL,FRMD4B,FERM domain-containing protein 4B,40116,0.0761207577268424,0.00711982728094247,0.0621658962561951,0.0900756191974896,1.51108953099942e-26
NMR metabolomics,X23424.Total Lipids in VLDL,CA13,Carbonic anhydrase 13,42483,0.110977341897946,0.0103863455761414,0.090620104568709,0.131334579227183,1.53457541417378e-26
NMR metabolomics,X23424.Total Lipids in VLDL,LONP1,"Lon protease homolog, mitochondrial",40223,0.0939703068701849,0.00879539339131273,0.076731335823212,0.111209277917158,1.62943458995057e-26
NMR metabolomics,X23424.Total Lipids in VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,40421,0.0327478882015784,0.00306886516711333,0.0267329124740362,0.0387628639291205,1.86245800137464e-26
NMR metabolomics,X23424.Total Lipids in VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40449,0.0819830670674001,0.00768654370481701,0.0669174414059587,0.0970486927288414,1.96750433414107e-26
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA12,Serpin A12,42249,0.111607329627875,0.0104845265710727,0.0910576575485722,0.132157001707177,2.36062222665005e-26
NMR metabolomics,X23424.Total Lipids in VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,40223,0.0470426156410125,0.00442940917099639,0.0383609736658596,0.0557242576161655,3.20199549315523e-26
NMR metabolomics,X23424.Total Lipids in VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42594,0.128580970021861,0.0121229087343798,0.104820068902477,0.152341871141246,3.53204375509703e-26
NMR metabolomics,X23424.Total Lipids in VLDL,TMSB10,Thymosin beta-10,42611,0.0794628667129361,0.0074967793782464,0.0647691791315731,0.094156554294299,3.79687485675999e-26
NMR metabolomics,X23424.Total Lipids in VLDL,GIP,Gastric inhibitory polypeptide,40223,0.0631277835725258,0.00595543765939735,0.051455125760107,0.0748004413849446,3.97844273819613e-26
NMR metabolomics,X23424.Total Lipids in VLDL,MIA,Melanoma-derived growth regulatory protein,42679,0.0404939737361291,0.00382218075512278,0.0330024994560885,0.0479854480161698,4.00439058390549e-26
NMR metabolomics,X23424.Total Lipids in VLDL,ITPA,Inosine triphosphate pyrophosphatase,40116,0.0721673894548934,0.00681607618139084,0.0588078801393674,0.0855268987704194,4.53941930380594e-26
NMR metabolomics,X23424.Total Lipids in VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,40189,0.0376729578343048,0.00356913853251099,0.0306774463105833,0.0446684693580264,6.39360121413594e-26
NMR metabolomics,X23424.Total Lipids in VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,42760,0.0356518530109168,0.00338261042760179,0.0290219365728173,0.0422817694490163,7.13190482804931e-26
NMR metabolomics,X23424.Total Lipids in VLDL,DDT,D-dopachrome decarboxylase,40527,0.0443898904047271,0.0042166596711577,0.0361252374492581,0.0526545433601962,8.50794316316449e-26
NMR metabolomics,X23424.Total Lipids in VLDL,CD72,B-cell differentiation antigen CD72,40283,0.0473635592672493,0.00449911970121349,0.0385452846528709,0.0561818338816278,8.55630720242198e-26
NMR metabolomics,X23424.Total Lipids in VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,40283,0.0447667487138724,0.00425271813957956,0.0364314211602965,0.0531020762674484,8.61721342048512e-26
NMR metabolomics,X23424.Total Lipids in VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,42565,0.0460856759517922,0.00438492639443742,0.0374912202186948,0.0546801316848895,9.78576010366476e-26
NMR metabolomics,X23424.Total Lipids in VLDL,BMPER,BMP-binding endothelial regulator protein,40283,0.0246779146856811,0.0023550981237532,0.0200619223631248,0.0292939070082374,1.42754628849225e-25
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL11,C-X-C motif chemokine 11,42711,0.0846048068703981,0.00808518588904692,0.0687578425278662,0.10045177121293,1.57939560290733e-25
NMR metabolomics,X23424.Total Lipids in VLDL,KLRD1,Natural killer cells antigen CD94,42754,0.0499265909423412,0.00477269937150686,0.0405721001741878,0.0592810817104947,1.63385963686049e-25
NMR metabolomics,X23424.Total Lipids in VLDL,CRLF1,Cytokine receptor-like factor 1,42676,0.0266539150576084,0.00254840865196879,0.0216590340997496,0.0316487960154672,1.66757118667131e-25
NMR metabolomics,X23424.Total Lipids in VLDL,SUOX,"Sulfite oxidase, mitochondrial",40482,0.0659554332872614,0.00630393339581821,0.0535997238314577,0.0783111427430651,1.67824729156155e-25
NMR metabolomics,X23424.Total Lipids in VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,40199,0.0564566210655992,0.00540262567259181,0.0458674747473193,0.0670457673838792,1.93024602782273e-25
NMR metabolomics,X23424.Total Lipids in VLDL,SLAMF6,SLAM family member 6,42346,0.0411301630867277,0.00393762785903338,0.0334124124830223,0.0488479136904331,1.93382001598898e-25
NMR metabolomics,X23424.Total Lipids in VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",40223,0.102811140729482,0.00983875207118956,0.0835271866699506,0.122095094789014,1.93387879285869e-25
NMR metabolomics,X23424.Total Lipids in VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,42346,0.0614196160062484,0.00588260356559346,0.0498897130176852,0.0729495189948116,2.02749955505404e-25
NMR metabolomics,X23424.Total Lipids in VLDL,ARFIP1,Arfaptin-1,40482,0.0720201746421375,0.00692775537943581,0.0584417740984433,0.0855985751858317,3.36327023252709e-25
NMR metabolomics,X23424.Total Lipids in VLDL,CCN4,CCN family member 4,42721,0.0421977526758123,0.00406089557414931,0.0342383973504796,0.0501571080011449,3.38092788625397e-25
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS3BP,Galectin-3-binding protein,40539,0.032330239247273,0.00311086894140591,0.0262329361221174,0.0384275423724286,3.47305003966456e-25
NMR metabolomics,X23424.Total Lipids in VLDL,FCN1,Ficolin-1,40515,0.0587386254576133,0.00565279561764847,0.0476591460470223,0.0698181048682043,3.53304932997779e-25
NMR metabolomics,X23424.Total Lipids in VLDL,C1RL,Complement C1r subcomponent-like protein,40519,0.0209158015965752,0.00201465413191941,0.0169670794980131,0.0248645236951372,3.8885308759127e-25
NMR metabolomics,X23424.Total Lipids in VLDL,LAP3,Cytosol aminopeptidase,42370,0.0509210332251954,0.00491102281593079,0.041295428505971,0.0605466379444197,4.29698205907255e-25
NMR metabolomics,X23424.Total Lipids in VLDL,GFRA1,GDNF family receptor alpha-1,42689,0.0312109456490733,0.00301324331931906,0.0253049887432079,0.0371169025549386,4.78137666602464e-25
NMR metabolomics,X23424.Total Lipids in VLDL,NID1,Nidogen-1,42652,0.040243386811794,0.00388537650026728,0.0326280488712701,0.0478587247523179,4.79760505989275e-25
NMR metabolomics,X23424.Total Lipids in VLDL,SNX9,Sorting nexin-9,42636,0.069998061236257,0.00677617612114448,0.0567167560388138,0.0832793664337001,6.38865481481798e-25
NMR metabolomics,X23424.Total Lipids in VLDL,SF3B4,Splicing factor 3B subunit 4,42587,0.0760227224184425,0.00736823118599846,0.0615809892938855,0.0904644555429995,7.2671295010874e-25
NMR metabolomics,X23424.Total Lipids in VLDL,MSTN,Growth/differentiation factor 8,42357,0.0557580926187944,0.00540428197090207,0.0451656999558264,0.0663504852817625,7.31265242712131e-25
NMR metabolomics,X23424.Total Lipids in VLDL,RGS10,Regulator of G-protein signaling 10,40482,0.0620466844040537,0.0060162199833367,0.0502548932367138,0.0738384755713937,7.91279007849078e-25
NMR metabolomics,X23424.Total Lipids in VLDL,MSR1,Macrophage scavenger receptor types I and II,42711,0.0481408530822619,0.00467315409162015,0.0389814710626864,0.0573002351018374,8.56080283634088e-25
NMR metabolomics,X23424.Total Lipids in VLDL,SNAP25,Synaptosomal-associated protein 25,40136,0.0495661752734403,0.0048133900841373,0.0401319307085312,0.0590004198383494,9.37361350629238e-25
NMR metabolomics,X23424.Total Lipids in VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42587,0.026144370583722,0.00254224562251121,0.0211615691636,0.0311271720038439,1.02843988183528e-24
NMR metabolomics,X23424.Total Lipids in VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42658,0.0533226099926176,0.00518946807358849,0.0431512525683841,0.063493967416851,1.12480091573379e-24
NMR metabolomics,X23424.Total Lipids in VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,42370,0.0685021484937383,0.00667540806727646,0.0554183486818764,0.0815859483056001,1.29542175281053e-24
NMR metabolomics,X23424.Total Lipids in VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40449,0.0479994268796158,0.0046768934449659,0.0388327157274826,0.057166138031749,1.32624483943591e-24
NMR metabolomics,X23424.Total Lipids in VLDL,CCL18,C-C motif chemokine 18,42477,0.0723996201069682,0.00705737873116508,0.0585671577938846,0.0862320824200518,1.33580686764452e-24
NMR metabolomics,X23424.Total Lipids in VLDL,TPK1,Thiamin pyrophosphokinase 1,40511,0.0284809717726602,0.002779793733588,0.0230325760548277,0.0339293674904927,1.58294458496764e-24
NMR metabolomics,X23424.Total Lipids in VLDL,XCL1,Lymphotactin,42721,0.0582989427295166,0.00569247956701436,0.0471416827781684,0.0694562026808647,1.58964082292401e-24
NMR metabolomics,X23424.Total Lipids in VLDL,CTRB1,Chymotrypsinogen B,42611,0.060100448186882,0.00588363261790821,0.048568528255782,0.0716323681179821,2.08986776458468e-24
NMR metabolomics,X23424.Total Lipids in VLDL,DYNLT3,Dynein light chain Tctex-type 3,40451,0.0450052745369545,0.00440655791902572,0.0363684210156641,0.0536421280582449,2.20939435586145e-24
NMR metabolomics,X23424.Total Lipids in VLDL,PPM1F,Protein phosphatase 1F,40511,0.0538886018328734,0.00527968084457559,0.0435404273775052,0.0642367762882416,2.3569671428364e-24
NMR metabolomics,X23424.Total Lipids in VLDL,MEP1B,Meprin A subunit beta,42636,0.122143409191386,0.0119734324217671,0.0986754816447229,0.14561133673805,2.40200859316211e-24
NMR metabolomics,X23424.Total Lipids in VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42587,-0.020355233281054,0.00199652202887848,-0.0242684164576558,-0.0164420501044521,2.55198681467623e-24
NMR metabolomics,X23424.Total Lipids in VLDL,CORO1A,Coronin-1A,42353,0.0919550542941303,0.00903943809555567,0.0742377556268412,0.109672352961419,3.22835986541245e-24
NMR metabolomics,X23424.Total Lipids in VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",42476,0.0749867218522829,0.00738706655152173,0.0605080714113003,0.0894653722932655,4.01337322757251e-24
NMR metabolomics,X23424.Total Lipids in VLDL,TST,Thiosulfate sulfurtransferase,42277,0.076636360035036,0.00755170272297854,0.0618350226979981,0.091437697372074,4.14446453279399e-24
NMR metabolomics,X23424.Total Lipids in VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",40449,0.0903254547035514,0.00890063442173805,0.0728802112369448,0.107770698170158,4.28508066869546e-24
NMR metabolomics,X23424.Total Lipids in VLDL,BDNF,Brain-derived neurotrophic factor,40527,0.0862494351574278,0.00850870632691172,0.0695723707566809,0.102926499558175,4.81220435144487e-24
NMR metabolomics,X23424.Total Lipids in VLDL,BTC,Probetacellulin,42346,0.0767019243560959,0.00758150379060021,0.0618421769265195,0.0915616717856723,5.68491780941975e-24
NMR metabolomics,X23424.Total Lipids in VLDL,CNDP1,Beta-Ala-His dipeptidase,42689,0.0473002579341939,0.00467742693681361,0.0381325011380392,0.0564680147303486,5.92154301059376e-24
NMR metabolomics,X23424.Total Lipids in VLDL,SCARF1,Scavenger receptor class F member 1,42794,0.0428163501128256,0.00423745812550341,0.0345109321868389,0.0511217680388123,6.42463914709461e-24
NMR metabolomics,X23424.Total Lipids in VLDL,STXBP3,Syntaxin-binding protein 3,42346,0.0443693704861288,0.00439221809319567,0.0357606230234653,0.0529781179487923,6.62875126287146e-24
NMR metabolomics,X23424.Total Lipids in VLDL,CD40LG,CD40 ligand,42754,0.0792917154619283,0.00785314716038537,0.063899547027573,0.0946838838962836,6.93147810905672e-24
NMR metabolomics,X23424.Total Lipids in VLDL,LEPR,Leptin receptor,42636,-0.0318945706079354,0.00315914348358361,-0.0380864918357592,-0.0257026493801115,7.00339775226291e-24
NMR metabolomics,X23424.Total Lipids in VLDL,AMIGO2,Amphoterin-induced protein 2,42587,0.0240103072226135,0.00238178818367471,0.0193420023826111,0.028678612062616,8.16948991733018e-24
NMR metabolomics,X23424.Total Lipids in VLDL,CCL26,C-C motif chemokine 26,42594,0.0953639236826108,0.00946696771701558,0.0768086669572603,0.113919180407961,8.80748694818009e-24
NMR metabolomics,X23424.Total Lipids in VLDL,OPLAH,5-oxoprolinase,40223,0.0691757341449218,0.00686600465947447,0.0557183650123518,0.0826331032774918,9.01930923414048e-24
NMR metabolomics,X23424.Total Lipids in VLDL,ING1,Inhibitor of growth protein 1,42292,0.0480883285993004,0.00477896214638746,0.038721562792381,0.0574550944062199,9.86810416316118e-24
NMR metabolomics,X23424.Total Lipids in VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,40482,0.0388247999707585,0.00386293121231357,0.0312534547946239,0.0463961451468931,1.14810403327237e-23
NMR metabolomics,X23424.Total Lipids in VLDL,MMP7,Matrilysin,42333,0.0513661206525189,0.00511575971255723,0.0413392316159067,0.0613930096891311,1.22765149245047e-23
NMR metabolomics,X23424.Total Lipids in VLDL,RBP2,Retinol-binding protein 2,42587,-0.0786887719087442,0.00783851873713657,-0.0940522686335319,-0.0633252751839566,1.24836828301878e-23
NMR metabolomics,X23424.Total Lipids in VLDL,PSPN,Persephin,42594,0.0948070535977743,0.00945244210692331,0.0762802670682046,0.113333840127344,1.36414769749778e-23
NMR metabolomics,X23424.Total Lipids in VLDL,LAMB1,Laminin subunit beta-1,40223,0.0309775992871735,0.00308993275352673,0.0249213310902611,0.0370338674840859,1.48782930138087e-23
NMR metabolomics,X23424.Total Lipids in VLDL,BPIFA2,BPI fold-containing family A member 2,39838,-0.115295002590141,0.0115016801128932,-0.137838295611412,-0.0927517095688703,1.51759496920881e-23
NMR metabolomics,X23424.Total Lipids in VLDL,MAGED1,Melanoma-associated antigen D1,42346,0.0490981637115087,0.00490044926859979,0.0394932831450532,0.0587030442779643,1.52573020089261e-23
NMR metabolomics,X23424.Total Lipids in VLDL,BGLAP,Osteocalcin,40527,0.0921430062898265,0.00919723397653737,0.0741164276958133,0.11016958488384,1.58262837905244e-23
NMR metabolomics,X23424.Total Lipids in VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,40511,0.061137380293771,0.00611073233675183,0.0491603449137375,0.0731144156738046,1.81496311210192e-23
NMR metabolomics,X23424.Total Lipids in VLDL,PCDH7,Protocadherin-7,40449,0.036857023386181,0.00368582112562195,0.0296328139799619,0.0440812327924,1.91508817351329e-23
NMR metabolomics,X23424.Total Lipids in VLDL,MMP3,Stromelysin-1,42611,-0.0512170463236859,0.00512520304064381,-0.0612624442833478,-0.041171648364024,1.97155128912971e-23
NMR metabolomics,X23424.Total Lipids in VLDL,PRG2,Bone marrow proteoglycan,40527,-0.0536579325496159,0.0053737587715816,-0.0641904997419158,-0.0431253653573159,2.21060313367309e-23
NMR metabolomics,X23424.Total Lipids in VLDL,SCRG1,Scrapie-responsive protein 1,40511,0.028960934282177,0.00290172720795161,0.0232735489545919,0.0346483196097622,2.31513754676236e-23
NMR metabolomics,X23424.Total Lipids in VLDL,STX16,Syntaxin-16,42346,0.0585206046244309,0.00586706064415154,0.0470211657618938,0.0700200434869679,2.38721336406684e-23
NMR metabolomics,X23424.Total Lipids in VLDL,FABP2,"Fatty acid-binding protein, intestinal",42636,-0.0799383060441416,0.00802479130231465,-0.0956668969966783,-0.0642097150916048,2.70763134825066e-23
NMR metabolomics,X23424.Total Lipids in VLDL,PARD3,Partitioning defective 3 homolog,40302,0.0751731244807029,0.00754615742945797,0.0603826559189653,0.0899635930424405,2.80484662956347e-23
NMR metabolomics,X23424.Total Lipids in VLDL,AMOTL2,Angiomotin-like protein 2,40404,0.0487477182247559,0.00489874878022478,0.0391461706155153,0.0583492658339965,3.11479344380628e-23
NMR metabolomics,X23424.Total Lipids in VLDL,TREML2,Trem-like transcript 2 protein,42611,0.0350924944000907,0.00352899580345416,0.0281756626253206,0.0420093261748609,3.22122842543682e-23
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42649,0.0215565881875982,0.00217619006532042,0.0172912556595702,0.0258219207156262,4.71739563336777e-23
NMR metabolomics,X23424.Total Lipids in VLDL,FAP,Prolyl endopeptidase FAP,42794,0.0274419646704675,0.0027717349919155,0.0220093640863131,0.0328745652546219,4.94848070002248e-23
NMR metabolomics,X23424.Total Lipids in VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42689,0.0428359305351075,0.00433264975304618,0.034343937019137,0.051327924051078,5.68641205301289e-23
NMR metabolomics,X23424.Total Lipids in VLDL,KLK7,Kallikrein-7,40009,0.0393022556295535,0.00397640138023119,0.0315085089243004,0.0470960023348067,6.11681899174817e-23
NMR metabolomics,X23424.Total Lipids in VLDL,PECAM1,Platelet endothelial cell adhesion molecule,42611,0.0300578486623652,0.00304785170347628,0.0240840593235517,0.0360316380011787,7.27641595096025e-23
NMR metabolomics,X23424.Total Lipids in VLDL,MENT,Protein MENT,40283,-0.023206365011216,0.00235379385442288,-0.0278198009658848,-0.0185929290565472,7.76871283601191e-23
NMR metabolomics,X23424.Total Lipids in VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,42459,0.0298303632058952,0.00302818429467303,0.0238951219883361,0.0357656044234544,8.13440679032651e-23
NMR metabolomics,X23424.Total Lipids in VLDL,TPMT,Thiopurine S-methyltransferase,42346,0.0727001780189193,0.00738214944649159,0.0582311651037957,0.0871691909340428,8.37564263344202e-23
NMR metabolomics,X23424.Total Lipids in VLDL,AFP,Alpha-fetoprotein,42459,0.0668376944471333,0.00680389999736287,0.053502050452302,0.0801733384419645,1.06661795227637e-22
NMR metabolomics,X23424.Total Lipids in VLDL,CD164,Sialomucin core protein 24,42611,0.0272074649905169,0.00277474985739571,0.0217689552700213,0.0326459747110125,1.2716142315126e-22
NMR metabolomics,X23424.Total Lipids in VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,40283,0.0375609653371739,0.00383285506879261,0.0300485694023404,0.0450733612720074,1.3940123561345e-22
NMR metabolomics,X23424.Total Lipids in VLDL,ARSA,Arylsulfatase A,42611,0.0441689876789445,0.00451401668360068,0.0353215149790871,0.0530164603788018,1.55570024797092e-22
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL16,C-X-C motif chemokine 16,42778,0.0236087609496965,0.00242215154511094,0.018861343921279,0.0283561779781139,2.24894364548708e-22
NMR metabolomics,X23424.Total Lipids in VLDL,TREH,Trehalase,40527,0.0735360555584487,0.0075428517801409,0.0587520660693726,0.0883200450475249,2.27833505506927e-22
NMR metabolomics,X23424.Total Lipids in VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",42357,0.0864904386000664,0.00888290994560298,0.0690799351066845,0.103900942093448,2.50041412785664e-22
NMR metabolomics,X23424.Total Lipids in VLDL,EGFL7,Epidermal growth factor-like protein 7,42346,0.0392329787214103,0.00403971346479816,0.0313151403304059,0.0471508171124147,3.1883746204663e-22
NMR metabolomics,X23424.Total Lipids in VLDL,CD74,HLA class II histocompatibility antigen gamma chain,42711,0.0349702606320915,0.00360285901740786,0.0279086569579721,0.0420318643062109,3.35062915266585e-22
NMR metabolomics,X23424.Total Lipids in VLDL,SDHB,Succinate dehydrogenase,40449,0.0654656220513593,0.00674456226640213,0.0522462800092111,0.0786849640935075,3.45828902803737e-22
NMR metabolomics,X23424.Total Lipids in VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,40116,0.0280970693520259,0.0028949724117347,0.0224229234250259,0.0337712152790259,3.51195813954843e-22
NMR metabolomics,X23424.Total Lipids in VLDL,FRZB,Secreted frizzled-related protein 3,42454,0.0245363571310364,0.00253075341383145,0.0195760804399268,0.029496633822146,3.7403704502473e-22
NMR metabolomics,X23424.Total Lipids in VLDL,SFRP1,Secreted frizzled-related protein 1,42457,0.0435034261769959,0.00448886582620344,0.0347052491576371,0.0523016031963546,3.88370645187849e-22
NMR metabolomics,X23424.Total Lipids in VLDL,GLO1,Lactoylglutathione lyase,42357,0.0568914131215434,0.00587184088368783,0.0453826049895153,0.0684002212535716,3.98637441923796e-22
NMR metabolomics,X23424.Total Lipids in VLDL,GSR,"Glutathione reductase, mitochondrial",40490,0.0221465780340889,0.00228513357521504,0.0176677162266674,0.0266254398415104,3.9919573262497e-22
NMR metabolomics,X23424.Total Lipids in VLDL,ARAF,Serine/threonine-protein kinase A-Raf,40302,0.0674784896996107,0.0069656939585979,0.0538257295407588,0.0811312498584626,4.17726370131452e-22
NMR metabolomics,X23424.Total Lipids in VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42495,0.0358787569000734,0.00370731065518959,0.0286124280159018,0.043145085784245,4.42889796571413e-22
NMR metabolomics,X23424.Total Lipids in VLDL,ASAH1,Acid ceramidase,40418,0.0448542257177337,0.00464170990500965,0.0357564743039148,0.0539519771315526,5.25887618922636e-22
NMR metabolomics,X23424.Total Lipids in VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40511,0.0297237694172053,0.00308348214662928,0.0236801444098119,0.0357673944245987,6.59826229420369e-22
NMR metabolomics,X23424.Total Lipids in VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40527,0.0618195815673492,0.00642156879337355,0.049233306732337,0.0744058564023614,7.46502493939795e-22
NMR metabolomics,X23424.Total Lipids in VLDL,ABCA2,ATP-binding cassette sub-family A member 2,40116,0.0353592033544642,0.00367364115829522,0.0281588666842056,0.0425595400247228,7.64736270691722e-22
NMR metabolomics,X23424.Total Lipids in VLDL,CD84,SLAM family member 5,42594,0.0305960625784673,0.0031817779702515,0.0243597777567743,0.0368323474001602,8.04731344564131e-22
NMR metabolomics,X23424.Total Lipids in VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42495,-0.116784712058147,0.0121620649867412,-0.14062235943216,-0.0929470646841342,9.19076094055269e-22
NMR metabolomics,X23424.Total Lipids in VLDL,SCRIB,Protein scribble homolog,40223,0.0886176674625327,0.00922623993010189,0.070534237199533,0.106701097725532,9.2683862055954e-22
NMR metabolomics,X23424.Total Lipids in VLDL,FGF2,Fibroblast growth factor 2,42594,0.0666142822050574,0.00693925971504896,0.0530133331635615,0.0802152312465534,9.42644869220573e-22
NMR metabolomics,X23424.Total Lipids in VLDL,CA4,Carbonic anhydrase 4,42794,-0.0234829808164988,0.00244791072568889,-0.028280885838849,-0.0186850757941486,1.00170266461877e-21
NMR metabolomics,X23424.Total Lipids in VLDL,FGF23,Fibroblast growth factor 23,42711,0.0529867579230251,0.00552473922573641,0.0421582690405818,0.0638152468054685,1.02467768187538e-21
NMR metabolomics,X23424.Total Lipids in VLDL,PRSS27,Serine protease 27,42603,0.0392095380228139,0.00409009905839672,0.0311929438683563,0.0472261321772714,1.06999960552387e-21
NMR metabolomics,X23424.Total Lipids in VLDL,SPINT2,Kunitz-type protease inhibitor 2,42676,0.0391629210405184,0.00409125651779917,0.031144058265632,0.0471817838154048,1.22439215036098e-21
NMR metabolomics,X23424.Total Lipids in VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,40199,0.039220788751083,0.00409724459899984,0.0311901893370433,0.0472513881651227,1.26694610086294e-21
NMR metabolomics,X23424.Total Lipids in VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",40283,0.0855835766177615,0.00894725207030892,0.068046962559956,0.103120190675567,1.35466648640962e-21
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,40527,0.022597315054363,0.00236767212458098,0.0179566776901842,0.0272379524185417,1.65357261055689e-21
NMR metabolomics,X23424.Total Lipids in VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',40483,0.0418490944254868,0.00438789438112441,0.033248821438483,0.0504493674124906,1.76444554086316e-21
NMR metabolomics,X23424.Total Lipids in VLDL,IMPA1,Inositol monophosphatase 1,42495,0.0584180452754524,0.00613493460613253,0.0463935734474326,0.0704425171034722,1.98424132098613e-21
NMR metabolomics,X23424.Total Lipids in VLDL,CDCP1,CUB domain-containing protein 1,42495,0.0524506102140762,0.00551851038637546,0.0416343298567803,0.0632668905713721,2.34989988464187e-21
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGAP1,Rho GTPase-activating protein 1,42346,0.0434875126566107,0.00458403034903806,0.0345028131724961,0.0524722121407253,2.78793996469253e-21
NMR metabolomics,X23424.Total Lipids in VLDL,DNM1,Dynamin-1,40449,0.109619346078498,0.0115634466053842,0.0869549907319445,0.13228370142505,3.05700731039884e-21
NMR metabolomics,X23424.Total Lipids in VLDL,IL12A_IL12B,Interleukin-12,42587,0.0787759944983377,0.00831300484709284,0.0624825049980357,0.0950694839986397,3.07259476286781e-21
NMR metabolomics,X23424.Total Lipids in VLDL,ACRBP,Acrosin-binding protein,40451,0.0375312730361681,0.00397884050847515,0.0297327456395568,0.0453298004327793,4.7784626924427e-21
NMR metabolomics,X23424.Total Lipids in VLDL,HPCAL1,Hippocalcin-like protein 1,42754,0.0691504611993204,0.00733711683406913,0.0547697122045449,0.0835312101940959,4.9996264761282e-21
NMR metabolomics,X23424.Total Lipids in VLDL,CCDC134,Coiled-coil domain-containing protein 134,40451,0.0466485293413474,0.00494936048312985,0.0369477827944129,0.0563492758882819,5.132313018259e-21
NMR metabolomics,X23424.Total Lipids in VLDL,GRK5,G protein-coupled receptor kinase 5,42357,0.0484945656054657,0.00515027504242796,0.0384000265223069,0.0585891046886245,5.4593394980363e-21
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTSL4,ADAMTS-like protein 4,40223,0.022771462611213,0.00241768530841941,0.018032799406711,0.0275101258157151,5.47535088877127e-21
NMR metabolomics,X23424.Total Lipids in VLDL,CBLN4,Cerebellin-4,42721,0.0310991286356398,0.0033033916103682,0.0246244810793181,0.0375737761919615,5.52083215776307e-21
NMR metabolomics,X23424.Total Lipids in VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42594,0.0776680598546669,0.00826793089649137,0.0614629152975438,0.09387320441179,6.70402081405307e-21
NMR metabolomics,X23424.Total Lipids in VLDL,ENO2,Gamma-enolase,42711,0.0613327906324969,0.00652910894978478,0.0485357370909187,0.074129844174075,6.70479125159549e-21
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTSL2,ADAMTS-like protein 2,40527,0.0326164477326434,0.00347175567962498,0.0258118066005784,0.0394210888647083,6.82783062336821e-21
NMR metabolomics,X23424.Total Lipids in VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40482,0.0872467069892776,0.0093141952142963,0.0689908843692568,0.105502529609298,8.87018488801078e-21
NMR metabolomics,X23424.Total Lipids in VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,40116,0.0384314767968343,0.00411535675550224,0.0303653775560499,0.0464975760376187,1.16583320128424e-20
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA9,Serpin A9,42538,0.0678988309081513,0.00727867671447458,0.0536326245477811,0.0821650372685215,1.24120984994854e-20
NMR metabolomics,X23424.Total Lipids in VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,40511,0.0309850834356732,0.00332368671180114,0.024470657480543,0.0374995093908035,1.34656163894936e-20
NMR metabolomics,X23424.Total Lipids in VLDL,FGR,Tyrosine-protein kinase Fgr,42311,0.0541035899574345,0.0058062046889942,0.0427234287670058,0.0654837511478631,1.36931599069573e-20
NMR metabolomics,X23424.Total Lipids in VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,42311,0.0492797616560005,0.00528932971842519,0.0389126754078872,0.0596468479041139,1.3875257004706e-20
NMR metabolomics,X23424.Total Lipids in VLDL,SLC27A4,Long-chain fatty acid transport protein 4,42311,0.0629498459539455,0.00675886576957371,0.049702469045581,0.07619722286231,1.4291085616126e-20
NMR metabolomics,X23424.Total Lipids in VLDL,CPXM1,Probable carboxypeptidase X1,42679,0.0655885752214319,0.00704697857023856,0.0517764972237643,0.0794006532190995,1.51039188032394e-20
NMR metabolomics,X23424.Total Lipids in VLDL,APRT,Adenine phosphoribosyltransferase,42480,0.0446641028835385,0.00480296012635967,0.0352503010358736,0.0540779047312035,1.6318185359179e-20
NMR metabolomics,X23424.Total Lipids in VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40483,0.0808073414375064,0.00868833648581284,0.0637782019253132,0.0978364809496996,1.65205616860794e-20
NMR metabolomics,X23424.Total Lipids in VLDL,TIMP1,Metalloproteinase inhibitor 1,42501,0.0276114015099765,0.00297076607477336,0.0217887000034207,0.0334341030165323,1.70811451217912e-20
NMR metabolomics,X23424.Total Lipids in VLDL,ITGA6,Integrin alpha-6,42594,0.0479529221343002,0.00516135813656663,0.0378366601866296,0.0580691840819708,1.76500140059401e-20
NMR metabolomics,X23424.Total Lipids in VLDL,TCOF1,Treacle protein,40511,0.0304029414176145,0.00327420455194571,0.023985500495801,0.0368203823394281,1.90064188039709e-20
NMR metabolomics,X23424.Total Lipids in VLDL,DDX58,Antiviral innate immune response receptor RIG-I,42346,0.0532651008106847,0.00574181244497406,0.0420111484185356,0.0645190532028339,2.01754525160275e-20
NMR metabolomics,X23424.Total Lipids in VLDL,UNC79,Protein unc-79 homolog,40080,0.0524531943351453,0.00565253906122774,0.0413742177751389,0.0635321708951516,2.02344698722861e-20
NMR metabolomics,X23424.Total Lipids in VLDL,C7orf50,Uncharacterized protein C7orf50,40483,0.0213953776011069,0.00231258238824254,0.0168627161201515,0.0259280390820623,2.60573582408088e-20
NMR metabolomics,X23424.Total Lipids in VLDL,ITGAL,Integrin alpha-L,40199,0.041951991009822,0.00453856368298415,0.0330564061911731,0.050847575828471,2.82569398002222e-20
NMR metabolomics,X23424.Total Lipids in VLDL,LPA,Apolipoprotein(a),40324,-0.170891833002859,0.018492222892118,-0.207136589871411,-0.134647076134308,2.87771316405686e-20
NMR metabolomics,X23424.Total Lipids in VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,40483,0.030552909956157,0.0033086483717909,0.0240679591474468,0.0370378607648672,3.0642303993309e-20
NMR metabolomics,X23424.Total Lipids in VLDL,DENR,Density-regulated protein,40199,0.0534397533814771,0.00579429260502441,0.0420829398756292,0.0647965668873249,3.42085062189812e-20
NMR metabolomics,X23424.Total Lipids in VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42722,0.0266209350109612,0.0028880587691932,0.0209603398233425,0.0322815301985798,3.48113113165421e-20
NMR metabolomics,X23424.Total Lipids in VLDL,EPCAM,Epithelial cell adhesion molecule,42616,-0.0924522057551547,0.0100370953772003,-0.112124912694467,-0.0727794988158421,3.70232396486037e-20
NMR metabolomics,X23424.Total Lipids in VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,40329,0.0521186949751676,0.00567150587328193,0.041002543463535,0.0632348464868002,4.64275656098985e-20
NMR metabolomics,X23424.Total Lipids in VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,40223,-0.0564820496162354,0.00616442484354144,-0.0685643223095767,-0.0443997769228942,5.96242495048702e-20
NMR metabolomics,X23424.Total Lipids in VLDL,TLR3,Toll-like receptor 3,42754,0.056737666386567,0.00619600960555179,0.0445934875596855,0.0688818452134485,6.08264286484606e-20
NMR metabolomics,X23424.Total Lipids in VLDL,IL6R,Interleukin-6 receptor subunit alpha,42582,0.0316198141038831,0.0034572618972371,0.0248435807852984,0.0383960474224678,6.75540550433335e-20
NMR metabolomics,X23424.Total Lipids in VLDL,NAA10,N-alpha-acetyltransferase 10,40116,0.0478266772997935,0.00522918855854187,0.0375774677250514,0.0580758868745355,6.94868269277676e-20
NMR metabolomics,X23424.Total Lipids in VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42495,0.0666257530352325,0.00728741556448579,0.0523424185288403,0.0809090875416246,6.97184122095163e-20
NMR metabolomics,X23424.Total Lipids in VLDL,ERI1,3'-5' exoribonuclease 1,40302,0.0319855881986664,0.0034993750956289,0.0251268130112338,0.038844363386099,7.30398714265851e-20
NMR metabolomics,X23424.Total Lipids in VLDL,C4BPB,C4b-binding protein beta chain,42679,0.0373319939815084,0.00408898879554181,0.0293175759422464,0.0453464120207703,7.81976507922138e-20
NMR metabolomics,X23424.Total Lipids in VLDL,CR1,Complement receptor type 1,40509,0.0335426506872636,0.0036765812373966,0.0263365514619662,0.0407487499125609,8.51501801459791e-20
NMR metabolomics,X23424.Total Lipids in VLDL,VSNL1,Visinin-like protein 1,40483,0.0355702676616007,0.00389967447090448,0.0279269056986279,0.0432136296245734,8.67428168518101e-20
NMR metabolomics,X23424.Total Lipids in VLDL,SCARA5,Scavenger receptor class A member 5,42711,0.0285213252170634,0.00313187408972997,0.0223828520011927,0.0346597984329342,9.66084436429839e-20
NMR metabolomics,X23424.Total Lipids in VLDL,CASP8,Caspase-8,42674,0.0565806282416217,0.00621447797981632,0.0444002514011817,0.0687610050820617,9.8559456571665e-20
NMR metabolomics,X23424.Total Lipids in VLDL,PTX3,Pentraxin-related protein PTX3,42594,-0.045143773194282,0.0049701316872881,-0.0548852313013666,-0.0354023150871973,1.20213268436206e-19
NMR metabolomics,X23424.Total Lipids in VLDL,FXN,"Frataxin, mitochondrial",42721,0.0672117566449619,0.0074169619435432,0.0526745112356173,0.0817490020543066,1.45579462789179e-19
NMR metabolomics,X23424.Total Lipids in VLDL,SMS,Spermine synthase,40136,0.0587677745239816,0.00648547529237465,0.0460562429509273,0.0714793060970359,1.50617107001354e-19
NMR metabolomics,X23424.Total Lipids in VLDL,EPPK1,Epiplakin,40223,0.0668137842392107,0.00737955245865958,0.0523498614202379,0.0812777070581834,1.61108903772485e-19
NMR metabolomics,X23424.Total Lipids in VLDL,TPP1,Tripeptidyl-peptidase 1,42545,0.041342372163128,0.00457039698817991,0.0323843940662953,0.0503003502599606,1.69021648272475e-19
NMR metabolomics,X23424.Total Lipids in VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40511,0.067793267654028,0.00749659031220432,0.0530999506421076,0.0824865846659485,1.76860704522639e-19
NMR metabolomics,X23424.Total Lipids in VLDL,RPE,Ribulose-phosphate 3-epimerase,40302,0.0641171469704038,0.00709916332671226,0.0502027868500478,0.0780315070907598,1.96995423086374e-19
NMR metabolomics,X23424.Total Lipids in VLDL,DHPS,Deoxyhypusine synthase,40451,0.0368777675191269,0.00410927474816985,0.028823589012714,0.0449319460255398,3.30356777377161e-19
NMR metabolomics,X23424.Total Lipids in VLDL,HDGF,Hepatoma-derived growth factor,42700,0.0846004563527585,0.00943689825676616,0.0661041357694969,0.10309677693602,3.51005099401116e-19
NMR metabolomics,X23424.Total Lipids in VLDL,OCLN,Occludin,40482,0.0409278263794671,0.00457227701358578,0.031966163432839,0.0498894893260952,4.06152381555896e-19
NMR metabolomics,X23424.Total Lipids in VLDL,DCTN2,Dynactin subunit 2,42587,0.084924730095857,0.00949411291030621,0.0663162687916568,0.103533191400057,4.2025205672381e-19
NMR metabolomics,X23424.Total Lipids in VLDL,PRDX6,Peroxiredoxin-6,42721,-0.0550717678364613,0.00615909678318538,-0.0671435975315047,-0.042999938141418,4.33003591423968e-19
NMR metabolomics,X23424.Total Lipids in VLDL,DGKZ,Diacylglycerol kinase zeta,42370,0.0316688574833841,0.00354293367840707,0.0247247074737063,0.038613007493062,4.46014990477249e-19
NMR metabolomics,X23424.Total Lipids in VLDL,LY75,Lymphocyte antigen 75,42594,0.0352725933142458,0.00395816760446024,0.0275145848095038,0.0430306018189879,5.68530211486595e-19
NMR metabolomics,X23424.Total Lipids in VLDL,LTA,Lymphotoxin-alpha,42594,0.0369631082135174,0.00414795007813549,0.0288331260603718,0.045093090366663,5.69393739555811e-19
NMR metabolomics,X23424.Total Lipids in VLDL,SCG2,Secretogranin-2,42636,0.0309279515268377,0.00347494423487309,0.0241170608264864,0.0377388422271889,6.2760265968356e-19
NMR metabolomics,X23424.Total Lipids in VLDL,CTSE,Cathepsin E,40283,0.0463653787838774,0.00520954655474876,0.0361546675365698,0.056576090031185,6.44711883769113e-19
NMR metabolomics,X23424.Total Lipids in VLDL,BOLA1,BolA-like protein 1,40136,0.0490097026007594,0.00550958078575708,0.0382109242606755,0.0598084809408433,6.73805821045444e-19
NMR metabolomics,X23424.Total Lipids in VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40449,0.105491177717066,0.0118815987569388,0.0822032441534662,0.128779111280666,7.79945619007373e-19
NMR metabolomics,X23424.Total Lipids in VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42587,0.0617403960518768,0.00695687461506173,0.0481049218063559,0.0753758702973978,7.89022516872886e-19
NMR metabolomics,X23424.Total Lipids in VLDL,CLSTN3,Calsyntenin-3,40483,0.0276928508341632,0.00312025848774734,0.0215771441981784,0.033808557470148,8.03315938743192e-19
NMR metabolomics,X23424.Total Lipids in VLDL,STK4,Serine/threonine-protein kinase 4,42636,0.0769929921716689,0.00867768886910746,0.0599847219882182,0.0940012623551195,8.04398208044392e-19
NMR metabolomics,X23424.Total Lipids in VLDL,NFASC,Neurofascin,42754,0.0260967036666098,0.00294651077630957,0.0203215425450431,0.0318718647881766,9.24475667770431e-19
NMR metabolomics,X23424.Total Lipids in VLDL,SCARB2,Lysosome membrane protein 2,42302,0.0314925861982273,0.00355778638030274,0.024519324892834,0.0384658475036207,9.71143458953731e-19
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA2,Annexin A2,40054,0.0653653345724004,0.00738270356122605,0.0508952355923973,0.0798354335524034,9.76835639935239e-19
NMR metabolomics,X23424.Total Lipids in VLDL,POSTN,Periostin,40527,-0.0347123285600562,0.00392343176256499,-0.0424022548146835,-0.0270224023054288,1.0279728616429e-18
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC5A,C-type lectin domain family 5 member A,42603,-0.0270657912154182,0.00306168301419483,-0.0330666899232401,-0.0210648925075964,1.07363885280324e-18
NMR metabolomics,X23424.Total Lipids in VLDL,GBP1,Guanylate-binding protein 1,40466,0.058831308830261,0.00666590358200526,0.0457661378095307,0.0718964798509913,1.24788063802906e-18
NMR metabolomics,X23424.Total Lipids in VLDL,IL17D,Interleukin-17D,42370,0.0307500533340237,0.00350298410694124,0.0238842044844189,0.0376159021836285,1.86304879506804e-18
NMR metabolomics,X23424.Total Lipids in VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40451,0.0491910014727291,0.00560706793343241,0.0382011483232015,0.0601808546222566,1.98921744395751e-18
NMR metabolomics,X23424.Total Lipids in VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",40223,0.0574250151742905,0.00655096035058231,0.0445851328871491,0.0702648974614318,2.12440744744797e-18
NMR metabolomics,X23424.Total Lipids in VLDL,GLRX,Glutaredoxin-1,42546,0.0498078683348142,0.00568410182356621,0.0386670287606244,0.0609487079090039,2.1346573435128e-18
NMR metabolomics,X23424.Total Lipids in VLDL,DEFB103A_DEFB103B,Beta-defensin 103,40135,0.0380396542115824,0.00434306192355795,0.0295272528414088,0.046552055581756,2.2655315363381e-18
NMR metabolomics,X23424.Total Lipids in VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42721,0.0236827953989881,0.00270624464822901,0.0183785558884592,0.0289870349095169,2.35900021577128e-18
NMR metabolomics,X23424.Total Lipids in VLDL,SPAG1,Sperm-associated antigen 1,40482,0.0509742351652388,0.0058248684567049,0.0395574929900972,0.0623909773403804,2.41173936519903e-18
NMR metabolomics,X23424.Total Lipids in VLDL,TNF,Tumor necrosis factor,42339,0.0341402419095774,0.00390424024779384,0.0264879310239015,0.0417925527952533,2.51187572553828e-18
NMR metabolomics,X23424.Total Lipids in VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,42346,0.0463159304908363,0.00530616371271113,0.0359158496139225,0.0567160113677501,2.8836597677043e-18
NMR metabolomics,X23424.Total Lipids in VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,40428,0.0367669304944772,0.00421209036649638,0.0285112333761443,0.0450226276128101,2.93432003784918e-18
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA4,Annexin A4,42584,0.0629717359773304,0.00723687660039758,0.0487874578405511,0.0771560141141097,3.65380503370525e-18
NMR metabolomics,X23424.Total Lipids in VLDL,TSHB,Thyrotropin subunit beta,42636,0.0700513467572814,0.00805229517471834,0.0542688482148334,0.0858338452997293,3.71544645540548e-18
NMR metabolomics,X23424.Total Lipids in VLDL,PLA2G15,Phospholipase A2 group XV,42679,0.0234302792840759,0.002698407688809,0.0181414002140103,0.0287191583541416,4.29316239571981e-18
NMR metabolomics,X23424.Total Lipids in VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40482,0.0511626976330214,0.00590010686841834,0.0395984881709215,0.0627269070951214,4.84743676124035e-18
NMR metabolomics,X23424.Total Lipids in VLDL,CD276,CD276 antigen,42618,-0.0323025207447521,0.00372833398253248,-0.0396100553505158,-0.0249949861389885,5.06817159827934e-18
NMR metabolomics,X23424.Total Lipids in VLDL,DSCAM,Down syndrome cell adhesion molecule,40482,0.0318712833452143,0.00368009723915005,0.0246582927564802,0.0390842739339484,5.33734891655462e-18
NMR metabolomics,X23424.Total Lipids in VLDL,CTSS,Cathepsin S,39872,0.0215308487181141,0.00248744548975609,0.0166554555581922,0.0264062418780361,5.5977839897648e-18
NMR metabolomics,X23424.Total Lipids in VLDL,S100P,Protein S100-P,42357,0.0478295653357572,0.00552874861846712,0.0369932180435616,0.0586659126279528,5.68850321168843e-18
NMR metabolomics,X23424.Total Lipids in VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,40449,0.0991702532415951,0.0114915424893582,0.076646829962453,0.121693676520737,6.96791304474843e-18
NMR metabolomics,X23424.Total Lipids in VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,40283,0.0616807635501843,0.00716446687577538,0.0476384084736646,0.0757231186267041,8.34587812380267e-18
NMR metabolomics,X23424.Total Lipids in VLDL,RPL14,60S ribosomal protein L14,40223,0.0350838421574804,0.00407537842336926,0.0270961004476767,0.0430715838672842,8.38992435379751e-18
NMR metabolomics,X23424.Total Lipids in VLDL,REN,Renin,42636,-0.0746585640094221,0.00868964303637602,-0.0916902643607191,-0.0576268636581251,9.507766171186e-18
NMR metabolomics,X23424.Total Lipids in VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,40302,0.0793869637036786,0.00924068386405216,0.0612752233301364,0.0974987040772209,9.77063117589497e-18
NMR metabolomics,X23424.Total Lipids in VLDL,NEK7,Serine/threonine-protein kinase Nek7,40302,0.0665505183939274,0.00774653226350257,0.0513673151574624,0.0817337216303925,9.77225317580214e-18
NMR metabolomics,X23424.Total Lipids in VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40483,0.0409903217534908,0.00477574605002655,0.0316298594954388,0.0503507840115429,1.04499349819963e-17
NMR metabolomics,X23424.Total Lipids in VLDL,CLTA,Clathrin light chain A,42357,0.0413973397215219,0.0048351193189811,0.031920505856319,0.0508741735867249,1.23348438523452e-17
NMR metabolomics,X23424.Total Lipids in VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,40199,0.0381257034578215,0.00445777095517741,0.0293884723856738,0.0468629345299693,1.36230076567178e-17
NMR metabolomics,X23424.Total Lipids in VLDL,AK1,Adenylate kinase isoenzyme 1,42636,0.0545479518197582,0.00639039782617585,0.0420227720804535,0.0670731315590628,1.53826445489724e-17
NMR metabolomics,X23424.Total Lipids in VLDL,IFNAR1,Interferon alpha/beta receptor 1,40449,0.0222955795923632,0.00261308793144344,0.017173927246734,0.0274172319379923,1.61863596040685e-17
NMR metabolomics,X23424.Total Lipids in VLDL,MYOM3,Myomesin-3,40283,-0.0803943026516623,0.00942537243214498,-0.0988680326186664,-0.0619205726846581,1.65973659469729e-17
NMR metabolomics,X23424.Total Lipids in VLDL,PPME1,Protein phosphatase methylesterase 1,42587,0.0515207691830344,0.00605084802320811,0.0396611070575465,0.0633804313085223,1.84771570516295e-17
NMR metabolomics,X23424.Total Lipids in VLDL,SLIT2,Slit homolog 2 protein,42311,0.0453403012515061,0.00533854844342807,0.0348767463023871,0.0558038562006251,2.22885107678126e-17
NMR metabolomics,X23424.Total Lipids in VLDL,ENTR1,Endosome-associated-trafficking regulator 1,40223,0.0504664114143944,0.00594363542503268,0.0388168859813304,0.0621159368474585,2.31445634832792e-17
NMR metabolomics,X23424.Total Lipids in VLDL,NGRN,Neugrin,40483,0.0199979776906647,0.00235570488763074,0.0153807961109085,0.024615159270421,2.34111771189296e-17
NMR metabolomics,X23424.Total Lipids in VLDL,C7,Complement component C7,40251,-0.0284840480106603,0.00335676767340207,-0.0350633126505284,-0.0219047833707923,2.42043690935796e-17
NMR metabolomics,X23424.Total Lipids in VLDL,CDA,Cytidine deaminase,40494,0.0404608613252181,0.00477003803205235,0.0311115867823955,0.0498101358680407,2.48252889301307e-17
NMR metabolomics,X23424.Total Lipids in VLDL,C5,Complement C5,40539,0.0129849884330013,0.00153258017897301,0.00998113128221421,0.0159888455837884,2.69473972013879e-17
NMR metabolomics,X23424.Total Lipids in VLDL,PVR,Poliovirus receptor,42711,0.0315360823397205,0.00372967937181024,0.0242259107709724,0.0388462539084685,3.06303183121897e-17
NMR metabolomics,X23424.Total Lipids in VLDL,NCF2,Neutrophil cytosol factor 2,42578,0.0707896035764732,0.00841846488568488,0.0542894124005308,0.0872897947524155,4.55626049610154e-17
NMR metabolomics,X23424.Total Lipids in VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,40199,0.0380305719383063,0.00452772295155648,0.0291562349532556,0.046904908923357,5.03451108602587e-17
NMR metabolomics,X23424.Total Lipids in VLDL,WAS,Wiskott-Aldrich syndrome protein,42370,0.0564437407005045,0.00673815492694289,0.0432369570436964,0.0696505243573125,5.98828493555801e-17
NMR metabolomics,X23424.Total Lipids in VLDL,CPQ,Carboxypeptidase Q,40516,0.0304321313855103,0.00363564480656049,0.0233062675646518,0.0375579952063689,6.41158414637031e-17
NMR metabolomics,X23424.Total Lipids in VLDL,SMARCA2,Probable global transcription activator SNF2L2,42311,0.0617686171772895,0.0073820173926401,0.0472998630877149,0.0762373712668641,6.47975755710955e-17
NMR metabolomics,X23424.Total Lipids in VLDL,PTN,Pleiotrophin,42357,0.0419849863553924,0.0050217308727909,0.0321423938447223,0.0518275788660626,6.85908045722064e-17
NMR metabolomics,X23424.Total Lipids in VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,40223,0.0353561177003108,0.00423895689062433,0.0270477621946871,0.0436644732059345,8.2593777077203e-17
NMR metabolomics,X23424.Total Lipids in VLDL,PALM2,Paralemmin-2,40483,0.0320039926070717,0.0038372802631455,0.0244829232913065,0.0395250619228368,8.27133525859865e-17
NMR metabolomics,X23424.Total Lipids in VLDL,ECE1,Endothelin-converting enzyme 1,42311,0.0301545698667526,0.00361639661266405,0.0230664325059311,0.0372427072275741,8.28360410831889e-17
NMR metabolomics,X23424.Total Lipids in VLDL,NPDC1,Neural proliferation differentiation and control protein 1,42636,0.0293229815519591,0.00352027111070651,0.0224232501749743,0.0362227129289439,8.88005505073371e-17
NMR metabolomics,X23424.Total Lipids in VLDL,CSTB,Cystatin-B,42437,0.0359857246650835,0.00432349119919394,0.0275116819146634,0.0444597674155036,9.38719041603471e-17
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,42370,0.0366113136817197,0.00439987052114999,0.0279875674602657,0.0452350599031737,9.57506357881733e-17
NMR metabolomics,X23424.Total Lipids in VLDL,ATP6V1F,V-type proton ATPase subunit F,42292,0.0560607519445025,0.00674339781486483,0.0428436922273674,0.0692778116616375,1.02085636965753e-16
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,40199,0.0297602746537969,0.00358000999591969,0.0227434550617943,0.0367770942457995,1.04367156859547e-16
NMR metabolomics,X23424.Total Lipids in VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40483,0.0692916880662089,0.00834413536570624,0.0529371827494247,0.0856461933829932,1.11909443160453e-16
NMR metabolomics,X23424.Total Lipids in VLDL,STX6,Syntaxin-6,42346,0.0557038076912068,0.00671638173470217,0.0425396994911906,0.0688679158912231,1.20361146942734e-16
NMR metabolomics,X23424.Total Lipids in VLDL,APOD,Apolipoprotein D,40033,-0.0368400348176702,0.00444099017556373,-0.0455443755617751,-0.0281356940735653,1.20978424928879e-16
NMR metabolomics,X23424.Total Lipids in VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,42346,0.044652399045411,0.00538449167688874,0.0340987953587091,0.055206002732113,1.21315340212792e-16
NMR metabolomics,X23424.Total Lipids in VLDL,PDZD2,PDZ domain-containing protein 2,40116,0.0509455884774044,0.00614760649901561,0.0388962797393338,0.062994897215475,1.29659111951558e-16
NMR metabolomics,X23424.Total Lipids in VLDL,NADK,NAD kinase,42636,0.0459376624104704,0.00554985712458432,0.0350599424462851,0.0568153823746557,1.37836331902791e-16
NMR metabolomics,X23424.Total Lipids in VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,40332,0.0479488005097687,0.00579629257938179,0.0365880670541804,0.059309533965357,1.46317077826648e-16
NMR metabolomics,X23424.Total Lipids in VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",42476,0.0800038115850528,0.0096888742639962,0.0610136180276202,0.0989940051424853,1.63014303630308e-16
NMR metabolomics,X23424.Total Lipids in VLDL,TPR,Nucleoprotein TPR,40116,0.0407405368825067,0.00494144354442324,0.0310553075354372,0.0504257662295763,1.84590701668992e-16
NMR metabolomics,X23424.Total Lipids in VLDL,EFCAB2,Dynein regulatory complex protein 8,40302,0.0292519168261092,0.00354968497986247,0.0222945342655787,0.0362092993866396,1.90413869643601e-16
NMR metabolomics,X23424.Total Lipids in VLDL,PDIA3,Protein disulfide-isomerase A3,40283,0.0207078151398039,0.00251658638075553,0.0157753058335231,0.0256403244460848,2.10703655783154e-16
NMR metabolomics,X23424.Total Lipids in VLDL,IFNGR2,Interferon gamma receptor 2,42495,0.0434953801850774,0.00529516819701266,0.0331168505189326,0.0538739098512222,2.33251961723709e-16
NMR metabolomics,X23424.Total Lipids in VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,42679,0.0812244187773128,0.00989839196739508,0.0618235705212184,0.100625267033407,2.49653900130569e-16
NMR metabolomics,X23424.Total Lipids in VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,40511,0.0223248695693935,0.00272225926438121,0.0169892414112063,0.0276604977275806,2.64424503051053e-16
NMR metabolomics,X23424.Total Lipids in VLDL,MNDA,Myeloid cell nuclear differentiation antigen,42611,0.0807718411447893,0.00985529934497972,0.0614554544286291,0.10008822786095,2.71411941862637e-16
NMR metabolomics,X23424.Total Lipids in VLDL,EFNA4,Ephrin-A4,42475,0.0283130272015896,0.00345516678570234,0.021540900301613,0.0350851541015662,2.74758589152841e-16
NMR metabolomics,X23424.Total Lipids in VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,42370,0.033041584573815,0.00403375018854481,0.0251354342042672,0.0409477349433628,2.82136303237796e-16
NMR metabolomics,X23424.Total Lipids in VLDL,SPOCK1,Testican-1,42495,0.0214427301633232,0.00262046326945551,0.0163066221551904,0.026578838171456,3.02370653436014e-16
NMR metabolomics,X23424.Total Lipids in VLDL,PTGES2,Prostaglandin E synthase 2,40102,0.0453031251535955,0.00553521419306326,0.0344541053351915,0.0561521449719995,3.03774624632241e-16
NMR metabolomics,X23424.Total Lipids in VLDL,IGF1R,Insulin-like growth factor 1 receptor,42587,0.0180534595196706,0.00220777181811409,0.013726226756167,0.0223806922831742,3.16416955199611e-16
NMR metabolomics,X23424.Total Lipids in VLDL,LAMA4,Laminin subunit alpha-4,42676,0.0274669553410582,0.00336106210273906,0.0208792736196897,0.0340546370624267,3.29900403848472e-16
NMR metabolomics,X23424.Total Lipids in VLDL,IL12B,Interleukin-12 subunit beta,42754,0.047073238099057,0.00576295854934636,0.0357778393423381,0.0583686368557758,3.40419328885813e-16
NMR metabolomics,X23424.Total Lipids in VLDL,TXN,Thioredoxin,40384,0.036856587939679,0.00452722591073031,0.0279832251546476,0.0457299507247105,4.33204143058449e-16
NMR metabolomics,X23424.Total Lipids in VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,40173,0.0227179855945807,0.00279291354313816,0.0172438750500299,0.0281920961391315,4.59498523441657e-16
NMR metabolomics,X23424.Total Lipids in VLDL,CFB,Complement factor B,40344,0.0267105714939784,0.00329422702697322,0.0202538865211109,0.0331672564668459,5.67019557162564e-16
NMR metabolomics,X23424.Total Lipids in VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,42754,0.0301164974652461,0.00371675659165645,0.0228316545455995,0.0374013403848927,5.82293809629601e-16
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,42408,0.0395322933491071,0.00488168090931082,0.0299641987668579,0.0491003879313563,6.06937532338216e-16
NMR metabolomics,X23424.Total Lipids in VLDL,HRG,Histidine-rich glycoprotein,40479,0.0254638187469755,0.0031441305431669,0.0193013228823683,0.0316263146115826,6.11861900692437e-16
NMR metabolomics,X23424.Total Lipids in VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",42370,0.0587024385240391,0.00726500515308855,0.0444630284239855,0.0729418486240926,7.02815549233889e-16
NMR metabolomics,X23424.Total Lipids in VLDL,CASP9,Caspase-9,40199,0.0513346599266429,0.00636721924709554,0.0388549102023357,0.0638144096509502,8.26008540299857e-16
NMR metabolomics,X23424.Total Lipids in VLDL,RANBP1,Ran-specific GTPase-activating protein,40223,0.0429974453524798,0.00533447877175734,0.0325418669598354,0.0534530237451242,8.3969013355321e-16
NMR metabolomics,X23424.Total Lipids in VLDL,PMM2,Phosphomannomutase 2,40116,0.0492756326994993,0.00611443664675246,0.0372913368718644,0.0612599285271341,8.50049618816725e-16
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINB8,Serpin B8,42754,0.0471591037289077,0.00585913408392251,0.0356752009244196,0.0586430065333958,9.05145689909033e-16
NMR metabolomics,X23424.Total Lipids in VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42754,0.0326288971302379,0.00406894201126176,0.0246537707881648,0.0406040234723109,1.15285999487053e-15
NMR metabolomics,X23424.Total Lipids in VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,42689,0.0557880818673516,0.0069609478147057,0.0421446241505284,0.0694315395841747,1.19682941443274e-15
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,42346,0.0387958109596852,0.00485226632594987,0.0292853689608234,0.0483062529585469,1.39887684897817e-15
NMR metabolomics,X23424.Total Lipids in VLDL,ICAM1,Intercellular adhesion molecule 1,42595,0.0236112473626384,0.00296167560377984,0.0178063631792299,0.0294161315460469,1.68348350271431e-15
NMR metabolomics,X23424.Total Lipids in VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,42357,0.0467908882109761,0.00587909256737026,0.0352678667789304,0.0583139096430218,1.87778459568873e-15
NMR metabolomics,X23424.Total Lipids in VLDL,DAPK2,Death-associated protein kinase 2,40199,0.0437780833796714,0.00551180145765753,0.0329749525226627,0.0545812142366802,2.17245608154868e-15
NMR metabolomics,X23424.Total Lipids in VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,40223,-0.0285146882131413,0.00359977489003719,-0.0355702469976142,-0.0214591294286684,2.57738423524128e-15
NMR metabolomics,X23424.Total Lipids in VLDL,FCRL1,Fc receptor-like protein 1,42636,0.0377877854147252,0.00477458126889997,0.0284296061276813,0.0471459647017692,2.67884701050172e-15
NMR metabolomics,X23424.Total Lipids in VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40482,0.0532073205636859,0.00673245794572456,0.0400117029900658,0.0664029381373061,2.973095279259e-15
NMR metabolomics,X23424.Total Lipids in VLDL,SERPING1,Plasma protease C1 inhibitor,40516,0.0147187779472303,0.00186393460769495,0.0110654661161482,0.0183720897783124,3.13021198516149e-15
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS7_LGALS7B,Galectin-7,42524,0.0347359995124573,0.00440550621672835,0.0261012073276697,0.0433707916972448,3.39761048168172e-15
NMR metabolomics,X23424.Total Lipids in VLDL,DMD,Dystrophin,40223,0.0412925319010281,0.00524640741291998,0.0310095733717049,0.0515754904303512,3.85873990439515e-15
NMR metabolomics,X23424.Total Lipids in VLDL,MARCO,Macrophage receptor MARCO,42636,0.020949285845233,0.00266388270648827,0.015728075740516,0.02617049594995,3.99698461482896e-15
NMR metabolomics,X23424.Total Lipids in VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,40302,0.0305234171824863,0.00388649217560663,0.0229058925182973,0.0381409418466753,4.41056974192568e-15
NMR metabolomics,X23424.Total Lipids in VLDL,CSNK1D,Casein kinase I isoform delta,40199,0.0502417524150211,0.00640235426812724,0.0376931380494917,0.0627903667805505,4.64148429876469e-15
NMR metabolomics,X23424.Total Lipids in VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",42495,0.0469300935068399,0.00598191145857189,0.035205547048039,0.0586546399656408,4.64631625219475e-15
NMR metabolomics,X23424.Total Lipids in VLDL,CCN5,CCN family member 5,42611,0.0306820279780267,0.00392613093306907,0.0229868113492113,0.0383772446068421,5.91210383069148e-15
NMR metabolomics,X23424.Total Lipids in VLDL,ADM,Pro-adrenomedullin,42721,0.0212961047041783,0.0027264236609719,0.0159523143286734,0.0266398950796832,6.08983215967066e-15
NMR metabolomics,X23424.Total Lipids in VLDL,IMMT,MICOS complex subunit MIC60,40451,0.0358634746292721,0.00459318414450043,0.0268608337060512,0.0448661155524929,6.32642671779083e-15
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB6,Integrin beta-6,42370,0.0247764987326427,0.0031771562923813,0.0185492723995754,0.0310037250657101,6.74338173408692e-15
NMR metabolomics,X23424.Total Lipids in VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,42558,0.0278844100389361,0.00357949905593279,0.0208685918893079,0.0349002281885644,7.19170197805764e-15
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42638,0.0284702305681062,0.00365623333911285,0.021304013223445,0.0356364479127674,7.37603193724592e-15
NMR metabolomics,X23424.Total Lipids in VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42636,0.0387903975834486,0.00498994771259629,0.0290101000667599,0.0485706951001373,8.17431260051087e-15
NMR metabolomics,X23424.Total Lipids in VLDL,CD302,CD302 antigen,42587,0.0253216077679494,0.00325794669456236,0.0189360322466071,0.0317071832892916,8.27004910648842e-15
NMR metabolomics,X23424.Total Lipids in VLDL,CSDE1,Cold shock domain-containing protein E1,40116,0.0921723188797118,0.0118711262329101,0.0689049114632081,0.115439726296216,8.93567854748223e-15
NMR metabolomics,X23424.Total Lipids in VLDL,RARRES1,Retinoic acid receptor responder protein 1,42346,0.0259205247271312,0.00335279103509744,0.0193490542983402,0.0324919951559222,1.14410175013684e-14
NMR metabolomics,X23424.Total Lipids in VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,42711,0.0408320507992004,0.00528583842243188,0.0304718074912339,0.0511922941071669,1.19893102802517e-14
NMR metabolomics,X23424.Total Lipids in VLDL,NID2,Nidogen-2,42611,0.0579702597932312,0.00750889643960641,0.0432528227716026,0.0726876968148597,1.24334323080049e-14
NMR metabolomics,X23424.Total Lipids in VLDL,VCAM1,Vascular cell adhesion protein 1,42663,-0.0219040392687881,0.00284150376734889,-0.0274733866527919,-0.0163346918847843,1.36083936294818e-14
NMR metabolomics,X23424.Total Lipids in VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,40182,0.0431685432016518,0.00561375875125685,0.0321655760491884,0.0541715103541152,1.59979071653234e-14
NMR metabolomics,X23424.Total Lipids in VLDL,TREML1,Trem-like transcript 1 protein,40532,0.0409575650254573,0.00533235651827966,0.0305061462496292,0.0514089838012855,1.70903809429458e-14
NMR metabolomics,X23424.Total Lipids in VLDL,CTSL,Cathepsin L1,42636,0.0192748905183842,0.00251957351125188,0.0143365264363306,0.0242132546004379,2.14519411863773e-14
NMR metabolomics,X23424.Total Lipids in VLDL,PODXL,Podocalyxin,42587,0.0118440966471906,0.00155296612521997,0.00880028304175949,0.0148879102526218,2.56930533972825e-14
NMR metabolomics,X23424.Total Lipids in VLDL,ENAH,Protein enabled homolog,42370,0.0365710790145934,0.00479975805462151,0.0271635532275352,0.0459786048016515,2.72316868542569e-14
NMR metabolomics,X23424.Total Lipids in VLDL,DPP4,Dipeptidyl peptidase 4,42441,0.0218260964793365,0.00286791134163358,0.0162049902497347,0.0274472027089384,2.9157120611048e-14
NMR metabolomics,X23424.Total Lipids in VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,40383,0.0460200659593367,0.00605348142724938,0.034155242361928,0.0578848895567455,3.14303735315844e-14
NMR metabolomics,X23424.Total Lipids in VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",40223,0.0707544302591191,0.00930808136255635,0.0525105907885087,0.0889982697297295,3.16716421147736e-14
NMR metabolomics,X23424.Total Lipids in VLDL,APOF,Apolipoprotein F,40532,-0.0183529635117191,0.00242345632248717,-0.023102937903794,-0.0136029891196443,3.9286143431393e-14
NMR metabolomics,X23424.Total Lipids in VLDL,APLP1,Amyloid-like protein 1,42636,-0.0396388043484937,0.00524180529260335,-0.0499127427219963,-0.0293648659749912,4.22455142767032e-14
NMR metabolomics,X23424.Total Lipids in VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42683,0.0237021532186977,0.00313500758441246,0.0175575383532493,0.0298467680841462,4.27486925397528e-14
NMR metabolomics,X23424.Total Lipids in VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42587,0.0418183468661398,0.00554281711772856,0.0309544253153918,0.0526822684168878,4.82889457318317e-14
NMR metabolomics,X23424.Total Lipids in VLDL,SDK2,Protein sidekick-2,40283,0.0310389125041426,0.00411760078712748,0.0229684149613727,0.0391094100469124,5.14026011471544e-14
NMR metabolomics,X23424.Total Lipids in VLDL,DKK4,Dickkopf-related protein 4,42477,0.0355511310340204,0.00471767184300487,0.0263044942217309,0.04479776784631,5.16976059908457e-14
NMR metabolomics,X23424.Total Lipids in VLDL,NRP2,Neuropilin-2,42611,-0.0219920499241699,0.00292034322052521,-0.0277159226363994,-0.0162681772119405,5.37142533488456e-14
NMR metabolomics,X23424.Total Lipids in VLDL,SLITRK2,SLIT and NTRK-like protein 2,42721,0.0303107022624311,0.00403456988059252,0.0224029452964697,0.0382184592283924,6.15275524608272e-14
NMR metabolomics,X23424.Total Lipids in VLDL,DDC,Aromatic-L-amino-acid decarboxylase,42613,-0.0362321770232907,0.00482816701136921,-0.0456953843655744,-0.0267689696810071,6.56250491447199e-14
NMR metabolomics,X23424.Total Lipids in VLDL,SLITRK6,SLIT and NTRK-like protein 6,42357,-0.0270686276425761,0.00361264043229511,-0.0341494028898745,-0.0199878523952777,7.17427414877715e-14
NMR metabolomics,X23424.Total Lipids in VLDL,GGH,Gamma-glutamyl hydrolase,42437,0.0260250758646702,0.00347512413696329,0.0192138325562222,0.0328363191731183,7.38092129785452e-14
NMR metabolomics,X23424.Total Lipids in VLDL,GRSF1,G-rich sequence factor 1,40014,0.0614968506924165,0.00821159763266053,0.0454021193324019,0.0775915820524312,7.47915091500566e-14
NMR metabolomics,X23424.Total Lipids in VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,40451,0.0513325723698358,0.00685961693486449,0.0378877231775014,0.0647774215621702,7.78804365853889e-14
NMR metabolomics,X23424.Total Lipids in VLDL,CFHR5,Complement factor H-related protein 5,40382,0.0322073438880649,0.00430558565046873,0.0237683960131462,0.0406462917629836,7.96673292455649e-14
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPTL1,Angiopoietin-related protein 1,42439,0.0220691490901655,0.00295461046747793,0.0162781125739088,0.0278601856064223,8.56046207512473e-14
NMR metabolomics,X23424.Total Lipids in VLDL,SCARF2,Scavenger receptor class F member 2,42711,-0.0229830355703467,0.00308028538392859,-0.0290203949228467,-0.0169456762178466,9.08754188923772e-14
NMR metabolomics,X23424.Total Lipids in VLDL,CD28,T-cell-specific surface glycoprotein CD28,42346,0.0288108688728141,0.003861817046647,0.0212417074613859,0.0363800302842422,9.16384371792268e-14
NMR metabolomics,X23424.Total Lipids in VLDL,CD300A,CMRF35-like molecule 8,40283,0.0236281625274232,0.003173836373616,0.0174074432351359,0.0298488818197106,1.04390298619585e-13
NMR metabolomics,X23424.Total Lipids in VLDL,RAB6A,Ras-related protein Rab-6A,42594,0.0347364962429366,0.00466890730184359,0.0255854379313231,0.04388755455455,1.06840109948591e-13
NMR metabolomics,X23424.Total Lipids in VLDL,MEPE,Matrix extracellular phosphoglycoprotein,42618,0.0194064936897504,0.00261538696760099,0.0142803352332524,0.0245326521462483,1.24039816585455e-13
NMR metabolomics,X23424.Total Lipids in VLDL,MMP1,Interstitial collagenase,42136,0.0687581354901562,0.00927544129695115,0.0505782705481319,0.0869380004321805,1.31220021339314e-13
NMR metabolomics,X23424.Total Lipids in VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,42587,0.0412690688133262,0.00557246407445886,0.0303470392273868,0.0521910983992655,1.38054433734846e-13
NMR metabolomics,X23424.Total Lipids in VLDL,MCTS1,Malignant T-cell-amplified sequence 1,40449,0.0205934975886009,0.00278488366057218,0.0151351256138794,0.0260518695633224,1.51744291738746e-13
NMR metabolomics,X23424.Total Lipids in VLDL,CD83,CD83 antigen,42594,0.026523948623379,0.00359259637493208,0.0194824597285121,0.0335654375182458,1.63953309793402e-13
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,40449,0.0369360062279389,0.00500362761972128,0.0271288960932852,0.0467431163625926,1.67118293560954e-13
NMR metabolomics,X23424.Total Lipids in VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40539,0.019163596798837,0.00260644748639954,0.0140549597254939,0.0242722338721801,2.08104012129266e-13
NMR metabolomics,X23424.Total Lipids in VLDL,GPR15L,Protein GPR15L,40449,0.0455414561388771,0.00619431203402649,0.0334006045521852,0.057682307725569,2.08587865774435e-13
NMR metabolomics,X23424.Total Lipids in VLDL,STAM,Signal transducing adapter molecule 1,40451,0.0279592878444211,0.00380728078459197,0.0204970175066208,0.0354215581822213,2.22216094545927e-13
NMR metabolomics,X23424.Total Lipids in VLDL,DPT,Dermatopontin,42794,0.0188527105899416,0.00257061771440733,0.0138142998697032,0.0238911213101799,2.36149664143138e-13
NMR metabolomics,X23424.Total Lipids in VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42587,0.0415508284502775,0.00567296807665224,0.0304318110200391,0.0526698458805159,2.53766327824866e-13
NMR metabolomics,X23424.Total Lipids in VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,42746,0.0390640859250998,0.00533647973281643,0.0286045856487796,0.04952358620142,2.61550399988623e-13
NMR metabolomics,X23424.Total Lipids in VLDL,BRDT,Bromodomain testis-specific protein,40116,0.0277396231884582,0.00379180197303717,0.0203076913213053,0.035171555055611,2.74031263658892e-13
NMR metabolomics,X23424.Total Lipids in VLDL,GNLY,Granulysin,42611,0.0396173452264821,0.00544613743728017,0.028942915849413,0.0502917746035513,3.67285391958011e-13
NMR metabolomics,X23424.Total Lipids in VLDL,SNX5,Sorting nexin-5,40223,0.0215337272346153,0.00296088313282391,0.0157303962942804,0.0273370581749501,3.76151878652856e-13
NMR metabolomics,X23424.Total Lipids in VLDL,EGFR,Epidermal growth factor receptor,42794,0.0120397922465004,0.00165692679031869,0.00879221573747574,0.015287368755525,3.89478186001491e-13
NMR metabolomics,X23424.Total Lipids in VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,42490,0.0747163558247857,0.0102829414221012,0.0545617906374674,0.0948709210121041,3.90784789876165e-13
NMR metabolomics,X23424.Total Lipids in VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40449,0.0320721178682321,0.00442023636979462,0.0234084545834347,0.0407357811530296,4.25717417835002e-13
NMR metabolomics,X23424.Total Lipids in VLDL,AHCY,Adenosylhomocysteinase,42636,0.0493678760003743,0.00680981515727132,0.0360206382921225,0.0627151137086261,4.41099499806591e-13
NMR metabolomics,X23424.Total Lipids in VLDL,CALB2,Calretinin,42311,0.0236146608630889,0.00325878091352272,0.0172274502725844,0.0300018714535935,4.51684770393726e-13
NMR metabolomics,X23424.Total Lipids in VLDL,CAT,Catalase,40361,0.03998230840535,0.00552047339049771,0.0291621805599745,0.0508024362507255,4.69299054479635e-13
NMR metabolomics,X23424.Total Lipids in VLDL,KIF22,Kinesin-like protein KIF22,40116,0.0920452827609132,0.012723544938696,0.067107134681069,0.116983430840757,4.99484304898734e-13
NMR metabolomics,X23424.Total Lipids in VLDL,ESAM,Endothelial cell-selective adhesion molecule,42794,0.023854056730953,0.00329851614675485,0.0173889650833135,0.0303191483785926,5.02271566316635e-13
NMR metabolomics,X23424.Total Lipids in VLDL,LGMN,Legumain,42676,0.0261625329904594,0.00362167589824448,0.0190640482299002,0.0332610177510186,5.32387612361775e-13
NMR metabolomics,X23424.Total Lipids in VLDL,EDF1,Endothelial differentiation-related factor 1,40482,0.0492214456477075,0.00681326916004854,0.0358674380940123,0.0625754532014026,5.35937270887651e-13
NMR metabolomics,X23424.Total Lipids in VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,42794,0.0117142063392153,0.00162206462272722,0.00853495967866992,0.0148934529997606,5.40348167090834e-13
NMR metabolomics,X23424.Total Lipids in VLDL,FAM3B,Protein FAM3B,42587,0.025873884628335,0.00358611249204569,0.0188451041439254,0.0329026651127445,5.68244868396346e-13
NMR metabolomics,X23424.Total Lipids in VLDL,CHCHD6,MICOS complex subunit MIC25,40451,0.0211878778497311,0.00294013222227692,0.0154252186940683,0.0269505370053939,6.11081981064461e-13
NMR metabolomics,X23424.Total Lipids in VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,40223,0.0382672567498445,0.00531471138139879,0.0278504224423029,0.0486840910573861,6.40138057164853e-13
NMR metabolomics,X23424.Total Lipids in VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,40116,0.0335162531279195,0.00466265388353814,0.0243774515161848,0.0426550547396543,6.99202511545242e-13
NMR metabolomics,X23424.Total Lipids in VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42679,-0.025519331514712,0.0035641267475054,-0.0325050199398225,-0.0185336430896014,8.48225122780146e-13
NMR metabolomics,X23424.Total Lipids in VLDL,CIT,Citron Rho-interacting kinase,40182,0.033016244165724,0.00461887241903776,0.02396325422441,0.042069234107038,9.35577162723174e-13
NMR metabolomics,X23424.Total Lipids in VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,42611,0.0223930190397213,0.00313387780587983,0.0162506185401968,0.0285354195392457,9.43208148592732e-13
NMR metabolomics,X23424.Total Lipids in VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42611,0.0282553608012461,0.00395437076578917,0.0205047941002993,0.0360059275021928,9.44009866872429e-13
NMR metabolomics,X23424.Total Lipids in VLDL,ADA,Adenosine deaminase,42754,0.0251590216743305,0.00352181949351116,0.0182562554670486,0.0320617878816124,9.54471334416564e-13
NMR metabolomics,X23424.Total Lipids in VLDL,S100A12,Protein S100-A12,42434,0.05456321549155,0.00764130753648384,0.0395862527200417,0.0695401782630583,9.78020214849047e-13
NMR metabolomics,X23424.Total Lipids in VLDL,COL15A1,Collagen alpha-1(XV) chain,40527,0.0203854066538187,0.00285458902311527,0.0147904121685128,0.0259804011391247,9.81304235558918e-13
NMR metabolomics,X23424.Total Lipids in VLDL,CTSC,Dipeptidyl peptidase 1,42616,0.0319149332973669,0.00447372857626004,0.0231464252878972,0.0406834413068365,1.02599205482972e-12
NMR metabolomics,X23424.Total Lipids in VLDL,COL2A1,Collagen alpha-1(II) chain,40223,0.0586978260862107,0.00823481811804088,0.0425575825748505,0.0748380695975708,1.08197603897134e-12
NMR metabolomics,X23424.Total Lipids in VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,40199,0.0425018793648321,0.00596727459642881,0.0308060211558316,0.0541977375738325,1.12608697673289e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CCL20,C-C motif chemokine 20,42754,0.0663390904786582,0.0093182381337806,0.0480753437364482,0.0846028372208682,1.13956392596858e-12
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,40302,0.0530449892968461,0.00745110358360315,0.0384408262729839,0.0676491523207082,1.15357268418642e-12
NMR metabolomics,X23424.Total Lipids in VLDL,ASGR2,Asialoglycoprotein receptor 2,40532,0.0195238310537648,0.0027438416358232,0.0141459014475513,0.0249017606599783,1.18225155445344e-12
NMR metabolomics,X23424.Total Lipids in VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40451,0.0272918660548425,0.00383636497930576,0.0197725906954032,0.0348111414142817,1.19578198276216e-12
NMR metabolomics,X23424.Total Lipids in VLDL,PRELP,Prolargin,42618,0.0176079947509009,0.00247568011604755,0.0127556617234477,0.0224603277783541,1.19828887485902e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CRYGD,Gamma-crystallin D,40483,0.0704786887748035,0.00990867783292848,0.0510576802222636,0.0898996973273433,1.20568806902843e-12
NMR metabolomics,X23424.Total Lipids in VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,40482,0.038283393899493,0.00538913785964507,0.0277206836945886,0.0488461041043973,1.28671154176667e-12
NMR metabolomics,X23424.Total Lipids in VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,40199,0.0280788781810307,0.00395806199172685,0.0203210766772461,0.0358366796848154,1.38197064416882e-12
NMR metabolomics,X23424.Total Lipids in VLDL,PSAP,Prosaposin,40440,0.0209325094671971,0.00295266781298822,0.0151452805537402,0.026719738380654,1.42812700059996e-12
NMR metabolomics,X23424.Total Lipids in VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,40116,0.0483862086912173,0.00682579603862171,0.0350076484555188,0.0617647689269159,1.43705391388631e-12
NMR metabolomics,X23424.Total Lipids in VLDL,GAS2,Growth arrest-specific protein 2,40302,0.0380240080946982,0.00536753554788518,0.0275036384208433,0.0485443777685532,1.48448578107872e-12
NMR metabolomics,X23424.Total Lipids in VLDL,FES,Tyrosine-protein kinase Fes/Fps,42346,0.0342183934288375,0.00483351476158393,0.024744704496133,0.043692082361542,1.52126359877946e-12
NMR metabolomics,X23424.Total Lipids in VLDL,HEPH,Hephaestin,40511,0.0190815981485246,0.00269763917309419,0.01379422536926,0.0243689709277892,1.60052526804194e-12
NMR metabolomics,X23424.Total Lipids in VLDL,FABP6,Gastrotropin,42334,0.0421948254498099,0.00597088425825418,0.0304918923036317,0.0538977585959881,1.66588452496007e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CST5,Cystatin-D,42357,0.0410448230296861,0.00581093228462493,0.0296553957518212,0.052434250307551,1.70666716150878e-12
NMR metabolomics,X23424.Total Lipids in VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,40199,0.0323617201310843,0.00458682675875816,0.0233715396839184,0.0413519005782503,1.82498076922056e-12
NMR metabolomics,X23424.Total Lipids in VLDL,STX7,Syntaxin-7,40199,0.0359405275578081,0.00509413499083471,0.025956022975772,0.0459250321398441,1.82609800318976e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CA2,Carbonic anhydrase 2,42573,0.0497887644395848,0.00705935586468341,0.0359524269448053,0.0636251019343642,1.83866870698259e-12
NMR metabolomics,X23424.Total Lipids in VLDL,WFDC1,WAP four-disulfide core domain protein 1,40229,0.0405100821964384,0.00574339167605901,0.0292530345113627,0.051767129881514,1.85131495219924e-12
NMR metabolomics,X23424.Total Lipids in VLDL,LIPF,Gastric triacylglycerol lipase,40223,0.0447678694058046,0.00635098868786733,0.0323199315775846,0.0572158072340245,1.91027844325763e-12
NMR metabolomics,X23424.Total Lipids in VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,42292,0.0346474112883991,0.00492492638951168,0.0249945555649562,0.044300267011842,2.08995875936455e-12
NMR metabolomics,X23424.Total Lipids in VLDL,ZBP1,Z-DNA-binding protein 1,40199,0.0286996732275867,0.00407930163120154,0.0207042420304316,0.0366951044247417,2.10437620037735e-12
NMR metabolomics,X23424.Total Lipids in VLDL,PRSS22,Brain-specific serine protease 4,40199,0.026221552201291,0.00372897431542775,0.0189127625430526,0.0335303418595293,2.15911764132598e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CCDC80,Coiled-coil domain-containing protein 80,42636,0.0267997068425657,0.00382231015309015,0.019307978942509,0.0342914347426224,2.47229593558248e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CD46,Membrane cofactor protein,42580,0.0205542257864316,0.00293879937401036,0.0147941790133712,0.0263142725594919,2.79664323297373e-12
NMR metabolomics,X23424.Total Lipids in VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39983,0.0350523880255697,0.00501196520953821,0.0252289362148748,0.0448758398362646,2.8349515084778e-12
NMR metabolomics,X23424.Total Lipids in VLDL,LACRT,Extracellular glycoprotein lacritin,40419,0.0367266272004948,0.00525589448595631,0.0264250740080205,0.0470281803929692,2.95251562145784e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CD300LF,CMRF35-like molecule 1,42721,0.0431288167931485,0.00619784672719981,0.0309810372078368,0.0552765963784601,3.59292624210411e-12
NMR metabolomics,X23424.Total Lipids in VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40511,0.0371550094506372,0.00534737022972187,0.0266741638003823,0.0476358551008921,3.9007780371552e-12
NMR metabolomics,X23424.Total Lipids in VLDL,BGN,Biglycan,42328,-0.084817785053014,0.0122212727363206,-0.108771479616202,-0.0608640904898256,4.09991336578252e-12
NMR metabolomics,X23424.Total Lipids in VLDL,XRCC4,DNA repair protein XRCC4,42311,0.0259952148300576,0.00374621739079674,0.0186526287440959,0.0333378009160192,4.13265359045491e-12
NMR metabolomics,X23424.Total Lipids in VLDL,PNLIP,Pancreatic triacylglycerol lipase,40532,0.0459868659973838,0.00664321376219749,0.0329661670234767,0.0590075649712909,4.68086485159946e-12
NMR metabolomics,X23424.Total Lipids in VLDL,IGHMBP2,DNA-binding protein SMUBP-2,40116,0.0386884553082013,0.00559650282339323,0.0277193097743506,0.0496576008420521,5.01088064179938e-12
NMR metabolomics,X23424.Total Lipids in VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40449,-0.0250122540501436,0.00361926009209973,-0.0321060038306591,-0.0179185042696281,5.07699018192686e-12
NMR metabolomics,X23424.Total Lipids in VLDL,TF,Serotransferrin,40539,0.0150056828848159,0.00217162711768251,0.0107492937341582,0.0192620720354736,5.11044672759834e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,42781,0.0417183319014452,0.00604023130877772,0.0298794785362408,0.0535571852666495,5.1795614329927e-12
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJB8,DnaJ homolog subfamily B member 8,42357,0.0408270953062601,0.00591376548592687,0.0292361149538435,0.0524180756586768,5.29736396808152e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CDH5,Cadherin-5,42794,-0.0210830487606138,0.0030637792416934,-0.0270880560743329,-0.0150780414468948,6.18676631474869e-12
NMR metabolomics,X23424.Total Lipids in VLDL,FAM3C,Protein FAM3C,42613,0.0217474141469476,0.00316180902945956,0.0155502684492068,0.0279445598446883,6.33182653520594e-12
NMR metabolomics,X23424.Total Lipids in VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,42679,-0.0167850357032175,0.00244100281524378,-0.0215694012210953,-0.0120006701853397,6.41374397023621e-12
NMR metabolomics,X23424.Total Lipids in VLDL,ROBO2,Roundabout homolog 2,42711,0.0163599866361553,0.00238106599737335,0.0116930972813035,0.021026875991007,6.6607004588738e-12
NMR metabolomics,X23424.Total Lipids in VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,42346,0.0261847780014744,0.00381828121778888,0.0187009468146082,0.0336686091883406,7.30843345930064e-12
NMR metabolomics,X23424.Total Lipids in VLDL,MDK,Midkine,42638,0.035554938798788,0.00518676417292177,0.0253888810198614,0.0457209965777147,7.44561450040942e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CABP2,Calcium-binding protein 2,40182,0.0451230121168041,0.00658549170988827,0.0322154483654231,0.0580305758681851,7.6784062845847e-12
NMR metabolomics,X23424.Total Lipids in VLDL,MYL3,Myosin light chain 3,40223,-0.0512720520560929,0.00748692306897377,-0.0659464212712815,-0.0365976828409043,7.87544904624532e-12
NMR metabolomics,X23424.Total Lipids in VLDL,C2orf69,UPF0565 protein C2orf69,40182,0.0425346948312027,0.00621356701240375,0.0303561034868914,0.054713286175514,8.02962495905756e-12
NMR metabolomics,X23424.Total Lipids in VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,42311,0.0587141417391809,0.00857871168960794,0.0418998668275493,0.0755284166508125,8.03406646516052e-12
NMR metabolomics,X23424.Total Lipids in VLDL,NPC2,NPC intracellular cholesterol transporter 2,40367,0.0238565043324715,0.00348691794747949,0.0170221451554117,0.0306908635095313,8.23408501707298e-12
NMR metabolomics,X23424.Total Lipids in VLDL,ELOB,Elongin-B,40116,0.0279423780401753,0.00408902172281533,0.0199278954634572,0.0359568606168933,8.72733993005711e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CD93,Complement component C1q receptor,42141,-0.0223973016793183,0.00328194438656662,-0.0288299126769889,-0.0159646906816477,9.22246147016995e-12
NMR metabolomics,X23424.Total Lipids in VLDL,CCL19,C-C motif chemokine 19,42711,0.0907491693711986,0.0133210299839071,0.0646399506027406,0.116858388139657,9.99938352547397e-12
NMR metabolomics,X23424.Total Lipids in VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42689,-0.0306905765933195,0.00451116133462951,-0.0395324528091933,-0.0218487003774456,1.06593813876504e-11
NMR metabolomics,X23424.Total Lipids in VLDL,PER3,Period circadian protein homolog 3,40199,0.0853664547637438,0.0125489067572807,0.0607705975194736,0.109962312008014,1.08004164829392e-11
NMR metabolomics,X23424.Total Lipids in VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",42587,0.0409312713383098,0.00602048038206355,0.0291311297894653,0.0527314128871544,1.10061509245437e-11
NMR metabolomics,X23424.Total Lipids in VLDL,LTB,Lymphotoxin-beta,40451,0.0248151005266865,0.0036496594783976,0.0176617679490272,0.0319684331043458,1.1045479369937e-11
NMR metabolomics,X23424.Total Lipids in VLDL,CRYM,Ketimine reductase mu-crystallin,40136,0.0525114021000408,0.00772509113801197,0.0373702234695374,0.0676525807305443,1.11980210685076e-11
NMR metabolomics,X23424.Total Lipids in VLDL,APOA1,Apolipoprotein A-I,40539,-0.0191051576136879,0.00281338828726544,-0.0246193986567282,-0.0135909165706476,1.17083657404591e-11
NMR metabolomics,X23424.Total Lipids in VLDL,CLU,Clusterin,40539,0.0218036401903982,0.00321569055948338,0.0155008866938108,0.0281063936869856,1.25800976057249e-11
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINI2,Serpin I2,40449,0.0384185902079537,0.00570491204841849,0.0272369625930535,0.049600217822854,1.72743081646502e-11
NMR metabolomics,X23424.Total Lipids in VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42587,0.0312056960691538,0.00463608033308285,0.0221189786163115,0.0402924135219962,1.75298523438241e-11
NMR metabolomics,X23424.Total Lipids in VLDL,GIMAP8,GTPase IMAP family member 8,40080,0.0361446217123044,0.00537043947974253,0.025618560332009,0.0466706830925997,1.77835625975811e-11
NMR metabolomics,X23424.Total Lipids in VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,40449,0.0305745289905631,0.00454683948207607,0.021662723605694,0.0394863343754322,1.84920381692275e-11
NMR metabolomics,X23424.Total Lipids in VLDL,RABEPK,Rab9 effector protein with kelch motifs,42346,0.0392959198890484,0.00584685862158216,0.0278360769907473,0.0507557627873494,1.88101352848498e-11
NMR metabolomics,X23424.Total Lipids in VLDL,THBD,Thrombomodulin,42636,0.0206262155004696,0.00306984827143644,0.0146093128884541,0.026643118112485,1.90384755680085e-11
NMR metabolomics,X23424.Total Lipids in VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42594,0.0261035355106247,0.00389468427475408,0.0184699543321068,0.0337371166891427,2.13298667143901e-11
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,40483,0.0257595994801435,0.00384899285539509,0.0182155734835691,0.0333036254767179,2.29692129997916e-11
NMR metabolomics,X23424.Total Lipids in VLDL,ITGBL1,Integrin beta-like protein 1,40527,0.0264681942893131,0.0039662480945611,0.0186943480239733,0.0342420405546528,2.61673853307834e-11
NMR metabolomics,X23424.Total Lipids in VLDL,UMOD,Uromodulin,42764,-0.03740035958847,0.00561342072438993,-0.0484026642082742,-0.0263980549686657,2.79271127685352e-11
NMR metabolomics,X23424.Total Lipids in VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,40182,0.0370810313229731,0.00556482863238771,0.0261739672034932,0.047988095442453,2.80244139440469e-11
NMR metabolomics,X23424.Total Lipids in VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42611,0.016088787286519,0.00241584204169547,0.0113537368847959,0.0208238376882422,2.85069979771893e-11
NMR metabolomics,X23424.Total Lipids in VLDL,CBLIF,Cobalamin binding intrinsic factor,42613,0.0547830439105064,0.00823073972117954,0.0386507940569945,0.0709152937640183,2.92495746886177e-11
NMR metabolomics,X23424.Total Lipids in VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42562,0.0456801065895347,0.00687090465182049,0.0322131334719665,0.0591470797071029,3.07926616550081e-11
NMR metabolomics,X23424.Total Lipids in VLDL,CFHR4,Complement factor H-related protein 4,40509,0.0504714539581931,0.00760547260925847,0.0355647276440465,0.0653781802723397,3.36570080759908e-11
NMR metabolomics,X23424.Total Lipids in VLDL,ECI2,Enoyl-CoA delta isomerase 2,40116,0.0415895665874891,0.00627655659316037,0.0292875156648948,0.0538916175100834,3.60709994527263e-11
NMR metabolomics,X23424.Total Lipids in VLDL,FOLR2,Folate receptor beta,42711,-0.0199034939257054,0.0030110910960201,-0.0258052324739048,-0.014001755377506,3.98576144785087e-11
NMR metabolomics,X23424.Total Lipids in VLDL,MANSC1,MANSC domain-containing protein 1,42679,-0.018835661303829,0.0028569846815741,-0.0244353512797142,-0.0132359713279438,4.4753197219228e-11
NMR metabolomics,X23424.Total Lipids in VLDL,FCRL3,Fc receptor-like protein 3,42370,0.037766304209242,0.00574845501615654,0.0264993323775752,0.0490332760409088,5.22698767369865e-11
NMR metabolomics,X23424.Total Lipids in VLDL,RCOR1,REST corepressor 1,42357,0.0295190470491341,0.00450396027306615,0.0206912849139244,0.0383468091843437,5.80951357425407e-11
NMR metabolomics,X23424.Total Lipids in VLDL,CD300C,CMRF35-like molecule 6,42711,0.0239441104495998,0.00365530376835734,0.0167797150636195,0.0311085058355802,5.94153781173792e-11
NMR metabolomics,X23424.Total Lipids in VLDL,ROBO1,Roundabout homolog 1,42638,0.016318944481655,0.00249284506554004,0.0114329681531966,0.0212049208101135,6.11154592889393e-11
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42706,0.0196267288477085,0.00300080838965344,0.0137451444039877,0.0255083132914292,6.35280545387325e-11
NMR metabolomics,X23424.Total Lipids in VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,40980,-0.021124622449191,0.00323848594627832,-0.0274720549038965,-0.0147771899944855,7.17372675535928e-11
NMR metabolomics,X23424.Total Lipids in VLDL,INSR,Insulin receptor,40199,0.011550864006114,0.00177245500978016,0.0080768521869449,0.0150248758252831,7.49256076733519e-11
NMR metabolomics,X23424.Total Lipids in VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,40116,0.0554730729019748,0.00853489953251056,0.0387446698182541,0.0722014759856954,8.4066842505163e-11
NMR metabolomics,X23424.Total Lipids in VLDL,PALM,Paralemmin-1,40384,0.0207905252744315,0.00321279735487627,0.014493442458874,0.0270876080899889,1.01316554472886e-10
NMR metabolomics,X23424.Total Lipids in VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,42587,0.0225469605838791,0.00349260448901412,0.0157014557854114,0.0293924653823468,1.11485000067691e-10
NMR metabolomics,X23424.Total Lipids in VLDL,HLA_E,,42594,0.0202338324713334,0.00313657020699624,0.0140861548656208,0.026381510077046,1.14975759061157e-10
NMR metabolomics,X23424.Total Lipids in VLDL,NFIC,Nuclear factor 1 C-type,40482,0.0310935406847553,0.00484044407007549,0.0216062703074073,0.0405808110621032,1.38353218011756e-10
NMR metabolomics,X23424.Total Lipids in VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,42587,0.0138435880830941,0.00215947953154017,0.00961100820127537,0.0180761679649128,1.49794715074119e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CA6,Carbonic anhydrase 6,42581,-0.040710537830339,0.00636131460212422,-0.0531787144505025,-0.0282423612101755,1.6086388401419e-10
NMR metabolomics,X23424.Total Lipids in VLDL,TSPAN1,Tetraspanin-1,42357,0.0440761443614143,0.00690443439301389,0.0305434529511071,0.0576088357717215,1.78608478714713e-10
NMR metabolomics,X23424.Total Lipids in VLDL,PSME2,Proteasome activator complex subunit 2,42441,0.0234857949527177,0.00368021250867377,0.0162725784357171,0.0306990114697183,1.81034139421345e-10
NMR metabolomics,X23424.Total Lipids in VLDL,MDM1,Nuclear protein MDM1,40182,0.0203428717449991,0.00319342695014501,0.0140837549227149,0.0266019885672833,1.96287359857544e-10
NMR metabolomics,X23424.Total Lipids in VLDL,APOB,Apolipoprotein B-100,40532,0.0144558699834299,0.00227429024445407,0.00999826110429997,0.0189134788625599,2.14727687149181e-10
NMR metabolomics,X23424.Total Lipids in VLDL,RNASE3,Eosinophil cationic protein,42578,0.0709619248085042,0.0111657622612722,0.0490770307764107,0.0928468188405978,2.14743975012899e-10
NMR metabolomics,X23424.Total Lipids in VLDL,VEGFB,Vascular endothelial growth factor B,40199,0.0191835211438749,0.00301866153440311,0.0132669445364448,0.025100097751305,2.16700849374835e-10
NMR metabolomics,X23424.Total Lipids in VLDL,SUSD2,Sushi domain-containing protein 2,42611,-0.0186493093230692,0.00293769110470743,-0.0244071838882957,-0.0128914347578426,2.2473353140149e-10
NMR metabolomics,X23424.Total Lipids in VLDL,VGF,Neurosecretory protein VGF,40482,0.0204029378375995,0.00321459440377053,0.0141023328062092,0.0267035428689897,2.28013502086818e-10
NMR metabolomics,X23424.Total Lipids in VLDL,COPB2,Coatomer subunit beta',40116,0.0280000312654868,0.00442186864389456,0.0193331687234535,0.0366668938075202,2.51228463559724e-10
NMR metabolomics,X23424.Total Lipids in VLDL,SEMA7A,Semaphorin-7A,42760,0.0183186930607883,0.00289465520604749,0.0126451688569352,0.0239922172646413,2.55415445175914e-10
NMR metabolomics,X23424.Total Lipids in VLDL,CHGA,Chromogranin-A,40527,-0.0630872674173224,0.00998609524627186,-0.0826600141000152,-0.0435145207346295,2.75772074818404e-10
NMR metabolomics,X23424.Total Lipids in VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,40116,0.0240204545405202,0.00381489272904428,0.0165432647915934,0.031497644289447,3.16141966499146e-10
NMR metabolomics,X23424.Total Lipids in VLDL,MTUS1,Microtubule-associated tumor suppressor 1,40302,0.0361690949267216,0.00575615770138202,0.0248870258320129,0.0474511640214304,3.433219292906e-10
NMR metabolomics,X23424.Total Lipids in VLDL,TPM3,Tropomyosin alpha-3 chain,40116,-0.0280419812583257,0.00447648796692054,-0.03681589767349,-0.0192680648431615,3.88641460040765e-10
NMR metabolomics,X23424.Total Lipids in VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",42346,0.0317070533418032,0.00506345949720998,0.0217826727272716,0.0416314339563347,3.92061080395247e-10
NMR metabolomics,X23424.Total Lipids in VLDL,PPM1A,Protein phosphatase 1A,42346,0.0202547631141313,0.00324129891459948,0.0139018172415164,0.0266077089867463,4.25933173001596e-10
NMR metabolomics,X23424.Total Lipids in VLDL,S100A11,Protein S100-A11,42531,0.0289091806197966,0.0046304390890975,0.0198335200051655,0.0379848412344277,4.4144776608124e-10
NMR metabolomics,X23424.Total Lipids in VLDL,NAGA,Alpha-N-acetylgalactosaminidase,40166,0.0357201604821772,0.00572350080603089,0.0245020989023567,0.0469382220619978,4.50931759775272e-10
NMR metabolomics,X23424.Total Lipids in VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,42311,0.0398257317535547,0.00638696766046977,0.027307275139034,0.0523441883680755,4.64249425592568e-10
NMR metabolomics,X23424.Total Lipids in VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,40080,0.0415305801972955,0.00666173921863724,0.0284735713287665,0.0545875890658244,4.7092738538161e-10
NMR metabolomics,X23424.Total Lipids in VLDL,SCT,Secretin,40182,0.031597929021909,0.00509726245229534,0.0216072946154102,0.0415885634284079,5.88616092214231e-10
NMR metabolomics,X23424.Total Lipids in VLDL,FCRL2,Fc receptor-like protein 2,42681,0.0331391697684291,0.00535883296178527,0.02263585716333,0.0436424823735282,6.42903135059937e-10
NMR metabolomics,X23424.Total Lipids in VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40482,-0.0246375721981853,0.00398365174627574,-0.0324455296208857,-0.0168296147754848,6.43849456132681e-10
NMR metabolomics,X23424.Total Lipids in VLDL,SV2A,Synaptic vesicle glycoprotein 2A,40182,0.0394361256923399,0.00637766866379249,0.0269358951113066,0.0519363562733732,6.49348183025877e-10
NMR metabolomics,X23424.Total Lipids in VLDL,PRDX1,Peroxiredoxin-1,42261,-0.0563228843613112,0.00912005261942087,-0.0741981874953761,-0.0384475812272463,6.78156811455836e-10
NMR metabolomics,X23424.Total Lipids in VLDL,RGMB,RGM domain family member B,42711,0.0178768746911128,0.0028976102687114,0.0121975585644385,0.0235561908177871,7.04506843427858e-10
NMR metabolomics,X23424.Total Lipids in VLDL,NCAM2,Neural cell adhesion molecule 2,42611,-0.0170636947394313,0.0027662210613215,-0.0224854880196214,-0.0116419014592411,7.08796428483219e-10
NMR metabolomics,X23424.Total Lipids in VLDL,TEK,Angiopoietin-1 receptor,42679,0.0137606371446107,0.00223230696686442,0.00938531548955645,0.018135958799665,7.28082968317725e-10
NMR metabolomics,X23424.Total Lipids in VLDL,DSG3,Desmoglein-3,42651,0.02205343860634,0.0035792504788497,0.0150381076677946,0.0290687695448854,7.41287874578961e-10
NMR metabolomics,X23424.Total Lipids in VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",40199,0.0272459379080142,0.00442267162360289,0.0185775015257525,0.0359143742902758,7.50422139060822e-10
NMR metabolomics,X23424.Total Lipids in VLDL,DPP7,Dipeptidyl peptidase 2,42551,0.0375204187760657,0.00612231800978345,0.0255206754768901,0.0495201620752412,9.12262420669333e-10
NMR metabolomics,X23424.Total Lipids in VLDL,AFAP1,Actin filament-associated protein 1,40283,0.0518282937375514,0.00846510059620841,0.0352366965689829,0.0684198909061199,9.51849738929338e-10
NMR metabolomics,X23424.Total Lipids in VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",42370,0.0370754864787935,0.00605842549638776,0.0252009725058735,0.0489500004517136,9.64363778153578e-10
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42636,0.0217132071995839,0.00355007474518737,0.0147550606990167,0.0286713537001512,9.84487746414639e-10
NMR metabolomics,X23424.Total Lipids in VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40449,0.0633816358609011,0.0103751383717512,0.0430463646522687,0.0837169070695335,1.03575049150023e-09
NMR metabolomics,X23424.Total Lipids in VLDL,SCGB1A1,Uteroglobin,42646,0.0346263385081488,0.00566971877714882,0.0235136897049371,0.0457389873113605,1.04160704001896e-09
NMR metabolomics,X23424.Total Lipids in VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,40451,0.0207805750189916,0.00341354766275689,0.0140900215999881,0.0274711284379951,1.18293149051584e-09
NMR metabolomics,X23424.Total Lipids in VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42619,0.0361954228277684,0.00594688422177226,0.0245395297530948,0.0478513159024421,1.1858460578776e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL8,Interleukin-8,42494,0.0431266266435523,0.00708775620029166,0.0292346244909807,0.057018628796124,1.1994047377717e-09
NMR metabolomics,X23424.Total Lipids in VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42594,0.0263085799164012,0.00432666605769563,0.0178283144433178,0.0347888453894847,1.23014162566035e-09
NMR metabolomics,X23424.Total Lipids in VLDL,PVALB,Parvalbumin alpha,42654,0.0678399027036383,0.0111693779367482,0.0459479219476119,0.0897318834596648,1.2833123154329e-09
NMR metabolomics,X23424.Total Lipids in VLDL,BSG,Basigin,42746,0.0134198669215658,0.00221157106051533,0.00908518764295576,0.0177545462001759,1.32945109392478e-09
NMR metabolomics,X23424.Total Lipids in VLDL,ENSA,Alpha-endosulfine,40451,0.032821745030805,0.00541079184546092,0.0222165930137016,0.0434268970479084,1.35365917882456e-09
NMR metabolomics,X23424.Total Lipids in VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,42357,-0.0191570575174873,0.00315959689358495,-0.0253498674289138,-0.0129642476060608,1.37148035104305e-09
NMR metabolomics,X23424.Total Lipids in VLDL,INSL5,Insulin-like peptide INSL5,40449,0.0608780197598392,0.0100455886191141,0.0411886660663755,0.0805673734533028,1.40326051530254e-09
NMR metabolomics,X23424.Total Lipids in VLDL,ICOSLG,ICOS ligand,42587,0.0119154145501564,0.00196979624477952,0.00805461391038854,0.0157762151899243,1.49575923313246e-09
NMR metabolomics,X23424.Total Lipids in VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,42346,0.0321973983356306,0.00532570315959805,0.0217590201428184,0.0426357765284428,1.52827524455884e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CD14,Monocyte differentiation antigen CD14,42416,0.0256618647710212,0.00424834427228684,0.017335109997339,0.0339886195447034,1.57820906954376e-09
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINI1,Neuroserpin,40267,0.018604887820861,0.00308247053146559,0.0125632455791885,0.0246465300625336,1.63336865664682e-09
NMR metabolomics,X23424.Total Lipids in VLDL,ACTN2,Alpha-actinin-2,40116,-0.0366532645927582,0.006075498900957,-0.0485612424386339,-0.0247452867468824,1.66197527389284e-09
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,42595,0.0198077367671302,0.00329400469620541,0.0133514875625676,0.0262639859716928,1.86548406068711e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CCL14,C-C motif chemokine 14,42618,0.0246511300768022,0.00409966483504981,0.0166157870001046,0.0326864731534999,1.86892826048511e-09
NMR metabolomics,X23424.Total Lipids in VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,42754,0.0211667224967608,0.00352514029405357,0.0142574475204158,0.0280759974731058,1.96821313249463e-09
NMR metabolomics,X23424.Total Lipids in VLDL,SNX2,Sorting nexin-2,40451,0.0501872994101152,0.0083620165152838,0.0337977470401589,0.0665768517800714,2.0113026848578e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CTSH,Pro-cathepsin H,42332,0.0454373524153367,0.00757596185527508,0.0305884671789975,0.0602862376516758,2.05554651755067e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,42636,0.0263896408536795,0.00440903403386524,0.0177479341473037,0.0350313475600554,2.21413782737872e-09
NMR metabolomics,X23424.Total Lipids in VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,40080,-0.0187839562304649,0.00314074267183984,-0.024939811867271,-0.0126281005936588,2.29110238637898e-09
NMR metabolomics,X23424.Total Lipids in VLDL,MTPN,Myotrophin,42357,0.0201741567985228,0.00337776448971685,0.0135537383986778,0.0267945751983679,2.3947139760693e-09
NMR metabolomics,X23424.Total Lipids in VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,42346,0.035075054927279,0.00587404415333933,0.0235619283867339,0.046588181467824,2.41597443589632e-09
NMR metabolomics,X23424.Total Lipids in VLDL,PTGDS,Prostaglandin-H2 D-isomerase,42555,0.0198313587332915,0.00332307787970722,0.0133181260890654,0.0263445913775177,2.466110247413e-09
NMR metabolomics,X23424.Total Lipids in VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,42357,0.0255632418613967,0.00428769321746311,0.017159363155169,0.0339671205676244,2.55544697707959e-09
NMR metabolomics,X23424.Total Lipids in VLDL,AZU1,Azurocidin,42216,0.0463495825677281,0.00777441375348028,0.0311117316109068,0.0615874335245495,2.55915645889591e-09
NMR metabolomics,X23424.Total Lipids in VLDL,SBSN,Suprabasin,40511,-0.0212823944804883,0.00357039793989779,-0.0282803744426879,-0.0142844145182886,2.58504738792682e-09
NMR metabolomics,X23424.Total Lipids in VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,42292,0.026037291797828,0.00438038544874319,0.0174517363182913,0.0346228472773646,2.8511242635954e-09
NMR metabolomics,X23424.Total Lipids in VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40482,0.0289843841694018,0.00488406718806411,0.0194116124807962,0.0385571558580075,3.03443106609892e-09
NMR metabolomics,X23424.Total Lipids in VLDL,COLEC12,Collectin-12,42618,0.016868934690122,0.00284613777019654,0.0112905046605368,0.0224473647197072,3.16170526235972e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CD101,Immunoglobulin superfamily member 2,40449,0.0263067602433062,0.00444182679229118,0.0176007797304155,0.0350127407561969,3.26333413858142e-09
NMR metabolomics,X23424.Total Lipids in VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40511,0.0200565397376532,0.00339499969706883,0.0134023403313983,0.0267107391439081,3.56965208635097e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40483,0.0251518410416272,0.00426520847243507,0.0167920324356545,0.0335116496476,3.80824644451401e-09
NMR metabolomics,X23424.Total Lipids in VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",40223,0.0291989305633059,0.00495693850866463,0.0194833310863232,0.0389145300402886,3.96232591553399e-09
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPTL4,Angiopoietin-related protein 4,42654,-0.0268174778649082,0.0045557087347848,-0.0357466669850864,-0.01788828874473,4.03693222231113e-09
NMR metabolomics,X23424.Total Lipids in VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,42370,0.0232689554573566,0.00395972240036857,0.0155078995526342,0.031030011362079,4.29389409519941e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40449,0.0244872497593791,0.00416694512328493,0.0163200373177407,0.0326544622010176,4.30785643339284e-09
NMR metabolomics,X23424.Total Lipids in VLDL,PRKD2,Serine/threonine-protein kinase D2,40116,0.0273771098186923,0.00466218481857914,0.0182392275742772,0.0365149920631074,4.4267658957412e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CRH,Corticoliberin,42322,0.0512048441735706,0.00874669226789968,0.0340613273284873,0.068348361018654,4.90779989355379e-09
NMR metabolomics,X23424.Total Lipids in VLDL,HGFAC,Hepatocyte growth factor activator,40428,0.0165532543478779,0.00282763340178117,0.0110110928803869,0.022095415815369,4.93009675427302e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,40199,0.0221001181163472,0.00377783779755573,0.014695556033138,0.0295046801995564,5.05761285660439e-09
NMR metabolomics,X23424.Total Lipids in VLDL,TGFA,Protransforming growth factor alpha,42594,0.0282202572239374,0.00482570324615883,0.0187618788614661,0.0376786355864087,5.09403962929599e-09
NMR metabolomics,X23424.Total Lipids in VLDL,PTGR1,Prostaglandin reductase 1,40511,0.0499211927803334,0.00853861232171725,0.0331855126297675,0.0666568729308992,5.15820132460548e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CPA2,Carboxypeptidase A2,42670,0.0391628803846989,0.0067148513991897,0.0260017716422871,0.0523239891271107,5.59296153411953e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,40199,0.0179387390681536,0.00307589808081106,0.011909978829764,0.0239674993065433,5.62968982309828e-09
NMR metabolomics,X23424.Total Lipids in VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,40199,0.0406015329637276,0.00697838290734105,0.0269239024653391,0.054279163462116,6.11479152666342e-09
NMR metabolomics,X23424.Total Lipids in VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,40223,-0.0140054485841594,0.00240907996356102,-0.018727245312739,-0.00928365185557981,6.28355788874726e-09
NMR metabolomics,X23424.Total Lipids in VLDL,GC,Vitamin D-binding protein,40539,0.0153376877466175,0.00263874656923757,0.0101657444709118,0.0205096310223231,6.32078343734241e-09
NMR metabolomics,X23424.Total Lipids in VLDL,CA1,Carbonic anhydrase 1,42362,0.035552733808947,0.00611986785902301,0.0235577928052619,0.0475476748126321,6.41480442621008e-09
NMR metabolomics,X23424.Total Lipids in VLDL,AOC3,Membrane primary amine oxidase,42689,-0.0178603068230982,0.00307504105557485,-0.0238873872920249,-0.0118332263541715,6.45892179547595e-09
NMR metabolomics,X23424.Total Lipids in VLDL,MYOM2,Myomesin-2,40116,-0.0297865719251052,0.00514904261274264,-0.0398786954460808,-0.0196944484041296,7.45588218671764e-09
NMR metabolomics,X23424.Total Lipids in VLDL,VWC2,Brorin,42456,0.0242064893377954,0.00419632821632325,0.0159816860338019,0.032431292641789,8.17689340984827e-09
NMR metabolomics,X23424.Total Lipids in VLDL,ASS1,Argininosuccinate synthase,40116,0.0455735375100258,0.00792453624586128,0.0300414464681377,0.0611056285519139,9.11297762976451e-09
NMR metabolomics,X23424.Total Lipids in VLDL,ECM1,Extracellular matrix protein 1,40269,0.0219077827899117,0.00381020165604748,0.0144397875440587,0.0293757780357648,9.17276456852161e-09
NMR metabolomics,X23424.Total Lipids in VLDL,NTRK2,BDNF/NT-3 growth factors receptor,42636,0.0149265500654457,0.00260267326140176,0.00982531047309821,0.0200277896577931,9.95616785433664e-09
NMR metabolomics,X23424.Total Lipids in VLDL,LYAR,Cell growth-regulating nucleolar protein,42346,0.0317205567865532,0.00553238106397179,0.0208770899011684,0.0425640236719379,1.00471772008524e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CFC1,Cryptic protein,42346,0.0276501427708932,0.00482299705217799,0.0181970685486244,0.0371032169931621,1.00849678050716e-08
NMR metabolomics,X23424.Total Lipids in VLDL,ALPP,"Alkaline phosphatase, placental type",42587,0.0587760974418929,0.0102566643293995,0.0386730353562699,0.0788791595275159,1.02274836481152e-08
NMR metabolomics,X23424.Total Lipids in VLDL,THBS4,Thrombospondin-4,42652,0.0266788450987003,0.00465563791119127,0.0175537947927654,0.0358038954046352,1.02318108765442e-08
NMR metabolomics,X23424.Total Lipids in VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,42721,0.0310857785752346,0.00543739587676687,0.0204284826567715,0.0417430744936977,1.10689032525796e-08
NMR metabolomics,X23424.Total Lipids in VLDL,PRTG,Protogenin,42721,0.0144622140647859,0.0025337785361135,0.00949600813400343,0.0194284199955683,1.16871521362307e-08
NMR metabolomics,X23424.Total Lipids in VLDL,SEL1L,Protein sel-1 homolog 1,40223,0.0190023082607297,0.00333073193753501,0.0124740736631611,0.0255305428582983,1.19237268549497e-08
NMR metabolomics,X23424.Total Lipids in VLDL,RALY,RNA-binding protein Raly,40451,0.0275432987116511,0.00482928234941764,0.0180779053067925,0.0370086921165097,1.20403818290075e-08
NMR metabolomics,X23424.Total Lipids in VLDL,TAFA5,Chemokine-like protein TAFA-5,42587,0.0223519456922285,0.00392610663297186,0.0146567766916037,0.0300471146928533,1.27328401717244e-08
NMR metabolomics,X23424.Total Lipids in VLDL,SAA4,Serum amyloid A-4 protein,40539,0.0188092157086349,0.00330451031369473,0.0123323754937932,0.0252860559234765,1.28686425865707e-08
NMR metabolomics,X23424.Total Lipids in VLDL,PPL,Periplakin,40199,0.0193430340802114,0.00339999684228737,0.0126790402693282,0.0260070278910947,1.3094477016459e-08
NMR metabolomics,X23424.Total Lipids in VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42654,0.0507823026722223,0.00897812259052855,0.0331851823947864,0.0683794229496583,1.57886501706893e-08
NMR metabolomics,X23424.Total Lipids in VLDL,COL6A3,Collagen alpha-3(VI) chain,42794,0.0218333300821091,0.00386244015513317,0.0142629473780481,0.0294037127861701,1.61093332842367e-08
NMR metabolomics,X23424.Total Lipids in VLDL,BCAM,Basal cell adhesion molecule,42611,-0.0141784649481581,0.00250981590373296,-0.0190977041194747,-0.0092592257768415,1.64467452488991e-08
NMR metabolomics,X23424.Total Lipids in VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",42346,0.0444600345248278,0.00787079978329198,0.0290332669495755,0.0598868021000801,1.64986858031702e-08
NMR metabolomics,X23424.Total Lipids in VLDL,VIT,Vitrin,40511,0.0221921907990644,0.00393087173525584,0.0144876821979629,0.0298966994001658,1.68553490439825e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CR2,Complement receptor type 2,42689,0.0275165240295798,0.00487690670191443,0.0179577868938275,0.0370752611653321,1.71258427207605e-08
NMR metabolomics,X23424.Total Lipids in VLDL,PCDH1,Protocadherin-1,42721,0.0124710119282998,0.00221078861759289,0.00813786623781777,0.0168041576187819,1.72475006755489e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CFHR2,Complement factor H-related protein 2,40451,0.0332868432049558,0.00590158869832918,0.0217197293562306,0.044853957053681,1.73828334358757e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40449,0.0454905725038733,0.00806891160038496,0.0296755057671188,0.0613056392406278,1.76425826283085e-08
NMR metabolomics,X23424.Total Lipids in VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,42618,0.0217157047247691,0.00386107964784156,0.0141479886149996,0.0292834208345385,1.90027418005653e-08
NMR metabolomics,X23424.Total Lipids in VLDL,SFTPD,Pulmonary surfactant-associated protein D,42636,0.0388290088949423,0.00690953852512006,0.025286313385707,0.0523717044041776,1.95176538848681e-08
NMR metabolomics,X23424.Total Lipids in VLDL,DSC2,Desmocollin-2,42488,-0.0202242271442714,0.00360780328077661,-0.0272955215745936,-0.0131529327139493,2.1155486907467e-08
NMR metabolomics,X23424.Total Lipids in VLDL,NECTIN2,Nectin-2,42613,0.0178892940182849,0.00320700557675009,0.0116035630878548,0.0241750249487151,2.47730613779047e-08
NMR metabolomics,X23424.Total Lipids in VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,42311,0.0237839108873813,0.00426510006380835,0.0154243147623169,0.0321435070124457,2.50397212793707e-08
NMR metabolomics,X23424.Total Lipids in VLDL,AGXT,Serine--pyruvate aminotransferase,42636,0.0426768892694569,0.0076540387044627,0.02767497340871,0.0576788051302038,2.5123753627051e-08
NMR metabolomics,X23424.Total Lipids in VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42611,0.0306515738151367,0.00549895884280305,0.0198736144832427,0.0414295331470306,2.53656948727251e-08
NMR metabolomics,X23424.Total Lipids in VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",42292,0.0265964019187025,0.00477784818798576,0.0172318194702504,0.0359609843671546,2.64853150001537e-08
NMR metabolomics,X23424.Total Lipids in VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,42346,0.0247846826601199,0.00445321535989793,0.0160563805547199,0.0335129847655198,2.66407484252988e-08
NMR metabolomics,X23424.Total Lipids in VLDL,NFYA,Nuclear transcription factor Y subunit alpha,40116,0.0222026887274991,0.00399077517990849,0.0143807693748785,0.0300246080801198,2.70641798328325e-08
NMR metabolomics,X23424.Total Lipids in VLDL,MOG,Myelin-oligodendrocyte glycoprotein,42721,0.0192328021554984,0.0034574685962019,0.0124561637069426,0.0260094406040541,2.70698818136597e-08
NMR metabolomics,X23424.Total Lipids in VLDL,HMOX1,Heme oxygenase 1,42500,-0.0273408816355497,0.00491749849655655,-0.0369791786888006,-0.0177025845822989,2.7510050343107e-08
NMR metabolomics,X23424.Total Lipids in VLDL,FGF16,Fibroblast growth factor 16,40199,0.0268006265848879,0.00483609940275685,0.0173218717554845,0.0362793814142913,3.06295720170894e-08
NMR metabolomics,X23424.Total Lipids in VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,40171,0.0221571543686848,0.00400508154625953,0.0143071945380161,0.0300071141993535,3.23377930991457e-08
NMR metabolomics,X23424.Total Lipids in VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,42587,0.0140337531956051,0.0025412130053409,0.00905297570513695,0.0190145306860733,3.40508851611134e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CENPF,Centromere protein F,40302,0.0306583644845629,0.00556111811048645,0.0197585729880095,0.0415581559811164,3.60680721232781e-08
NMR metabolomics,X23424.Total Lipids in VLDL,IFNG,Interferon gamma,42370,0.0634168227002939,0.01150610707294,0.0408648528373314,0.0859687925632564,3.62311240078547e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CD80,T-lymphocyte activation antigen CD80,40511,0.0195872172500632,0.00355634515954614,0.0126167807373528,0.0265576537627736,3.71533520840599e-08
NMR metabolomics,X23424.Total Lipids in VLDL,C1QA,Complement C1q subcomponent subunit A,42701,-0.0122739799186392,0.00224249181322478,-0.0166692638725597,-0.0078786959647186,4.49441365681317e-08
NMR metabolomics,X23424.Total Lipids in VLDL,NTRK3,NT-3 growth factor receptor,42711,-0.012094942712576,0.0022151142233219,-0.0164365665902869,-0.00775331883486506,4.84025444504235e-08
NMR metabolomics,X23424.Total Lipids in VLDL,PLXNB2,Plexin-B2,42743,0.0134016141183317,0.00245457965091566,0.008590638002537,0.0182125902341264,4.84954057377359e-08
NMR metabolomics,X23424.Total Lipids in VLDL,IL5RA,Interleukin-5 receptor subunit alpha,42594,-0.0321024558848243,0.00588107483928398,-0.0436293625698209,-0.0205755491998277,4.88432117774964e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CDH3,Cadherin-3,42711,0.0208175279927325,0.00381661676241055,0.0133369591384078,0.0282980968470572,4.99897428102782e-08
NMR metabolomics,X23424.Total Lipids in VLDL,LYZL2,Lysozyme-like protein 2,40080,0.0200294661128193,0.00367446993805855,0.0128275050342245,0.027231427191414,5.11856260212299e-08
NMR metabolomics,X23424.Total Lipids in VLDL,LUZP2,Leucine zipper protein 2,40451,0.0255163704275444,0.00468746711632878,0.01632893487954,0.0347038059755488,5.33306639628325e-08
NMR metabolomics,X23424.Total Lipids in VLDL,RHOC,Rho-related GTP-binding protein RhoC,42443,0.0635025572421896,0.0116912308460261,0.0405877447839785,0.0864173697004008,5.68240874808289e-08
NMR metabolomics,X23424.Total Lipids in VLDL,GRN,Progranulin,42552,0.0135034730161938,0.00249869156386458,0.0086060375510192,0.0184009084813684,6.62090645491309e-08
NMR metabolomics,X23424.Total Lipids in VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,40451,0.0221163174789474,0.00409517976210257,0.0140897651452264,0.0301428698126685,6.77794968849193e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,40527,-0.018214130311191,0.00338124777200912,-0.0248413759443289,-0.0115868846780531,7.31547725827077e-08
NMR metabolomics,X23424.Total Lipids in VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,40223,0.0155182570595088,0.00288559689544641,0.00986248714443387,0.0211740269745838,7.69275942839678e-08
NMR metabolomics,X23424.Total Lipids in VLDL,ATXN2,Ataxin-2,40136,0.0605981298153444,0.0112741061215849,0.0385008818170379,0.0826953778136509,7.8163431835051e-08
NMR metabolomics,X23424.Total Lipids in VLDL,SPP1,Osteopontin,42771,-0.0258090366173334,0.00480934653323116,-0.0352353558224664,-0.0163827174122003,8.16282989491875e-08
NMR metabolomics,X23424.Total Lipids in VLDL,COL24A1,Collagen alpha-1(XXIV) chain,40449,0.0304638995792408,0.00568133064205243,0.0193284915208181,0.0415993076376636,8.3884335294062e-08
NMR metabolomics,X23424.Total Lipids in VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,42357,0.029445024451819,0.00549360925463805,0.0186775503127285,0.0402124985909096,8.46872496113661e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CA12,Carbonic anhydrase 12,42587,-0.0180445883167371,0.00337057559752546,-0.024650916487887,-0.0114382601455872,8.76620329492034e-08
NMR metabolomics,X23424.Total Lipids in VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42754,0.0194511424537738,0.00363441995501069,0.0123276793419529,0.0265746055655948,8.84399663125516e-08
NMR metabolomics,X23424.Total Lipids in VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42587,0.0215499931273179,0.00402894566877464,0.0136532596165196,0.0294467266381162,8.99990562276552e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CILP,Cartilage intermediate layer protein 1,40527,0.0301146161824125,0.00563078891163739,0.0190782699156032,0.0411509624492218,9.05581066657015e-08
NMR metabolomics,X23424.Total Lipids in VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,40451,0.0248754972080494,0.00466038519259849,0.0157411422305563,0.0340098521855424,9.5989326836113e-08
NMR metabolomics,X23424.Total Lipids in VLDL,CHRDL1,Chordin-like protein 1,42654,0.0175372284029337,0.00328851628596203,0.0110917364824481,0.0239827203234193,9.8236099249096e-08
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA1,Alpha-1-antitrypsin,40327,-0.00445462613821891,0.000835729477133817,-0.00609265591340119,-0.00281659636303662,1.00007963898728e-07
NMR metabolomics,X23424.Total Lipids in VLDL,KLRK1,NKG2-D type II integral membrane protein,40483,0.0265198029839332,0.00498074232891247,0.0167575480192648,0.0362820579486017,1.0319166729923e-07
NMR metabolomics,X23424.Total Lipids in VLDL,EGFLAM,Pikachurin,40449,0.0168144956060366,0.0031609842137696,0.0106189665470482,0.023010024665025,1.06114349779715e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CTSV,Cathepsin L2,42677,0.0226654231400081,0.00426485668926563,0.0143063040290475,0.0310245422509687,1.08676111056926e-07
NMR metabolomics,X23424.Total Lipids in VLDL,ICAM5,Intercellular adhesion molecule 5,42636,0.0247642895876486,0.00466725488147024,0.0156164700199669,0.0339121091553303,1.1385813646112e-07
NMR metabolomics,X23424.Total Lipids in VLDL,ITGA11,Integrin alpha-11,42594,-0.0183318466943807,0.00345643151270678,-0.025106452459286,-0.0115572409294755,1.15288449458884e-07
NMR metabolomics,X23424.Total Lipids in VLDL,PDIA5,Protein disulfide-isomerase A5,40080,0.0331429046563913,0.00625989582347308,0.0208735088423841,0.0454123004703986,1.21678139153596e-07
NMR metabolomics,X23424.Total Lipids in VLDL,DUSP3,Dual specificity protein phosphatase 3,42311,0.0461019584127337,0.00871486204435155,0.0290208288058047,0.0631830880196628,1.24257267967884e-07
NMR metabolomics,X23424.Total Lipids in VLDL,LY9,T-lymphocyte surface antigen Ly-9,42443,0.0164972322385264,0.00312212572042573,0.010377865826492,0.0226165986505608,1.28414719835497e-07
NMR metabolomics,X23424.Total Lipids in VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,40482,0.0221463132160383,0.00419276274032544,0.0139284982450004,0.0303641281870762,1.30134035327106e-07
NMR metabolomics,X23424.Total Lipids in VLDL,ICAM4,Intercellular adhesion molecule 4,42594,-0.0283710043173037,0.00537314629987129,-0.0389023710650514,-0.017839637569556,1.31097186356141e-07
NMR metabolomics,X23424.Total Lipids in VLDL,IDS,Iduronate 2-sulfatase,42754,0.00468172577069528,0.000889497072675369,0.00293831150825156,0.006425140033139,1.43618845243834e-07
NMR metabolomics,X23424.Total Lipids in VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42679,0.0150883923332991,0.00286711128192276,0.00946885422073049,0.0207079304458677,1.44227878515806e-07
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA7,Thyroxine-binding globulin,40539,0.00990559057037609,0.00188442130371523,0.00621212481509424,0.013599056325658,1.49432974584257e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CA7,Carbonic anhydrase 7,40302,-0.0189034665546989,0.00359679152674054,-0.0259531779471104,-0.0118537551622874,1.50239320514393e-07
NMR metabolomics,X23424.Total Lipids in VLDL,BAX,Apoptosis regulator BAX,42292,0.0473581197483618,0.009032537568664,0.0296543461137804,0.0650618933829432,1.60393717967144e-07
NMR metabolomics,X23424.Total Lipids in VLDL,PROK1,Prokineticin-1,42594,0.0294824778872248,0.00562958414986861,0.0184484929534823,0.0405164628209672,1.65622973528912e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CAPG,Macrophage-capping protein,42461,0.0311800361963535,0.00595539648912356,0.0195074590776713,0.0428526133150357,1.66967014812833e-07
NMR metabolomics,X23424.Total Lipids in VLDL,NECTIN1,Nectin-1,40199,0.0174871746440637,0.00334121574166517,0.0109383917903999,0.0240359574977274,1.69139333246041e-07
NMR metabolomics,X23424.Total Lipids in VLDL,MUC16,Mucin-16,42587,0.102181529940429,0.0195444133420957,0.0638744797899218,0.140488580090937,1.73770927715759e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42689,0.0230027972810523,0.00440104618877091,0.0143767467510613,0.0316288478110432,1.75168078148371e-07
NMR metabolomics,X23424.Total Lipids in VLDL,COL9A2,Collagen alpha-2(IX) chain,40302,0.0237757456230549,0.0045677647635272,0.0148229266865416,0.0327285645595682,1.97336484917938e-07
NMR metabolomics,X23424.Total Lipids in VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,42370,0.0227774061837894,0.00438805369754872,0.0141768209365939,0.0313779914309849,2.12533402910634e-07
NMR metabolomics,X23424.Total Lipids in VLDL,DKK3,Dickkopf-related protein 3,42794,-0.0159300384897585,0.00307199034724929,-0.0219511395703671,-0.00990893740914985,2.18438838134081e-07
NMR metabolomics,X23424.Total Lipids in VLDL,REG3A,Regenerating islet-derived protein 3-alpha,42794,-0.0345113385945215,0.00665934077352192,-0.0475636465106245,-0.0214590306784186,2.22189860472799e-07
NMR metabolomics,X23424.Total Lipids in VLDL,MMP12,Macrophage metalloelastase,42592,0.0295649104179396,0.00570846765094393,0.0183763138220895,0.0407535070137897,2.26151824586757e-07
NMR metabolomics,X23424.Total Lipids in VLDL,PI3,Elafin,42446,0.0298621294349373,0.0057855717867402,0.0185224087329265,0.041201850136948,2.48545226536574e-07
NMR metabolomics,X23424.Total Lipids in VLDL,REG1A,Lithostathine-1-alpha,42575,-0.0272939238071776,0.00531505504311229,-0.0377114316916777,-0.0168764159226775,2.8578687777961e-07
NMR metabolomics,X23424.Total Lipids in VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",40199,0.0190588449686336,0.00371949521930871,0.0117686343387885,0.0263490555984787,3.04125849201005e-07
NMR metabolomics,X23424.Total Lipids in VLDL,LCP1,Plastin-2,40527,0.0249954380588449,0.00489432203709354,0.0154025668661415,0.0345883092515482,3.32582682603225e-07
NMR metabolomics,X23424.Total Lipids in VLDL,PZP,Pregnancy zone protein,40539,0.0264982320845226,0.00520004090517244,0.0163061519103846,0.0366903122586606,3.52908163024843e-07
NMR metabolomics,X23424.Total Lipids in VLDL,ASPN,Asporin,40511,0.0146137321029072,0.00286870344583391,0.00899107334907271,0.0202363908567417,3.5587035927501e-07
NMR metabolomics,X23424.Total Lipids in VLDL,TDO2,"Tryptophan 2,3-dioxygenase",40182,0.0200571043860978,0.00395049840884248,0.0123141275047666,0.0278000812674291,3.89502093389463e-07
NMR metabolomics,X23424.Total Lipids in VLDL,HMBS,Porphobilinogen deaminase,42721,0.022231948900383,0.00439435329999086,0.0136190164324009,0.030844881368365,4.26519562595587e-07
NMR metabolomics,X23424.Total Lipids in VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,40182,0.0392343843872972,0.00776838856501684,0.0240083427998642,0.0544604259747302,4.47686094855666e-07
NMR metabolomics,X23424.Total Lipids in VLDL,AGER,Advanced glycosylation end product-specific receptor,42587,0.0215664669618178,0.0042737598123716,0.0131898977295695,0.0299430361940661,4.56468937102843e-07
NMR metabolomics,X23424.Total Lipids in VLDL,SLC16A1,Monocarboxylate transporter 1,42311,0.0294886076007801,0.00585161393909862,0.0180194442801468,0.0409577709214134,4.73218963824084e-07
NMR metabolomics,X23424.Total Lipids in VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",40223,0.0172086994450667,0.0034222177847619,0.0105011525869334,0.0239162463032,5.02043907891146e-07
NMR metabolomics,X23424.Total Lipids in VLDL,GZMH,Granzyme H,42357,0.0396963370711923,0.00789828808322222,0.0242156924280768,0.0551769817143079,5.07546692927829e-07
NMR metabolomics,X23424.Total Lipids in VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",40223,0.0354390854274703,0.00706111843092712,0.0215992933028532,0.0492788775520875,5.2777663699341e-07
NMR metabolomics,X23424.Total Lipids in VLDL,F3,Tissue factor,42636,-0.0139294959982466,0.00277941891257642,-0.0193771570668964,-0.0084818349295968,5.464944210086e-07
NMR metabolomics,X23424.Total Lipids in VLDL,SCN4B,Sodium channel subunit beta-4,40223,0.022523426962171,0.00449377674075582,0.0137156245502896,0.0313312293740525,5.4664312566576e-07
NMR metabolomics,X23424.Total Lipids in VLDL,PDCD6,Programmed cell death protein 6,42636,-0.0358806298971451,0.00716956346021294,-0.0499329742791624,-0.0218282855151277,5.66930401987675e-07
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42754,0.0211170820312226,0.0042259101407891,0.0128342981552759,0.0293998659071692,5.89397558351855e-07
NMR metabolomics,X23424.Total Lipids in VLDL,SNU13,NHP2-like protein 1,40116,0.0323375153702482,0.00647264550146828,0.0196511301873704,0.0450239005531261,5.94293320495333e-07
NMR metabolomics,X23424.Total Lipids in VLDL,FOSB,Protein fosB,42311,0.0195159540638972,0.00390685517174309,0.0118585179272808,0.0271733902005137,5.94972480872266e-07
NMR metabolomics,X23424.Total Lipids in VLDL,PDCD1,Programmed cell death protein 1,42689,0.0228852828680172,0.0045873399703655,0.0138940965261008,0.0318764692099335,6.15142938990948e-07
NMR metabolomics,X23424.Total Lipids in VLDL,C8B,Complement component C8 beta chain,40539,0.0154541973646765,0.00309951876069858,0.00937914059370726,0.0215292541356457,6.25538662938951e-07
NMR metabolomics,X23424.Total Lipids in VLDL,GSTT2B,Glutathione S-transferase theta-2B,40483,0.121937109120662,0.0244579064685162,0.0739996124423704,0.169874605798954,6.26904053262121e-07
NMR metabolomics,X23424.Total Lipids in VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,42607,0.0112960530224045,0.00226694881790502,0.00685283333931067,0.0157392727054984,6.34084128985453e-07
NMR metabolomics,X23424.Total Lipids in VLDL,MPO,Myeloperoxidase,42611,0.0235556748321611,0.00473181382877862,0.014281319727755,0.0328300299365672,6.49921390118969e-07
NMR metabolomics,X23424.Total Lipids in VLDL,KLK6,Kallikrein-6,42656,0.0159887719848931,0.00322835224978154,0.00966120157532127,0.0223163423944649,7.41124729286892e-07
NMR metabolomics,X23424.Total Lipids in VLDL,PKD1,Polycystin-1,40511,0.0135550756370335,0.00273861866836462,0.00818738304703888,0.0189227682270282,7.54363029043372e-07
NMR metabolomics,X23424.Total Lipids in VLDL,NXPH1,Neurexophilin-1,42311,0.0195751119396302,0.00396381654007487,0.0118060315210835,0.027344192358177,7.97152499629288e-07
NMR metabolomics,X23424.Total Lipids in VLDL,CDH15,Cadherin-15,42692,0.0313153438060932,0.00634877698092222,0.0188717409234857,0.0437589466887008,8.21503420461657e-07
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42495,0.0194823461509484,0.00395897984628761,0.0117227456522247,0.0272419466496721,8.71110916389073e-07
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42721,0.0174394592093277,0.00354704306534047,0.0104872548012604,0.024391663617395,8.90848850668168e-07
NMR metabolomics,X23424.Total Lipids in VLDL,SIL1,Nucleotide exchange factor SIL1,40223,0.0155331240382109,0.00316214004841249,0.00933532954332238,0.0217309185330993,9.13442997955753e-07
NMR metabolomics,X23424.Total Lipids in VLDL,S100A13,Protein S100-A13,40199,0.0178461717133896,0.00363411215488558,0.0107233118898138,0.0249690315369653,9.20383661898983e-07
NMR metabolomics,X23424.Total Lipids in VLDL,NPHS1,Nephrin,40199,0.0168368842617724,0.00343304613176708,0.010108113843509,0.0235656546800359,9.507414617487e-07
NMR metabolomics,X23424.Total Lipids in VLDL,APOBR,Apolipoprotein B receptor,40223,-0.0212214034139213,0.00435270269117451,-0.0297527006886233,-0.0126901061392193,1.10072130776672e-06
NMR metabolomics,X23424.Total Lipids in VLDL,GBA,Lysosomal acid glucosylceramidase,40182,0.0275904663406861,0.00566174457320748,0.0164934469771994,0.0386874857041727,1.11373705614267e-06
NMR metabolomics,X23424.Total Lipids in VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,42636,-0.0143385056983212,0.00294367162490588,-0.0201081020831367,-0.00856890931350567,1.12322432962943e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CLASP1,CLIP-associating protein 1,40080,0.0360878380842476,0.00742205072127613,0.0215406186705463,0.0506350574979488,1.17683846567686e-06
NMR metabolomics,X23424.Total Lipids in VLDL,RAB44,Ras-related protein Rab-44,40451,0.0207966384770451,0.00427864901136335,0.012410486414773,0.0291827905393173,1.18633261570726e-06
NMR metabolomics,X23424.Total Lipids in VLDL,GUCA2A,Guanylin,42563,-0.0179814252472766,0.00371131932168693,-0.025255611117783,-0.0107072393767702,1.28017581152957e-06
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,42346,0.0203028313713662,0.00419164189235014,0.01208721326236,0.0285184494803725,1.28929848828928e-06
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42721,0.0168667746241956,0.0034851911416337,0.0100357999865936,0.0236977492617977,1.31566506349992e-06
NMR metabolomics,X23424.Total Lipids in VLDL,HSPB6,Heat shock protein beta-6,42721,0.0194277198118268,0.00401513631389226,0.011558052636598,0.0272973869870556,1.32185695524011e-06
NMR metabolomics,X23424.Total Lipids in VLDL,IL1R1,Interleukin-1 receptor type 1,42590,-0.0116132499172357,0.00240020292827073,-0.0163176476566463,-0.00690885217782509,1.32316226077733e-06
NMR metabolomics,X23424.Total Lipids in VLDL,MET,Hepatocyte growth factor receptor,42654,-0.00974576294647464,0.00202008347705437,-0.0137051265615012,-0.00578639933144807,1.41938960962604e-06
NMR metabolomics,X23424.Total Lipids in VLDL,IL1B,Interleukin-1 beta,42293,0.0279346673770248,0.00579318318931929,0.016580028325959,0.0392893064280906,1.43731349632175e-06
NMR metabolomics,X23424.Total Lipids in VLDL,BRD1,Bromodomain-containing protein 1,40302,-0.0150512625072667,0.00312472983225353,-0.0211757329784837,-0.00892679203604983,1.47790984052844e-06
NMR metabolomics,X23424.Total Lipids in VLDL,SLAMF7,SLAM family member 7,42594,-0.0291737915969136,0.0060613426218542,-0.0410540231357478,-0.0172935600580794,1.50235148778116e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40527,-0.0194337132166992,0.0040426718395154,-0.0273573500221494,-0.011510076411249,1.55067321490803e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CRTAP,Cartilage-associated protein,40182,0.0235088842050825,0.00489378391866762,0.013917067724494,0.033100700685671,1.57720037348782e-06
NMR metabolomics,X23424.Total Lipids in VLDL,DLL4,Delta-like protein 4,40223,0.0420587959630494,0.00875977810273847,0.024889630881682,0.0592279610444168,1.59667580657823e-06
NMR metabolomics,X23424.Total Lipids in VLDL,GBP4,Guanylate-binding protein 4,42311,0.0241234986714346,0.00502957639436287,0.0142655289384833,0.0339814684043858,1.63377590442698e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CHI3L1,Chitinase-3-like protein 1,42416,0.0400809619113552,0.00839021086923798,0.0236361486076488,0.0565257752150617,1.79742474209248e-06
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS3,Galectin-3,42669,0.0145036092194555,0.0030420286176948,0.0085412331287737,0.0204659853101373,1.8825022410618e-06
NMR metabolomics,X23424.Total Lipids in VLDL,LIF,Leukemia inhibitory factor,42311,0.0249383674601727,0.00523933836210918,0.0146692642704387,0.0352074706499067,1.95823462349994e-06
NMR metabolomics,X23424.Total Lipids in VLDL,ACAN,Aggrecan core protein,42488,0.0134555889242631,0.00282792490013655,0.00791285611999547,0.0189983217285308,1.97465854466874e-06
NMR metabolomics,X23424.Total Lipids in VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,40223,0.0157424491372615,0.00330922868048589,0.00925636092350918,0.0222285373510139,1.9884940963788e-06
NMR metabolomics,X23424.Total Lipids in VLDL,GZMB,Granzyme B,42594,0.0321280439926106,0.00676214578230216,0.0188742382592984,0.0453818497259228,2.04350779723607e-06
NMR metabolomics,X23424.Total Lipids in VLDL,IGSF21,Immunoglobulin superfamily member 21,40223,0.01921219724615,0.00404450930808007,0.0112849590023131,0.027139435489987,2.05785781732259e-06
NMR metabolomics,X23424.Total Lipids in VLDL,DDI2,Protein DDI1 homolog 2,40283,0.0376891009300226,0.00799258701045191,0.0220236303895368,0.0533545714705083,2.44048839594679e-06
NMR metabolomics,X23424.Total Lipids in VLDL,PRL,Prolactin,42711,-0.0357588531122658,0.00762033868664411,-0.0506947169380882,-0.0208229892864433,2.72460806808404e-06
NMR metabolomics,X23424.Total Lipids in VLDL,ITGAM,Integrin alpha-M,42611,-0.0151135858192413,0.00322177727863502,-0.0214282692853659,-0.00879890235311663,2.74460543477572e-06
NMR metabolomics,X23424.Total Lipids in VLDL,EPHB4,Ephrin type-B receptor 4,42794,-0.0126026617023094,0.00268737383201074,-0.0178699144130504,-0.00733540899156833,2.76424527368297e-06
NMR metabolomics,X23424.Total Lipids in VLDL,RPA2,Replication protein A 32 kDa subunit,40199,0.0151547404042631,0.00323711682934395,0.008809991418749,0.0214994893897773,2.88108333424223e-06
NMR metabolomics,X23424.Total Lipids in VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,40116,0.0479480992097875,0.0102613891025818,0.0278357765687273,0.0680604218508478,3.00860088456947e-06
NMR metabolomics,X23424.Total Lipids in VLDL,NPR1,Atrial natriuretic peptide receptor 1,40116,-0.0195535029087026,0.00419557410129678,-0.0277768281472443,-0.011330177670161,3.19162991634555e-06
NMR metabolomics,X23424.Total Lipids in VLDL,KLK8,Kallikrein-8,42154,0.0176853053678594,0.00381066051021475,0.0102164107678384,0.0251541999678803,3.50112896274023e-06
NMR metabolomics,X23424.Total Lipids in VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42587,-0.0195670867128419,0.00422035623446101,-0.0278389849323854,-0.0112951884932983,3.57950351361613e-06
NMR metabolomics,X23424.Total Lipids in VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,40182,0.0508749077547721,0.0109771251874664,0.0293597423873381,0.0723900731222062,3.61692921412458e-06
NMR metabolomics,X23424.Total Lipids in VLDL,KIF1C,Kinesin-like protein KIF1C,40116,0.0170097576112219,0.00367043023797626,0.00981571434478842,0.0242038008776554,3.62349088560965e-06
NMR metabolomics,X23424.Total Lipids in VLDL,SCGB3A1,Secretoglobin family 3A member 1,40283,-0.0126203728245239,0.00272699252833343,-0.0179652781800575,-0.00727546746899042,3.73499477749675e-06
NMR metabolomics,X23424.Total Lipids in VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,42346,0.0185787149492803,0.00403132184348938,0.0106773241360411,0.0264801057625195,4.09218104344264e-06
NMR metabolomics,X23424.Total Lipids in VLDL,LRRC25,Leucine-rich repeat-containing protein 25,42587,0.0184096109158355,0.00399470377581307,0.0105799915152419,0.0262392303164291,4.09319605383353e-06
NMR metabolomics,X23424.Total Lipids in VLDL,TNC,Tenascin,42689,-0.0225935869378663,0.0049172308081451,-0.0322313593218307,-0.0129558145539019,4.371327435803e-06
NMR metabolomics,X23424.Total Lipids in VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42681,0.0140545664174378,0.00305924731537903,0.00805844167929495,0.0200506911555808,4.38503862871435e-06
NMR metabolomics,X23424.Total Lipids in VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,42370,0.0201895682421534,0.00439842834012975,0.0115686486954991,0.0288104877888078,4.46961472975884e-06
NMR metabolomics,X23424.Total Lipids in VLDL,XG,Glycoprotein Xg,42734,0.016041397642228,0.00351069225107017,0.00916044083013052,0.0229223544543256,4.93685644256282e-06
NMR metabolomics,X23424.Total Lipids in VLDL,DCC,Netrin receptor DCC,40182,0.0107982131279198,0.00236789477311858,0.00615713937260741,0.0154392868832322,5.16431136354758e-06
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40511,0.0149688799318973,0.00328251685442363,0.008535146897227,0.0214026129665676,5.16454299350666e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC14A,C-type lectin domain family 14 member A,42611,-0.0154770133264044,0.00339853659225558,-0.0221381450472253,-0.00881588160558341,5.30929575435583e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CLGN,Calmegin,40182,0.021564867982102,0.00474436706287546,0.0122659085388661,0.0308638274253379,5.54264481195737e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CREBZF,CREB/ATF bZIP transcription factor,40080,-0.0121297618806746,0.00267249943141201,-0.0173678607662422,-0.00689166299510706,5.71998240071242e-06
NMR metabolomics,X23424.Total Lipids in VLDL,RSPO1,R-spondin-1,42495,0.0156792153340982,0.00345826018518004,0.00890102537114536,0.0224574052970511,5.84252166259147e-06
NMR metabolomics,X23424.Total Lipids in VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",42311,0.0129547883586861,0.00285950031438737,0.00735016774248685,0.0185594089748853,5.93811848341881e-06
NMR metabolomics,X23424.Total Lipids in VLDL,GLYR1,Putative oxidoreductase GLYR1,40451,0.0271862176373443,0.00600246538691287,0.0154213854789951,0.0389510497956935,5.98231489851367e-06
NMR metabolomics,X23424.Total Lipids in VLDL,GIMAP7,GTPase IMAP family member 7,40283,-0.0146894749872525,0.00324817887821722,-0.0210559055885582,-0.00832304438594672,6.17848735835241e-06
NMR metabolomics,X23424.Total Lipids in VLDL,INSL3,Insulin-like 3,40483,0.03607687477959,0.00798123100527593,0.0204336620092492,0.0517200875499308,6.24055681484956e-06
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA1,Annexin A1,40235,0.0191410273966861,0.00423927493747272,0.0108320485192396,0.0274500062741326,6.39227452602971e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CCL15,C-C motif chemokine 15,42794,0.0205417272264804,0.00455160557801708,0.011620580293567,0.0294628741593939,6.44310631416018e-06
NMR metabolomics,X23424.Total Lipids in VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,40116,0.0226431501096443,0.00501804864879319,0.0128077747580096,0.0324785254612789,6.47855993524195e-06
NMR metabolomics,X23424.Total Lipids in VLDL,RAB37,Ras-related protein Rab-37,42370,0.0370506051559044,0.0082372077113315,0.0209056780416947,0.0531955322701142,6.91961079589003e-06
NMR metabolomics,X23424.Total Lipids in VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42495,0.0315831723781249,0.00702952507064205,0.0178053032396665,0.0453610415165833,7.08418028388797e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CHAD,Chondroadherin,40283,0.0238035384029541,0.00530164170435018,0.0134123206624277,0.0341947561434804,7.19951212472666e-06
NMR metabolomics,X23424.Total Lipids in VLDL,TRIM26,Tripartite motif-containing protein 26,40080,0.0257749367650679,0.00574530502659691,0.014514138912938,0.0370357346171978,7.32270183082988e-06
NMR metabolomics,X23424.Total Lipids in VLDL,STX3,Syntaxin-3,40483,0.0177032944243928,0.00396088579322608,0.0099399582696697,0.0254666305791159,7.91557243611708e-06
NMR metabolomics,X23424.Total Lipids in VLDL,RAB39B,Ras-related protein Rab-39B,40116,0.0421543799832656,0.00943665614094141,0.0236585339470204,0.0606502260195107,8.00881466296761e-06
NMR metabolomics,X23424.Total Lipids in VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,42676,0.01274111946205,0.00285291794048957,0.00714940029869047,0.0183328386254096,8.03449812346481e-06
NMR metabolomics,X23424.Total Lipids in VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42611,0.0161418501641005,0.00362204005763809,0.00904265165112983,0.0232410486770711,8.39588320824986e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CLIC5,Chloride intracellular channel protein 5,40182,-0.0144006421609387,0.00323264172138082,-0.0207366199348451,-0.0080646643870323,8.48173349943197e-06
NMR metabolomics,X23424.Total Lipids in VLDL,PFDN2,Prefoldin subunit 2,42311,0.0250628191769125,0.00564099250730688,0.014006473862591,0.036119164491234,8.94479799636492e-06
NMR metabolomics,X23424.Total Lipids in VLDL,VWF,von Willebrand factor,42794,-0.0324987366378881,0.00731608846603425,-0.0468382700313152,-0.0181592032444609,8.979173728802e-06
NMR metabolomics,X23424.Total Lipids in VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,42475,0.0120567921179182,0.00272025477941766,0.00672509275025958,0.0173884914855768,9.40113886294941e-06
NMR metabolomics,X23424.Total Lipids in VLDL,PRUNE2,Protein prune homolog 2,40302,0.0136056293924286,0.00307102562059897,0.00758641917605459,0.0196248396088026,9.49936306206523e-06
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGAP5,Rho GTPase-activating protein 5,40080,0.0361165185799885,0.00815277888932923,0.0201370719569032,0.0520959652030738,9.51691305045769e-06
NMR metabolomics,X23424.Total Lipids in VLDL,LAG3,Lymphocyte activation gene 3 protein,42587,-0.01848870979008,0.00418161959943179,-0.0266846842049663,-0.0102927353751937,9.88249653655249e-06
NMR metabolomics,X23424.Total Lipids in VLDL,IL31RA,Interleukin-31 receptor subunit alpha,40145,0.0173092182018839,0.00391658296493972,0.00963271559060201,0.0249857208131657,9.9895360461911e-06
NMR metabolomics,X23424.Total Lipids in VLDL,CLPS,Colipase,42590,0.0327738755899621,0.00742464782947348,0.0182215658441941,0.0473261853357301,1.02177609174858e-05
NMR metabolomics,X23424.Total Lipids in VLDL,EBI3_IL27,Interleukin-27,42689,-0.0138221085435,0.00314246211631392,-0.0199813342914753,-0.00766288279552473,1.09838347808638e-05
NMR metabolomics,X23424.Total Lipids in VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,40199,0.0156328975501823,0.00355500589743499,0.00866508599120969,0.0226007091091549,1.10567681413211e-05
NMR metabolomics,X23424.Total Lipids in VLDL,FGF5,Fibroblast growth factor 5,42370,-0.0148119839350459,0.00336944519205334,-0.0214160965114704,-0.00820787135862136,1.11141898711501e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ARG1,Arginase-1,42488,0.0231732187966083,0.00527684497581043,0.0128306026440198,0.0335158349491967,1.13445904829563e-05
NMR metabolomics,X23424.Total Lipids in VLDL,RNASET2,Ribonuclease T2,42749,0.0123466796798609,0.00281510505165155,0.00682907377862387,0.017864285581098,1.16395390812169e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,40449,0.0251310398285179,0.0057309659880659,0.0138983464919087,0.036363733165127,1.16968569449866e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CBS,Cystathionine beta-synthase,40223,0.0229069804176639,0.00524128521347541,0.0126340613992522,0.0331798994360757,1.25103020439617e-05
NMR metabolomics,X23424.Total Lipids in VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,42572,0.0152176053114768,0.00348338769023287,0.00839016543862041,0.0220450451843333,1.25974009806901e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CTRL,Chymotrypsin-like protease CTRL-1,40483,-0.0315038509259407,0.00721664117844464,-0.0456484676356921,-0.0173592342161892,1.27993357673309e-05
NMR metabolomics,X23424.Total Lipids in VLDL,FUCA1,Tissue alpha-L-fucosidase,42721,0.0373868354895912,0.00856723185596295,0.0205950610519038,0.0541786099272786,1.28691189958122e-05
NMR metabolomics,X23424.Total Lipids in VLDL,SPTLC1,Serine palmitoyltransferase 1,40483,0.0172224154743066,0.00395033400614567,0.0094797608222611,0.0249650701263521,1.31372399329856e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ALCAM,CD166 antigen,42794,0.00871564110422598,0.0020011646324177,0.00479335842468729,0.0126379237837647,1.33866864411028e-05
NMR metabolomics,X23424.Total Lipids in VLDL,TBC1D17,TBC1 domain family member 17,42311,0.0200199370247237,0.00461772380768849,0.0109691983616542,0.0290706756877931,1.46543222147109e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC4D,C-type lectin domain family 4 member D,42594,0.0274723211945305,0.006338838128805,0.0150481984620727,0.0398964439269883,1.47513102977025e-05
NMR metabolomics,X23424.Total Lipids in VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,40302,0.0194493812754091,0.00449696229273642,0.0106353351816458,0.0282634273691725,1.53860414521877e-05
NMR metabolomics,X23424.Total Lipids in VLDL,SIRPB1,Signal-regulatory protein beta-1,42600,0.0211986225741677,0.00490256352953567,0.0115895980562778,0.0308076470920576,1.54340875417511e-05
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42676,0.0121570130870276,0.0028137887040435,0.00664198722710231,0.0176720389469528,1.56780834633908e-05
NMR metabolomics,X23424.Total Lipids in VLDL,QPCT,Glutaminyl-peptide cyclotransferase,42681,0.0119870936658378,0.00277903547398914,0.00654018413681912,0.0174340031948565,1.61905723248814e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CX3CL1,Fractalkine,42495,-0.0150539677415442,0.00350988149564346,-0.0219333354730053,-0.00817460001008298,1.80726103935975e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CYTL1,Cytokine-like protein 1,40527,0.0111906002956084,0.00261088187624158,0.00607327181817489,0.0163079287730419,1.83308701015444e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ACE,Angiotensin-converting enzyme,40532,-0.0117091638985716,0.00273926460278869,-0.0170781225200375,-0.00634020527710579,1.93077008673131e-05
NMR metabolomics,X23424.Total Lipids in VLDL,STX5,Syntaxin-5,40199,0.0179220702199259,0.00419483710300218,0.00970018949804165,0.0261439509418102,1.94996341914012e-05
NMR metabolomics,X23424.Total Lipids in VLDL,SRPX,Sushi repeat-containing protein SRPX,40511,-0.0161332065502645,0.00377627115262609,-0.0235346980094117,-0.00873171509111738,1.95084993055414e-05
NMR metabolomics,X23424.Total Lipids in VLDL,KEL,Kell blood group glycoprotein,42311,0.0157816213181399,0.00369477622478903,0.00853985991755338,0.0230233827187264,1.95676424853419e-05
NMR metabolomics,X23424.Total Lipids in VLDL,FLT1,Vascular endothelial growth factor receptor 1,42559,0.00939312149770341,0.00220358945044706,0.00507408617482716,0.0137121568205796,2.03406385819512e-05
NMR metabolomics,X23424.Total Lipids in VLDL,AMPD3,AMP deaminase 3,40483,0.0307448866914939,0.00722204578762191,0.0165896769477549,0.0449000964352328,2.08780999000904e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,40532,0.0176368490173812,0.0041463012298752,0.00951009860682576,0.0257635994279366,2.12016594534257e-05
NMR metabolomics,X23424.Total Lipids in VLDL,GPC1,Glypican-1,42721,0.0129323728957094,0.00304470732972963,0.00696474652943933,0.0188999992619795,2.17621346447577e-05
NMR metabolomics,X23424.Total Lipids in VLDL,COL1A1,Collagen alpha-1(I) chain,42794,-0.0108380972563469,0.00255371526477263,-0.0158433791753012,-0.00583281533739255,2.20975972951476e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,40199,0.0193191022486113,0.00455964828126312,0.0103821916173356,0.028256012879887,2.28399733075871e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,42357,-0.00922650182199392,0.00217810970982053,-0.0134955968532422,-0.00495740679074569,2.29070598991253e-05
NMR metabolomics,X23424.Total Lipids in VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,42590,0.0357791386790843,0.00847091484875403,0.0191761455755264,0.0523821317826422,2.4184426790055e-05
NMR metabolomics,X23424.Total Lipids in VLDL,TFPI2,Tissue factor pathway inhibitor 2,42635,0.0161518294693094,0.00383158895941662,0.00864191510885284,0.023661743829766,2.50922480879675e-05
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42778,0.0122559734933291,0.00291293104927734,0.00654662863674552,0.0179653183499127,2.59942112755626e-05
NMR metabolomics,X23424.Total Lipids in VLDL,PROCR,Endothelial protein C receptor,40116,-0.0149900929501296,0.0035719252994484,-0.0219910665370484,-0.00798911936321069,2.73044959428279e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CD5L,CD5 antigen-like,40479,0.0204456170160869,0.00487416159737954,0.010892260285223,0.0299989737469508,2.75328845263071e-05
NMR metabolomics,X23424.Total Lipids in VLDL,RPS10,40S ribosomal protein S10,40116,-0.0173873532845195,0.00416290996471452,-0.0255466568153599,-0.00922804975367902,2.98027104000862e-05
NMR metabolomics,X23424.Total Lipids in VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40451,0.0188956440050372,0.00453098284651759,0.0100149176258627,0.0277763703842117,3.06453342193178e-05
NMR metabolomics,X23424.Total Lipids in VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40451,0.0280155727475568,0.00672834395721155,0.0148280185914222,0.0412031269036915,3.15306988526843e-05
NMR metabolomics,X23424.Total Lipids in VLDL,VAMP5,Vesicle-associated membrane protein 5,42357,0.0234221440472919,0.00564724796527482,0.0123535380353532,0.0344907500592305,3.38186766529915e-05
NMR metabolomics,X23424.Total Lipids in VLDL,PADI4,Protein-arginine deiminase type-4,42292,0.0303338555989296,0.00732077288503256,0.0159851407442658,0.0446825704535934,3.44146341895856e-05
NMR metabolomics,X23424.Total Lipids in VLDL,NEDD9,Enhancer of filamentation 1,40199,0.0140791875557474,0.00340237043266274,0.00741054150772839,0.0207478336037663,3.52873452985518e-05
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA6,Corticosteroid-binding globulin,40539,0.00660380055974785,0.00160300053471698,0.00346191951170258,0.00974568160779313,3.82142452951146e-05
NMR metabolomics,X23424.Total Lipids in VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42495,0.0127519028958994,0.00309642552137342,0.0066829088740075,0.0188208969177913,3.84041903620573e-05
NMR metabolomics,X23424.Total Lipids in VLDL,SATB1,DNA-binding protein SATB1,40482,0.0123036942033715,0.00298951289897887,0.0064442489213729,0.0181631394853701,3.88887412195679e-05
NMR metabolomics,X23424.Total Lipids in VLDL,STC2,Stanniocalcin-2,42591,0.0104247806725361,0.00253390235394886,0.00545833205879634,0.0153912292862759,3.90981161667653e-05
NMR metabolomics,X23424.Total Lipids in VLDL,SPRR3,Small proline-rich protein 3,40483,0.0294212452543251,0.00715099671260185,0.0154052916976254,0.0434371988110247,3.9113666838347e-05
NMR metabolomics,X23424.Total Lipids in VLDL,HSPA2,Heat shock-related 70 kDa protein 2,40451,0.0144041074215083,0.00350252448624057,0.00753915942847678,0.0212690554145398,3.94191055557953e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CD34,Hematopoietic progenitor cell antigen CD34,42674,0.0101623436038322,0.0024721159943125,0.00531699625497973,0.0150076909526847,3.96647439739252e-05
NMR metabolomics,X23424.Total Lipids in VLDL,GFRA2,GDNF family receptor alpha-2,42587,0.0089136071209753,0.00216948213900786,0.0046614221285199,0.0131657921134307,4.00375037649022e-05
NMR metabolomics,X23424.Total Lipids in VLDL,DDX25,ATP-dependent RNA helicase DDX25,40182,-0.0159019586007963,0.00387348200260831,-0.0234939833259085,-0.00830993387568397,4.06641763346415e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CTSF,Cathepsin F,42679,0.0165282368467587,0.00403004987925954,0.00862933908340996,0.0244271346101074,4.13338227502294e-05
NMR metabolomics,X23424.Total Lipids in VLDL,FMR1,Synaptic functional regulator FMR1,42346,0.0148137661577415,0.00361207037807818,0.00773410821670823,0.0218934240987747,4.13514449108393e-05
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42618,0.0122200800288661,0.00298584381872043,0.00636782614417409,0.0180723339135582,4.28924393208354e-05
NMR metabolomics,X23424.Total Lipids in VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",40223,0.0318906861791526,0.00779437237838884,0.0166137163175105,0.0471676560407947,4.31638308036947e-05
NMR metabolomics,X23424.Total Lipids in VLDL,LGALS4,Galectin-4,42618,-0.0235171924571859,0.00575235939923573,-0.0347918168796879,-0.0122425680346838,4.3713556226763e-05
NMR metabolomics,X23424.Total Lipids in VLDL,IL7R,Interleukin-7 receptor subunit alpha,42611,-0.0219099300055155,0.00536005341942647,-0.0324156347075914,-0.0114042253034396,4.38335540750687e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,40199,0.0139545485681699,0.00342042244306353,0.00725052057976538,0.0206585765565744,4.53975391884031e-05
NMR metabolomics,X23424.Total Lipids in VLDL,IL1RL1,Interleukin-1 receptor-like 1,42760,-0.0189679115840993,0.00466144638667598,-0.0281043465019842,-0.00983147666621439,4.74614155770534e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CNTN4,Contactin-4,42611,-0.00993869125985009,0.00245039130328081,-0.0147414582142805,-0.0051359243054197,5.02109509931326e-05
NMR metabolomics,X23424.Total Lipids in VLDL,BOC,Brother of CDO,42357,-0.00967059070977043,0.0023858988432331,-0.0143469524425073,-0.00499422897703356,5.08062760946588e-05
NMR metabolomics,X23424.Total Lipids in VLDL,MILR1,Allergin-1,42370,-0.021274670735737,0.00525102085731434,-0.0315666716160731,-0.0109826698554009,5.11755037024869e-05
NMR metabolomics,X23424.Total Lipids in VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42570,0.0755068890300677,0.0186490882083562,0.0389546761416895,0.112059101918446,5.17655096956719e-05
NMR metabolomics,X23424.Total Lipids in VLDL,BST2,Bone marrow stromal antigen 2,42711,0.021029006053995,0.00520574629658829,0.010825743312682,0.0312322687953081,5.38439621988376e-05
NMR metabolomics,X23424.Total Lipids in VLDL,QSOX1,Sulfhydryl oxidase 1,40342,0.0178708608642505,0.00442848548965811,0.00919102930452065,0.0265506924239804,5.48654490386771e-05
NMR metabolomics,X23424.Total Lipids in VLDL,PMS1,PMS1 protein homolog 1,40182,0.0214266696852552,0.00531246654974213,0.0110142352477606,0.0318391041227498,5.53754195318008e-05
NMR metabolomics,X23424.Total Lipids in VLDL,VIM,Vimentin,42357,0.0475757369907782,0.0117991925092297,0.024449319672688,0.0707021543088685,5.55879723080283e-05
NMR metabolomics,X23424.Total Lipids in VLDL,EPHB6,Ephrin type-B receptor 6,42476,0.0138091294902072,0.00342682156713987,0.00709255921861308,0.0205256997618014,5.6154693302865e-05
NMR metabolomics,X23424.Total Lipids in VLDL,GSAP,Gamma-secretase-activating protein,42346,0.0350703553864818,0.00872777949731521,0.017963907571744,0.0521768032012196,5.89597042366756e-05
NMR metabolomics,X23424.Total Lipids in VLDL,RCC1,Regulator of chromosome condensation,40451,0.0215265758735518,0.0053574183605759,0.0110260358868231,0.0320271158602806,5.90541486032848e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ROBO4,Roundabout homolog 4,40223,-0.00746919148496576,0.00186025819024831,-0.0111152975378525,-0.00382308543207907,5.98047362664899e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,40116,-0.0133174923854101,0.00332064469734438,-0.0198259559922051,-0.00680902877861515,6.09900992739228e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CD109,CD109 antigen,42611,-0.0137414766632424,0.00342764426689888,-0.0204596594263642,-0.00702329390012056,6.13024675699786e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CD59,CD59 glycoprotein,42130,0.0101836967777318,0.00254653859553295,0.00519248113048726,0.0151749124249764,6.39548555915582e-05
NMR metabolomics,X23424.Total Lipids in VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",40223,0.0150945765756742,0.00377971508021565,0.00768633501845157,0.0225028181328969,6.55067246332168e-05
NMR metabolomics,X23424.Total Lipids in VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",42676,0.0114730965401296,0.00287666587780508,0.00583483141963159,0.0171113616606275,6.68909946199303e-05
NMR metabolomics,X23424.Total Lipids in VLDL,MST1,Hepatocyte growth factor-like protein,40370,0.0266000216811033,0.00667798525344859,0.0135111705843441,0.0396888727778625,6.84129213581848e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CD300E,CMRF35-like molecule 2,42677,0.0175025200639893,0.00440300869476944,0.0088726230222412,0.0261324171057374,7.07083229010961e-05
NMR metabolomics,X23424.Total Lipids in VLDL,ERC2,ERC protein 2,40182,0.0307904349697185,0.00775454382527354,0.0155915290721824,0.0459893408672547,7.2139188963946e-05
NMR metabolomics,X23424.Total Lipids in VLDL,BCL2L15,Bcl-2-like protein 15,40199,0.0227879851989829,0.00574731089090442,0.0115232558528102,0.0340527145451555,7.38659209451512e-05
NMR metabolomics,X23424.Total Lipids in VLDL,LMOD1,Leiomodin-1,40482,-0.0144250743589589,0.00364885370104567,-0.0215768276130084,-0.00727332110490935,7.7545505225281e-05
NMR metabolomics,X23424.Total Lipids in VLDL,PDRG1,p53 and DNA damage-regulated protein 1,40182,0.0206811945767937,0.00523574691496149,0.0104191306234691,0.0309432585301182,7.86398058875058e-05
NMR metabolomics,X23424.Total Lipids in VLDL,HSBP1,Heat shock factor-binding protein 1,40223,0.0380917838050375,0.0096537488952102,0.0191704359704256,0.0570131316396495,8.00262907848804e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CNPY2,Protein canopy homolog 2,42357,0.0247382548436864,0.00628285618051286,0.0124238567298812,0.0370526529574916,8.27859860712718e-05
NMR metabolomics,X23424.Total Lipids in VLDL,DSG4,Desmoglein-4,42543,0.0200737227459063,0.00510055539016908,0.0100766341811749,0.0300708113106377,8.3411416890923e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CKAP4,Cytoskeleton-associated protein 4,42713,0.0115889530065273,0.00294757373333998,0.00581170848918094,0.0173661975238737,8.47706559946445e-05
NMR metabolomics,X23424.Total Lipids in VLDL,TK1,"Thymidine kinase, cytosolic",40302,0.0182272605453236,0.00463763911714172,0.00913748787572587,0.0273170332149214,8.53584152981443e-05
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,42794,-0.00991814530083041,0.00252782154040265,-0.0148726755200196,-0.00496361508164122,8.76668442723542e-05
NMR metabolomics,X23424.Total Lipids in VLDL,SPARCL1,SPARC-like protein 1,42644,-0.0110535797515014,0.00281921053816694,-0.0165792324063086,-0.00552792709669421,8.86907973213916e-05
NMR metabolomics,X23424.Total Lipids in VLDL,GDF15,Growth/differentiation factor 15,42794,-0.0184433559929621,0.00471160244783323,-0.0276780967907153,-0.00920861519520902,9.10504013339032e-05
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL12,Stromal cell-derived factor 1,42370,0.0160428468202912,0.0040990835865718,0.00800864299061052,0.024077050649972,9.13253842208598e-05
NMR metabolomics,X23424.Total Lipids in VLDL,UROS,Uroporphyrinogen-III synthase,40182,0.0270918908787345,0.00693259003505437,0.0135040144100279,0.040679767347441,9.3659102998234e-05
NMR metabolomics,X23424.Total Lipids in VLDL,NXPH3,Neurexophilin-3,40199,0.0122514868492574,0.00314148565188411,0.00609417497156451,0.0184087987269502,9.68035001058273e-05
NMR metabolomics,X23424.Total Lipids in VLDL,SCGB2A2,Mammaglobin-A,40116,-0.0126067330825278,0.00325062174628368,-0.0189779517052438,-0.00623551445981177,0.000105826277114456
NMR metabolomics,X23424.Total Lipids in VLDL,FAM171B,Protein FAM171B,40451,0.0104388749288246,0.00269698304592819,0.00515278815880534,0.0157249616988439,0.00010919208848729
NMR metabolomics,X23424.Total Lipids in VLDL,COL9A1,Collagen alpha-1(IX) chain,42594,0.019152260107973,0.00495408873725308,0.00944224618295693,0.028862274032989,0.00011117992533436
NMR metabolomics,X23424.Total Lipids in VLDL,ATP6V1D,V-type proton ATPase subunit D,42587,0.010276324410151,0.00266347702858123,0.00505590943413179,0.0154967393861702,0.000114743460492128
NMR metabolomics,X23424.Total Lipids in VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",42311,0.0117962616460977,0.00306627901874919,0.00578635476934932,0.0178061685228462,0.000120093333666262
NMR metabolomics,X23424.Total Lipids in VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,42587,-0.013233225265567,0.00345412868266086,-0.0200033174835823,-0.00646313304755175,0.000128136924581282
NMR metabolomics,X23424.Total Lipids in VLDL,FSTL3,Follistatin-related protein 3,42574,0.0131922667135911,0.00344627766189047,0.0064375624962858,0.0199469709308964,0.000129790059982924
NMR metabolomics,X23424.Total Lipids in VLDL,DGCR6,Protein DGCR6,40136,0.0173193996597333,0.00452805416566289,0.00844441349503401,0.0261943858244325,0.000131546539814251
NMR metabolomics,X23424.Total Lipids in VLDL,FABP1,"Fatty acid-binding protein, liver",42618,-0.03658866792806,0.00959575362343486,-0.0553963450299924,-0.0177809908261277,0.000137900785519136
NMR metabolomics,X23424.Total Lipids in VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,42370,0.014406456142507,0.00378132465167791,0.00699505982521833,0.0218178524597957,0.000139656554860543
NMR metabolomics,X23424.Total Lipids in VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,40116,0.0203778095291609,0.0053598376684164,0.00987252769906476,0.0308830913592571,0.000144345411241775
NMR metabolomics,X23424.Total Lipids in VLDL,GBP2,Guanylate-binding protein 2,42370,0.0234866122784344,0.00619055456765307,0.0113531253258344,0.0356200992310345,0.000148936723744957
NMR metabolomics,X23424.Total Lipids in VLDL,GFAP,Glial fibrillary acidic protein,42326,0.0189088025217481,0.00498687615127469,0.00913452526524966,0.0286830797782465,0.000150281674721481
NMR metabolomics,X23424.Total Lipids in VLDL,TGFBR2,TGF-beta receptor type-2,42679,0.0138118846705557,0.00365289570232526,0.00665220909399821,0.0209715602471132,0.000156824173636198
NMR metabolomics,X23424.Total Lipids in VLDL,LEO1,RNA polymerase-associated protein LEO1,40482,0.0125509014869777,0.00332011114898807,0.00604348363496112,0.0190583193389943,0.00015746818011906
NMR metabolomics,X23424.Total Lipids in VLDL,NDRG1,Protein NDRG1,42311,0.0250623007519979,0.00663775052785624,0.0120523097173996,0.0380722917865961,0.000160248685018933
NMR metabolomics,X23424.Total Lipids in VLDL,CD48,CD48 antigen,42654,0.0119057240404133,0.00315761337854189,0.00571680181847115,0.0180946462623554,0.000163629411594398
NMR metabolomics,X23424.Total Lipids in VLDL,TCN2,Transcobalamin-2,42771,-0.0118332933966934,0.00314183219425943,-0.0179912844974419,-0.00567530229594491,0.000166339557464367
NMR metabolomics,X23424.Total Lipids in VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42587,0.0135193419453346,0.00359047454293687,0.00648201184117835,0.0205566720494909,0.000167036655315026
NMR metabolomics,X23424.Total Lipids in VLDL,CENPJ,Centromere protein J,40302,0.027238866719852,0.0072404034806969,0.0130476758976861,0.0414300575420179,0.000169382596953389
NMR metabolomics,X23424.Total Lipids in VLDL,GGT5,Glutathione hydrolase 5 proenzyme,42495,0.00904784793280191,0.00240547099096971,0.00433312479050128,0.0137625710751025,0.000169715132955494
NMR metabolomics,X23424.Total Lipids in VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40483,0.0208802780896754,0.00555158895686125,0.00999916373422737,0.0317613924451235,0.000169998452107997
NMR metabolomics,X23424.Total Lipids in VLDL,YAP1,Transcriptional coactivator YAP1,40483,0.0110299355142846,0.00293548803720968,0.00527637896135365,0.0167834920672156,0.000172521079022736
NMR metabolomics,X23424.Total Lipids in VLDL,TIMP2,Metalloproteinase inhibitor 2,40511,-0.0106843518288939,0.0028442299904259,-0.0162590426101286,-0.00510966104765912,0.000173170271642842
NMR metabolomics,X23424.Total Lipids in VLDL,TMPRSS11D,Transmembrane protease serine 11D,40470,0.0156996077758685,0.00418355624506305,0.00749983753554491,0.023899378016192,0.000175821652502335
NMR metabolomics,X23424.Total Lipids in VLDL,CD86,T-lymphocyte activation antigen CD86,40449,0.0116113081412976,0.00309945203711689,0.00553638214854854,0.0176862341340468,0.000180397198023668
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL14,C-X-C motif chemokine 14,42370,0.0215462774429755,0.00575680454278678,0.0102629405391134,0.0328296143468376,0.000182791037555662
NMR metabolomics,X23424.Total Lipids in VLDL,ART3,Ecto-ADP-ribosyltransferase 3,42689,-0.0137166857386834,0.00366555207482544,-0.0209011678053412,-0.00653220367202551,0.000183280534528608
NMR metabolomics,X23424.Total Lipids in VLDL,SSH3,Protein phosphatase Slingshot homolog 3,40080,0.01103652578153,0.00295743445810508,0.00523995424364406,0.016833097319416,0.00019109092870628
NMR metabolomics,X23424.Total Lipids in VLDL,NEO1,Neogenin,40482,0.00844651315545629,0.00226870894054728,0.00399984363198361,0.012893182678929,0.000197789029877194
NMR metabolomics,X23424.Total Lipids in VLDL,YY1,Transcriptional repressor protein YY1,40199,0.0107283834465101,0.00288216810387918,0.00507933396290691,0.0163774329301133,0.000198376072439865
NMR metabolomics,X23424.Total Lipids in VLDL,CD248,Endosialin,40527,-0.0154854865407527,0.00416212820098825,-0.0236432578146897,-0.00732771526681575,0.000199734598724558
NMR metabolomics,X23424.Total Lipids in VLDL,PNMA2,Paraneoplastic antigen Ma2,40136,0.0168424365866672,0.00454049878672569,0.00794305896468488,0.0257418142086496,0.000208795289398979
NMR metabolomics,X23424.Total Lipids in VLDL,MB,Myoglobin,42794,-0.0199877764099697,0.00540700106731129,-0.0305854985018998,-0.00939005431803954,0.000219323754476065
NMR metabolomics,X23424.Total Lipids in VLDL,AGT,Angiotensinogen,40532,0.00900065227981395,0.00243752436317196,0.0042231045279969,0.013778200031631,0.000223069055704736
NMR metabolomics,X23424.Total Lipids in VLDL,BRK1,Protein BRICK1,42311,0.0168761942083713,0.00457818835015487,0.00790294504206773,0.0258494433746748,0.000228530014699009
NMR metabolomics,X23424.Total Lipids in VLDL,PCDH12,Protocadherin-12,40482,0.00969660624556243,0.0026335318915417,0.0045348837381407,0.0148583287529842,0.000232510991596962
NMR metabolomics,X23424.Total Lipids in VLDL,CD55,Complement decay-accelerating factor,42201,0.0101945027679458,0.0027764823258663,0.00475259740924782,0.0156364081266437,0.00024187583850294
NMR metabolomics,X23424.Total Lipids in VLDL,EXTL1,Exostosin-like 1,40116,0.0177658311523839,0.00484019490903066,0.00827904913068377,0.027252613174084,0.000243250406609866
NMR metabolomics,X23424.Total Lipids in VLDL,PREB,Prolactin regulatory element-binding protein,42370,0.0110271575868639,0.00300547359560988,0.0051364293394685,0.0169178858342592,0.000244437290042851
NMR metabolomics,X23424.Total Lipids in VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40527,0.0138337983740212,0.00377596400898827,0.00643290891640419,0.0212346878316382,0.000249783385101714
NMR metabolomics,X23424.Total Lipids in VLDL,LXN,Latexin,42461,-0.0252978717115437,0.00690658445452545,-0.0388347772424136,-0.0117609661806738,0.000250382543402499
NMR metabolomics,X23424.Total Lipids in VLDL,C1QL2,Complement C1q-like protein 2,40199,0.0164642486925956,0.00450547710950857,0.00763351355795879,0.0252949838272324,0.000259110037754586
NMR metabolomics,X23424.Total Lipids in VLDL,GAST,Gastrin,40483,0.0541065269912059,0.014841610728364,0.0250169699636124,0.0831960840187993,0.000267970785690133
NMR metabolomics,X23424.Total Lipids in VLDL,CSF1,Macrophage colony-stimulating factor 1,42676,0.0103252638528395,0.00283316709556834,0.00477225634552559,0.0158782713601535,0.000268997533752043
NMR metabolomics,X23424.Total Lipids in VLDL,CXADR,Coxsackievirus and adenovirus receptor,42594,0.0192460219231112,0.00528233436691138,0.00889264656396487,0.0295993972822575,0.000270003766961061
NMR metabolomics,X23424.Total Lipids in VLDL,CCL25,C-C motif chemokine 25,42754,0.0177652590968207,0.00487889160627263,0.00820263154852632,0.027327886645115,0.000272328753089941
NMR metabolomics,X23424.Total Lipids in VLDL,CSF3,Granulocyte colony-stimulating factor,42370,0.0181166258818852,0.00498051489386305,0.00835481668991359,0.0278784350738567,0.000276347379268019
NMR metabolomics,X23424.Total Lipids in VLDL,IL34,Interleukin-34,42292,0.0135473623578051,0.0037271229682475,0.00624220134003997,0.0208525233755702,0.000279257030541569
NMR metabolomics,X23424.Total Lipids in VLDL,LMNB1,Lamin-B1,40434,0.0220860167173602,0.00609785410487429,0.0101342226718066,0.0340378107629138,0.000293698072749741
NMR metabolomics,X23424.Total Lipids in VLDL,CLC,Galectin-10,42611,-0.0241947029228862,0.00670558969834597,-0.0373376587316443,-0.0110517471141281,0.000309522092503381
NMR metabolomics,X23424.Total Lipids in VLDL,CALCB,Calcitonin gene-related peptide 2,40483,0.0150475975660529,0.00418774019492958,0.00683962678399093,0.0232555683481149,0.000327968900554795
NMR metabolomics,X23424.Total Lipids in VLDL,NRTN,Neurturin,42370,0.0179931265332482,0.00501851047582357,0.00815684600063401,0.0278294070658624,0.00033784107784717
NMR metabolomics,X23424.Total Lipids in VLDL,FCRL6,Fc receptor-like protein 6,42594,0.0256020436499661,0.00714307770454289,0.0116016113490621,0.0396024759508702,0.000339345519685515
NMR metabolomics,X23424.Total Lipids in VLDL,CCL28,C-C motif chemokine 28,42538,0.0213177545834647,0.00598417205922288,0.0095887773473879,0.0330467318195416,0.000368821749729472
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42594,0.0128010753484238,0.00359621968459984,0.00575248476660808,0.0198496659302394,0.000372716609340659
NMR metabolomics,X23424.Total Lipids in VLDL,ULBP2,UL16-binding protein 2,42495,0.0144234137767803,0.00407579159597875,0.00643486224866191,0.0224119653048986,0.000403320362045639
NMR metabolomics,X23424.Total Lipids in VLDL,LRRC38,Leucine-rich repeat-containing protein 38,40182,0.017451920003601,0.00494176838410832,0.00776605397074866,0.0271377860364533,0.000414882653028529
NMR metabolomics,X23424.Total Lipids in VLDL,CHL1,Neural cell adhesion molecule L1-like protein,42668,-0.0109568574615928,0.00310494575092815,-0.0170425511334119,-0.00487116378977359,0.00041877569130166
NMR metabolomics,X23424.Total Lipids in VLDL,KLK11,Kallikrein-11,42543,0.0117156527705941,0.00333479521512917,0.00517945414894097,0.0182518513922473,0.000444283559836083
NMR metabolomics,X23424.Total Lipids in VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42495,0.0383118246294556,0.0109355424421214,0.0168781614428976,0.0597454878160135,0.00046082940288591
NMR metabolomics,X23424.Total Lipids in VLDL,ATXN10,Ataxin-10,42311,0.0257633782256365,0.00735723731391704,0.0113431930903591,0.0401835633609139,0.000463709413155704
NMR metabolomics,X23424.Total Lipids in VLDL,AHNAK2,Protein AHNAK2,40223,0.0108134119068181,0.00308859172309095,0.0047597721295598,0.0168670516840763,0.000465205509641802
NMR metabolomics,X23424.Total Lipids in VLDL,CD99,CD99 antigen,42611,-0.00720084674615082,0.00205896275409046,-0.0112364137441681,-0.00316527974813351,0.000471482554029045
NMR metabolomics,X23424.Total Lipids in VLDL,IL18BP,Interleukin-18-binding protein,42689,0.0115057329846576,0.00329161925993681,0.00505415923518146,0.0179573067341338,0.000474759630118062
NMR metabolomics,X23424.Total Lipids in VLDL,CASP1,Caspase-1,42311,0.0245858638253512,0.00704329272134635,0.0107810100915123,0.03839071755919,0.000483380709537143
NMR metabolomics,X23424.Total Lipids in VLDL,SCGN,Secretagogin,42370,-0.0160937313881551,0.00461245930411796,-0.0251341516242263,-0.00705331115208387,0.000486075292341928
NMR metabolomics,X23424.Total Lipids in VLDL,FGA,Fibrinogen alpha chain,40284,0.0110227140902642,0.00316117877564037,0.00482680369000904,0.0172186244905193,0.000490546254297251
NMR metabolomics,X23424.Total Lipids in VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],42370,0.0201835374795049,0.00579605084581635,0.00882327782170486,0.0315437971373049,0.000498754486273534
NMR metabolomics,X23424.Total Lipids in VLDL,NME3,Nucleoside diphosphate kinase 3,42638,0.00848304585755536,0.00243967541053956,0.00370128205289782,0.0132648096622129,0.000508431256557527
NMR metabolomics,X23424.Total Lipids in VLDL,MMP13,Collagenase 3,42311,-0.0118084561495951,0.00340008266276927,-0.0184726181686228,-0.00514429413056729,0.000516352513724992
NMR metabolomics,X23424.Total Lipids in VLDL,EIF5,Eukaryotic translation initiation factor 5,40116,0.0156435672216134,0.00450436095417914,0.00681501975142226,0.0244721146918045,0.000516702434542495
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42495,0.0120369886868718,0.00347190026770407,0.00523206416217187,0.0188419132115718,0.0005280154038517
NMR metabolomics,X23424.Total Lipids in VLDL,SAFB2,Scaffold attachment factor B2,40482,0.00970814285885549,0.00280447685786926,0.00421136821743174,0.0152049175002792,0.000538844318917529
NMR metabolomics,X23424.Total Lipids in VLDL,SPESP1,Sperm equatorial segment protein 1,40511,0.0112198708213544,0.00324448705680047,0.00486067619002549,0.0175790654526834,0.000545931928955116
NMR metabolomics,X23424.Total Lipids in VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42582,-0.0239714498420035,0.00693800391642887,-0.0375699375182041,-0.0103729621658029,0.000551807510179727
NMR metabolomics,X23424.Total Lipids in VLDL,SELL,L-selectin,40539,0.00840930622644529,0.00243693608903779,0.00363291149193122,0.0131857009609594,0.000561024608867322
NMR metabolomics,X23424.Total Lipids in VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,40302,0.0237724663630714,0.00689883972189786,0.0102507405081516,0.0372941922179912,0.000571341369503398
NMR metabolomics,X23424.Total Lipids in VLDL,CDH17,Cadherin-17,42636,-0.0243342083185721,0.00708012770422593,-0.0382112586188549,-0.0104571580182892,0.000590034529604639
NMR metabolomics,X23424.Total Lipids in VLDL,EP300,Histone acetyltransferase p300,40199,0.010853437439615,0.00316515861840714,0.00464972654753698,0.017057148331693,0.000607953600727815
NMR metabolomics,X23424.Total Lipids in VLDL,CST1,Cystatin-SN,39042,0.0385629785128524,0.0112598230161212,0.0164937254012549,0.0606322316244498,0.000617693522753666
NMR metabolomics,X23424.Total Lipids in VLDL,IL1RAP,Interleukin-1 receptor accessory protein,42611,-0.0156109871826019,0.0045696844689166,-0.0245675687416784,-0.00665440562352534,0.000636882595727863
NMR metabolomics,X23424.Total Lipids in VLDL,CCL21,C-C motif chemokine 21,42676,0.0146698568000811,0.00429606060900603,0.00624957800642928,0.0230901355937329,0.000640349825617562
NMR metabolomics,X23424.Total Lipids in VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40482,0.014936383346306,0.00437816227383605,0.00635518528958736,0.0235175814030247,0.000648176973399803
NMR metabolomics,X23424.Total Lipids in VLDL,S100A14,Protein S100-A14,40482,0.0190191681605174,0.00559700581724394,0.00804903675871926,0.0299892995623155,0.000680908508678177
NMR metabolomics,X23424.Total Lipids in VLDL,VEGFD,Vascular endothelial growth factor D,42734,-0.0124862700386377,0.00367530717630678,-0.019689872104199,-0.00528266797307642,0.000682400523075968
NMR metabolomics,X23424.Total Lipids in VLDL,PRSS53,Serine protease 53,40483,0.0129232925595593,0.00381009681662123,0.00545550279898169,0.0203910823201369,0.000696596159624079
NMR metabolomics,X23424.Total Lipids in VLDL,BLVRB,Flavin reductase,42611,0.0226672573657828,0.00669491735474871,0.00954521935047534,0.0357892953810903,0.000711898557665733
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,40199,0.0107428433806172,0.00317503765972908,0.00451976956754819,0.0169659171936862,0.000718093301140109
NMR metabolomics,X23424.Total Lipids in VLDL,TXNDC15,Thioredoxin domain-containing protein 15,42679,0.0094816077289853,0.00280503129965057,0.00398374638167019,0.0149794690763004,0.000726346485702787
NMR metabolomics,X23424.Total Lipids in VLDL,RBPMS,RNA-binding protein with multiple splicing,40199,0.0220535206991581,0.00652580401269024,0.00926294483428526,0.034844096564031,0.000728876046639289
NMR metabolomics,X23424.Total Lipids in VLDL,OMD,Osteomodulin,42676,-0.014524063029991,0.00429991632789729,-0.0229518990326697,-0.00609622702731236,0.00073286937451173
NMR metabolomics,X23424.Total Lipids in VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",40527,0.0141542102311653,0.0041917052753486,0.00593846789148202,0.0223699525708485,0.000736026006190163
NMR metabolomics,X23424.Total Lipids in VLDL,WFDC2,WAP four-disulfide core domain protein 2,41948,0.0150339878568989,0.00446503729265184,0.00628251476330129,0.0237854609504965,0.000762024325068981
NMR metabolomics,X23424.Total Lipids in VLDL,B2M,Beta-2-microglobulin,40539,0.0107898166322506,0.00320535935918784,0.00450731228824247,0.0170723209762588,0.000764699536258683
NMR metabolomics,X23424.Total Lipids in VLDL,RNASE6,Ribonuclease K6,40468,0.0116473601718424,0.00347238020328196,0.00484149497340979,0.0184532253702751,0.000798320801212112
NMR metabolomics,X23424.Total Lipids in VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,40182,0.0286800516455668,0.00859314272906673,0.011837491896596,0.0455226113945376,0.000848008728514248
NMR metabolomics,X23424.Total Lipids in VLDL,CXCL9,C-X-C motif chemokine 9,42676,0.0229357613070596,0.00689626290803087,0.00941908600731905,0.0364524366068001,0.000883927992469262
NMR metabolomics,X23424.Total Lipids in VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,42711,0.0078754712480298,0.0023725615640635,0.00322525058246534,0.0125256919135943,0.000904509987631371
NMR metabolomics,X23424.Total Lipids in VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40511,0.0096176889252538,0.00290002495048144,0.00393364002231017,0.0153017378281974,0.000914671232457096
NMR metabolomics,X23424.Total Lipids in VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,42311,0.013348514566402,0.00403349752154257,0.00544285942417853,0.0212541697086254,0.000937433382763349
NMR metabolomics,X23424.Total Lipids in VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,40182,0.0217169111960074,0.00657187381084675,0.00883603852674776,0.034597783865267,0.000954424775779177
NMR metabolomics,X23424.Total Lipids in VLDL,GSTP1,Glutathione S-transferase P,42237,-0.0236117552016085,0.00714956417549049,-0.0376249009855699,-0.00959860941764715,0.0009606951929649
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,42794,-0.00973712447711874,0.00294941470320859,-0.0155179772954076,-0.0039562716588299,0.000964599804030856
NMR metabolomics,X23424.Total Lipids in VLDL,PCDHB15,Protocadherin beta-15,40451,-0.0135172879638425,0.00411414587865376,-0.0215810138860038,-0.00545356204168109,0.00102089781511483
NMR metabolomics,X23424.Total Lipids in VLDL,PEPD,Xaa-Pro dipeptidase,40532,0.0088622280414429,0.00269765335312518,0.00357482746931755,0.0141496286135683,0.00102233079562675
NMR metabolomics,X23424.Total Lipids in VLDL,ODAM,Odontogenic ameloblast-associated protein,42292,0.0188155808259081,0.00573584244032069,0.00757332964287958,0.0300578320089367,0.0010394857110525
NMR metabolomics,X23424.Total Lipids in VLDL,PLA2G1B,Phospholipase A2,42782,-0.0152033520612847,0.00464556026779422,-0.0243086501861614,-0.00609805393640804,0.00106805464013908
NMR metabolomics,X23424.Total Lipids in VLDL,IL10RA,Interleukin-10 receptor subunit alpha,42370,0.0193197705575575,0.00591642202117807,0.00772358339604853,0.0309159577190666,0.00109570000398201
NMR metabolomics,X23424.Total Lipids in VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,40136,-0.0108213966283456,0.0033196283686449,-0.0173278682308896,-0.0043149250258016,0.00111822922668538
NMR metabolomics,X23424.Total Lipids in VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,40451,0.0219866380277013,0.00675038635157737,0.00875588077860961,0.0352173952767929,0.00112892715818912
NMR metabolomics,X23424.Total Lipids in VLDL,NGF,Beta-nerve growth factor,42495,0.00398605758923681,0.00122433237100273,0.00158636614207145,0.00638574903640217,0.0011339659175266
NMR metabolomics,X23424.Total Lipids in VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,40223,0.021522027716518,0.00661686036489607,0.00855298140132172,0.0344910740317143,0.00114696502225662
NMR metabolomics,X23424.Total Lipids in VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,40116,0.0122041517599348,0.00375222933015285,0.00484978227283519,0.0195585212470344,0.00114739109707134
NMR metabolomics,X23424.Total Lipids in VLDL,TMEM25,Transmembrane protein 25,40482,-0.0151371743644111,0.00465760272387263,-0.0242660757032015,-0.00600827302562076,0.00115746048749774
NMR metabolomics,X23424.Total Lipids in VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,40080,0.0196234179985242,0.00604088381901545,0.0077832857132539,0.0314635502837945,0.00116393577392634
NMR metabolomics,X23424.Total Lipids in VLDL,ITGAV,Integrin alpha-V,42721,0.00540055475256855,0.00166923570649399,0.00212885276784033,0.00867225673729678,0.00121787490767593
NMR metabolomics,X23424.Total Lipids in VLDL,KIT,Mast/stem cell growth factor receptor Kit,42663,-0.00991639040246108,0.00306516318792639,-0.0159241102507968,-0.00390867055412535,0.00121854470167421
NMR metabolomics,X23424.Total Lipids in VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,40223,-0.00845583417630083,0.00262071650063724,-0.0135924385175498,-0.00331922983505183,0.00125664506792411
NMR metabolomics,X23424.Total Lipids in VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42711,0.0234422925540904,0.00726774168323764,0.00919751885494466,0.0376870662532362,0.00126040303104675
NMR metabolomics,X23424.Total Lipids in VLDL,KIF20B,Kinesin-like protein KIF20B,40136,0.025660354037033,0.00800074502221577,0.00997889379349009,0.0413418142805759,0.00134398169821519
NMR metabolomics,X23424.Total Lipids in VLDL,REG3G,Regenerating islet-derived protein 3-gamma,40451,0.0134050485012058,0.00418524921537489,0.00520196003907101,0.0216081369633406,0.00136416975964409
NMR metabolomics,X23424.Total Lipids in VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,40302,0.0186811475228202,0.00585681687556079,0.00720178644672102,0.0301605085989193,0.00142844926126575
NMR metabolomics,X23424.Total Lipids in VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40539,-0.00643505355079845,0.00201949855720362,-0.0103932707229175,-0.00247683637867935,0.00144415096877168
NMR metabolomics,X23424.Total Lipids in VLDL,MKI67,Proliferation marker protein Ki-67,40199,0.0126113388330963,0.00395920673416694,0.0048512936341291,0.0203713840320635,0.0014499757579918
NMR metabolomics,X23424.Total Lipids in VLDL,BCL2,Apoptosis regulator Bcl-2,40449,0.0185390602190633,0.00583985415022149,0.00709294608462919,0.0299851743534974,0.00150459863738099
NMR metabolomics,X23424.Total Lipids in VLDL,MYBPC1,"Myosin-binding protein C, slow-type",40511,-0.0232055380949093,0.00732241895710529,-0.0375574792508357,-0.00885359693898293,0.0015331450200775
NMR metabolomics,X23424.Total Lipids in VLDL,OLFM4,Olfactomedin-4,39870,0.0398433889420948,0.0126066892230781,0.0151342780648616,0.064552499819328,0.00157940891417404
NMR metabolomics,X23424.Total Lipids in VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",42636,0.0234803049354704,0.00743379425667034,0.00891006819239656,0.0380505416785443,0.00158885538004571
NMR metabolomics,X23424.Total Lipids in VLDL,EFHD1,EF-hand domain-containing protein D1,40482,0.0116167630493503,0.00368542971498775,0.0043933208079743,0.0188402052907263,0.00162536960004102
NMR metabolomics,X23424.Total Lipids in VLDL,GUK1,Guanylate kinase,40116,-0.0123761685414837,0.00392964124711548,-0.0200782653858301,-0.0046740716971374,0.00164024816831541
NMR metabolomics,X23424.Total Lipids in VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,42346,0.018152174731205,0.00577471168975819,0.00683373981927896,0.0294706096431311,0.00167374004302335
NMR metabolomics,X23424.Total Lipids in VLDL,SOX9,Transcription factor SOX-9,40182,0.00889873554289912,0.00283148215935941,0.00334903051055468,0.0144484405752436,0.00167794512898114
NMR metabolomics,X23424.Total Lipids in VLDL,NLGN2,Neuroligin-2,40136,-0.0154263498300917,0.00491489510710436,-0.0250595442400163,-0.00579315542016718,0.00170153751942764
NMR metabolomics,X23424.Total Lipids in VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,42346,0.00956588781072593,0.0030534179176269,0.00358118869217721,0.0155505869292747,0.00173500382601124
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40449,0.00685107259748828,0.00219787113844863,0.00254324516612896,0.0111589000288476,0.00183074639195474
NMR metabolomics,X23424.Total Lipids in VLDL,TLR4,Toll-like receptor 4,40199,0.00933692761409712,0.00299640041545392,0.00346398279980744,0.0152098724283868,0.00183763978161499
NMR metabolomics,X23424.Total Lipids in VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,42587,-0.00842278274270949,0.0027070772208726,-0.0137286540956198,-0.00311691138979919,0.00186598000294375
NMR metabolomics,X23424.Total Lipids in VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40449,0.0162139366570244,0.00521331509108804,0.0059958390784918,0.0264320342355569,0.0018749053619502
NMR metabolomics,X23424.Total Lipids in VLDL,CRISP3,Cysteine-rich secretory protein 3,40439,-0.00864671971315093,0.00278765383059129,-0.0141105212211099,-0.003182918205192,0.00192829892945336
NMR metabolomics,X23424.Total Lipids in VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,40223,0.0117089151563098,0.00378991529943352,0.00428068116942008,0.0191371491431995,0.0020099750549299
NMR metabolomics,X23424.Total Lipids in VLDL,TSC1,Hamartin,40199,0.0231776624450323,0.00750539860452186,0.00846708118016943,0.0378882437098951,0.00201920262346961
NMR metabolomics,X23424.Total Lipids in VLDL,GM2A,Ganglioside GM2 activator,40269,0.0128784436473053,0.00417755392724624,0.00469043794990266,0.0210664493447079,0.00205586672514268
NMR metabolomics,X23424.Total Lipids in VLDL,CHRM1,Muscarinic acetylcholine receptor M1,40182,-0.0116987173908034,0.00380218157691933,-0.0191509932815653,-0.00424644150004154,0.00209719741712876
NMR metabolomics,X23424.Total Lipids in VLDL,AGR2,Anterior gradient protein 2 homolog,42215,0.0317598145320148,0.0103251233201,0.0115225728246188,0.0519970562394108,0.00210250902502026
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB1,Integrin beta-1,42638,0.00669397380109034,0.00217700019357013,0.00242705342169288,0.0109608941804878,0.00211022748786982
NMR metabolomics,X23424.Total Lipids in VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,40116,-0.0122475872824952,0.00398985270746855,-0.0200676985891335,-0.0044274759758568,0.00214811073493161
NMR metabolomics,X23424.Total Lipids in VLDL,KIAA1549L,UPF0606 protein KIAA1549L,40302,-0.0090842415626875,0.00296114939276884,-0.0148880943725144,-0.00328038875286057,0.00216153236291564
NMR metabolomics,X23424.Total Lipids in VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,42794,0.01280915457648,0.00419164398783708,0.00459353236031931,0.0210247767926407,0.00224837063116869
NMR metabolomics,X23424.Total Lipids in VLDL,SLC12A2,Solute carrier family 12 member 2,40116,-0.00850248988654093,0.00278599855672473,-0.0139630470577214,-0.00304193271536047,0.00227971012803495
NMR metabolomics,X23424.Total Lipids in VLDL,LMNB2,Lamin-B2,40483,0.00892463142155883,0.00292620208123716,0.00318927534233399,0.0146599875007837,0.0022944623175549
NMR metabolomics,X23424.Total Lipids in VLDL,CPA4,Carboxypeptidase A4,40060,0.013760965799409,0.00451373114903371,0.00491405274730296,0.0226078788515151,0.00230394485839924
NMR metabolomics,X23424.Total Lipids in VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40482,0.0225340170047807,0.00739810685023123,0.00803372757832753,0.037034306431234,0.00232507340213498
NMR metabolomics,X23424.Total Lipids in VLDL,SHISA5,Protein shisa-5,40527,0.00864295338051906,0.00284229220324801,0.00307206066215296,0.0142138460988852,0.00236458706506155
NMR metabolomics,X23424.Total Lipids in VLDL,SEMA6C,Semaphorin-6C,40199,0.00812826411000342,0.00268381685477268,0.00286798307464897,0.0133885451453579,0.00246242099400317
NMR metabolomics,X23424.Total Lipids in VLDL,SPON1,Spondin-1,42638,0.0103975060231104,0.0034523823717359,0.003630836574508,0.0171641754717127,0.00260280495928202
NMR metabolomics,X23424.Total Lipids in VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,40483,0.0166115945126657,0.00552241484605682,0.00578766141439432,0.0274355276109371,0.00263525894294348
NMR metabolomics,X23424.Total Lipids in VLDL,NPTX2,Neuronal pentraxin-2,40527,-0.0100913363753077,0.00335554708175657,-0.0166682086555505,-0.00351446409506478,0.00264105965335852
NMR metabolomics,X23424.Total Lipids in VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,40199,0.025558985487059,0.00851333369444601,0.00887285144594487,0.0422451195281732,0.00268611282960316
NMR metabolomics,X23424.Total Lipids in VLDL,KIAA1549,UPF0606 protein KIAA1549,40302,0.0216975902654713,0.00723639277599883,0.00751426042451363,0.035880920106429,0.00272003219793693
NMR metabolomics,X23424.Total Lipids in VLDL,KLK4,Kallikrein-4,42721,-0.0194177410866068,0.00647941110033581,-0.032117386843265,-0.00671809532994863,0.00273291136517698
NMR metabolomics,X23424.Total Lipids in VLDL,TTN,Titin,40116,-0.0201168593116891,0.00671308826384226,-0.0332745123088199,-0.00695920631455823,0.00273566024871684
NMR metabolomics,X23424.Total Lipids in VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,40302,0.0160951574127372,0.00537391468703073,0.00556228462615699,0.0266280301993175,0.00275002437027388
NMR metabolomics,X23424.Total Lipids in VLDL,CST6,Cystatin-M,42332,0.0154497619559134,0.00516814544691018,0.00532019687996948,0.0255793270318574,0.00280024214726081
NMR metabolomics,X23424.Total Lipids in VLDL,RNASE1,Ribonuclease pancreatic,40532,0.00806303948210119,0.00269758638006358,0.00277577017717657,0.0133503087870258,0.00280507947109463
NMR metabolomics,X23424.Total Lipids in VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,42311,0.0454660414887945,0.0152185361482811,0.0156377106381635,0.0752943723394254,0.00281749329410679
NMR metabolomics,X23424.Total Lipids in VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,40199,0.010783116419625,0.00362443874884427,0.00367921647189029,0.0178870163673598,0.00293516284825121
NMR metabolomics,X23424.Total Lipids in VLDL,L1CAM,Neural cell adhesion molecule L1,42679,0.00883097852644383,0.00298237524842238,0.00298552303953597,0.0146764340133517,0.00307120741862125
NMR metabolomics,X23424.Total Lipids in VLDL,JAM2,Junctional adhesion molecule B,42711,0.00856970801096124,0.00289605880976739,0.00289343274381716,0.0142459832781053,0.00309080609089604
NMR metabolomics,X23424.Total Lipids in VLDL,SOD3,Extracellular superoxide dismutase,40532,-0.0176433102534915,0.00596337536511559,-0.0293315259691181,-0.00595509453786495,0.003096668715226
NMR metabolomics,X23424.Total Lipids in VLDL,FABP9,Fatty acid-binding protein 9,42594,0.0171187640547595,0.00578918750151948,0.00577195655178129,0.0284655715577376,0.00311166134379632
NMR metabolomics,X23424.Total Lipids in VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,40182,0.00908778602497062,0.00307555965299256,0.00305968910510521,0.015115882944836,0.00313495151609451
NMR metabolomics,X23424.Total Lipids in VLDL,NAPRT,Nicotinate phosphoribosyltransferase,40483,0.0102012299510158,0.00345906374282698,0.0034214650150749,0.0169809948869567,0.00319322933833053
NMR metabolomics,X23424.Total Lipids in VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,40116,0.013486780623701,0.00457339374711083,0.00452292887936378,0.0224506323680382,0.00319515124332306
NMR metabolomics,X23424.Total Lipids in VLDL,CEP112,Centrosomal protein of 112 kDa,40116,0.0135115478137825,0.00458869045643243,0.00451771451917494,0.0225053811083901,0.00324124681432622
NMR metabolomics,X23424.Total Lipids in VLDL,RSPO3,R-spondin-3,42721,0.0089103306353895,0.00302949217583027,0.00297252597076217,0.0148481353000168,0.00327501430075014
NMR metabolomics,X23424.Total Lipids in VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,40527,0.0190493517997827,0.00647835835440907,0.00635176942514089,0.0317469341744244,0.00328387850112362
NMR metabolomics,X23424.Total Lipids in VLDL,NMRK2,Nicotinamide riboside kinase 2,40080,-0.0127674863195339,0.00434203967654771,-0.0212778840855674,-0.00425708855350042,0.00328441028101681
NMR metabolomics,X23424.Total Lipids in VLDL,MSLN,Mesothelin,42553,0.0178111857383906,0.00607277926141839,0.00590853838601051,0.0297138330907706,0.0033632320410281
NMR metabolomics,X23424.Total Lipids in VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",42311,0.015763704703319,0.00539531787192769,0.00518888167434075,0.0263385277322973,0.00348678045063633
NMR metabolomics,X23424.Total Lipids in VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,40199,0.00724927846899045,0.00248785267632012,0.00237308722340301,0.0121254697145779,0.0035769762056906
NMR metabolomics,X23424.Total Lipids in VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,42591,-0.0129786104644246,0.00446157113292382,-0.0217232898849553,-0.00423393104389394,0.00363208853036882
NMR metabolomics,X23424.Total Lipids in VLDL,CALB1,Calbindin,42587,0.0134807741753838,0.00464770192605767,0.00437127840031078,0.0225902699504569,0.00373144555482246
NMR metabolomics,X23424.Total Lipids in VLDL,CD7,T-cell antigen CD7,40166,0.0132379472000938,0.00456883630076433,0.00428302805059571,0.0221928663495919,0.00376961218157756
NMR metabolomics,X23424.Total Lipids in VLDL,SLAMF8,SLAM family member 8,42346,0.0163307422908202,0.00564161516233082,0.00527317657265182,0.0273883080089886,0.0038015404374837
NMR metabolomics,X23424.Total Lipids in VLDL,IFNGR1,Interferon gamma receptor 1,42676,0.00643708738622468,0.00223045150865671,0.00206540242925754,0.0108087723431918,0.00390788919357899
NMR metabolomics,X23424.Total Lipids in VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,40457,0.0111207587565165,0.00387347291878433,0.00352875183569919,0.0187127656773338,0.00409932264803268
NMR metabolomics,X23424.Total Lipids in VLDL,PGA4,Pepsin A-4,40532,0.0236240003738623,0.00823724831569426,0.00747899367510159,0.0397690070726231,0.00413905463393168
NMR metabolomics,X23424.Total Lipids in VLDL,AIF1L,Allograft inflammatory factor 1-like,40223,0.0162437433022843,0.00569078991086078,0.00508979507699714,0.0273976915275714,0.00431997141875827
NMR metabolomics,X23424.Total Lipids in VLDL,PIGR,Polymeric immunoglobulin receptor,42464,0.0104152750784697,0.00364945090452213,0.00326235130560637,0.0175681988513331,0.00432489900764149
NMR metabolomics,X23424.Total Lipids in VLDL,APOH,Beta-2-glycoprotein 1,42611,-0.0105772332748982,0.00371207812604924,-0.0178529064019547,-0.00330156014784169,0.00438670564431657
NMR metabolomics,X23424.Total Lipids in VLDL,C9orf40,Uncharacterized protein C9orf40,40449,0.0236128685030672,0.00829740784181736,0.00734994913310522,0.0398757878730293,0.0044378284757949
NMR metabolomics,X23424.Total Lipids in VLDL,IL4R,Interleukin-4 receptor subunit alpha,42594,-0.0110015664643379,0.00386681710215212,-0.0185805279845561,-0.00342260494411978,0.00444617241888281
NMR metabolomics,X23424.Total Lipids in VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,40451,0.0083751427477765,0.00294403079474848,0.00260484239006948,0.0141454431054835,0.00445212047214776
NMR metabolomics,X23424.Total Lipids in VLDL,NTF4,Neurotrophin-4,42346,0.0113146192810797,0.00398048757243914,0.00351286363909898,0.0191163749230604,0.00448272041570531
NMR metabolomics,X23424.Total Lipids in VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,40302,0.0188985800549104,0.00666142913234286,0.00584217895551837,0.0319549811543024,0.00456197908995548
NMR metabolomics,X23424.Total Lipids in VLDL,FDX2,"Ferredoxin-2, mitochondrial",40116,0.0163716932260587,0.00577344980568965,0.00505573160690695,0.0276876548452104,0.00458113707442782
NMR metabolomics,X23424.Total Lipids in VLDL,CEP152,Centrosomal protein of 152 kDa,40080,0.0120399101324069,0.00426243989063611,0.00368552794676013,0.0203942923180537,0.00474180323871108
NMR metabolomics,X23424.Total Lipids in VLDL,CEP164,Centrosomal protein of 164 kDa,42370,0.0189841534242259,0.00673339219666269,0.00578670471876703,0.0321816021296848,0.00481847003175825
NMR metabolomics,X23424.Total Lipids in VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",40199,0.0101661861099758,0.00360913759390826,0.0030922764259156,0.017240095794036,0.00485924597324395
NMR metabolomics,X23424.Total Lipids in VLDL,TGFB2,Transforming growth factor beta-2 proprotein,40451,0.0149963832525026,0.00532410663131752,0.0045611342551203,0.025431632249885,0.00486050683947282
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,42636,0.00773786934390774,0.00275520901190474,0.00233765968057445,0.013138079007241,0.00498522593367395
NMR metabolomics,X23424.Total Lipids in VLDL,IL17C,Interleukin-17C,42370,-0.0213460904642097,0.00761965259669114,-0.0362806095537243,-0.00641157137469506,0.00509473990823871
NMR metabolomics,X23424.Total Lipids in VLDL,UNG,Uracil-DNA glycosylase,40451,0.00975768632510859,0.0034847121001225,0.00292765060886849,0.0165877220413487,0.00511672755358964
NMR metabolomics,X23424.Total Lipids in VLDL,PRDX2,Peroxiredoxin-2,40333,0.0178560237593979,0.00638105074441216,0.00534916430035003,0.0303628832184457,0.00514623852110812
NMR metabolomics,X23424.Total Lipids in VLDL,SULT1A1,Sulfotransferase 1A1,42711,-0.0363195082846485,0.0129805643789728,-0.0617614144674352,-0.0108776021018617,0.00514942332996061
NMR metabolomics,X23424.Total Lipids in VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,40065,0.0250759056307994,0.00896657632464989,0.0075014160344856,0.0426503952271132,0.00517345202127025
NMR metabolomics,X23424.Total Lipids in VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",40116,-0.0116218385927939,0.00417258160700174,-0.0198000985425174,-0.00344357864307052,0.00535724492587993
NMR metabolomics,X23424.Total Lipids in VLDL,SEPTIN8,Septin-8,40470,0.009224244406753,0.00331324669688777,0.00273028088085297,0.015718207932653,0.00537742010757836
NMR metabolomics,X23424.Total Lipids in VLDL,GLP1R,Glucagon-like peptide 1 receptor,40136,-0.010799349176924,0.00387975954797697,-0.0184036778909588,-0.00319502046288911,0.00538664792336686
NMR metabolomics,X23424.Total Lipids in VLDL,JCHAIN,Immunoglobulin J chain,42370,-0.0177492396138998,0.00638933020741904,-0.0302723268204411,-0.00522615240735845,0.00547804174317167
NMR metabolomics,X23424.Total Lipids in VLDL,DDA1,DET1- and DDB1-associated protein 1,40116,0.0114048114964442,0.00411834459174451,0.00333285609662497,0.0194767668962634,0.00562767139608536
NMR metabolomics,X23424.Total Lipids in VLDL,MELTF,Melanotransferrin,40511,0.00852822492204514,0.00308349010028363,0.00248458432548922,0.0145718655186011,0.00568806002244647
NMR metabolomics,X23424.Total Lipids in VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42638,-0.00961891168727372,0.00348008544218174,-0.0164398791539499,-0.00279794422059751,0.00571775071552102
NMR metabolomics,X23424.Total Lipids in VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40483,-0.00736794137118746,0.00266898811925558,-0.0125991580849284,-0.00213672465744652,0.00577928745837014
NMR metabolomics,X23424.Total Lipids in VLDL,CA9,Carbonic anhydrase 9,42721,-0.0136314875813257,0.00493975752797689,-0.0233134123361604,-0.00394956282649099,0.00579596175261976
NMR metabolomics,X23424.Total Lipids in VLDL,NME1,Nucleoside diphosphate kinase A,40199,-0.00620817737680043,0.00225100498913248,-0.0106201471555001,-0.00179620759810078,0.00582596352373521
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC10A,C-type lectin domain family 10 member A,42495,-0.0102449607598715,0.00371485465627007,-0.0175260758861608,-0.00296384563358214,0.00582647620669197
NMR metabolomics,X23424.Total Lipids in VLDL,BRD3,Bromodomain-containing protein 3,40116,0.0140247286256677,0.00508682979923742,0.00405454221916235,0.023994915032173,0.00584193264139608
NMR metabolomics,X23424.Total Lipids in VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,40116,-0.010944314791148,0.00397466999502742,-0.0187346679814018,-0.00315396160089425,0.00590564697435964
NMR metabolomics,X23424.Total Lipids in VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,42351,0.0153975569420141,0.0056059076066416,0.00440997803299656,0.0263851358510316,0.00602862465538032
NMR metabolomics,X23424.Total Lipids in VLDL,GPNMB,Transmembrane glycoprotein NMB,42315,0.00814445326708524,0.00296714538047486,0.00232884832135451,0.013960058212816,0.00606156755923857
NMR metabolomics,X23424.Total Lipids in VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,40199,-0.017256386992088,0.00629059265746128,-0.0295859486007121,-0.00492682538346386,0.00609411157768211
NMR metabolomics,X23424.Total Lipids in VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40451,0.0139207494663597,0.00510452848568831,0.00391587363441064,0.0239256252983088,0.00639854486303019
NMR metabolomics,X23424.Total Lipids in VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,42439,0.0166439492359339,0.00610711775324217,0.00467399843957925,0.0286139000322886,0.00643204129619329
NMR metabolomics,X23424.Total Lipids in VLDL,DPEP1,Dipeptidase 1,42476,-0.0138670923047269,0.00509714550260038,-0.0238574974898237,-0.0038766871196302,0.00652561917307965
NMR metabolomics,X23424.Total Lipids in VLDL,PRKCQ,Protein kinase C theta type,42370,0.0121579646227033,0.00446923636058459,0.00339826135595755,0.0209176678894491,0.00652949730661577
NMR metabolomics,X23424.Total Lipids in VLDL,CDKL5,Cyclin-dependent kinase-like 5,40136,-0.0149991080849253,0.00552464780688744,-0.0258274177864247,-0.00417079838342597,0.00663909937605165
NMR metabolomics,X23424.Total Lipids in VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42794,0.019409537458567,0.00715914035464086,0.00537762236347093,0.0334414525536631,0.00671335043570522
NMR metabolomics,X23424.Total Lipids in VLDL,NELL2,Protein kinase C-binding protein NELL2,42676,0.00799683348442776,0.00294976251389077,0.00221529895720184,0.0137783680116537,0.0067163692076038
NMR metabolomics,X23424.Total Lipids in VLDL,IL25,Interleukin-25,40036,0.00967608352904432,0.00357577310424087,0.00266756824473222,0.0166845988133564,0.00682031893086092
NMR metabolomics,X23424.Total Lipids in VLDL,TSPAN8,Tetraspanin-8,40449,0.0282920819432152,0.0104592658886196,0.00779192080152079,0.0487922430849096,0.00684117486382903
NMR metabolomics,X23424.Total Lipids in VLDL,SCN2B,Sodium channel subunit beta-2,40182,-0.00802639463480126,0.00297930698270503,-0.0138658363209031,-0.00218695294869941,0.00706973352077026
NMR metabolomics,X23424.Total Lipids in VLDL,TMOD4,Tropomodulin-4,40080,-0.0113629901531588,0.00421952566590524,-0.0196332604583331,-0.00309271984798453,0.00709303989720287
NMR metabolomics,X23424.Total Lipids in VLDL,ATP1B4,Protein ATP1B4,40080,-0.0116435637131899,0.00432435605043527,-0.020119301572043,-0.00316782585433679,0.00710154905486914
NMR metabolomics,X23424.Total Lipids in VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",40268,-0.017469337314684,0.00649888439831553,-0.0302071507353824,-0.00473152389398554,0.00719777399327236
NMR metabolomics,X23424.Total Lipids in VLDL,SDC1,Syndecan-1,42636,0.0111294912146649,0.00414094769926837,0.00301323372409893,0.019245748705231,0.00720415622788197
NMR metabolomics,X23424.Total Lipids in VLDL,EPHX2,Bifunctional epoxide hydrolase 2,42357,0.0170287271945753,0.00633989579621212,0.0046025314339995,0.029454922955151,0.00724117669764093
NMR metabolomics,X23424.Total Lipids in VLDL,DIPK2B,Divergent protein kinase domain 2B,40283,0.00765102983600635,0.00284879727911307,0.00206738716894474,0.013234672503068,0.00724846509694368
NMR metabolomics,X23424.Total Lipids in VLDL,BABAM1,BRISC and BRCA1-A complex member 1,40199,0.00795018920564538,0.002974856246926,0.00211947096167043,0.0137809074496203,0.00754079511561202
NMR metabolomics,X23424.Total Lipids in VLDL,THBS2,Thrombospondin-2,42611,0.0105188893677929,0.00395616934333395,0.0027647974548583,0.0182729812807274,0.00784992438135338
NMR metabolomics,X23424.Total Lipids in VLDL,CLSTN2,Calsyntenin-2,42754,-0.0107441949742407,0.00404143253315081,-0.0186654027392163,-0.00282298720926511,0.00785787935299078
NMR metabolomics,X23424.Total Lipids in VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40451,0.0126300574559536,0.00477020741042805,0.00328045093151461,0.0219796639803926,0.00811553849857447
NMR metabolomics,X23424.Total Lipids in VLDL,NMI,N-myc-interactor,40421,0.0193633628505534,0.00734419676248587,0.00496873719608111,0.0337579885050257,0.00838684319859732
NMR metabolomics,X23424.Total Lipids in VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,42721,-0.0110252760149208,0.00419046525450033,-0.0192385879137415,-0.0028119641161002,0.00852208710978616
NMR metabolomics,X23424.Total Lipids in VLDL,IL2RA,Interleukin-2 receptor subunit alpha,42517,-0.0111511456049295,0.0042475530486835,-0.0194763495803491,-0.00282594162950981,0.00866688681962643
NMR metabolomics,X23424.Total Lipids in VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42676,0.0112839837298825,0.00430611649123,0.00284399540707173,0.0197239720526933,0.00879110329864382
NMR metabolomics,X23424.Total Lipids in VLDL,DBH,Dopamine beta-hydroxylase,40515,0.0292892660479649,0.011191803936835,0.00735333033176838,0.0512252017641615,0.00888169268245122
NMR metabolomics,X23424.Total Lipids in VLDL,PRR4,Proline-rich protein 4,40198,-0.0185909177692705,0.00710726109544633,-0.0325211495163453,-0.00466068602219567,0.00891496068314994
NMR metabolomics,X23424.Total Lipids in VLDL,IFNW1,Interferon omega-1,40116,-0.00985912424467748,0.00377076686248465,-0.0172498272951474,-0.00246842119420757,0.00894493245940328
NMR metabolomics,X23424.Total Lipids in VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,40302,0.0230160538111418,0.0088272074601978,0.00571472718915416,0.0403173804331295,0.00913549077772597
NMR metabolomics,X23424.Total Lipids in VLDL,DNPEP,Aspartyl aminopeptidase,40483,0.0151698993898113,0.00583035707354579,0.00374239952566154,0.026597399253961,0.00928348864451077
NMR metabolomics,X23424.Total Lipids in VLDL,TXNL1,Thioredoxin-like protein 1,40124,0.0261043351362499,0.0100814589821456,0.00634467553124461,0.0458639947412552,0.00962872904588655
NMR metabolomics,X23424.Total Lipids in VLDL,CNTN1,Contactin-1,42794,-0.00732735101012958,0.00283566366202042,-0.0128852517876896,-0.00176945023256957,0.00977654637960179
NMR metabolomics,X23424.Total Lipids in VLDL,SCG3,Secretogranin-3,42638,-0.00899153878237719,0.00348061368853534,-0.0158135416119065,-0.00216953595284794,0.00979591155810652
NMR metabolomics,X23424.Total Lipids in VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,40283,0.00995130386766686,0.00385300357341888,0.00239941686376586,0.0175031908715679,0.00981462678405261
NMR metabolomics,X23424.Total Lipids in VLDL,TFF3,Trefoil factor 3,42613,-0.0113231784048628,0.00438846489002875,-0.0199245695893192,-0.00272178722040649,0.00988443938486046
NMR metabolomics,X23424.Total Lipids in VLDL,MFAP4,Microfibril-associated glycoprotein 4,40283,-0.00857498077507814,0.00332347909160559,-0.0150889997946251,-0.00206096175553119,0.00988929032731417
NMR metabolomics,X23424.Total Lipids in VLDL,LTO1,Protein LTO1 homolog,42370,0.0110759296005819,0.00429512166344867,0.00265749114022253,0.0194943680609413,0.00992736945394048
NMR metabolomics,X23424.Total Lipids in VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,42346,0.0322093503301453,0.0125232236449078,0.00766383198612599,0.0567548686741646,0.0101230538973121
NMR metabolomics,X23424.Total Lipids in VLDL,NRXN3,Neurexin-3,40182,0.00934673069839784,0.00363535069569854,0.00222144333482869,0.016472018061967,0.0101516037790284
NMR metabolomics,X23424.Total Lipids in VLDL,LEG1,Protein LEG1 homolog,39926,-0.0183701141167792,0.00715895717005095,-0.032401670170079,-0.0043385580634793,0.01030037901433
NMR metabolomics,X23424.Total Lipids in VLDL,MYOM1,Myomesin-1,40136,0.0126230152726958,0.00492254472620664,0.00297482760933077,0.0222712029360608,0.0103508290601092
NMR metabolomics,X23424.Total Lipids in VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",42311,0.0132374726319695,0.00517931154212767,0.00308602200939927,0.0233889232545397,0.0106044649823155
NMR metabolomics,X23424.Total Lipids in VLDL,TERF1,Telomeric repeat-binding factor 1,40199,-0.00771468363033909,0.00302420732378742,-0.0136421299849624,-0.00178723727571575,0.0107555510899411
NMR metabolomics,X23424.Total Lipids in VLDL,SEPTIN7,Septin-7,40302,0.0141757865878346,0.00556294244198349,0.00327241940154693,0.0250791537741222,0.0108397240463678
NMR metabolomics,X23424.Total Lipids in VLDL,CAPS,Calcyphosin,40483,0.0269312490883367,0.0105760304324323,0.00620222944076948,0.047660268735904,0.0108958895330527
NMR metabolomics,X23424.Total Lipids in VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",40080,0.015118586161324,0.00593827212709542,0.003479572792217,0.0267575995304311,0.0109115178212603
NMR metabolomics,X23424.Total Lipids in VLDL,CDK1,Cyclin-dependent kinase 1,40080,0.00959605871684467,0.00376919543966516,0.00220843565510097,0.0169836817785884,0.0109127712100604
NMR metabolomics,X23424.Total Lipids in VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42545,0.00733441029284522,0.0028815859493633,0.00168650183209315,0.0129823187535973,0.0109305191724844
NMR metabolomics,X23424.Total Lipids in VLDL,NCAN,Neurocan core protein,42711,0.00984498368972214,0.00387100684357344,0.00225781027631819,0.0174321571031261,0.0109933365141654
NMR metabolomics,X23424.Total Lipids in VLDL,FOLH1,Glutamate carboxypeptidase 2,40199,0.0264183113808214,0.0103898525341983,0.00605420041379278,0.04678242234785,0.011013439041454
NMR metabolomics,X23424.Total Lipids in VLDL,RGMA,Repulsive guidance molecule A,42711,-0.00829313749833186,0.0032637047631501,-0.014689998834106,-0.00189627616255767,0.0110640558238302
NMR metabolomics,X23424.Total Lipids in VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",40080,0.0239895110448746,0.00945059519296522,0.0054663444666628,0.0425126776230865,0.0111494697313583
NMR metabolomics,X23424.Total Lipids in VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,40302,0.013540752937873,0.00535107068018996,0.00305265440470072,0.0240288514710454,0.0114044993951876
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,42172,0.0172015455700288,0.00680521570907665,0.00386332278023852,0.030539768359819,0.0114929995174728
NMR metabolomics,X23424.Total Lipids in VLDL,ELAVL4,ELAV-like protein 4,40136,0.0218740093089496,0.0086863661997007,0.00484873155753621,0.0388992870603629,0.0118097742607306
NMR metabolomics,X23424.Total Lipids in VLDL,IL20RB,Interleukin-20 receptor subunit beta,40199,0.0105801920253909,0.0042019042709567,0.00234445965431573,0.018815924396466,0.0118180241649962
NMR metabolomics,X23424.Total Lipids in VLDL,TPSAB1,Tryptase alpha/beta-1,42741,0.0134069351381377,0.00533974920324273,0.00294102669978194,0.0238728435764934,0.0120580270637942
NMR metabolomics,X23424.Total Lipids in VLDL,BCAN,Brevican core protein,42495,0.00886429781637598,0.00353295711751404,0.00193970186604846,0.0157888937667035,0.0121180898883554
NMR metabolomics,X23424.Total Lipids in VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40482,0.0126100294179343,0.00504877975634423,0.00271442109549965,0.022505637740369,0.0125164649964979
NMR metabolomics,X23424.Total Lipids in VLDL,JUN,Transcription factor AP-1,42370,0.0121983267489445,0.00488542016266639,0.0026229032301184,0.0217737502677707,0.012541109679397
NMR metabolomics,X23424.Total Lipids in VLDL,HYAL1,Hyaluronidase-1,42544,-0.0058782585814707,0.00236305971219865,-0.0105098556173801,-0.00124666154556134,0.0128742976535162
NMR metabolomics,X23424.Total Lipids in VLDL,PRR5,Proline-rich protein 5,40199,0.0121285631324364,0.00488827000480913,0.00254755392301054,0.0217095723418623,0.0131105071149447
NMR metabolomics,X23424.Total Lipids in VLDL,LHB,Lutropin subunit beta,42346,0.0212920202992665,0.00859204969548627,0.00445160289611342,0.0381324377024196,0.0132205999928544
NMR metabolomics,X23424.Total Lipids in VLDL,EPO,Erythropoietin,42594,0.0186272779887134,0.0075343699772855,0.00385991283323383,0.033394643144193,0.0134367283789508
NMR metabolomics,X23424.Total Lipids in VLDL,REG1B,Lithostathine-1-beta,42794,-0.0147504168575587,0.00596727915675012,-0.0264462840047889,-0.00305454971032844,0.0134524916974011
NMR metabolomics,X23424.Total Lipids in VLDL,CST7,Cystatin-F,42642,0.0235791189427133,0.00954111999284668,0.00487852375673383,0.0422797141286928,0.0134739897205683
NMR metabolomics,X23424.Total Lipids in VLDL,CPTP,Ceramide-1-phosphate transfer protein,40116,-0.0100947813594677,0.00408982088038619,-0.0181108302850247,-0.00207873243391082,0.0135919970792121
NMR metabolomics,X23424.Total Lipids in VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,42705,-0.00507120552037928,0.00205836113351497,-0.00910559334206862,-0.00103681769868994,0.0137630857911196
NMR metabolomics,X23424.Total Lipids in VLDL,CTRC,Chymotrypsin-C,42626,0.0165937799625249,0.00674180039014498,0.00337985119784073,0.0298077087272091,0.0138548658049042
NMR metabolomics,X23424.Total Lipids in VLDL,LIFR,Leukemia inhibitory factor receptor,42594,-0.0060470499328254,0.00246179084825578,-0.0108721599954067,-0.00122193987024407,0.0140477553290374
NMR metabolomics,X23424.Total Lipids in VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,42346,0.00903941236078925,0.00368162873355386,0.00182342004302369,0.0162554046785548,0.0140905193405619
NMR metabolomics,X23424.Total Lipids in VLDL,DLL1,Delta-like protein 1,42679,-0.00786814738411929,0.0032060455954452,-0.0141519967511919,-0.00158429801704669,0.0141339819944336
NMR metabolomics,X23424.Total Lipids in VLDL,TEF,Thyrotroph embryonic factor,40116,0.0108668997938459,0.00444374670710683,0.00215715624791652,0.0195766433397753,0.014483376410012
NMR metabolomics,X23424.Total Lipids in VLDL,CRISP2,Cysteine-rich secretory protein 2,42721,0.0147948210615662,0.00605264353503526,0.0029316397328971,0.0266580023902353,0.0145237400737031
NMR metabolomics,X23424.Total Lipids in VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,40136,0.0154489805176221,0.00632306994124847,0.00305576343277512,0.0278421976024691,0.0145704533185698
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,42311,0.0192357010990192,0.00787846702899469,0.00379390572218961,0.0346774964758488,0.0146373315191065
NMR metabolomics,X23424.Total Lipids in VLDL,CDH1,Cadherin-1,42188,0.00990112097157512,0.00405540181940266,0.0019525334055459,0.0178497085376043,0.0146410605978047
NMR metabolomics,X23424.Total Lipids in VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,40116,0.00811719252270665,0.0033319619698815,0.0015865470617389,0.0146478379836744,0.0148599895353526
NMR metabolomics,X23424.Total Lipids in VLDL,PON1,Serum paraoxonase/arylesterase 1,40532,-0.00676674014989495,0.0027897519701528,-0.0122346540113944,-0.00129882628839546,0.015299850888191
NMR metabolomics,X23424.Total Lipids in VLDL,SEPTIN3,Neuronal-specific septin-3,40482,-0.0185161440671243,0.00765162021633177,-0.0335133196911345,-0.003518968443114,0.0155405304689104
NMR metabolomics,X23424.Total Lipids in VLDL,CYB5A,Cytochrome b5,40080,0.0180907428433239,0.00747633286611542,0.00343713042573768,0.0327443552609101,0.0155481020852847
NMR metabolomics,X23424.Total Lipids in VLDL,PPM1B,Protein phosphatase 1B,40199,0.0150893484872162,0.00623923387955088,0.00286045008329647,0.0273182468911359,0.015602407202837
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB7,Integrin beta-7,42721,0.0113388987391761,0.00469657001051696,0.0021336215185628,0.0205441759597893,0.0157789418225839
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42662,-0.0121222287852261,0.00502639878694865,-0.0219739704076455,-0.00227048716280675,0.0158910858603307
NMR metabolomics,X23424.Total Lipids in VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,42173,-0.021022725581416,0.00875386343633615,-0.0381802979166349,-0.00386515324619716,0.0163403362770418
NMR metabolomics,X23424.Total Lipids in VLDL,CEP350,Centrosome-associated protein 350,40080,0.00929070163522574,0.00388852569077327,0.00166919128131014,0.0169122119891413,0.016899236880069
NMR metabolomics,X23424.Total Lipids in VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42586,0.0147271851356439,0.00616582742843202,0.00264216337591717,0.0268122068953707,0.0169302800254074
NMR metabolomics,X23424.Total Lipids in VLDL,TG,Thyroglobulin,40451,-0.028086119054403,0.0117643088267946,-0.0511441643549205,-0.0050280737538856,0.016984386005712
NMR metabolomics,X23424.Total Lipids in VLDL,RAD51,DNA repair protein RAD51 homolog 1,40302,0.0132461447807962,0.00555169836392894,0.00236481598749549,0.0241274735740969,0.0170511321347628
NMR metabolomics,X23424.Total Lipids in VLDL,OSM,Oncostatin-M,42534,0.017005641061032,0.00712940202135394,0.00303201309917825,0.0309792690228857,0.0170798652579813
NMR metabolomics,X23424.Total Lipids in VLDL,REG4,Regenerating islet-derived protein 4,42638,0.0127787628603104,0.00536053602281136,0.00227211225560012,0.0232854134650206,0.0171459506621709
NMR metabolomics,X23424.Total Lipids in VLDL,TBR1,T-box brain protein 1,40182,0.011793202313605,0.00496223261152166,0.00206722639502252,0.0215191782321874,0.0174904330115529
NMR metabolomics,X23424.Total Lipids in VLDL,LAYN,Layilin,42476,-0.00917805540228833,0.0038627187289915,-0.0167489841111117,-0.00160712669346499,0.0175126659134581
NMR metabolomics,X23424.Total Lipids in VLDL,SNX18,Sorting nexin-18,40449,0.0105785209971601,0.00447529337974831,0.00180694597285339,0.0193500960214668,0.0181074014254617
NMR metabolomics,X23424.Total Lipids in VLDL,CD209,CD209 antigen,42668,-0.00934155867503394,0.00395525339756034,-0.0170938553342522,-0.00158926201581568,0.0182000815573636
NMR metabolomics,X23424.Total Lipids in VLDL,MTR,Methionine synthase,40116,0.0160276216305249,0.00678866196608578,0.00272184417699678,0.029333399084053,0.0182461590609886
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC12A,C-type lectin domain family 12 member A,40199,0.00499409754634931,0.00211748657600005,0.00084382385738921,0.00914437123530941,0.0183662174522179
NMR metabolomics,X23424.Total Lipids in VLDL,MUC2,Mucin-2,40527,0.0223909422980504,0.00949873445477374,0.00377342276669386,0.0410084618294069,0.0184274912212376
NMR metabolomics,X23424.Total Lipids in VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40449,-0.0169597656946601,0.00719943203378806,-0.0310706524808847,-0.00284887890843547,0.018504458368622
NMR metabolomics,X23424.Total Lipids in VLDL,CCN3,CCN family member 3,42779,0.00848946608868295,0.00361560845785557,0.00140287351128603,0.0155760586660799,0.0188885397235955
NMR metabolomics,X23424.Total Lipids in VLDL,NINJ1,Ninjurin-1,42346,0.0129230284127474,0.00550484870161758,0.00213352495757689,0.0237125318679178,0.0189109630659598
NMR metabolomics,X23424.Total Lipids in VLDL,CEP290,Centrosomal protein of 290 kDa,40302,0.0130411795423504,0.00557563024406903,0.00211294426397507,0.0239694148207257,0.019355105042714
NMR metabolomics,X23424.Total Lipids in VLDL,MANSC4,MANSC domain-containing protein 4,40116,0.0171188747932911,0.00732398942047742,0.0027638555291553,0.0314738940574268,0.0194379093107642
NMR metabolomics,X23424.Total Lipids in VLDL,COMP,Cartilage oligomeric matrix protein,42511,0.0080054256991471,0.00342889932663842,0.00128478301893579,0.0147260683793584,0.0195742703291164
NMR metabolomics,X23424.Total Lipids in VLDL,MAPK13,Mitogen-activated protein kinase 13,40080,0.00995757199462554,0.00427444656081541,0.00157965673542735,0.0183354872538237,0.0198477078436693
NMR metabolomics,X23424.Total Lipids in VLDL,FABP3,"Fatty acid-binding protein, heart",40511,0.0124365915652065,0.00535804816270567,0.00193481716630343,0.0229383659641096,0.0202988603770426
NMR metabolomics,X23424.Total Lipids in VLDL,DEFB118,Beta-defensin 118,40136,0.0135249512082618,0.00583170364610457,0.00209481206189687,0.0249550903546268,0.0204019193076023
NMR metabolomics,X23424.Total Lipids in VLDL,METAP1,Methionine aminopeptidase 1,42311,0.00689699189744424,0.00297754371849704,0.00106100620919005,0.0127329775856984,0.020555260128385
NMR metabolomics,X23424.Total Lipids in VLDL,SEZ6L2,Seizure 6-like protein 2,42587,-0.00559611511876337,0.00241955269206409,-0.010338438395209,-0.000853791842317751,0.0207447678836714
NMR metabolomics,X23424.Total Lipids in VLDL,SEZ6,Seizure protein 6 homolog,40182,-0.00740932679251657,0.00320865056028882,-0.0136982818906826,-0.00112037169435048,0.0209524819197308
NMR metabolomics,X23424.Total Lipids in VLDL,ENOPH1,Enolase-phosphatase E1,40451,0.0129125143911644,0.00561676823536346,0.00190364864985197,0.0239213801324767,0.0215275722881171
NMR metabolomics,X23424.Total Lipids in VLDL,ENO1,Alpha-enolase,42588,0.0183731119216153,0.00800893666491022,0.00267559605839129,0.0340706277848394,0.0218015180192522
NMR metabolomics,X23424.Total Lipids in VLDL,KIAA2013,Uncharacterized protein KIAA2013,40451,0.0125515117352024,0.00548394995426974,0.00180296982483368,0.023300053645571,0.0221110326716776
NMR metabolomics,X23424.Total Lipids in VLDL,GBP6,Guanylate-binding protein 6,40116,-0.0107961676116597,0.00471985440236089,-0.020047082240287,-0.00154525298303234,0.0221918552208286
NMR metabolomics,X23424.Total Lipids in VLDL,COMMD9,COMM domain-containing protein 9,40451,0.00923731072522561,0.0040540965018541,0.00129128158159157,0.0171833398688596,0.0227146908953994
NMR metabolomics,X23424.Total Lipids in VLDL,PSMG4,Proteasome assembly chaperone 4,40199,0.0132457668499324,0.00582179416426087,0.00183505028798112,0.0246564834118838,0.0229128651180547
NMR metabolomics,X23424.Total Lipids in VLDL,CD27,CD27 antigen,42679,-0.010258643519621,0.0045113105743027,-0.0191008122452543,-0.00141647479398773,0.022982653090313
NMR metabolomics,X23424.Total Lipids in VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,40482,0.00627042945862077,0.00277618685105181,0.000829103230559233,0.0117117556866823,0.0239242794763737
NMR metabolomics,X23424.Total Lipids in VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",40136,0.00746433275133549,0.00331614140238154,0.00096469560266767,0.0139639699000033,0.0244110642648555
NMR metabolomics,X23424.Total Lipids in VLDL,EPHA4,Ephrin type-A receptor 4,40283,0.00667147553953315,0.00297807139744886,0.00083445560053338,0.0125084954785329,0.0250976686118349
NMR metabolomics,X23424.Total Lipids in VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,40136,-0.014115290858852,0.00630182049618722,-0.0264668590313789,-0.00176372268632501,0.0251190308098322
NMR metabolomics,X23424.Total Lipids in VLDL,SLC51B,Organic solute transporter subunit beta,40116,-0.0176486960467652,0.00788231372524649,-0.0330980309482483,-0.0021993611452821,0.0251743546292867
NMR metabolomics,X23424.Total Lipids in VLDL,TP73,Tumor protein p73,40182,0.00790945047799257,0.00353583734378048,0.00097920928418282,0.0148396916718023,0.0253103398955638
NMR metabolomics,X23424.Total Lipids in VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",40059,0.00604829460106208,0.00270874507270348,0.000739154258563264,0.0113574349435609,0.0255773440536212
NMR metabolomics,X23424.Total Lipids in VLDL,HLA_DRA,,42549,-0.00840266831416965,0.00376628683105764,-0.0157845905030426,-0.00102074612529669,0.0256962168092801
NMR metabolomics,X23424.Total Lipids in VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,42660,-0.0119409674631082,0.00538488292347925,-0.0224953379931276,-0.00138659693308888,0.026605704925812
NMR metabolomics,X23424.Total Lipids in VLDL,TLR1,Toll-like receptor 1,40199,0.00605606645558232,0.00273807742620866,0.000689434700213358,0.0114226982109513,0.0270012871414713
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGAP30,Rho GTPase-activating protein 30,40302,0.00860808514162733,0.00389797282273638,0.00096805840906403,0.0162481118741906,0.02724028801397
NMR metabolomics,X23424.Total Lipids in VLDL,PTTG1,Securin,40302,0.00918387980343598,0.00418828829489444,0.00097483474544288,0.0173929248614291,0.0283458778577221
NMR metabolomics,X23424.Total Lipids in VLDL,EFNA1,Ephrin-A1,42590,0.00676758001958392,0.00308876797199721,0.000713594794469395,0.0128215652446984,0.0284668622872992
NMR metabolomics,X23424.Total Lipids in VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,40136,0.01118227383252,0.00510790611952681,0.00117077783824743,0.0211937698267925,0.0286027072169726
NMR metabolomics,X23424.Total Lipids in VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,40080,0.019363238105718,0.00885522380457967,0.00200699944874185,0.0367194767626941,0.0287896023252095
NMR metabolomics,X23424.Total Lipids in VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,40182,0.00809366533136036,0.00371026471660466,0.000821546486815224,0.0153657841759055,0.0291730960370725
NMR metabolomics,X23424.Total Lipids in VLDL,ID4,DNA-binding protein inhibitor ID-4,40302,-0.00968351898658091,0.00444058159900594,-0.0183870589206326,-0.000979979052529271,0.0292274770802143
NMR metabolomics,X23424.Total Lipids in VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",40080,0.0114470855468409,0.00526837798347734,0.00112106469922535,0.0217731063944565,0.029817530063271
NMR metabolomics,X23424.Total Lipids in VLDL,FSTL1,Follistatin-related protein 1,40223,-0.00501929155355863,0.0023152028078527,-0.00955708905694992,-0.000481494050167339,0.0301822416278727
NMR metabolomics,X23424.Total Lipids in VLDL,IGLON5,IgLON family member 5,40080,-0.0210144663711331,0.00969414287461571,-0.0400149864053799,-0.00201394633688633,0.0301994064596434
NMR metabolomics,X23424.Total Lipids in VLDL,RRP15,RRP15-like protein,40136,-0.0203372157602297,0.00939354930587424,-0.0387485723997432,-0.00192585912071613,0.0304077508457663
NMR metabolomics,X23424.Total Lipids in VLDL,AIDA,"Axin interactor, dorsalization-associated protein",40182,0.0185816041445366,0.00859776284229463,0.00172998897363917,0.0354332193154341,0.0307003558509401
NMR metabolomics,X23424.Total Lipids in VLDL,NELL1,Protein kinase C-binding protein NELL1,42679,0.00962339749340027,0.00445561264478259,0.000890396709626391,0.0183563982771742,0.030802849680422
NMR metabolomics,X23424.Total Lipids in VLDL,FCRL5,Fc receptor-like protein 5,42611,-0.0128911047777491,0.00601009644060179,-0.0246708938013286,-0.00111131575416956,0.0319780935782884
NMR metabolomics,X23424.Total Lipids in VLDL,DUOX2,Dual oxidase 2,42357,0.0155396345289606,0.00728748292724016,0.00125616799156987,0.0298231010663513,0.0329946193373279
NMR metabolomics,X23424.Total Lipids in VLDL,TOP1,DNA topoisomerase 1,40449,0.024430050818252,0.0114625174296389,0.00196351665615984,0.0468965849803442,0.0330861294460898
NMR metabolomics,X23424.Total Lipids in VLDL,IL17A,Interleukin-17A,42347,-0.00934457595301337,0.00440487094027813,-0.0179781229959585,-0.000711028910068242,0.0339052247035022
NMR metabolomics,X23424.Total Lipids in VLDL,INHBB,Inhibin beta B chain,40283,0.0117842152961413,0.00557095574525114,0.000865142035449058,0.0227032885568335,0.0344270441247236
NMR metabolomics,X23424.Total Lipids in VLDL,DKKL1,Dickkopf-like protein 1,42587,-0.0189292383851097,0.00896046588457906,-0.0364917515188847,-0.00136672525133475,0.0346596124134984
NMR metabolomics,X23424.Total Lipids in VLDL,CCDC50,Coiled-coil domain-containing protein 50,40482,0.0162426785098389,0.00770883540078687,0.00113336112429668,0.0313519958953812,0.0351377578154207
NMR metabolomics,X23424.Total Lipids in VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40451,0.020763515605794,0.00987064665260338,0.00141704816669135,0.0401099830448966,0.0354388152222438
NMR metabolomics,X23424.Total Lipids in VLDL,PCDH17,Protocadherin-17,42636,0.00797625502195414,0.00379343527963089,0.0005411218738776,0.0154113881700307,0.0355151913280577
NMR metabolomics,X23424.Total Lipids in VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",40136,-0.0117991073099362,0.00561455865728251,-0.0228036422782099,-0.000794572341662456,0.0356181502564948
NMR metabolomics,X23424.Total Lipids in VLDL,SOX2,Transcription factor SOX-2,40461,0.00513632855593861,0.00244484061433798,0.000344440951836182,0.00992821616004105,0.0356732375852787
NMR metabolomics,X23424.Total Lipids in VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,42357,0.00591547017692804,0.00282475223228101,0.000378955801657261,0.0114519845521988,0.0362652141471609
NMR metabolomics,X23424.Total Lipids in VLDL,GFRAL,GDNF family receptor alpha-like,40109,-0.013372005126635,0.00642399888328773,-0.025963042937879,-0.000780967315391082,0.0374049852422132
NMR metabolomics,X23424.Total Lipids in VLDL,OMG,Oligodendrocyte-myelin glycoprotein,42587,0.0140262617933619,0.00674493078907416,0.000806197446776541,0.0272463261399473,0.0375879686586281
NMR metabolomics,X23424.Total Lipids in VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,40116,-0.00441952581241427,0.00212549980331766,-0.00858550542691689,-0.000253546197911661,0.0376141806553805
NMR metabolomics,X23424.Total Lipids in VLDL,PGLYRP4,Peptidoglycan recognition protein 4,40116,0.0125827704167181,0.00605656036948849,0.000711912092520674,0.0244536287409156,0.0377746903696338
NMR metabolomics,X23424.Total Lipids in VLDL,IL5,Interleukin-5,42370,0.0295397333602478,0.0142245624534054,0.00165959095157315,0.0574198757689224,0.0378512885970434
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42711,-0.00983840668767835,0.00474253186997068,-0.0191337691528209,-0.000543044222535814,0.038051302647603
NMR metabolomics,X23424.Total Lipids in VLDL,TGFBR3,Transforming growth factor beta receptor type 3,42794,-0.00669485815612768,0.00322937898675272,-0.013024440970163,-0.000365275342092343,0.0381808210373679
NMR metabolomics,X23424.Total Lipids in VLDL,GAL,Galanin peptides,42676,0.0135376786678281,0.00654286773914955,0.000713657899094992,0.0263616994365612,0.0385581384970029
NMR metabolomics,X23424.Total Lipids in VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",40116,0.0186206314624461,0.00900125153369769,0.000978178456398592,0.0362630844684936,0.0386004100943183
NMR metabolomics,X23424.Total Lipids in VLDL,CGA,Glycoprotein hormones alpha chain,42611,-0.0132443016672164,0.00642292478117724,-0.0258332342383238,-0.000655369096109039,0.0392235267746151
NMR metabolomics,X23424.Total Lipids in VLDL,CDH6,Cadherin-6,42636,-0.00811797968216823,0.00394272974821856,-0.0158457299886766,-0.000390229375659857,0.0395159113493663
NMR metabolomics,X23424.Total Lipids in VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,42346,0.00644682110177296,0.00313241999415252,0.000307277913234024,0.0125863642903119,0.0396005770697829
NMR metabolomics,X23424.Total Lipids in VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40482,0.0151216237331039,0.00736568555873613,0.000684880037981134,0.0295583674282267,0.0400972701669121
NMR metabolomics,X23424.Total Lipids in VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40483,0.0134430111550405,0.0065485217209917,0.000607908581896762,0.0262781137281842,0.0401119283764996
NMR metabolomics,X23424.Total Lipids in VLDL,SLC13A1,Solute carrier family 13 member 1,40451,0.0131072120519228,0.00639182089949945,0.000579243088903864,0.0256351810149417,0.0403268223294458
NMR metabolomics,X23424.Total Lipids in VLDL,CPVL,Probable serine carboxypeptidase CPVL,42698,0.00860183064335906,0.00421306167828347,0.000344229753923451,0.0168594315327947,0.0412001573245667
NMR metabolomics,X23424.Total Lipids in VLDL,OGN,Mimecan,42611,0.00919974854231726,0.00451778860004262,0.000344882886233728,0.0180546141984008,0.0417359356077841
NMR metabolomics,X23424.Total Lipids in VLDL,SUMF1,Formylglycine-generating enzyme,40199,0.0133562922318773,0.00656320696697468,0.000492406576606961,0.0262201778871477,0.0418722427775693
NMR metabolomics,X23424.Total Lipids in VLDL,RBM19,Probable RNA-binding protein 19,40116,-0.0100409608845254,0.00493972400915082,-0.019722819942461,-0.000359101826589766,0.0421073103439416
NMR metabolomics,X23424.Total Lipids in VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",40182,-0.010372300546046,0.00510274402260022,-0.0203736788303424,-0.000370922261749583,0.0421077714484867
NMR metabolomics,X23424.Total Lipids in VLDL,NCAM1,Neural cell adhesion molecule 1,42689,-0.00625923786362056,0.00307997808289879,-0.0122959949061022,-0.000222480821138935,0.042149460523601
NMR metabolomics,X23424.Total Lipids in VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,40136,0.0120411577298228,0.00593619796022997,0.000406209727772097,0.0236761057318736,0.0425406266805268
NMR metabolomics,X23424.Total Lipids in VLDL,ENDOU,Poly(U)-specific endoribonuclease,39633,0.0113448207517536,0.005597369180624,0.000373977157730522,0.0223156643457766,0.042706905200018
NMR metabolomics,X23424.Total Lipids in VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40482,-0.00488896743667399,0.00242481561058197,-0.00964160603341466,-0.000136328839933315,0.0438003716151641
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42611,-0.00786329292687096,0.00390454985299752,-0.0155162106387461,-0.000210375214995827,0.0440421094800561
NMR metabolomics,X23424.Total Lipids in VLDL,SH3GL3,Endophilin-A3,40250,0.0175635161406538,0.00872729237582964,0.000458023084027752,0.0346690091972799,0.0441933874595919
NMR metabolomics,X23424.Total Lipids in VLDL,CRTAC1,Cartilage acidic protein 1,42794,0.00612120279623714,0.00304398259582292,0.000154996908424205,0.0120874086840501,0.044353698122101
NMR metabolomics,X23424.Total Lipids in VLDL,CA14,Carbonic anhydrase 14,42721,-0.00735278125863421,0.00366569800025242,-0.014537549339129,-0.000168013178139474,0.0448938497828007
NMR metabolomics,X23424.Total Lipids in VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,40136,-0.0105211939053243,0.00525406088839899,-0.0208191532465863,-0.000223234564062258,0.0452569013998668
NMR metabolomics,X23424.Total Lipids in VLDL,IL6,Interleukin-6,42587,0.0156195340106027,0.00783505768584318,0.00026282094635011,0.0309762470748554,0.0462221335228109
NMR metabolomics,X23424.Total Lipids in VLDL,KRT8,"Keratin, type II cytoskeletal 8",40136,0.0165041976292816,0.00828928097080829,0.000257206926497382,0.0327511883320659,0.0465025410625371
NMR metabolomics,X23424.Total Lipids in VLDL,IL36G,Interleukin-36 gamma,40154,0.0139669177139549,0.0070405532031227,0.000167433435834356,0.0277664019920754,0.0473051350642622
NMR metabolomics,X23424.Total Lipids in VLDL,FCAR,Immunoglobulin alpha Fc receptor,42594,0.00986563630119716,0.00497400825779571,0.000116580115917562,0.0196146924864768,0.0473389188188847
NMR metabolomics,X23424.Total Lipids in VLDL,AGBL2,Cytosolic carboxypeptidase 2,40136,0.0184166946578158,0.00929213964396382,0.000204100955646686,0.0366292883599849,0.0475081485945485
NMR metabolomics,X23424.Total Lipids in VLDL,FCRLB,Fc receptor-like B,42346,0.0131238394589313,0.00662621861040355,0.000136450982540372,0.0261112279353223,0.0476577822935966
NMR metabolomics,X23424.Total Lipids in VLDL,ARTN,Artemin,42370,0.00903167478939818,0.00456190843087853,9.03342648762538e-05,0.0179730153139201,0.0477465719460699
NMR metabolomics,X23424.Total Lipids in VLDL,NRCAM,Neuronal cell adhesion molecule,42636,0.00584820832171992,0.00296037897049284,4.58655395539614e-05,0.0116505511038859,0.0482326352535387
NMR metabolomics,X23424.Total Lipids in VLDL,REXO2,"Oligoribonuclease, mitochondrial",40116,-0.00964314430721957,0.00490316004756285,-0.0192533380004427,-3.29506139963871e-05,0.0492407465988546
NMR metabolomics,X23424.Total Lipids in VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,40116,-0.0111962342912501,0.00570664737856347,-0.0223812631532345,-1.12054292656753e-05,0.0497920822052293
NMR metabolomics,X23424.Total Lipids in VLDL,EDN1,Endothelin-1,40223,0.0060976022975417,0.00311041490895799,1.18907598404151e-06,0.0121940155190994,0.0499762609302501
NMR metabolomics,X23424.Total Lipids in VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,42458,0.00693346174170655,0.00354402619030034,-1.28295912821159e-05,0.0138797530746952,0.0504413678350608
NMR metabolomics,X23424.Total Lipids in VLDL,CDH23,Cadherin-23,40483,-0.00519637652646183,0.00266813584778242,-0.0104259227881154,3.31697351917161e-05,0.0514914089522222
NMR metabolomics,X23424.Total Lipids in VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,40483,0.00787594479123743,0.00407909601592744,-0.000119083399980355,0.0158709729824552,0.0535320063928521
NMR metabolomics,X23424.Total Lipids in VLDL,NPTXR,Neuronal pentraxin receptor,42636,0.00666949838101883,0.00346143198061056,-0.000114908300977873,0.0134539050630155,0.0540252092354671
NMR metabolomics,X23424.Total Lipids in VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,42346,0.00992283542463289,0.00516794352184648,-0.000206333878186209,0.020052004727452,0.0548701215512677
NMR metabolomics,X23424.Total Lipids in VLDL,ACRV1,Acrosomal protein SP-10,40199,0.0157354990164307,0.0081990460757467,-0.000334631292032834,0.0318056293248942,0.0549865599253171
NMR metabolomics,X23424.Total Lipids in VLDL,CSRP3,Cysteine and glycine-rich protein 3,40116,-0.0195900429227595,0.010225351530318,-0.0396317319221827,0.000451646076663727,0.0554127204309856
NMR metabolomics,X23424.Total Lipids in VLDL,DPP10,Inactive dipeptidyl peptidase 10,42594,0.00701497913318477,0.00366440101038597,-0.000167246847171731,0.0141972051135413,0.0555955714696641
NMR metabolomics,X23424.Total Lipids in VLDL,KRT19,"Keratin, type I cytoskeletal 19",42562,-0.013735325773698,0.00719253063834054,-0.0278326858248454,0.000362034277449505,0.0561977102968497
NMR metabolomics,X23424.Total Lipids in VLDL,FGF9,Fibroblast growth factor 9,40065,0.00803444851093525,0.00421477934393703,-0.000226519003181335,0.0162954160250518,0.0566433400770596
NMR metabolomics,X23424.Total Lipids in VLDL,SPRING1,SREBP regulating gene protein,40080,0.0115266454842473,0.00605256990929495,-0.000336391537970829,0.0233896825064654,0.0568816189325127
NMR metabolomics,X23424.Total Lipids in VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",40116,-0.0076237827783851,0.00400810429607044,-0.0154796671986832,0.000232101641912951,0.0571854201248737
NMR metabolomics,X23424.Total Lipids in VLDL,CLNS1A,Methylosome subunit pICln,40182,0.00646875162986898,0.00341100951777178,-0.000216827024963706,0.0131543302847017,0.0579289920052187
NMR metabolomics,X23424.Total Lipids in VLDL,IL31,Interleukin-31,40199,0.0108595747442207,0.00576445642545302,-0.000438759849667191,0.0221579093381086,0.0596068312450924
NMR metabolomics,X23424.Total Lipids in VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,42311,0.0127955067107717,0.00681891138675688,-0.000569559607271774,0.0261605730288152,0.060612470093442
NMR metabolomics,X23424.Total Lipids in VLDL,CRHR1,Corticotropin-releasing factor receptor 1,42357,0.0114486996359689,0.00610302872291416,-0.000513236660942898,0.0234106359328806,0.0606904940469664
NMR metabolomics,X23424.Total Lipids in VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",40302,0.0135553169980561,0.0072294029736076,-0.000614312830214831,0.027724946826327,0.0608153915475475
NMR metabolomics,X23424.Total Lipids in VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40527,-0.00519853619233741,0.00277369712796224,-0.0106349825631434,0.00023791017846857,0.0609249418150487
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42495,0.00865212344652207,0.00462197322237285,-0.000406944069328712,0.0177111909623728,0.0612348297534443
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,42475,-0.00654678200121257,0.00350105332506632,-0.0134088465183426,0.00031528251591742,0.0615132465384976
NMR metabolomics,X23424.Total Lipids in VLDL,PDGFRB,Platelet-derived growth factor receptor beta,42794,0.00657625709172229,0.00352280104117568,-0.000328432948982033,0.0134809471324266,0.0619553023981308
NMR metabolomics,X23424.Total Lipids in VLDL,MFAP3,Microfibril-associated glycoprotein 3,42357,0.00922757770511019,0.00494813927995688,-0.000470775283605295,0.0189259306938257,0.0622235305239086
NMR metabolomics,X23424.Total Lipids in VLDL,SPINT1,Kunitz-type protease inhibitor 1,42565,0.00496813342235774,0.00266560426365251,-0.000256450934401172,0.0101927177791167,0.0623727412999431
NMR metabolomics,X23424.Total Lipids in VLDL,EPN1,Epsin-1,40302,0.0084768417109852,0.00455159817462589,-0.000444290711281534,0.0173979741332519,0.062574804913004
NMR metabolomics,X23424.Total Lipids in VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,40065,-0.00983697505167869,0.00532324116768475,-0.0202705277403408,0.000596577636983425,0.0646396695574287
NMR metabolomics,X23424.Total Lipids in VLDL,PALM3,Paralemmin-3,40116,0.0134950316038641,0.00731983067898707,-0.000851836526950523,0.0278418997346788,0.0652647081047924
NMR metabolomics,X23424.Total Lipids in VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,40182,-0.00596560752389119,0.00324274861640472,-0.0123213948120444,0.000390179764262054,0.0658427455562671
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC6A,C-type lectin domain family 6 member A,42346,0.00890473890819527,0.0048499166840565,-0.000601097792555457,0.018410575608946,0.0663713166931259
NMR metabolomics,X23424.Total Lipids in VLDL,NOP56,Nucleolar protein 56,40116,0.0209806557808624,0.0114485793024883,-0.00145855965201475,0.0434198712137395,0.0668894253380413
NMR metabolomics,X23424.Total Lipids in VLDL,NOS2,"Nitric oxide synthase, inducible",40116,-0.0074591614294614,0.00407549877270123,-0.0154471390239558,0.000528816165032998,0.0672405422470279
NMR metabolomics,X23424.Total Lipids in VLDL,FRMD7,FERM domain-containing protein 7,40182,0.00625620799741903,0.00342341904277356,-0.000453693326417143,0.0129661093212552,0.0676556953921807
NMR metabolomics,X23424.Total Lipids in VLDL,TMPRSS11B,Transmembrane protease serine 11B,40136,0.014552101342335,0.00797058361343481,-0.00107024253999723,0.0301744452246672,0.0679187936178353
NMR metabolomics,X23424.Total Lipids in VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,40223,0.00744097559483208,0.00408942461545116,-0.000574296651452194,0.0154562478411163,0.0688523108571753
NMR metabolomics,X23424.Total Lipids in VLDL,NOS1,"Nitric oxide synthase, brain",42311,-0.0100628553079494,0.00553229810574295,-0.0209061595952056,0.000780448979306739,0.0689451129975251
NMR metabolomics,X23424.Total Lipids in VLDL,CCND2,G1/S-specific cyclin-D2,40302,0.00683772701485478,0.00377391363184894,-0.00055914370356915,0.0142345977332787,0.0700379424185062
NMR metabolomics,X23424.Total Lipids in VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,40223,-0.00731753812647011,0.00405096047652849,-0.015257420660466,0.000622344407525724,0.0708876323483137
NMR metabolomics,X23424.Total Lipids in VLDL,CHGB,Secretogranin-1,42664,-0.00791035925432265,0.00438280859506387,-0.0165006641006478,0.000679945592002537,0.071118796553468
NMR metabolomics,X23424.Total Lipids in VLDL,PDCL2,Phosducin-like protein 2,40080,0.00978888537170604,0.00542719535814538,-0.000848417530258898,0.020426188273671,0.0713102302302624
NMR metabolomics,X23424.Total Lipids in VLDL,CA11,Carbonic anhydrase-related protein 11,42346,0.00596386263820721,0.00331302408000759,-0.000529664558607679,0.0124573898350221,0.0718635628248424
NMR metabolomics,X23424.Total Lipids in VLDL,MAG,Myelin-associated glycoprotein,40182,0.00902204128472674,0.00501786033407731,-0.00081296497006479,0.0188570475395183,0.0722067092973824
NMR metabolomics,X23424.Total Lipids in VLDL,SAT1,Diamine acetyltransferase 1,40116,-0.00942404713389123,0.00525727792485148,-0.0197283118666001,0.000880217598817666,0.0730691142022418
NMR metabolomics,X23424.Total Lipids in VLDL,AKAP12,A-kinase anchor protein 12,40283,-0.00403229244561509,0.00225142977909373,-0.00844509481263882,0.000380509921408626,0.0733218626726123
NMR metabolomics,X23424.Total Lipids in VLDL,SMPD1,Sphingomyelin phosphodiesterase,42644,-0.00900037220752226,0.00502753585413384,-0.0188543424816246,0.000853598066580068,0.073441772024184
NMR metabolomics,X23424.Total Lipids in VLDL,RALB,Ras-related protein Ral-B,40199,0.00548789628044344,0.0030659042811869,-0.000521276110682879,0.0114970686715698,0.0734851896995287
NMR metabolomics,X23424.Total Lipids in VLDL,BTLA,B- and T-lymphocyte attenuator,40080,0.0160701436637661,0.00900912904495231,-0.00158774926434039,0.0337280365918726,0.0744901655527672
NMR metabolomics,X23424.Total Lipids in VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",40199,0.0117386816861148,0.00658694561673513,-0.0011717317226861,0.0246490950949156,0.0747583631955441
NMR metabolomics,X23424.Total Lipids in VLDL,CDHR1,Cadherin-related family member 1,42311,0.00777488563778374,0.00436426603146575,-0.000779075783889133,0.0163288470594566,0.074855966432719
NMR metabolomics,X23424.Total Lipids in VLDL,VCAN,Versican core protein,42711,-0.00554552277697023,0.00311442630736639,-0.0116497983394083,0.000558752785467885,0.0750015703586833
NMR metabolomics,X23424.Total Lipids in VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,40136,-0.00617376233271139,0.0034800532732816,-0.0129946667483433,0.000647142082920554,0.0760839275490984
NMR metabolomics,X23424.Total Lipids in VLDL,CALY,Neuron-specific vesicular protein calcyon,40116,-0.00710189322739783,0.00400699682179444,-0.0149556069981149,0.000751820543319279,0.0763605209517668
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42746,0.00728800042610144,0.00411496853294623,-0.000777337898473176,0.0153533387506761,0.0765673678546032
NMR metabolomics,X23424.Total Lipids in VLDL,NECTIN4,Nectin-4,42679,-0.00622917297113224,0.00351840232906869,-0.0131252415361069,0.000666895593842396,0.0766739641981393
NMR metabolomics,X23424.Total Lipids in VLDL,CFD,Complement factor D,40539,0.00379232588608778,0.00214226747955193,-0.000406518373833998,0.00799117014600957,0.0767141519026512
NMR metabolomics,X23424.Total Lipids in VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42611,0.00776600692820724,0.00438777437523766,-0.000834030847258572,0.0163660447036731,0.0767632782012954
NMR metabolomics,X23424.Total Lipids in VLDL,MERTK,Tyrosine-protein kinase Mer,42754,-0.00460132005702914,0.00260300450108744,-0.00970320887916052,0.000500568765102238,0.0771342619985259
NMR metabolomics,X23424.Total Lipids in VLDL,MYH7B,Myosin-7B,40080,-0.00810440662469507,0.00458863958400899,-0.0170981402093527,0.000889326959962538,0.0773921005510926
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJA4,DnaJ homolog subfamily A member 4,40483,0.0127429065329098,0.00722075794140831,-0.00140977903225047,0.0268955920980701,0.0776311048632808
NMR metabolomics,X23424.Total Lipids in VLDL,DRAXIN,Draxin,42495,0.00785300024815993,0.00447350080767401,-0.000915061334881128,0.016621061831201,0.0792056409804096
NMR metabolomics,X23424.Total Lipids in VLDL,IL6ST,Interleukin-6 receptor subunit beta,42636,0.00312260100668806,0.00178233415496686,-0.000370773937046982,0.0066159759504231,0.0798012820324659
NMR metabolomics,X23424.Total Lipids in VLDL,CD200,OX-2 membrane glycoprotein,42594,-0.00490150525711642,0.00279916981814103,-0.0103878781006728,0.000584867586439995,0.0799590114981226
NMR metabolomics,X23424.Total Lipids in VLDL,INSL4,Early placenta insulin-like peptide,40451,-0.00867014783028923,0.00497479166737162,-0.0184207394983376,0.00108044383775914,0.0813930196796503
NMR metabolomics,X23424.Total Lipids in VLDL,GID8,Glucose-induced degradation protein 8 homolog,40482,0.00607090379893098,0.00349939904761698,-0.000787918334398301,0.0129297259322603,0.0827961226666332
NMR metabolomics,X23424.Total Lipids in VLDL,TNPO1,Transportin-1,40302,0.00627462485908248,0.0036235900346695,-0.000827611608869734,0.0133768613270347,0.0833717658571614
NMR metabolomics,X23424.Total Lipids in VLDL,HMCN2,Hemicentin-2,40269,-0.0103161513937578,0.00597411019849503,-0.0220254073828081,0.00139310459529244,0.0842297317204559
NMR metabolomics,X23424.Total Lipids in VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,40182,0.00753619277118178,0.00437903470190485,-0.00104671524455173,0.0161191007869153,0.0852841937874466
NMR metabolomics,X23424.Total Lipids in VLDL,CDH4,Cadherin-4,40136,0.00875601591818939,0.00508857706494125,-0.00121759512909547,0.0187296269654742,0.0853299307408979
NMR metabolomics,X23424.Total Lipids in VLDL,IL17RA,Interleukin-17 receptor A,42611,0.00769204737206245,0.00448440452121247,-0.00109738548951399,0.0164814802336389,0.0863154404928336
NMR metabolomics,X23424.Total Lipids in VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42618,0.0130072165989555,0.00760235704446555,-0.00189340320819693,0.027907836406108,0.0871143251184806
NMR metabolomics,X23424.Total Lipids in VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",40116,-0.0104720126243446,0.00613497675771997,-0.0224965670694758,0.00155254182078651,0.0878623746399509
NMR metabolomics,X23424.Total Lipids in VLDL,PCARE,Photoreceptor cilium actin regulator,40136,0.014640591046157,0.00859845164602019,-0.00221237418004258,0.0314935562723566,0.0886524647765032
NMR metabolomics,X23424.Total Lipids in VLDL,DOC2B,Double C2-like domain-containing protein beta,40182,0.00630395559646492,0.0037028858605534,-0.000953700690219738,0.0135616118831496,0.0887004633813266
NMR metabolomics,X23424.Total Lipids in VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40482,0.00563728785487715,0.00331877648236523,-0.000867514050558687,0.012142089760313,0.0894213321947932
NMR metabolomics,X23424.Total Lipids in VLDL,PAPPA,Pappalysin-1,42370,0.00807171339695656,0.00476773194679873,-0.00127304121876895,0.0174164680126821,0.0904813743123868
NMR metabolomics,X23424.Total Lipids in VLDL,SEMA4C,Semaphorin-4C,42587,-0.00479612254040195,0.00283488735280707,-0.0103525017519038,0.00076025667109991,0.09070333195184
NMR metabolomics,X23424.Total Lipids in VLDL,GSTM4,Glutathione S-transferase Mu 4,40116,-0.0128600811359076,0.00762116242678392,-0.0277975594924041,0.00207739722058889,0.0915516981153405
NMR metabolomics,X23424.Total Lipids in VLDL,ITM2A,Integral membrane protein 2A,42594,-0.0106087363263418,0.00629492203640461,-0.0229467835176949,0.00172931086501121,0.0919569240928469
NMR metabolomics,X23424.Total Lipids in VLDL,SLC39A14,Zinc transporter ZIP14,42311,-0.00592033109890572,0.00352032241301814,-0.0128201630284213,0.000979500830609833,0.092639540723643
NMR metabolomics,X23424.Total Lipids in VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,40110,0.0059055299275905,0.00351637380663137,-0.000986562733406981,0.012797622588588,0.0930954335541132
NMR metabolomics,X23424.Total Lipids in VLDL,SHPK,Sedoheptulokinase,40302,-0.00704329383108028,0.00420000831785316,-0.0152753101340725,0.00118872247191192,0.0935762115386611
NMR metabolomics,X23424.Total Lipids in VLDL,IGFL4,Insulin growth factor-like family member 4,40199,0.0126098659110958,0.00752990393494773,-0.00214874580140178,0.0273684776235933,0.0940336233810163
NMR metabolomics,X23424.Total Lipids in VLDL,DOCK9,Dedicator of cytokinesis protein 9,40136,0.0206324332782148,0.0123464381164618,-0.00356658543005035,0.0448314519864799,0.0947257168225349
NMR metabolomics,X23424.Total Lipids in VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40451,0.0108758380227996,0.00650987509938577,-0.00188351717199648,0.0236351932175958,0.0948151321616777
NMR metabolomics,X23424.Total Lipids in VLDL,RBP7,Retinoid-binding protein 7,40449,0.0102056140852593,0.00612868259284722,-0.00180660379672121,0.0222178319672399,0.0958964030032216
NMR metabolomics,X23424.Total Lipids in VLDL,AMBN,Ameloblastin,42370,-0.00486073299007349,0.00292343900122533,-0.0105906734324751,0.000869207452328155,0.096401016928261
NMR metabolomics,X23424.Total Lipids in VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42495,-0.00489990123588482,0.00296038589531266,-0.0107022575906976,0.000902455118927988,0.0979163979799064
NMR metabolomics,X23424.Total Lipids in VLDL,MRC1,Macrophage mannose receptor 1,40532,0.00493104891475872,0.00298195332080172,-0.000913579594012658,0.0107756774235301,0.0982302984400245
NMR metabolomics,X23424.Total Lipids in VLDL,NTF3,Neurotrophin-3,42594,0.00604623327709653,0.00365894016498454,-0.00112528944627317,0.0132177560004662,0.0984652981343122
NMR metabolomics,X23424.Total Lipids in VLDL,DEFB104A_DEFB104B,Beta-defensin 104,40136,0.00904781284934434,0.00548178724002285,-0.00169649014110046,0.0197921158397891,0.0988648274297856
NMR metabolomics,X23424.Total Lipids in VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,42240,-0.00674565121685476,0.00411480939039185,-0.0148106776220228,0.00131937518831326,0.101162555250169
NMR metabolomics,X23424.Total Lipids in VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40527,-0.0236412740489484,0.0145133356638801,-0.0520874119501534,0.0048048638522566,0.103354666865777
NMR metabolomics,X23424.Total Lipids in VLDL,MYO6,Unconventional myosin-VI,40482,0.00603038257336245,0.00371345471061793,-0.00124798865944869,0.0133087538061736,0.104419126526277
NMR metabolomics,X23424.Total Lipids in VLDL,ACHE,Acetylcholinesterase,40283,0.00549339703661724,0.00339713187464966,-0.00116498143769609,0.0121517755109306,0.105891806425919
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,42737,0.00510633478766917,0.00317455294048105,-0.00111578897567369,0.011328458551012,0.107744449352527
NMR metabolomics,X23424.Total Lipids in VLDL,PMCH,Pro-MCH,40116,-0.0139142642014241,0.0086700403900635,-0.0309075433659486,0.00307901496310032,0.108551925928616
NMR metabolomics,X23424.Total Lipids in VLDL,CD2,T-cell surface antigen CD2,40116,0.0063054709908754,0.00394139031626881,-0.00141965402901146,0.0140305960107623,0.10966992515957
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA11,Serpin A11,42794,-0.00662819030679551,0.00416519000233969,-0.0147919627113813,0.00153558209779028,0.111558651479019
NMR metabolomics,X23424.Total Lipids in VLDL,APOA4,Apolipoprotein A-IV,40539,0.00586544904998796,0.00368613693197237,-0.0013593793366779,0.0130902774366538,0.111588286474544
NMR metabolomics,X23424.Total Lipids in VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40511,0.0121052597484799,0.00761104176191997,-0.00281238210488322,0.0270229016018431,0.111753101018356
NMR metabolomics,X23424.Total Lipids in VLDL,IL11,Interleukin-11,42370,0.0101498219708956,0.00639475505003726,-0.00238389792717746,0.0226835418689686,0.112488986730225
NMR metabolomics,X23424.Total Lipids in VLDL,DENND2B,DENN domain-containing protein 2B,40116,-0.0081051024854498,0.00511066317245941,-0.0181220023034702,0.00191179733257064,0.112786427841559
NMR metabolomics,X23424.Total Lipids in VLDL,IL21R,Interleukin-21 receptor,40199,0.00906183745569764,0.00572396894591455,-0.00215714167829487,0.0202808165896902,0.113418561868608
NMR metabolomics,X23424.Total Lipids in VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,40302,0.00651677538808887,0.0041437398807804,-0.00160495477824072,0.0146385055544184,0.115821494622812
NMR metabolomics,X23424.Total Lipids in VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40482,0.0185150942367443,0.0117749356209105,-0.0045637795802402,0.0415939680537288,0.115882190382564
NMR metabolomics,X23424.Total Lipids in VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,40080,0.00943556499089139,0.00600616370061944,-0.00233651586232271,0.0212076458441055,0.116216282246632
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC1A,C-type lectin domain family 1 member A,42357,-0.00560707312247111,0.00357732554219726,-0.0126186311851777,0.00140448494023551,0.117047020295264
NMR metabolomics,X23424.Total Lipids in VLDL,SEMA3G,Semaphorin-3G,40283,0.0071663381640381,0.00457226704880651,-0.00179530525162265,0.0161279815796989,0.117061672428637
NMR metabolomics,X23424.Total Lipids in VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,40080,0.0102372408817899,0.00654853935411499,-0.00259789625227544,0.0230723780158553,0.118014371998925
NMR metabolomics,X23424.Total Lipids in VLDL,TCN1,Transcobalamin-1,40337,0.00544908598182732,0.00348696554285151,-0.00138536648216163,0.0122835384458163,0.118151239452888
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42611,0.00513726856713277,0.0032924865864391,-0.00131600514228786,0.0115905422765534,0.118712463494831
NMR metabolomics,X23424.Total Lipids in VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,40116,-0.00774469625353542,0.00497604719081668,-0.0174977487475361,0.00200835624046527,0.119643105953717
NMR metabolomics,X23424.Total Lipids in VLDL,SCP2,Non-specific lipid-transfer protein,42346,0.0117358208466592,0.00754310214239022,-0.00304865935242559,0.0265203010457441,0.119771440930401
NMR metabolomics,X23424.Total Lipids in VLDL,HEPACAM2,HEPACAM family member 2,40483,-0.00666002494235584,0.00430408826377122,-0.0150960379393474,0.00177598805463576,0.121801640688449
NMR metabolomics,X23424.Total Lipids in VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,40080,0.0122967107355113,0.00795025115779845,-0.00328578153377363,0.0278792030047963,0.121962933997378
NMR metabolomics,X23424.Total Lipids in VLDL,STX1B,Syntaxin-1B,40182,0.00641398279362502,0.00414977749721229,-0.00171958110091106,0.0145475466881611,0.122224951231062
NMR metabolomics,X23424.Total Lipids in VLDL,PLA2G2A,"Phospholipase A2, membrane associated",42602,-0.00893826554473049,0.00580996798905607,-0.0203258028032804,0.00244927171381941,0.123965574477305
NMR metabolomics,X23424.Total Lipids in VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,42311,-0.00757930399972566,0.00493378468500106,-0.0172495219823277,0.00209091398287642,0.124512264445335
NMR metabolomics,X23424.Total Lipids in VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42794,0.00425900705774485,0.00279341325658977,-0.00121608292517109,0.0097340970406608,0.127367032876685
NMR metabolomics,X23424.Total Lipids in VLDL,GIPC2,PDZ domain-containing protein GIPC2,40483,0.00480417770968098,0.00316238268673086,-0.00139409235631151,0.0110024477756735,0.128749242360864
NMR metabolomics,X23424.Total Lipids in VLDL,KRT14,"Keratin, type I cytoskeletal 14",41948,0.00452436829381479,0.00298651791405687,-0.00132920681773668,0.0103779434053663,0.129814683389897
NMR metabolomics,X23424.Total Lipids in VLDL,CTNNA1,Catenin alpha-1,40136,-0.00539404271503358,0.00359793154215848,-0.0124459885376642,0.00165790310759705,0.133848892785747
NMR metabolomics,X23424.Total Lipids in VLDL,SKIV2L,Helicase SKI2W,40116,-0.00610213059172164,0.00407361533915053,-0.0140864166564567,0.0018821554730134,0.134171409582358
NMR metabolomics,X23424.Total Lipids in VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,42636,0.00887063414300964,0.00593191162215719,-0.00275591263641846,0.0204971809224377,0.13483120361616
NMR metabolomics,X23424.Total Lipids in VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,42566,0.00459577423154215,0.00307814053296177,-0.00143738121306291,0.0106289296761472,0.135451390364437
NMR metabolomics,X23424.Total Lipids in VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,40182,-0.00854192561567242,0.00572298060060513,-0.0197589675928585,0.00267511636151364,0.135579568714613
NMR metabolomics,X23424.Total Lipids in VLDL,IL9,Interleukin-9,40302,0.00858302980885244,0.00575202670337685,-0.00269094252976618,0.0198570021474711,0.135681702368523
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42594,0.0131670177904546,0.00884807892590152,-0.00417521690431234,0.0305092524852216,0.136742346850146
NMR metabolomics,X23424.Total Lipids in VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",42370,0.0172579843337904,0.0116282566826075,-0.00553339876412027,0.040049367431701,0.137795168903727
NMR metabolomics,X23424.Total Lipids in VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40483,0.00575816145993972,0.00388158531699362,-0.00184974576136778,0.0133660686812472,0.137981185616706
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB2,Integrin beta-2,42569,0.00432627829946266,0.00291670339261977,-0.00139046035007209,0.0100430169489974,0.138024461988491
NMR metabolomics,X23424.Total Lipids in VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40539,0.00283436496451504,0.0019140598469271,-0.000917192335462075,0.00658592226449216,0.138684145266685
NMR metabolomics,X23424.Total Lipids in VLDL,FGFR4,Fibroblast growth factor receptor 4,40283,0.00800648070022777,0.00542652583812368,-0.00262950994249465,0.0186424713429502,0.140124293169356
NMR metabolomics,X23424.Total Lipids in VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,40136,-0.0112195378285616,0.00760786062514298,-0.0261309446538418,0.00369186899671867,0.140314005233824
NMR metabolomics,X23424.Total Lipids in VLDL,OTOA,Otoancorin,40136,-0.00822227345648426,0.00558975290464097,-0.0191781891495806,0.00273364223661204,0.141332116819886
NMR metabolomics,X23424.Total Lipids in VLDL,OPTC,Opticin,42587,-0.00694208516275602,0.00472204998597558,-0.0161973031352682,0.00231313280975612,0.14154672403243
NMR metabolomics,X23424.Total Lipids in VLDL,TLR2,Toll-like receptor 2,40302,0.00351799041121027,0.00239468273697362,-0.00117558775325802,0.00821156857567856,0.141838289774082
NMR metabolomics,X23424.Total Lipids in VLDL,CHP1,Calcineurin B homologous protein 1,40136,0.0111363011519752,0.00758208127731869,-0.00372457815156941,0.0259971804555199,0.141925088967743
NMR metabolomics,X23424.Total Lipids in VLDL,ICAM3,Intercellular adhesion molecule 3,42794,-0.00400816240205771,0.00274132415790611,-0.00938115775155369,0.00136483294743828,0.143729683609842
NMR metabolomics,X23424.Total Lipids in VLDL,FOLR1,Folate receptor alpha,42600,0.00451611532054367,0.00309495562001013,-0.0015499976946762,0.0105822283357635,0.14453740320521
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,42357,0.00726658984339975,0.00499045775609088,-0.00251470735853838,0.0170478870453379,0.145389697147408
NMR metabolomics,X23424.Total Lipids in VLDL,ZPR1,Zinc finger protein ZPR1,40136,0.0145129597899661,0.00997363026099592,-0.00503535552158586,0.0340612751015182,0.145661096486164
NMR metabolomics,X23424.Total Lipids in VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,42636,0.00420213664711022,0.00289204166830228,-0.00146626502276225,0.00987053831698269,0.146247087322293
NMR metabolomics,X23424.Total Lipids in VLDL,LMOD2,Leiomodin-2,40136,0.00927041096351548,0.00638116159305239,-0.00323666575886721,0.0217774876858982,0.146314086836122
NMR metabolomics,X23424.Total Lipids in VLDL,IL4,Interleukin-4,42370,0.0138853138394031,0.00955840712485685,-0.00484916412531636,0.0326197918041225,0.1463362328984
NMR metabolomics,X23424.Total Lipids in VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,42618,0.0438072846295704,0.0302119614861931,-0.0154081598833679,0.103022729142509,0.147082431104809
NMR metabolomics,X23424.Total Lipids in VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,40255,-0.00712327867312305,0.00494102996330383,-0.0168076974011985,0.00256114005495244,0.149426999622787
NMR metabolomics,X23424.Total Lipids in VLDL,MYOC,Myocilin,42611,-0.00656230996366462,0.00455636645589135,-0.0154927882172117,0.00236816828988242,0.149819817753417
NMR metabolomics,X23424.Total Lipids in VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,40182,-0.00671676762476334,0.00471411125142045,-0.0159564256775474,0.00252289042802074,0.154237172668544
NMR metabolomics,X23424.Total Lipids in VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,42357,0.0112798853829381,0.00792378886544713,-0.00425074079333828,0.0268105115592145,0.154601367037748
NMR metabolomics,X23424.Total Lipids in VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,40116,-0.00703748956650156,0.0049752187411547,-0.0167889182991648,0.00271393916616165,0.157241138025226
NMR metabolomics,X23424.Total Lipids in VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,42754,-0.00689053657355089,0.00488355342645692,-0.0164623012894065,0.00268122814230467,0.158277053740742
NMR metabolomics,X23424.Total Lipids in VLDL,NPTX1,Neuronal pentraxin-1,42611,0.00573998902835532,0.00408535508637991,-0.0022673069409493,0.0137472849976599,0.160039689376991
NMR metabolomics,X23424.Total Lipids in VLDL,OFD1,Oral-facial-digital syndrome 1 protein,40302,0.00944407632543461,0.00672948501009169,-0.00374571429434509,0.0226338669452143,0.160529218880477
NMR metabolomics,X23424.Total Lipids in VLDL,KLK15,Kallikrein-15,40429,0.00759711222027934,0.00545311335607531,-0.00309098995762827,0.018285214398187,0.163596046913158
NMR metabolomics,X23424.Total Lipids in VLDL,AMY2B,Alpha-amylase 2B,41779,-0.00711828203860564,0.00512176149802225,-0.0171569345747292,0.00292037049751797,0.164610767109586
NMR metabolomics,X23424.Total Lipids in VLDL,PADI2,Protein-arginine deiminase type-2,42370,0.007896258683394,0.00568339200875259,-0.00324318965376108,0.0190357070205491,0.164747792259291
NMR metabolomics,X23424.Total Lipids in VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,40302,0.00902558783290318,0.00650849702329517,-0.00373106633275535,0.0217822419985617,0.165549136407552
NMR metabolomics,X23424.Total Lipids in VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,40302,0.00521999339153743,0.00376753784511218,-0.00216438078488244,0.0126043675679573,0.165921797303935
NMR metabolomics,X23424.Total Lipids in VLDL,TEX101,Testis-expressed protein 101,40182,0.00749164792999065,0.00541255316161992,-0.0031169562667844,0.0181002521267657,0.166348419267924
NMR metabolomics,X23424.Total Lipids in VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",40116,-0.00610912678388075,0.00443116791955712,-0.0147942159062127,0.00257596233845122,0.168024166548343
NMR metabolomics,X23424.Total Lipids in VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",40199,0.00663352704646314,0.00482760078885876,-0.00282857049970002,0.0160956245926263,0.169443715793162
NMR metabolomics,X23424.Total Lipids in VLDL,PXDNL,Peroxidasin-like protein,40451,-0.00781297117214856,0.00569458251329671,-0.0189743528982101,0.00334841055391299,0.170090561172642
NMR metabolomics,X23424.Total Lipids in VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40532,0.00527321526023582,0.00385215213123407,-0.00227700291698296,0.0128234334374546,0.171057312810295
NMR metabolomics,X23424.Total Lipids in VLDL,PI16,Peptidase inhibitor 16,40532,-0.00350752919773447,0.0025638999568292,-0.0085327731131197,0.00151771471765076,0.171325263057098
NMR metabolomics,X23424.Total Lipids in VLDL,CRNN,Cornulin,42209,0.00959245825753528,0.00705311919708485,-0.00423165536875102,0.0234165718838216,0.173843783155499
NMR metabolomics,X23424.Total Lipids in VLDL,NCR1,Natural cytotoxicity triggering receptor 1,42566,0.00536231059265186,0.0039468858404712,-0.0023735856546717,0.0130982068399754,0.17429054984359
NMR metabolomics,X23424.Total Lipids in VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,42357,0.00463466488880074,0.00341363904613028,-0.0020560676416146,0.0113253974192161,0.174585225072836
NMR metabolomics,X23424.Total Lipids in VLDL,PKLR,Pyruvate kinase PKLR,42636,0.00901412494060116,0.00664100109764673,-0.00400223721078644,0.0220304870919888,0.17469462802901
NMR metabolomics,X23424.Total Lipids in VLDL,SLK,STE20-like serine/threonine-protein kinase,40302,0.0110570881100781,0.0081709629246707,-0.00495799922227645,0.0270721754424327,0.176013768872705
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,42357,0.00436067225991625,0.00322424430460067,-0.00195884657710107,0.0106801910969336,0.176250367758211
NMR metabolomics,X23424.Total Lipids in VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,42611,-0.00628778865726294,0.00465334608520036,-0.0154083469842556,0.00283276966972976,0.176641259536526
NMR metabolomics,X23424.Total Lipids in VLDL,PSAPL1,Proactivator polypeptide-like 1,40449,-0.00704438751615532,0.00521773966414705,-0.0172711572578835,0.0031823822255729,0.177016147270774
NMR metabolomics,X23424.Total Lipids in VLDL,CD160,CD160 antigen,42754,0.00669519824324476,0.00499946080645572,-0.00310374493740847,0.016494141423898,0.180533205557764
NMR metabolomics,X23424.Total Lipids in VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,40116,-0.00661155390047733,0.0049522403742957,-0.0163179450340969,0.00309483723314225,0.181883486933977
NMR metabolomics,X23424.Total Lipids in VLDL,TJP3,Tight junction protein ZO-3,40136,-0.00574377100990538,0.00430416580227595,-0.0141799359823662,0.00269239396255548,0.182078335629244
NMR metabolomics,X23424.Total Lipids in VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,42611,-0.0049943531178355,0.00374498479107593,-0.0123345233083443,0.00234581707267332,0.182353997107075
NMR metabolomics,X23424.Total Lipids in VLDL,NUP50,Nuclear pore complex protein Nup50,40116,-0.00473171444878608,0.00355188305111782,-0.011693405228977,0.00222997633140485,0.182831905277754
NMR metabolomics,X23424.Total Lipids in VLDL,CLINT1,Clathrin interactor 1,40080,0.00627562772336559,0.0047257583987756,-0.00298685873823459,0.0155381141849658,0.184218492895408
NMR metabolomics,X23424.Total Lipids in VLDL,SCARB1,Scavenger receptor class B member 1,42311,0.0078748033644477,0.00593088585784799,-0.00374973291693436,0.0194993396458298,0.184279933183818
NMR metabolomics,X23424.Total Lipids in VLDL,TFF2,Trefoil factor 2,42654,0.0078625356117056,0.0059308593546493,-0.00376194872340702,0.0194870199468182,0.184961844811547
NMR metabolomics,X23424.Total Lipids in VLDL,RTKN2,Rhotekin-2,40116,-0.00697872072047349,0.00527997818117615,-0.0173274779555787,0.00337003651463176,0.186284801854642
NMR metabolomics,X23424.Total Lipids in VLDL,DCTPP1,dCTP pyrophosphatase 1,42636,0.00425997496743952,0.00322578672497229,-0.00206256701350617,0.0105825169483852,0.186657150794561
NMR metabolomics,X23424.Total Lipids in VLDL,IGLC2,Immunoglobulin lambda constant 2,40519,-0.00341086805009271,0.00258871087166994,-0.00848474135856579,0.00166300525838036,0.187666489920734
NMR metabolomics,X23424.Total Lipids in VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42658,0.00873091552873487,0.00662702714103599,-0.00425805766769567,0.0217198887251654,0.187703241479191
NMR metabolomics,X23424.Total Lipids in VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,40177,0.00511254822484907,0.00388699859888611,-0.0025059690289677,0.0127310654786658,0.188438373991957
NMR metabolomics,X23424.Total Lipids in VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,42311,0.00880168769409728,0.00669500401551699,-0.00432052017631603,0.0219238955645106,0.188645487349352
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,42676,0.00377672373174105,0.00288654018058103,-0.00188089502219776,0.00943434248567986,0.190762965087928
NMR metabolomics,X23424.Total Lipids in VLDL,ITGAX,Integrin alpha-X,40302,0.0072736175616798,0.00556604060799112,-0.0036358220299828,0.0181830571533424,0.191312843721101
NMR metabolomics,X23424.Total Lipids in VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42638,0.00457535573400976,0.00354892458304023,-0.00238053644874908,0.0115312479167686,0.197342699393735
NMR metabolomics,X23424.Total Lipids in VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,42311,-0.00805043982954408,0.0062559680629149,-0.0203121372328573,0.00421125757376913,0.198172219670703
NMR metabolomics,X23424.Total Lipids in VLDL,CNTNAP2,Contactin-associated protein-like 2,42594,-0.00548751794351034,0.0042677638784658,-0.0138523351453033,0.00287729925828263,0.198532868318859
NMR metabolomics,X23424.Total Lipids in VLDL,PLIN3,Perilipin-3,42636,0.00549453979822944,0.00428211010748861,-0.00289839601244823,0.0138874756089071,0.19946572381737
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINB5,Serpin B5,42357,0.00636551601736603,0.0049610569966906,-0.00335815569614754,0.0160891877308796,0.199480779113846
NMR metabolomics,X23424.Total Lipids in VLDL,IL20RA,Interleukin-20 receptor subunit alpha,42370,0.00587897892872053,0.00458805321364864,-0.0031136053700308,0.0148715632274719,0.200087420006835
NMR metabolomics,X23424.Total Lipids in VLDL,MMP9,Matrix metalloproteinase-9,42594,-0.00782918267285572,0.00612304964748953,-0.0198303599819352,0.00417199463622376,0.201045629384741
NMR metabolomics,X23424.Total Lipids in VLDL,SHH,Sonic hedgehog protein,40199,-0.00552399762600557,0.00432126500205573,-0.0139936770300348,0.00294568177802366,0.201160466830502
NMR metabolomics,X23424.Total Lipids in VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,42311,0.00658159042363015,0.00514877876188517,-0.00351001594966478,0.0166731967969251,0.201172684589519
NMR metabolomics,X23424.Total Lipids in VLDL,TSPAN7,Tetraspanin-7,40136,-0.0123199894460815,0.00964212780522846,-0.0312185599443292,0.00657858105216633,0.201373452068442
NMR metabolomics,X23424.Total Lipids in VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,40223,0.0043750893317205,0.00342779994838567,-0.00234339856711541,0.0110935772305564,0.201856959555567
NMR metabolomics,X23424.Total Lipids in VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,40182,0.00517779208073266,0.00408464688008082,-0.00282811580422574,0.0131836999656911,0.204959497960134
NMR metabolomics,X23424.Total Lipids in VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,40182,0.00922581201854369,0.00729062822501274,-0.00506381930248127,0.0235154433395687,0.20574246980207
NMR metabolomics,X23424.Total Lipids in VLDL,ANGPT2,Angiopoietin-2,42721,-0.00487138909207903,0.00385101404874099,-0.0124193766276114,0.00267659844345332,0.205906493713451
NMR metabolomics,X23424.Total Lipids in VLDL,BMP10,Bone morphogenetic protein 10,40283,0.0037097781396236,0.00293689778574959,-0.0020465415204456,0.0094660977996928,0.206557468016258
NMR metabolomics,X23424.Total Lipids in VLDL,GAGE2A,G antigen 2A,40080,0.00858363160471577,0.00682002652821111,-0.00478362039057801,0.0219508836000095,0.208204687675426
NMR metabolomics,X23424.Total Lipids in VLDL,CD33,Myeloid cell surface antigen CD33,42679,0.0102739809487329,0.00816829452684069,-0.00573587632387482,0.0262838382213407,0.208490300145694
NMR metabolomics,X23424.Total Lipids in VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,42357,0.00392042568256631,0.00312982667711906,-0.00221403460458704,0.0100548859697197,0.210373011009434
NMR metabolomics,X23424.Total Lipids in VLDL,HRAS,GTPase Hras,40286,0.012753096238637,0.0101911837951282,-0.00722162399981424,0.0327278164770882,0.210820377252753
NMR metabolomics,X23424.Total Lipids in VLDL,LY6D,Lymphocyte antigen 6D,42548,0.00518190267183437,0.00415884231007888,-0.00296942825592023,0.013333233599589,0.212787564317135
NMR metabolomics,X23424.Total Lipids in VLDL,LCN15,Lipocalin-15,40482,-0.00794939493441686,0.0063953380383119,-0.0204842574895082,0.00458546762067447,0.213894241550666
NMR metabolomics,X23424.Total Lipids in VLDL,CNTN2,Contactin-2,42721,0.00564855353116507,0.00454564666317179,-0.00326091392865164,0.0145580209909818,0.214026024014481
NMR metabolomics,X23424.Total Lipids in VLDL,CORO6,Coronin-6,40136,-0.00472734859573807,0.00380649139649765,-0.0121880717328735,0.00273337454139732,0.214293590389643
NMR metabolomics,X23424.Total Lipids in VLDL,LYPLA2,Acyl-protein thioesterase 2,40136,0.0142209403222278,0.0114582430195495,-0.00823721599608923,0.0366790966405449,0.214591712166624
NMR metabolomics,X23424.Total Lipids in VLDL,ACTN4,Alpha-actinin-4,42370,0.00413047385868777,0.00334108263287483,-0.0024180481017469,0.0106789958191224,0.216380964121895
NMR metabolomics,X23424.Total Lipids in VLDL,FBLN2,Fibulin-2,40527,-0.00412209513937266,0.00333745696887813,-0.0106635107983738,0.00241932051962847,0.216818666857391
NMR metabolomics,X23424.Total Lipids in VLDL,ACTA2,"Actin, aortic smooth muscle",42357,-0.00552958004931114,0.0044797395596496,-0.0143098695862243,0.00325070948760207,0.21709342330192
NMR metabolomics,X23424.Total Lipids in VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,40080,0.00337272114129336,0.0027517859843711,-0.00202077938807399,0.00876622167066071,0.220357660342005
NMR metabolomics,X23424.Total Lipids in VLDL,CNTN5,Contactin-5,42640,0.00475092452073757,0.00388293234439437,-0.0028596228742754,0.0123614719157505,0.221147102853049
NMR metabolomics,X23424.Total Lipids in VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,40136,0.00701917164813481,0.00574839102483548,-0.00424767476054273,0.0182860180568123,0.222086892811498
NMR metabolomics,X23424.Total Lipids in VLDL,LAMA1,Laminin subunit alpha-1,40116,-0.00673552477561756,0.00551676738650421,-0.0175483888531658,0.0040773393019307,0.222143137989526
NMR metabolomics,X23424.Total Lipids in VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,40136,0.00754369020299803,0.00619444620948688,-0.00459742436759626,0.0196848047735923,0.223320500552447
NMR metabolomics,X23424.Total Lipids in VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40482,-0.00365921422450457,0.0030099966113323,-0.00955880758271587,0.00224037913370674,0.224129541767284
NMR metabolomics,X23424.Total Lipids in VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,40116,-0.00629971173498689,0.00520826171041826,-0.0165079046874067,0.00390848121743291,0.226473460956932
NMR metabolomics,X23424.Total Lipids in VLDL,TUBB3,Tubulin beta-3 chain,40136,-0.00347774440002139,0.0028775785671558,-0.00911779839164676,0.00216230959160398,0.226855637558141
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC4M,C-type lectin domain family 4 member M,40504,-0.00609866614573202,0.00505155806463588,-0.0159997199524183,0.0038023876609543,0.227347967682423
NMR metabolomics,X23424.Total Lipids in VLDL,FDX1,"Adrenodoxin, mitochondrial",40116,0.00763608884321067,0.0063371119597849,-0.00478465059796773,0.0200568282843891,0.228237394223876
NMR metabolomics,X23424.Total Lipids in VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,40136,0.00619359826756657,0.00514565770142139,-0.00389189082721935,0.0162790873623525,0.228748867276093
NMR metabolomics,X23424.Total Lipids in VLDL,RBM25,RNA-binding protein 25,40080,-0.00584370465713801,0.00485634862446914,-0.0153621479610975,0.00367473864682152,0.228881608874745
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,42587,0.00991949120762103,0.00826946054446237,-0.00628865145952521,0.0261276338747673,0.230341962699927
NMR metabolomics,X23424.Total Lipids in VLDL,BRD2,Bromodomain-containing protein 2,40136,0.00437868227507855,0.00365826772362868,-0.00279152246323366,0.0115488870133908,0.231360635494559
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC2L,C-type lectin domain family 2 member L,40182,0.00601383316057581,0.00503935613882243,-0.00386330487151615,0.0158909711926678,0.232748964907135
NMR metabolomics,X23424.Total Lipids in VLDL,RBP1,Retinol-binding protein 1,40182,0.00833233963223311,0.00699035397912172,-0.00536875416684545,0.0220334334313117,0.233296092522256
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC1,Sialoadhesin,42676,0.00523980347973607,0.00439985062200403,-0.00338390373939182,0.013863510698864,0.233711903762632
NMR metabolomics,X23424.Total Lipids in VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,42346,-0.00969627238973543,0.00821111108946383,-0.0257900501250845,0.00639750534561368,0.237674871607383
NMR metabolomics,X23424.Total Lipids in VLDL,GLI2,Zinc finger protein GLI2,40199,-0.00387159646677266,0.00328302390462251,-0.0103063233198328,0.00256313038628746,0.238313158792944
NMR metabolomics,X23424.Total Lipids in VLDL,GPR101,Probable G-protein coupled receptor 101,40136,-0.00727843296792254,0.00617870694325002,-0.0193886985766926,0.00483183264084751,0.238827632801511
NMR metabolomics,X23424.Total Lipids in VLDL,HCG22,Protein PBMUCL2,40116,-0.00686224099768385,0.00583245970101689,-0.018293862011677,0.00456938001630925,0.239396661266227
NMR metabolomics,X23424.Total Lipids in VLDL,MUCL3,Mucin-like protein 3,40080,-0.00509807773737565,0.0043552662045133,-0.0136343994982217,0.00343824402347042,0.241803400681372
NMR metabolomics,X23424.Total Lipids in VLDL,GPR158,Probable G-protein coupled receptor 158,40482,0.00429827213457112,0.00367957970464927,-0.00291370408654145,0.0115102483556837,0.242774103228559
NMR metabolomics,X23424.Total Lipids in VLDL,KIRREL2,Kin of IRRE-like protein 2,42311,0.00480725517488417,0.00412125629775691,-0.00327040716871937,0.0128849175184877,0.243452213870285
NMR metabolomics,X23424.Total Lipids in VLDL,MFAP3L,Microfibrillar-associated protein 3-like,40182,0.00803153413204978,0.00690367254974088,-0.00549966406544235,0.0215627323295419,0.244704173343304
NMR metabolomics,X23424.Total Lipids in VLDL,ZP4,Zona pellucida sperm-binding protein 4,40080,-0.0037496770205736,0.00322709164997338,-0.0100747766545214,0.00257542261337423,0.245286551904171
NMR metabolomics,X23424.Total Lipids in VLDL,S100A3,Protein S100-A3,40451,0.00515137598947166,0.00444626620303525,-0.00356330576847743,0.0138660577474208,0.246650086488213
NMR metabolomics,X23424.Total Lipids in VLDL,KLK1,Kallikrein-1,42505,-0.0152804603925233,0.0132164869418061,-0.0411847747984633,0.0106238540134167,0.247633780586204
NMR metabolomics,X23424.Total Lipids in VLDL,RAB6B,Ras-related protein Rab-6B,42311,0.00580739026471855,0.00502615301878554,-0.0040438696521011,0.0156586501815382,0.247933614427938
NMR metabolomics,X23424.Total Lipids in VLDL,PLAU,Urokinase-type plasminogen activator,42611,0.00345644663448433,0.00300440488421258,-0.00243218693857233,0.00934508020754098,0.24997510199463
NMR metabolomics,X23424.Total Lipids in VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,40080,-0.00994218554672316,0.00865299706929763,-0.0269020598025465,0.0070176887091002,0.250586375764742
NMR metabolomics,X23424.Total Lipids in VLDL,CCNE1,G1/S-specific cyclin-E1,40199,0.0104031639245895,0.00906569107091077,-0.00736559057439561,0.0281719184235746,0.251187065456981
NMR metabolomics,X23424.Total Lipids in VLDL,FBN2,Fibrillin-2,40182,0.00713992452618516,0.00622860872079169,-0.00506814856656654,0.0193479976189369,0.251691333523278
NMR metabolomics,X23424.Total Lipids in VLDL,PRC1,Protein regulator of cytokinesis 1,40451,0.00521363988260933,0.00454915042774312,-0.00370269495576718,0.0141299747209859,0.251791001032599
NMR metabolomics,X23424.Total Lipids in VLDL,HIP1,Huntingtin-interacting protein 1,40116,0.00391150912281407,0.00341875638895264,-0.00278925339953309,0.0106122716451612,0.25259390708043
NMR metabolomics,X23424.Total Lipids in VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,40116,0.00838485666598281,0.0073331998329044,-0.00598821500650981,0.0227579283384754,0.252893313582845
NMR metabolomics,X23424.Total Lipids in VLDL,POF1B,Protein POF1B,40199,-0.00544776063093505,0.00477146193560428,-0.0147998260247194,0.00390430476284934,0.253587675513567
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC4C,C-type lectin domain family 4 member C,42594,0.00552541285397012,0.00489135742880275,-0.00406164770648327,0.0151124734144235,0.258653353468026
NMR metabolomics,X23424.Total Lipids in VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,40116,0.00613571624980738,0.00546170127741381,-0.00456921825392369,0.0168406507535385,0.261289152369951
NMR metabolomics,X23424.Total Lipids in VLDL,NEFL,Neurofilament light polypeptide,42262,0.00528465433914836,0.00471714862830749,-0.00396095697233433,0.014530265650631,0.262603574690343
NMR metabolomics,X23424.Total Lipids in VLDL,IL33,Interleukin-33,42370,0.00442174263865467,0.00395500369006197,-0.00333006459386679,0.0121735498711761,0.263582138304555
NMR metabolomics,X23424.Total Lipids in VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,40199,0.00607147921143052,0.00548831108735887,-0.00468561051979286,0.0168285689426539,0.268639743336431
NMR metabolomics,X23424.Total Lipids in VLDL,VNN2,Vascular non-inflammatory molecule 2,42587,0.00512025492224177,0.00463923390387325,-0.00397264352934981,0.0142131533738334,0.269749442356821
NMR metabolomics,X23424.Total Lipids in VLDL,TNNI3,"Troponin I, cardiac muscle",42357,0.00945962925298956,0.00859554734923824,-0.00738764355151739,0.0263069020574965,0.271122833314741
NMR metabolomics,X23424.Total Lipids in VLDL,SERPINA3,Alpha-1-antichymotrypsin,40502,0.00170861809096674,0.00155283769816146,-0.00133494379742972,0.00475217997936321,0.271216223465156
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,40302,0.00511598840591488,0.00464960928365423,-0.00399724579004741,0.0142292226018772,0.271223092345407
NMR metabolomics,X23424.Total Lipids in VLDL,GPA33,Cell surface A33 antigen,42587,-0.0155132006709914,0.0141560832941482,-0.0432591239275219,0.012232722585539,0.273156188594327
NMR metabolomics,X23424.Total Lipids in VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,40182,-0.00455865685879476,0.00419267887238264,-0.0127763074486647,0.00365899373107523,0.276932616479314
NMR metabolomics,X23424.Total Lipids in VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,40116,-0.00376232119090279,0.00347272210856177,-0.0105688565236839,0.00304421414187826,0.278658145849883
NMR metabolomics,X23424.Total Lipids in VLDL,ALPI,Intestinal-type alkaline phosphatase,40199,0.0138728149318411,0.0128238028926099,-0.0112618387376743,0.0390074686013565,0.279364245381228
NMR metabolomics,X23424.Total Lipids in VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42618,0.00440359322948715,0.00408172640321349,-0.00359659052081128,0.0124037769797856,0.28067150612454
NMR metabolomics,X23424.Total Lipids in VLDL,KIRREL1,Kin of IRRE-like protein 1,40136,-0.00632415117463487,0.00588676282815324,-0.0178622063178152,0.00521390396854548,0.282711792272237
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,40283,-0.00474037216605281,0.00442143011533085,-0.0134063751921013,0.00392563085999565,0.283682510112624
NMR metabolomics,X23424.Total Lipids in VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,40287,-0.00548704572286768,0.00513185784219777,-0.0155454870935753,0.00457139564783994,0.28499726542162
NMR metabolomics,X23424.Total Lipids in VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,40483,0.00342428653317288,0.00320430877350746,-0.00285615866290175,0.0097047317292475,0.285249983454798
NMR metabolomics,X23424.Total Lipids in VLDL,SUSD5,Sushi domain-containing protein 5,40235,-0.00378144344138822,0.00355385708940292,-0.0107470033366179,0.00318411645384151,0.287334187877055
NMR metabolomics,X23424.Total Lipids in VLDL,GH2,Growth hormone variant,42346,0.0180943793993408,0.0170197692655026,-0.0152643683610442,0.0514531271597258,0.287738468741009
NMR metabolomics,X23424.Total Lipids in VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,42346,0.0137328459947066,0.0129437562570749,-0.0116369162691602,0.0391026082585734,0.288726215382684
NMR metabolomics,X23424.Total Lipids in VLDL,EPHA2,Ephrin type-A receptor 2,42125,0.00363577966034797,0.00343462448769146,-0.00309608433552729,0.0103676436562232,0.289816859502291
NMR metabolomics,X23424.Total Lipids in VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,40136,0.00810271020150937,0.00773525267301855,-0.00705838503760699,0.0232638054406257,0.294890201394586
NMR metabolomics,X23424.Total Lipids in VLDL,CDH22,Cadherin-22,40302,-0.00300808483654128,0.00287416153703598,-0.00864144144913179,0.00262527177604924,0.295308902036152
NMR metabolomics,X23424.Total Lipids in VLDL,AMIGO1,Amphoterin-induced protein 1,40182,0.00541322249163233,0.00517230421950326,-0.00472449377859406,0.0155509387618587,0.295317034519122
NMR metabolomics,X23424.Total Lipids in VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,40223,-0.00224189313031115,0.00214752870259864,-0.00645104938740448,0.00196726312678218,0.296535596327684
NMR metabolomics,X23424.Total Lipids in VLDL,PEAR1,Platelet endothelial aggregation receptor 1,42794,0.0024164327057579,0.00231865770199773,-0.00212813639015765,0.00696100180167346,0.297351952475322
NMR metabolomics,X23424.Total Lipids in VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,40182,0.00542633525945063,0.00521094988077605,-0.00478712650687043,0.0156397970257717,0.297743831602974
NMR metabolomics,X23424.Total Lipids in VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42613,-0.00340496502505219,0.00331132428667531,-0.00989516062693579,0.00308523057683142,0.303837169020462
NMR metabolomics,X23424.Total Lipids in VLDL,EDNRB,Endothelin receptor type B,40199,0.00465810541608677,0.00456098889366877,-0.00428143281550402,0.0135976436476776,0.307138155534772
NMR metabolomics,X23424.Total Lipids in VLDL,RYR1,Ryanodine receptor 1,40116,-0.00359846933150871,0.00352920200816561,-0.0105157052675133,0.00331876660449589,0.307928022808221
NMR metabolomics,X23424.Total Lipids in VLDL,RETN,Resistin,42598,0.00449983937189309,0.00442251492718492,-0.00416828988538936,0.0131679686291755,0.308941476150465
NMR metabolomics,X23424.Total Lipids in VLDL,HDAC8,Histone deacetylase 8,40199,0.00614794941543703,0.00604641097586012,-0.00570301609724882,0.0179989149281229,0.309274182309103
NMR metabolomics,X23424.Total Lipids in VLDL,CDC123,Cell division cycle protein 123 homolog,40080,0.00656508182461459,0.00645946829770619,-0.00609547603888955,0.0192256396881187,0.30948524415773
NMR metabolomics,X23424.Total Lipids in VLDL,UPK3BL1,Uroplakin-3b-like protein 1,40281,-0.00565432412466965,0.00557105976702345,-0.0165736012680356,0.00526495301869632,0.310153777047175
NMR metabolomics,X23424.Total Lipids in VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,40116,0.00497612160371856,0.00491430445706102,-0.00465591513212103,0.0146081583395582,0.311283714728465
NMR metabolomics,X23424.Total Lipids in VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,42370,0.00375685734788596,0.0037373513213275,-0.00356835124191594,0.0110820659376879,0.314809766186963
NMR metabolomics,X23424.Total Lipids in VLDL,RGS8,Regulator of G-protein signaling 8,42370,0.006597512547381,0.00658028824083537,-0.00629985240465632,0.0194948774994183,0.316063831603454
NMR metabolomics,X23424.Total Lipids in VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42594,0.0154104464589678,0.0153842362096128,-0.0147426565118733,0.0455635494298089,0.31650480311518
NMR metabolomics,X23424.Total Lipids in VLDL,UNC5D,Netrin receptor UNC5D,40199,0.0026790664318037,0.00267634939842186,-0.00256657838910314,0.00792471125271055,0.316841468413313
NMR metabolomics,X23424.Total Lipids in VLDL,IL17F,Interleukin-17F,42370,0.00767717094119942,0.00771284501429812,-0.00744000528682489,0.0227943471692237,0.319572328439904
NMR metabolomics,X23424.Total Lipids in VLDL,SAP18,Histone deacetylase complex subunit SAP18,40302,-0.00752977626304961,0.0075734255989595,-0.0223736904370102,0.00731413791091101,0.320129392608933
NMR metabolomics,X23424.Total Lipids in VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",40199,0.0028822014246022,0.00290880656410016,-0.0028190594410341,0.00858346229023851,0.321778862172679
NMR metabolomics,X23424.Total Lipids in VLDL,KLK3,Prostate-specific antigen,40527,0.00991574809261793,0.0100361461544785,-0.00975509837015988,0.0295865945553958,0.323171999363087
NMR metabolomics,X23424.Total Lipids in VLDL,GKN1,Gastrokine-1,42017,0.00283158579285891,0.00286625972224035,-0.00278628326273217,0.00844945484844999,0.323218930368086
NMR metabolomics,X23424.Total Lipids in VLDL,NPHS2,Podocin,40199,-0.0105185266835849,0.0107457046456789,-0.0315801077891155,0.0105430544219456,0.327671308936708
NMR metabolomics,X23424.Total Lipids in VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,40116,0.006037289298406,0.00617230649788377,-0.00606043143744618,0.0181350100342582,0.328034008083636
NMR metabolomics,X23424.Total Lipids in VLDL,S100G,Protein S100-G,40482,-0.0047999834007198,0.00492850395199045,-0.0144598511466211,0.00485988434518147,0.330115637742232
NMR metabolomics,X23424.Total Lipids in VLDL,TYMP,Thymidine phosphorylase,42563,0.0064254079236444,0.006612129565983,-0.00653436602568228,0.0193851818729711,0.331187172172566
NMR metabolomics,X23424.Total Lipids in VLDL,UPK3A,Uroplakin-3a,40136,0.00507155628048656,0.00522910560656616,-0.00517749070838312,0.0153206032693562,0.332132387280877
NMR metabolomics,X23424.Total Lipids in VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,40182,0.00364863117196155,0.00377066671459376,-0.00374187558864222,0.0110391379325653,0.333247711837198
NMR metabolomics,X23424.Total Lipids in VLDL,DCUN1D2,DCN1-like protein 2,40080,0.00791209998474481,0.00819910139408489,-0.00815813874766158,0.0239823387171512,0.334568255374708
NMR metabolomics,X23424.Total Lipids in VLDL,FH,"Fumarate hydratase, mitochondrial",40136,0.00839213457154361,0.00875686413233814,-0.00877131912783915,0.0255555882709264,0.337907828380021
NMR metabolomics,X23424.Total Lipids in VLDL,TPSG1,Tryptase gamma,40199,0.00260446067412955,0.00271992159898837,-0.00272658565988766,0.00793550700814676,0.338310803935145
NMR metabolomics,X23424.Total Lipids in VLDL,MATN3,Matrilin-3,42475,0.00319355481007324,0.00334116592976496,-0.00335513041226609,0.00974224003241258,0.339180338807621
NMR metabolomics,X23424.Total Lipids in VLDL,S100A16,Protein S100-A16,42292,-0.00592030979277216,0.00619412681297646,-0.018060798346206,0.0062201787606617,0.339193915320914
NMR metabolomics,X23424.Total Lipids in VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,40136,0.00397124717761877,0.00415620820457709,-0.00417492090335233,0.0121174152585899,0.339347201312235
NMR metabolomics,X23424.Total Lipids in VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,40182,0.00700520130433671,0.00733515266748782,-0.00737169792393941,0.0213821005326128,0.339589708955871
NMR metabolomics,X23424.Total Lipids in VLDL,DLGAP5,Disks large-associated protein 5,40482,0.00494543559641648,0.00519143938449186,-0.00522978559718756,0.0151206567900205,0.340806297382045
NMR metabolomics,X23424.Total Lipids in VLDL,IL22,Interleukin-22,40451,0.00681150713911135,0.00715196154162671,-0.00720633748247701,0.0208293517606997,0.340916099046808
NMR metabolomics,X23424.Total Lipids in VLDL,TFAP2A,Transcription factor AP-2-alpha,40136,0.00593229817841336,0.00624045139757516,-0.00629898656083394,0.0181635829176607,0.341818286439881
NMR metabolomics,X23424.Total Lipids in VLDL,IL19,Interleukin-19,42261,0.00699796893281243,0.00736604418255912,-0.00743947766500345,0.0214354155306283,0.342114167416161
NMR metabolomics,X23424.Total Lipids in VLDL,SLC44A4,Choline transporter-like protein 4,40182,-0.00689771255869382,0.00729487786207354,-0.021195673168358,0.00740024805097031,0.344396095015778
NMR metabolomics,X23424.Total Lipids in VLDL,RNASE10,Inactive ribonuclease-like protein 10,40223,-0.00477928831097369,0.00505867360357112,-0.0146942885739731,0.00513571195202571,0.344796477285178
NMR metabolomics,X23424.Total Lipids in VLDL,MMP8,Neutrophil collagenase,42681,0.00700640372831512,0.00743785941335155,-0.00757180072185392,0.0215846081784842,0.346213631065268
NMR metabolomics,X23424.Total Lipids in VLDL,IL13,Interleukin-13,42370,-0.00453026941748962,0.00484566360234123,-0.0140277700780784,0.00496723124309919,0.349850746601782
NMR metabolomics,X23424.Total Lipids in VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,40116,0.010470649599469,0.0112792843503308,-0.0116367477271794,0.0325780469261174,0.353268353366074
NMR metabolomics,X23424.Total Lipids in VLDL,BMP4,Bone morphogenetic protein 4,42475,-0.00440239774962615,0.00475325487392377,-0.0137187773025167,0.00491398180326444,0.354366196666159
NMR metabolomics,X23424.Total Lipids in VLDL,AMY2A,Pancreatic alpha-amylase,42114,-0.00461993392261829,0.00499329798090557,-0.0144067979651932,0.00516693011995663,0.35486514196444
NMR metabolomics,X23424.Total Lipids in VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,42311,0.00428603324793214,0.00465144661397442,-0.00483080211545773,0.013402868611322,0.356837219678897
NMR metabolomics,X23424.Total Lipids in VLDL,PTK7,Inactive tyrosine-protein kinase 7,42311,0.00358200059129859,0.0038959531799522,-0.00405406764140772,0.0112180688240049,0.357895077757591
NMR metabolomics,X23424.Total Lipids in VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,40116,0.00353951237376702,0.0038681664088458,-0.00404209378757075,0.0111211185351048,0.360192816034823
NMR metabolomics,X23424.Total Lipids in VLDL,CASP4,Caspase-4,40302,0.0161069910014265,0.0176655789546398,-0.0185175437496675,0.0507315257525205,0.361908219012535
NMR metabolomics,X23424.Total Lipids in VLDL,IL2RG,Cytokine receptor common subunit gamma,40451,0.00338175555718196,0.0037407335782372,-0.00395008225616295,0.0107135933705269,0.365995979220629
NMR metabolomics,X23424.Total Lipids in VLDL,ISM2,Isthmin-2,40527,0.00399171376798745,0.00442931907040673,-0.00468975161000974,0.0126731791459846,0.367499770971074
NMR metabolomics,X23424.Total Lipids in VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,40136,-0.00267473331162412,0.00296890737961872,-0.00849379177567681,0.00314432515242858,0.367653322018404
NMR metabolomics,X23424.Total Lipids in VLDL,MSLNL,Mesothelin-like protein,40182,-0.00362634092513512,0.004026511224339,-0.0115183029248396,0.00426562107456933,0.367812197661527
NMR metabolomics,X23424.Total Lipids in VLDL,SPRR1B,Cornifin-B,40302,-0.00762925541535226,0.00849443959886804,-0.0242783570291336,0.00901984619842909,0.36912665331798
NMR metabolomics,X23424.Total Lipids in VLDL,SCN3B,Sodium channel subunit beta-3,40136,0.00442081153776619,0.00492572059788852,-0.0052336008340953,0.0140752239096277,0.369474377865957
NMR metabolomics,X23424.Total Lipids in VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,40302,0.00341150673525044,0.00380129698743707,-0.00403903536012621,0.0108620488306271,0.369493697052125
NMR metabolomics,X23424.Total Lipids in VLDL,CSF2RB,Cytokine receptor common subunit beta,40199,-0.00398689544572996,0.00445150033692007,-0.0127118361060933,0.00473804521463338,0.370470212929735
NMR metabolomics,X23424.Total Lipids in VLDL,DNAJA1,DnaJ homolog subfamily A member 1,40080,-0.00436609766113619,0.00487698525899269,-0.0139249887687619,0.00519279344648948,0.370675819387857
NMR metabolomics,X23424.Total Lipids in VLDL,SYT1,Synaptotagmin-1,40483,0.00387505502335219,0.00432936021569799,-0.00461049099941586,0.0123606010461202,0.370771892036451
NMR metabolomics,X23424.Total Lipids in VLDL,AREG,Amphiregulin,42587,0.00387558368237132,0.00433884682564519,-0.00462855609589325,0.0123797234606359,0.371750616334522
NMR metabolomics,X23424.Total Lipids in VLDL,KLK12,Kallikrein-12,42346,0.0125894600763341,0.0142438418168159,-0.0153284698846251,0.0405073900372932,0.376791812787589
NMR metabolomics,X23424.Total Lipids in VLDL,GUCY2C,Heat-stable enterotoxin receptor,40302,-0.00725841791084875,0.00824040127855786,-0.0234096044168222,0.00889276859512465,0.378427237997798
NMR metabolomics,X23424.Total Lipids in VLDL,CD82,CD82 antigen,40302,-0.00368218650883838,0.00418933912017375,-0.0118932911843789,0.00452891816670216,0.379451684619984
NMR metabolomics,X23424.Total Lipids in VLDL,MYH4,Myosin-4,40116,-0.0040671808024027,0.00463996024713354,-0.0131615028867844,0.00502714128197904,0.380747616295451
NMR metabolomics,X23424.Total Lipids in VLDL,CNTF,Ciliary neurotrophic factor,40136,-0.00306658215871006,0.00351605360373866,-0.00995804722203783,0.00382488290461772,0.383137000434691
NMR metabolomics,X23424.Total Lipids in VLDL,HDDC2,5'-deoxynucleotidase HDDC2,40449,0.0038925430067733,0.0044884227467828,-0.00490476557692099,0.0126898515904676,0.385828614307365
NMR metabolomics,X23424.Total Lipids in VLDL,CBLN1,Cerebellin-1,40136,0.00840297469262813,0.00970838597831655,-0.0106254618248723,0.0274314112101286,0.386762674184091
NMR metabolomics,X23424.Total Lipids in VLDL,SHD,SH2 domain-containing adapter protein D,40083,-0.00778271900936908,0.00899477479044109,-0.0254124775986336,0.00984703957989547,0.386921251782541
NMR metabolomics,X23424.Total Lipids in VLDL,DCLRE1C,Protein artemis,40080,0.00274699912852995,0.00319719941782193,-0.00351951173040104,0.00901350998746094,0.390255073723171
NMR metabolomics,X23424.Total Lipids in VLDL,CD177,CD177 antigen,42595,-0.0115297238237865,0.0134367057838117,-0.0378656671600574,0.0148062195124845,0.390865472209287
NMR metabolomics,X23424.Total Lipids in VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",40482,0.00391767578120991,0.00457501839820682,-0.00504936027927546,0.0128847118416953,0.391839459154829
NMR metabolomics,X23424.Total Lipids in VLDL,PRND,Prion-like protein doppel,40483,-0.00457604285192083,0.00534867643259363,-0.0150594486598043,0.00590736295596268,0.392266680696177
NMR metabolomics,X23424.Total Lipids in VLDL,SEZ6L,Seizure 6-like protein,42679,0.00244337082403561,0.00286064945089759,-0.00316350209972367,0.00805024374779489,0.393047301375018
NMR metabolomics,X23424.Total Lipids in VLDL,STEAP4,Metalloreductase STEAP4,40136,0.00633013466099109,0.00745001476596929,-0.00827189428030872,0.0209321636022909,0.39552115442942
NMR metabolomics,X23424.Total Lipids in VLDL,CAPN3,Calpain-3,40451,-0.00331290285154062,0.00390628906955239,-0.0109692294278633,0.00434342372478206,0.396403294499653
NMR metabolomics,X23424.Total Lipids in VLDL,IL2,Interleukin-2,42370,-0.00277091386534748,0.00327418157025545,-0.00918830974304816,0.0036464820123532,0.397405205647417
NMR metabolomics,X23424.Total Lipids in VLDL,MYL4,Myosin light chain 4,40223,-0.00450651189251364,0.00533555442751983,-0.0149641985704525,0.00595117478542523,0.398341787370343
NMR metabolomics,X23424.Total Lipids in VLDL,ERCC1,DNA excision repair protein ERCC-1,40080,0.00294824266794367,0.00349580475942534,-0.00390353466053,0.00980001999641734,0.399042344999897
NMR metabolomics,X23424.Total Lipids in VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,42587,0.00272573515860709,0.00324804345168246,-0.00364043000669054,0.00909190032390471,0.401376022454236
NMR metabolomics,X23424.Total Lipids in VLDL,KRT17,"Keratin, type I cytoskeletal 17",40116,0.00336992011280931,0.00403370609470703,-0.00453614383281647,0.0112759840584351,0.403488194176863
NMR metabolomics,X23424.Total Lipids in VLDL,TNN,Tenascin-N,40527,0.00374837445645658,0.00450347700439147,-0.00507844047215071,0.0125751893850639,0.405240811032148
NMR metabolomics,X23424.Total Lipids in VLDL,ZP3,Zona pellucida sperm-binding protein 3,40223,0.0230019637338787,0.0277122864408507,-0.0313141176901886,0.077318045157946,0.406541121638259
NMR metabolomics,X23424.Total Lipids in VLDL,OSTN,Osteocrin,40182,-0.00355056983734238,0.00427940070318026,-0.0119381952155757,0.00483705554089094,0.406732911456574
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC11A,C-type lectin domain family 11 member A,42592,0.00413458344181757,0.00500338717510964,-0.00567205542139732,0.0139412223050325,0.408616388511434
NMR metabolomics,X23424.Total Lipids in VLDL,GIPR,Gastric inhibitory polypeptide receptor,40199,0.00413607011112722,0.00500938342413171,-0.00568232140017092,0.0139544616224254,0.40901232772506
NMR metabolomics,X23424.Total Lipids in VLDL,IL1A,Interleukin-1 alpha,42370,0.00491123357980728,0.005949517277498,-0.0067498202840888,0.0165722874437034,0.409111592558896
NMR metabolomics,X23424.Total Lipids in VLDL,PITHD1,PITH domain-containing protein 1,40065,-0.00680995093873638,0.00825912663093644,-0.0229978391353718,0.00937793725789904,0.409652905326229
NMR metabolomics,X23424.Total Lipids in VLDL,IL3RA,Interleukin-3 receptor subunit alpha,42370,0.00273889294747765,0.00334049018960117,-0.00380846782414064,0.00928625371909594,0.412283674321238
NMR metabolomics,X23424.Total Lipids in VLDL,SLAMF1,Signaling lymphocytic activation molecule,42370,0.00505498380711876,0.00618107163623926,-0.0070599165999102,0.0171698842141477,0.413476630807123
NMR metabolomics,X23424.Total Lipids in VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,40302,0.0058808982112068,0.00721062746624846,-0.00825193162264017,0.0200137280450538,0.414753542295931
NMR metabolomics,X23424.Total Lipids in VLDL,PGM2,Phosphoglucomutase-2,40182,0.00494403528981298,0.00611625933523484,-0.00704383300724731,0.0169319035868733,0.418910667670539
NMR metabolomics,X23424.Total Lipids in VLDL,SAG,S-arrestin,40136,-0.00433098396276156,0.00536055683989663,-0.014837675368959,0.00617570744343583,0.419145299774064
NMR metabolomics,X23424.Total Lipids in VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42495,0.00508327050066293,0.00630145507323435,-0.00726758144287639,0.0174341224442023,0.419864129463948
NMR metabolomics,X23424.Total Lipids in VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,40527,0.00247411409330589,0.00307162346911657,-0.00354626790616259,0.00849449609277438,0.420562868163905
NMR metabolomics,X23424.Total Lipids in VLDL,IL15RA,Interleukin-15 receptor subunit alpha,42370,0.00295478989618234,0.00369028342906745,-0.00427816562478986,0.0101877454171545,0.423322925059719
NMR metabolomics,X23424.Total Lipids in VLDL,IFNL2,Interferon lambda-2,40136,0.00506306885945079,0.00633343387946637,-0.00735046154430329,0.0174765992632049,0.424064714445966
NMR metabolomics,X23424.Total Lipids in VLDL,EVI2B,Protein EVI2B,40080,-0.00332710885543741,0.00418890023765972,-0.0115373533212505,0.00488313561037564,0.427056820589963
NMR metabolomics,X23424.Total Lipids in VLDL,FGF3,Fibroblast growth factor 3,40199,0.002362841711854,0.00297657734316976,-0.00347124988075873,0.00819693330446672,0.427322216789412
NMR metabolomics,X23424.Total Lipids in VLDL,ANPEP,Aminopeptidase N,42666,0.00224078601466447,0.00282706621315656,-0.0033002637631224,0.00778183579245133,0.428013871217661
NMR metabolomics,X23424.Total Lipids in VLDL,IKZF2,Zinc finger protein Helios,42346,0.00710508522485095,0.00897491531021836,-0.010485748783177,0.0246959192328789,0.428572983792166
NMR metabolomics,X23424.Total Lipids in VLDL,TSLP,Thymic stromal lymphopoietin,42357,0.00489847185581728,0.00622113620282912,-0.0072949551017278,0.0170918988133624,0.43106670173891
NMR metabolomics,X23424.Total Lipids in VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,40182,-0.00296540353567067,0.0037958074969864,-0.010405186229764,0.00447437915842267,0.434683312844649
NMR metabolomics,X23424.Total Lipids in VLDL,CPE,Carboxypeptidase E,42588,-0.00306033471337721,0.00393605847992325,-0.0107750093340268,0.00465433990727236,0.436870188247278
NMR metabolomics,X23424.Total Lipids in VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42611,-0.00237556288264275,0.00306378664877134,-0.00838058471423458,0.00362945894894909,0.438135757959787
NMR metabolomics,X23424.Total Lipids in VLDL,DIPK1C,Divergent protein kinase domain 1C,40182,0.00333135578413922,0.00429896666801629,-0.0050946188851727,0.0117573304534511,0.438403535024118
NMR metabolomics,X23424.Total Lipids in VLDL,PGR,Progesterone receptor,40199,0.00770035740801693,0.0100061457276214,-0.0119116882181211,0.027312403034155,0.441575802605244
NMR metabolomics,X23424.Total Lipids in VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,40429,0.00309849892310358,0.00403140674369537,-0.00480305829453933,0.0110000561407465,0.442152897059939
NMR metabolomics,X23424.Total Lipids in VLDL,PLB1,"Phospholipase B1, membrane-associated",40483,0.00468620749666167,0.0061403766091743,-0.00734893065731996,0.0167213456506433,0.44537249987944
NMR metabolomics,X23424.Total Lipids in VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42674,-0.00269686142981884,0.00355483625400082,-0.00966434048766044,0.00427061762802277,0.44807775896936
NMR metabolomics,X23424.Total Lipids in VLDL,GSN,Gelsolin,40488,-0.00150218359556529,0.00198138243030542,-0.00538569315896392,0.00238132596783333,0.448377460563493
NMR metabolomics,X23424.Total Lipids in VLDL,CD164L2,CD164 sialomucin-like 2 protein,40182,-0.00282015496842717,0.00372845018525703,-0.010127917331531,0.00448760739467661,0.449432818452649
NMR metabolomics,X23424.Total Lipids in VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,40116,-0.00372928022900307,0.00493416964818092,-0.0134002527394377,0.00594169228143153,0.449781186163833
NMR metabolomics,X23424.Total Lipids in VLDL,CNTNAP4,Contactin-associated protein-like 4,40182,0.00790290604338336,0.0105241497308495,-0.0127244274290816,0.0285302395158483,0.452710506011789
NMR metabolomics,X23424.Total Lipids in VLDL,PYDC1,Pyrin domain-containing protein 1,40223,-0.00325888215418544,0.00437721847755992,-0.0118382303702029,0.00532046606183199,0.456583963366803
NMR metabolomics,X23424.Total Lipids in VLDL,TCP11,T-complex protein 11 homolog,40302,0.00450359749894886,0.0060542641650768,-0.00736276026460166,0.0163699552624994,0.456969659893765
NMR metabolomics,X23424.Total Lipids in VLDL,CLSPN,Claspin,42292,0.0026415349812956,0.00357788296630011,-0.00437111563265261,0.00965418559524381,0.46034811332401
NMR metabolomics,X23424.Total Lipids in VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,40302,0.0040621444040429,0.00552783100509789,-0.00677240436594897,0.0148966931740348,0.462444405104339
NMR metabolomics,X23424.Total Lipids in VLDL,MORN4,MORN repeat-containing protein 4,40080,-0.00573591011689191,0.00786656957429964,-0.0211543864825192,0.00968256624873539,0.465925528286565
NMR metabolomics,X23424.Total Lipids in VLDL,CADPS,Calcium-dependent secretion activator 1,40182,0.00318764611470333,0.00438147244055703,-0.00540003986878846,0.0117753320981951,0.466917758098424
NMR metabolomics,X23424.Total Lipids in VLDL,FZD10,Frizzled-10,40182,0.00449428455257302,0.00620714373067709,-0.00767171715955408,0.0166602862647001,0.469050243030994
NMR metabolomics,X23424.Total Lipids in VLDL,TMEM132A,Transmembrane protein 132A,40223,0.00462913687679432,0.00640931694303043,-0.00793312433154533,0.017191398085134,0.470155360806504
NMR metabolomics,X23424.Total Lipids in VLDL,RAP1A,Ras-related protein Rap-1A,40199,0.00517999698743681,0.00726343107439942,-0.00905632791838606,0.0194163218932597,0.47576115426998
NMR metabolomics,X23424.Total Lipids in VLDL,LPO,Lactoperoxidase,42134,-0.00440313050540234,0.00620727126585775,-0.0165693821864835,0.00776312117567885,0.478119824858049
NMR metabolomics,X23424.Total Lipids in VLDL,H2AP,Huntingtin-interacting protein M,40080,-0.00379589706907792,0.00538878784814485,-0.0143579212514418,0.00676612711328598,0.481194741321949
NMR metabolomics,X23424.Total Lipids in VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40449,-0.00220473713360184,0.00315770085168026,-0.00839383080289515,0.00398435653569146,0.485060531670728
NMR metabolomics,X23424.Total Lipids in VLDL,RASA1,Ras GTPase-activating protein 1,42311,0.00230312302266008,0.00330392181187357,-0.00417256372861212,0.00877880977393228,0.48576030958404
NMR metabolomics,X23424.Total Lipids in VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,40182,0.00560198443915237,0.00803776230599073,-0.0101520296805895,0.0213559985588942,0.485843690747832
NMR metabolomics,X23424.Total Lipids in VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40451,-0.00643865447425756,0.00925600071817856,-0.0245804158818875,0.0117031069333724,0.48668151864272
NMR metabolomics,X23424.Total Lipids in VLDL,BSND,Barttin,40080,0.00242120393560256,0.003492908079075,-0.00442489589938444,0.00926730377058957,0.488213198012754
NMR metabolomics,X23424.Total Lipids in VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,42794,0.00221172122844731,0.00320400346224184,-0.0040681255575467,0.00849156801444132,0.490017791053616
NMR metabolomics,X23424.Total Lipids in VLDL,EPHA10,Ephrin type-A receptor 10,42311,-0.00471194152921723,0.00683177145712185,-0.0181022135851761,0.00867833052674159,0.490388736998547
NMR metabolomics,X23424.Total Lipids in VLDL,MLLT1,Protein ENL,40080,0.00468313889678033,0.00679197342697474,-0.00862912902009016,0.0179954068136508,0.490516588531375
NMR metabolomics,X23424.Total Lipids in VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42594,0.00276676548525945,0.00401594235260733,-0.00510448152585093,0.0106380124963698,0.49086948160213
NMR metabolomics,X23424.Total Lipids in VLDL,GAD2,Glutamate decarboxylase 2,40199,-0.00324035180700667,0.00471726859680796,-0.0124861982567503,0.00600549464273693,0.492152204129037
NMR metabolomics,X23424.Total Lipids in VLDL,DPEP2,Dipeptidase 2,42587,0.00204774901256057,0.00300828192276679,-0.00384848355606234,0.00794398158118348,0.496070682946568
NMR metabolomics,X23424.Total Lipids in VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42794,0.00190852586828559,0.00280516605180727,-0.00358959959325666,0.00740665132982784,0.496287425539511
NMR metabolomics,X23424.Total Lipids in VLDL,OBP2B,Odorant-binding protein 2b,42462,-0.00425936174146711,0.00626606808050322,-0.0165408551792534,0.00802213169631921,0.496674431347002
NMR metabolomics,X23424.Total Lipids in VLDL,IFNL1,Interferon lambda-1,42311,0.0031702265526132,0.00467032247697329,-0.00598360550225445,0.0123240586074808,0.497274988281226
NMR metabolomics,X23424.Total Lipids in VLDL,PRG3,Proteoglycan 3,40527,-0.00341278609236275,0.00509105820249978,-0.0133912601692623,0.00656568798453681,0.502648957261604
NMR metabolomics,X23424.Total Lipids in VLDL,ADA2,Adenosine deaminase 2,42572,-0.00302263631713208,0.00452193382050082,-0.0118856266053137,0.00584035397104953,0.503865025652482
NMR metabolomics,X23424.Total Lipids in VLDL,TMPRSS5,Transmembrane protease serine 5,42438,-0.00257780172224783,0.00388606644245952,-0.0101944919494685,0.00503888850497284,0.50712133618654
NMR metabolomics,X23424.Total Lipids in VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,40136,-0.00396052245550055,0.00598202143717099,-0.0156852844723557,0.0077642395613546,0.507939712559318
NMR metabolomics,X23424.Total Lipids in VLDL,DCDC2C,Doublecortin domain-containing protein 2C,40080,0.00428675256504344,0.00647909179122292,-0.00841226734575348,0.0169857724758404,0.508223264262747
NMR metabolomics,X23424.Total Lipids in VLDL,ENG,Endoglin,42794,0.00116623616982906,0.00177206808407824,-0.0023070172749643,0.00463948961462241,0.510471177950792
NMR metabolomics,X23424.Total Lipids in VLDL,EPB41L5,Band 4.1-like protein 5,40182,0.00407508852767201,0.00626855011354401,-0.00821126969487426,0.0163614467502183,0.515651101500228
NMR metabolomics,X23424.Total Lipids in VLDL,HBZ,Hemoglobin subunit zeta,40511,0.00699134520952695,0.0108695764074985,-0.01431302454917,0.0282957149682239,0.520105356042537
NMR metabolomics,X23424.Total Lipids in VLDL,THY1,Thy-1 membrane glycoprotein,42711,0.00196302080869825,0.00306956712266924,-0.00405333075173346,0.00797937236912996,0.522501637441533
NMR metabolomics,X23424.Total Lipids in VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,42495,0.00336795160536033,0.00530724291140448,-0.00703424450099245,0.0137701477117131,0.525703284567595
NMR metabolomics,X23424.Total Lipids in VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,40136,0.00381818127375338,0.0060578354106466,-0.00805517613111396,0.0156915386786207,0.528519301641999
NMR metabolomics,X23424.Total Lipids in VLDL,OMP,Olfactory marker protein,40136,-0.00323593788439141,0.00514836036705673,-0.0133267242038226,0.00685484843503978,0.529664966208443
NMR metabolomics,X23424.Total Lipids in VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42711,-0.00304872250181601,0.00485260408067975,-0.0125598264999483,0.0064623814963163,0.52984080865582
NMR metabolomics,X23424.Total Lipids in VLDL,EFNB2,Ephrin-B2,40182,0.00350429426027489,0.00558139172354064,-0.00743523351786477,0.0144438220384145,0.530113205615082
NMR metabolomics,X23424.Total Lipids in VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,40116,-0.00384045225053787,0.00612949582994307,-0.0158542640772263,0.00817335957615054,0.5309655670962
NMR metabolomics,X23424.Total Lipids in VLDL,FAM3D,Protein FAM3D,40449,0.00548734196890976,0.0087595203790266,-0.0116813179739824,0.0226560019118019,0.531036987051814
NMR metabolomics,X23424.Total Lipids in VLDL,PFDN6,Prefoldin subunit 6,40182,0.00411512479016323,0.00662707059252813,-0.0088739335711919,0.0171041831515184,0.534640903559449
NMR metabolomics,X23424.Total Lipids in VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,40199,0.00184110527175004,0.00299846266306492,-0.0040358815478572,0.00771809209135729,0.539217177287596
NMR metabolomics,X23424.Total Lipids in VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,40302,0.0029592948906495,0.00484199458798025,-0.00653101450179179,0.0124496042830908,0.541097762976239
NMR metabolomics,X23424.Total Lipids in VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,42346,-0.00198361283830351,0.00325028623964427,-0.00835417386800628,0.00438694819139925,0.541681151422686
NMR metabolomics,X23424.Total Lipids in VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,40199,0.0025044821367406,0.00410505431339821,-0.00554142431751988,0.0105503885910011,0.541810019616051
NMR metabolomics,X23424.Total Lipids in VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",40116,0.00243710927101739,0.00399474668576387,-0.0053925942330798,0.0102668127751146,0.541822466728793
NMR metabolomics,X23424.Total Lipids in VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,40116,-0.00420862013239358,0.00691640130392602,-0.0177647666880886,0.00934752642330141,0.542869524629349
NMR metabolomics,X23424.Total Lipids in VLDL,ESPL1,Separin,40080,0.00355249176616854,0.0058851298651209,-0.00798236276946843,0.0150873463018055,0.546096497188221
NMR metabolomics,X23424.Total Lipids in VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,40532,0.00166529546032262,0.00278154534967415,-0.00378653342503872,0.00711712434568395,0.54938869198745
NMR metabolomics,X23424.Total Lipids in VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,40080,-0.00153653705448968,0.00257992052585998,-0.00659318128517524,0.00352010717619588,0.551471333318908
NMR metabolomics,X23424.Total Lipids in VLDL,CSH1,Chorionic somatomammotropin hormone 1,40532,-0.00172635348313381,0.00291141249834796,-0.00743272197989581,0.00398001501362819,0.553219213587938
NMR metabolomics,X23424.Total Lipids in VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",40482,-0.00224551379914364,0.00379243523606928,-0.00967868686183944,0.00518765926355215,0.553793209021628
NMR metabolomics,X23424.Total Lipids in VLDL,KLK14,Kallikrein-14,42721,-0.0028294900476312,0.00480662505141143,-0.0122504751483976,0.00659149505313521,0.556096113622963
NMR metabolomics,X23424.Total Lipids in VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,40136,0.00420013618945322,0.00717856623230948,-0.00986985362587337,0.0182701260047798,0.558496563165301
NMR metabolomics,X23424.Total Lipids in VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42711,0.00169543729673049,0.00290131690577343,-0.00399114383858543,0.00738201843204641,0.558982378732436
NMR metabolomics,X23424.Total Lipids in VLDL,PSCA,Prostate stem cell antigen,40449,0.0158246777521891,0.0271968145804436,-0.0374810788254804,0.0691304343298586,0.560674144634612
NMR metabolomics,X23424.Total Lipids in VLDL,HEBP1,Heme-binding protein 1,42357,0.00312344971067583,0.00537555683949169,-0.00741264169472787,0.0136595411160795,0.561218909355586
NMR metabolomics,X23424.Total Lipids in VLDL,PPT1,Palmitoyl-protein thioesterase 1,40182,0.00456380505427774,0.00788177921704244,-0.0108844822111254,0.0200120923196809,0.562579222008354
NMR metabolomics,X23424.Total Lipids in VLDL,UGDH,UDP-glucose 6-dehydrogenase,40116,0.00565915849618924,0.00978740242418061,-0.0135241502552048,0.0248424672475832,0.563135335640756
NMR metabolomics,X23424.Total Lipids in VLDL,MN1,Transcriptional activator MN1,40182,-0.00349671647220414,0.00606528975649353,-0.0153846843949315,0.00839125145052318,0.564280508542067
NMR metabolomics,X23424.Total Lipids in VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",40182,0.00460814607687808,0.00806283387483485,-0.0111950083177982,0.0204113004715544,0.56765257169417
NMR metabolomics,X23424.Total Lipids in VLDL,LY96,Lymphocyte antigen 96,42495,-0.00206738222257133,0.00364340605009336,-0.00920845808075432,0.00507369363561166,0.570430842306245
NMR metabolomics,X23424.Total Lipids in VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,40482,-0.00261087278906493,0.00463062932425909,-0.0116869062646127,0.00646516068648289,0.572883230154208
NMR metabolomics,X23424.Total Lipids in VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,40136,-0.00361042880217396,0.00640435693173697,-0.0161629683883784,0.0089421107840305,0.57293875129942
NMR metabolomics,X23424.Total Lipids in VLDL,IL24,Interleukin-24,42370,0.00290565413581952,0.00515799900619318,-0.00720402391631912,0.0130153321879582,0.573219970188736
NMR metabolomics,X23424.Total Lipids in VLDL,ADRA2A,Alpha-2A adrenergic receptor,40116,-0.00397183672238926,0.00711725643870739,-0.0179216593422557,0.00997798589747722,0.576816713875319
NMR metabolomics,X23424.Total Lipids in VLDL,CLMP,CXADR-like membrane protein,42721,0.00123998232304563,0.00223863689226687,-0.00314774598579743,0.00562771063188869,0.579656028631804
NMR metabolomics,X23424.Total Lipids in VLDL,KLHL41,Kelch-like protein 41,40482,-0.00269714109778293,0.00489608905249988,-0.0122934756406827,0.00689919344511684,0.581729142581022
NMR metabolomics,X23424.Total Lipids in VLDL,SUSD4,Sushi domain-containing protein 4,40451,-0.00234537100985218,0.00428858027000583,-0.0107509883390636,0.00606024631935923,0.584466853440724
NMR metabolomics,X23424.Total Lipids in VLDL,TXK,Tyrosine-protein kinase TXK,40302,0.00418318295623037,0.00767371814222969,-0.0108573046025398,0.0192236705150006,0.585674250435897
NMR metabolomics,X23424.Total Lipids in VLDL,HTR1B,5-hydroxytryptamine receptor 1B,40136,-0.00239841507560778,0.00442382951730198,-0.0110691209295197,0.00627229077830411,0.587720626628227
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA10,Annexin A10,42311,-0.00469599588037725,0.00879933943210196,-0.0219427011672971,0.0125507094065426,0.593574790284889
NMR metabolomics,X23424.Total Lipids in VLDL,DHODH,Dihydroorotate dehydrogenase,40116,0.00265425135868226,0.00497655643338855,-0.00709979925075929,0.0124083019681238,0.593801481516285
NMR metabolomics,X23424.Total Lipids in VLDL,CDC25A,M-phase inducer phosphatase 1,40080,-0.00211470363168066,0.00398851399538786,-0.00993219106264086,0.00570278379927954,0.595985212918203
NMR metabolomics,X23424.Total Lipids in VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,40136,-0.00386014924013804,0.00728430050385939,-0.0181373782277024,0.0104170797474264,0.5961731331941
NMR metabolomics,X23424.Total Lipids in VLDL,NEB,Nebulin,40116,-0.0020819615215224,0.00392925955901647,-0.00978331025719467,0.00561938721414987,0.59621905683779
NMR metabolomics,X23424.Total Lipids in VLDL,ALMS1,Alstrom syndrome protein 1,40302,-0.00241594545145995,0.0045610503680708,-0.0113556041728787,0.00652371326995882,0.596337060837016
NMR metabolomics,X23424.Total Lipids in VLDL,DCUN1D1,DCN1-like protein 1,40136,-0.00404726940718481,0.00766662814454297,-0.019073860570489,0.0109793217561194,0.597574342522022
NMR metabolomics,X23424.Total Lipids in VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,40136,-0.00278363621689649,0.0052773669940835,-0.0131272755253001,0.00756000309150716,0.597880116173315
NMR metabolomics,X23424.Total Lipids in VLDL,SELENOP,Selenoprotein P,40539,0.00123705142587669,0.00235204546044454,-0.0033729576765946,0.00584706052834798,0.59893526142293
NMR metabolomics,X23424.Total Lipids in VLDL,CPLX2,Complexin-2,40080,-0.00170332560074929,0.00324881534482007,-0.00807100367659663,0.00466435247509806,0.600086626086678
NMR metabolomics,X23424.Total Lipids in VLDL,ART5,Ecto-ADP-ribosyltransferase 5,40136,0.00342797047029104,0.00658378435082282,-0.00947624685732168,0.0163321877979038,0.602608114311087
NMR metabolomics,X23424.Total Lipids in VLDL,COPE,Coatomer subunit epsilon,42311,0.00250690353968825,0.00483912897677287,-0.00697778925478658,0.0119915963341631,0.604433163651685
NMR metabolomics,X23424.Total Lipids in VLDL,TPBGL,Trophoblast glycoprotein-like,40182,-0.00217633097358831,0.00429713600059354,-0.0105987175347517,0.00624605558757503,0.612543357373648
NMR metabolomics,X23424.Total Lipids in VLDL,CGN,Cingulin,40182,0.00211162263662421,0.00421571250381764,-0.00615117387085838,0.0103744191441068,0.616456169695903
NMR metabolomics,X23424.Total Lipids in VLDL,DNLZ,DNL-type zinc finger protein,40136,0.00465817391995102,0.0093134918899326,-0.0135962701843169,0.0229126180242189,0.616977180255896
NMR metabolomics,X23424.Total Lipids in VLDL,GFRA3,GDNF family receptor alpha-3,42474,0.00146758284975627,0.00293655809674389,-0.00428807101986175,0.00722323671937429,0.617250302557946
NMR metabolomics,X23424.Total Lipids in VLDL,PLAUR,Urokinase plasminogen activator surface receptor,42547,-0.001429062263775,0.0028614554988944,-0.00703751504160802,0.00417939051405803,0.617493198541897
NMR metabolomics,X23424.Total Lipids in VLDL,FAM171A2,Protein FAM171A2,40482,0.00812546447440277,0.0163407706692977,-0.0239024460374208,0.0401533749862263,0.619021749549714
NMR metabolomics,X23424.Total Lipids in VLDL,MYL6B,Myosin light chain 6B,40182,0.00462559362623829,0.00930470640343718,-0.0136116309244986,0.0228628181769752,0.619111500002197
NMR metabolomics,X23424.Total Lipids in VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,42370,0.00149798579723751,0.00303670930546051,-0.00445396444146509,0.00744993603594011,0.621814178096176
NMR metabolomics,X23424.Total Lipids in VLDL,HSP90B1,Endoplasmin,42247,-0.00334886873539444,0.00680541622056485,-0.0166874845277015,0.00998974705691266,0.62266488314876
NMR metabolomics,X23424.Total Lipids in VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,40302,-0.00318759343995206,0.00648171775633193,-0.0158917602423626,0.00951657336245852,0.622883036480755
NMR metabolomics,X23424.Total Lipids in VLDL,TPSD1,Tryptase delta,40482,-0.00192104695637218,0.0039238631180674,-0.00961181866778428,0.00576972475503992,0.624440275475434
NMR metabolomics,X23424.Total Lipids in VLDL,EPGN,Epigen,40451,0.0022716088524745,0.00464967820215085,-0.00684176042374117,0.0113849781286902,0.625168531096383
NMR metabolomics,X23424.Total Lipids in VLDL,HLA_A,,40482,-0.00165282599793205,0.00338962305235816,-0.00829648718055405,0.00499083518468994,0.625833093391499
NMR metabolomics,X23424.Total Lipids in VLDL,ANXA5,Annexin A5,42261,-0.00152315408278942,0.00312877909879864,-0.00765556111643475,0.00460925295085591,0.626393643883594
NMR metabolomics,X23424.Total Lipids in VLDL,CA3,Carbonic anhydrase 3,42770,0.00292099973982694,0.00607205467599321,-0.00898022742511975,0.0148222269047736,0.630484286916005
NMR metabolomics,X23424.Total Lipids in VLDL,RELB,Transcription factor RelB,40199,0.0024166107801329,0.0050830619627601,-0.00754619066687689,0.0123794122271427,0.634494069033071
NMR metabolomics,X23424.Total Lipids in VLDL,TNR,Tenascin-R,42495,-0.00204399382701064,0.00432472360228586,-0.0105204520874909,0.00643246443346964,0.636484977801254
NMR metabolomics,X23424.Total Lipids in VLDL,KDM3A,Lysine-specific demethylase 3A,40199,-0.00422049296855725,0.00896500387575302,-0.0217919005650332,0.0133509146279187,0.637811286027789
NMR metabolomics,X23424.Total Lipids in VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42636,-0.0015683355919829,0.00336918143478993,-0.00817193120417116,0.00503526002020537,0.641584881095715
NMR metabolomics,X23424.Total Lipids in VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,40080,0.00270567172040644,0.00592451843938415,-0.00890638442078649,0.0143177278615994,0.647902579574114
NMR metabolomics,X23424.Total Lipids in VLDL,TGFBR1,TGF-beta receptor type-1,40199,0.00100906665646728,0.00221093371359189,-0.00332436342217283,0.00534249673510738,0.64811250760031
NMR metabolomics,X23424.Total Lipids in VLDL,VASN,Vasorin,42449,-0.00127348506310638,0.00280617681571104,-0.00677359162190002,0.00422662149568726,0.649969433857014
NMR metabolomics,X23424.Total Lipids in VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",40136,-0.00205015639146572,0.00456290493955868,-0.0109934500730007,0.00689313729006929,0.653217327733402
NMR metabolomics,X23424.Total Lipids in VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,40482,0.00184208045169412,0.00410274931700442,-0.00619930820963454,0.00988346911302278,0.653449769220273
NMR metabolomics,X23424.Total Lipids in VLDL,FZD8,Frizzled-8,40136,0.00209897376423898,0.00468104004513845,-0.00707586472423238,0.0112738122527103,0.653874128298095
NMR metabolomics,X23424.Total Lipids in VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,40116,-0.00166164250781356,0.00370984102253567,-0.00893293091198348,0.00560964589635636,0.654233335068117
NMR metabolomics,X23424.Total Lipids in VLDL,TET2,Methylcytosine dioxygenase TET2,40286,0.00467762380762595,0.0104663819461641,-0.0158364848068557,0.0251917324221076,0.654942349805091
NMR metabolomics,X23424.Total Lipids in VLDL,SLC4A1,Band 3 anion transport protein,40527,-0.00212879585211271,0.00479299626009157,-0.0115230685218922,0.00726547681766678,0.656944645985647
NMR metabolomics,X23424.Total Lipids in VLDL,MSMB,Beta-microseminoprotein,42559,-0.0032721845074179,0.00737966882593774,-0.0177363354062559,0.0111919663914201,0.657479757126693
NMR metabolomics,X23424.Total Lipids in VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",42611,-0.00169850013336309,0.00384562610491911,-0.00923592729900454,0.00583892703227836,0.658734678186137
NMR metabolomics,X23424.Total Lipids in VLDL,IL15,Interleukin-15,42594,0.00148063998833459,0.00338402963292516,-0.00515205809219872,0.00811333806886791,0.661728611658832
NMR metabolomics,X23424.Total Lipids in VLDL,CHEK2,Serine/threonine-protein kinase Chk2,42357,0.00148079541182328,0.00338991196712546,-0.00516343204374263,0.00812502286738919,0.662246049148757
NMR metabolomics,X23424.Total Lipids in VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,40080,0.00224384440252192,0.00517223307892243,-0.00789373243216605,0.0123814212372099,0.664424068442196
NMR metabolomics,X23424.Total Lipids in VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,40136,-0.00183467034887739,0.00428861495806625,-0.0102403556666872,0.00657101496893246,0.668805008396236
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42679,0.00194569486685203,0.0045694264399953,-0.00701038095553877,0.0109017706892428,0.6702551055825
NMR metabolomics,X23424.Total Lipids in VLDL,FSHB,Follitropin subunit beta,40223,-0.00235179212685377,0.00553726240526345,-0.0132048264411701,0.00850124218746259,0.671048292385587
NMR metabolomics,X23424.Total Lipids in VLDL,MMP15,Matrix metalloproteinase-15,40511,0.00208373330495628,0.0049922479127182,-0.0077010726039714,0.0118685392138839,0.676398310128209
NMR metabolomics,X23424.Total Lipids in VLDL,TAGLN3,Transgelin-3,40080,0.00259381286597684,0.00627150773452049,-0.00969834229368332,0.014885968025637,0.6791848831706
NMR metabolomics,X23424.Total Lipids in VLDL,NENF,Neudesin,40451,0.00464763866396944,0.0112450853838002,-0.0173927286882789,0.0266880060162178,0.679391779078026
NMR metabolomics,X23424.Total Lipids in VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,40302,-0.0034051511786993,0.00829697176449448,-0.0196672158371085,0.0128569134797099,0.681513923351772
NMR metabolomics,X23424.Total Lipids in VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40482,-0.00171113769294203,0.00417257340436586,-0.00988938156549912,0.00646710617961506,0.681746468598646
NMR metabolomics,X23424.Total Lipids in VLDL,SMC3,Structural maintenance of chromosomes protein 3,40080,0.00223277164032515,0.00568421616670818,-0.00890829204642288,0.0133738353270732,0.694473397533576
NMR metabolomics,X23424.Total Lipids in VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42676,0.00230133709920671,0.00585968518913303,-0.00918364587149404,0.0137863200699075,0.694517186209212
NMR metabolomics,X23424.Total Lipids in VLDL,HTR1A,5-hydroxytryptamine receptor 1A,40136,-0.00312624572983909,0.00802601312163205,-0.0188572314482379,0.0126047399885597,0.696903421236879
NMR metabolomics,X23424.Total Lipids in VLDL,PCNA,Proliferating cell nuclear antigen,40080,0.00248052853576365,0.00639909260688661,-0.0100616929737341,0.0150227500452614,0.69829186060157
NMR metabolomics,X23424.Total Lipids in VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,40136,-0.00119204158980514,0.00308760196426111,-0.0072437414397569,0.00485965826014663,0.699449671170225
NMR metabolomics,X23424.Total Lipids in VLDL,RUVBL1,RuvB-like 1,42346,0.00413397885763393,0.0107826382153348,-0.0169999920444224,0.0252679497596902,0.701435219047331
NMR metabolomics,X23424.Total Lipids in VLDL,GHRHR,Growth hormone-releasing hormone receptor,42311,0.00218502229375457,0.00573587189266999,-0.00905728661587861,0.0134273312033878,0.703254036242034
NMR metabolomics,X23424.Total Lipids in VLDL,SLC1A4,Neutral amino acid transporter A,40182,0.00202550020134875,0.00533082520009045,-0.00842291719082854,0.012473917593526,0.703982471042545
NMR metabolomics,X23424.Total Lipids in VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,40302,0.0026987876520706,0.0071434832492208,-0.0113024395164022,0.0167000148205434,0.705588505472134
NMR metabolomics,X23424.Total Lipids in VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,40116,-0.00145515403990748,0.00386122553980504,-0.00902315609792536,0.00611284801811039,0.706282548262906
NMR metabolomics,X23424.Total Lipids in VLDL,KCNIP4,Kv channel-interacting protein 4,42311,0.00188863352277821,0.00503104522988749,-0.00797221512780127,0.0117494821733577,0.707372157491461
NMR metabolomics,X23424.Total Lipids in VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,42113,0.00142651427443626,0.00383847555364562,-0.00609689781070916,0.00894992635958168,0.710170253205398
NMR metabolomics,X23424.Total Lipids in VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",40116,0.00188031879114917,0.0050696942092691,-0.00805628185901827,0.0118169194413166,0.710723732300953
NMR metabolomics,X23424.Total Lipids in VLDL,CYTH3,Cytohesin-3,40080,-0.00281347935617268,0.00764205779637993,-0.0177919126370773,0.012164953924732,0.712763106492643
NMR metabolomics,X23424.Total Lipids in VLDL,DDX1,ATP-dependent RNA helicase DDX1,40449,0.00184299958512425,0.00511131950150263,-0.0081751866378209,0.0118611858080694,0.718426060367616
NMR metabolomics,X23424.Total Lipids in VLDL,IL2RB,Interleukin-2 receptor subunit beta,42370,0.00144347642113342,0.00400647879996778,-0.00640922202680342,0.00929617486907026,0.718639378660157
NMR metabolomics,X23424.Total Lipids in VLDL,EXOSC10,Exosome component 10,40116,0.0022137637138115,0.00618022001558383,-0.00989946751673281,0.0143269949443558,0.720199491654185
NMR metabolomics,X23424.Total Lipids in VLDL,TSPAN15,Tetraspanin-15,40116,0.00190955607405668,0.00533250580270805,-0.00854215529925111,0.0123612674473645,0.720277399692271
NMR metabolomics,X23424.Total Lipids in VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40482,0.000974784299778796,0.00273697970867749,-0.00438969592922908,0.00633926452878667,0.721732434247668
NMR metabolomics,X23424.Total Lipids in VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",40116,0.00189353839348872,0.00531816140910222,-0.00853005796835162,0.0123171347553291,0.721809008718508
NMR metabolomics,X23424.Total Lipids in VLDL,ZNF830,Zinc finger protein 830,40451,-0.00281153515158256,0.00792282259810322,-0.0183402674438649,0.0127171971406997,0.722697121704174
NMR metabolomics,X23424.Total Lipids in VLDL,PGLYRP1,Peptidoglycan recognition protein 1,42737,0.00153332897762278,0.00433862847680662,-0.0069703828369182,0.0100370407921638,0.723784122464724
NMR metabolomics,X23424.Total Lipids in VLDL,PSMA1,Proteasome subunit alpha type-1,42346,0.00165641421541858,0.00471660224818091,-0.007588126191016,0.0109009546218532,0.725452920775052
NMR metabolomics,X23424.Total Lipids in VLDL,IL20,Interleukin-20,42370,-0.00175092244832864,0.00501816689137684,-0.0115865295554272,0.00808468465876996,0.727157390308826
NMR metabolomics,X23424.Total Lipids in VLDL,CTSB,Cathepsin B,42659,0.00188702255904155,0.00547215828675642,-0.00883840768300103,0.0126124528010841,0.730219565489879
NMR metabolomics,X23424.Total Lipids in VLDL,FGF6,Fibroblast growth factor 6,40199,-0.00145825454354692,0.00424289357598621,-0.00977432595247988,0.00685781686538605,0.731083436755034
NMR metabolomics,X23424.Total Lipids in VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40451,-0.00157468526147527,0.00458734367913642,-0.0105658788725827,0.00741650834963211,0.731403759035139
NMR metabolomics,X23424.Total Lipids in VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,40199,-0.00146039516141737,0.00426553350179288,-0.0098208408249314,0.00690005050209667,0.732078214528109
NMR metabolomics,X23424.Total Lipids in VLDL,SLITRK1,SLIT and NTRK-like protein 1,40199,0.00114819564883048,0.00335616216794797,-0.00542988220034753,0.0077262734980085,0.732270382708823
NMR metabolomics,X23424.Total Lipids in VLDL,ERVV_1,,40116,-0.00150342520744335,0.0044656612129507,-0.0102561211848267,0.00724927076994003,0.736377037248264
NMR metabolomics,X23424.Total Lipids in VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",42311,0.00140057453746122,0.00417371094282683,-0.00677989891047936,0.00958104798540181,0.737200090935138
NMR metabolomics,X23424.Total Lipids in VLDL,SCIN,Adseverin,40136,0.00247468195134217,0.00746019805178901,-0.0121473062301643,0.0170966701328486,0.740108563339511
NMR metabolomics,X23424.Total Lipids in VLDL,EDDM3B,Epididymal secretory protein E3-beta,40451,0.0017847242916455,0.00538380191727649,-0.00876752746621642,0.0123369760495074,0.740273859763816
NMR metabolomics,X23424.Total Lipids in VLDL,GPHA2,Glycoprotein hormone alpha-2,40449,0.0015596387462086,0.00475865541815288,-0.00776732587337105,0.0108866033657882,0.743108470326009
NMR metabolomics,X23424.Total Lipids in VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,40080,0.00193263267594103,0.00590042347171896,-0.00963219732862813,0.0134974626805102,0.743264771009545
NMR metabolomics,X23424.Total Lipids in VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40449,0.00583761077452965,0.0178985424118135,-0.0292435323526248,0.0409187539016841,0.744316883446952
NMR metabolomics,X23424.Total Lipids in VLDL,MORF4L1,Mortality factor 4-like protein 1,40302,0.00132802775722107,0.00408409974487337,-0.00667680774273073,0.00933286325717287,0.745058343279924
NMR metabolomics,X23424.Total Lipids in VLDL,MAPT,Microtubule-associated protein tau,42311,-0.00175474151474582,0.0054301220726534,-0.0123977807771465,0.00888829774765485,0.746587135756414
NMR metabolomics,X23424.Total Lipids in VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,40199,0.00160062909265384,0.00500820198794417,-0.00821544680371673,0.0114167049890244,0.749276469764847
NMR metabolomics,X23424.Total Lipids in VLDL,IL10,Interleukin-10,42370,0.00276480577332247,0.00866801280206869,-0.0142244993187322,0.0197541108653771,0.749756966331078
NMR metabolomics,X23424.Total Lipids in VLDL,ZNF174,Zinc finger protein 174,40199,0.00122132676080054,0.00382994467118022,-0.00628536479471268,0.00872801831631377,0.749816830136027
NMR metabolomics,X23424.Total Lipids in VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",40199,0.000923506385501681,0.00290653067116985,-0.00477329372999123,0.0066203065009946,0.750692023931259
NMR metabolomics,X23424.Total Lipids in VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,40182,-0.00167046443948145,0.00529915957342756,-0.0120568172033995,0.00871588832443656,0.752591530060341
NMR metabolomics,X23424.Total Lipids in VLDL,WIF1,Wnt inhibitory factor 1,42721,-0.00110439533682647,0.00351463519173337,-0.00799308031262387,0.00578428963897093,0.753353037232381
NMR metabolomics,X23424.Total Lipids in VLDL,PFDN4,Prefoldin subunit 4,40080,0.00166436747331756,0.00537258774162702,-0.00886590450027139,0.0121946394469065,0.756727504004433
NMR metabolomics,X23424.Total Lipids in VLDL,TFF1,Trefoil factor 1,42556,-0.00261174405946397,0.00845539613750145,-0.0191843204889668,0.0139608323700389,0.757413911059579
NMR metabolomics,X23424.Total Lipids in VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",40080,-0.00172811346707852,0.00568113799993429,-0.0128631439469497,0.00940691701279268,0.760993234827181
NMR metabolomics,X23424.Total Lipids in VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39845,0.0015943842979932,0.0052556840552946,-0.00870675645038422,0.0118955250463706,0.761618553479953
NMR metabolomics,X23424.Total Lipids in VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,40199,0.00191678667130833,0.00635376046500281,-0.0105365838400972,0.0143701571827138,0.762903610428561
NMR metabolomics,X23424.Total Lipids in VLDL,LTA4H,Leukotriene A-4 hydrolase,42721,-0.00179838819130345,0.0059620112642865,-0.013483930269305,0.0098871538866981,0.762930239070969
NMR metabolomics,X23424.Total Lipids in VLDL,WNT9A,Protein Wnt-9a,42370,-0.000907577614696073,0.00302920406664659,-0.00684481758532338,0.00502966235593124,0.764479939450316
NMR metabolomics,X23424.Total Lipids in VLDL,PLXDC1,Plexin domain-containing protein 1,42346,-0.000949689179225925,0.00321686908189884,-0.00725475257974764,0.00535537422129579,0.767829276473156
NMR metabolomics,X23424.Total Lipids in VLDL,CD58,Lymphocyte function-associated antigen 3,42600,0.000529121160683749,0.00180757220183664,-0.00301372035491606,0.00407196267628356,0.769737063923478
NMR metabolomics,X23424.Total Lipids in VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,40527,0.000634268276755082,0.00216952821232044,-0.00361800701939298,0.00488654357290315,0.770022022658152
NMR metabolomics,X23424.Total Lipids in VLDL,HDAC9,Histone deacetylase 9,40136,0.00191201453257839,0.00671385425416347,-0.011247139805582,0.0150711688707388,0.775813164708659
NMR metabolomics,X23424.Total Lipids in VLDL,FGF12,Fibroblast growth factor 12,40199,0.00132482601663994,0.0047903076085248,-0.00806417689606868,0.0107138289293486,0.78212020325534
NMR metabolomics,X23424.Total Lipids in VLDL,MYBPC2,"Myosin-binding protein C, fast-type",40223,-0.00238071121258957,0.00867300519321441,-0.0193798013912898,0.0146183789661107,0.783708088623243
NMR metabolomics,X23424.Total Lipids in VLDL,IL3,Interleukin-3,40080,0.00173516270320667,0.00632229327441583,-0.0106565321146483,0.0141268575210617,0.783742898854407
NMR metabolomics,X23424.Total Lipids in VLDL,COL4A4,Collagen alpha-4(IV) chain,40284,-0.00149490469852735,0.00547313343660535,-0.0122222462342738,0.00923243683721913,0.784754473238927
NMR metabolomics,X23424.Total Lipids in VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40527,0.000700085029153469,0.00258355334320528,-0.00436367952352887,0.00576384958183581,0.786413212042198
NMR metabolomics,X23424.Total Lipids in VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,40080,-0.00125284585646551,0.00462699884045617,-0.0103217635837596,0.00781607187082858,0.786574168615721
NMR metabolomics,X23424.Total Lipids in VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,40080,0.00394201422420535,0.0146615752673632,-0.0247946732998265,0.0326787017482372,0.788037103011987
NMR metabolomics,X23424.Total Lipids in VLDL,ESR1,Estrogen receptor,40199,-0.0015127056746801,0.00565830421956941,-0.0126029819450362,0.00957757059567594,0.789210411470316
NMR metabolomics,X23424.Total Lipids in VLDL,ADAMTSL5,ADAMTS-like protein 5,40511,-0.00107741462311701,0.00403408803028535,-0.00898422716247629,0.00682939791624226,0.789414266357211
NMR metabolomics,X23424.Total Lipids in VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,40136,0.00090781212920736,0.00340303655186482,-0.00576213951244769,0.00757776377086241,0.789654885770774
NMR metabolomics,X23424.Total Lipids in VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42611,-0.00318798318620195,0.0120989311629233,-0.0269018882655317,0.0205259218931278,0.792174695288287
NMR metabolomics,X23424.Total Lipids in VLDL,WFDC12,WAP four-disulfide core domain protein 12,42698,-0.00175699546642252,0.00667469749230111,-0.0148394025513327,0.0113254116184877,0.792375611147282
NMR metabolomics,X23424.Total Lipids in VLDL,DEFB116,Beta-defensin 116,40136,0.00207205288711393,0.00787782526992381,-0.0133684846419367,0.0175125904161646,0.792537446660203
NMR metabolomics,X23424.Total Lipids in VLDL,CBX2,Chromobox protein homolog 2,40116,-0.00106048452182692,0.00410727686498105,-0.00911074717718978,0.00698977813353594,0.796260121861319
NMR metabolomics,X23424.Total Lipids in VLDL,MORF4L2,Mortality factor 4-like protein 2,40080,-0.000960657967262783,0.00376078653090308,-0.00833179956783281,0.00641048363330724,0.798387560223947
NMR metabolomics,X23424.Total Lipids in VLDL,ABO,Histo-blood group ABO system transferase,40532,0.00377793434495922,0.0148373808105493,-0.0253033320437174,0.0328592007336358,0.799019122815466
NMR metabolomics,X23424.Total Lipids in VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40451,0.00198426987424923,0.00782929869461004,-0.0133611555671865,0.0173296953156849,0.799931624059973
NMR metabolomics,X23424.Total Lipids in VLDL,PRTN3,Myeloblastin,42276,-0.00124673103543288,0.00497736636524755,-0.0110023691113181,0.00850890704045232,0.802220055127336
NMR metabolomics,X23424.Total Lipids in VLDL,AXL,Tyrosine-protein kinase receptor UFO,42689,0.000699772337246046,0.00282201274969629,-0.00483137265215869,0.00623091732665078,0.804161984732006
NMR metabolomics,X23424.Total Lipids in VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,40116,0.00116881305906668,0.00486878337227981,-0.00837400235060174,0.0107116284687351,0.810286190582236
NMR metabolomics,X23424.Total Lipids in VLDL,GJA8,Gap junction alpha-8 protein,40080,0.00155812640489517,0.00667652502068876,-0.0115278626356548,0.0146441154454451,0.815475498714224
NMR metabolomics,X23424.Total Lipids in VLDL,PODXL2,Podocalyxin-like protein 2,42679,-0.00067197117390567,0.00288310122890831,-0.00632284958256595,0.00497890723475461,0.815708763954356
NMR metabolomics,X23424.Total Lipids in VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",40116,-0.00164000604038597,0.00715344516495649,-0.0156607585637007,0.0123807464829287,0.818670351217281
NMR metabolomics,X23424.Total Lipids in VLDL,DAND5,DAN domain family member 5,40199,0.00129997831061561,0.00567056271089284,-0.00981432460273434,0.0124142812239656,0.818678625028771
NMR metabolomics,X23424.Total Lipids in VLDL,TNXB,Tenascin-X,42611,-0.00060269100461202,0.00263176966448682,-0.00576095954700619,0.00455557753778215,0.818867754708311
NMR metabolomics,X23424.Total Lipids in VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,40116,0.00133074655749153,0.00586386444931652,-0.0101624277631688,0.0128239208781519,0.820474491424154
NMR metabolomics,X23424.Total Lipids in VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42674,-0.00161147312925361,0.00730733195651235,-0.0159338437640178,0.0127108975055106,0.825463113224106
NMR metabolomics,X23424.Total Lipids in VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,40182,-0.00139527206399658,0.00648603369830903,-0.0141078981126823,0.0113173539846891,0.82967817490164
NMR metabolomics,X23424.Total Lipids in VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40451,-0.00116072786008833,0.00541259985590018,-0.0117694235776527,0.00944796785747603,0.830200640481616
NMR metabolomics,X23424.Total Lipids in VLDL,MAGEA3,Melanoma-associated antigen 3,40302,-0.00189378852994646,0.00887941299399927,-0.019297437998185,0.0155098609382921,0.831113599622319
NMR metabolomics,X23424.Total Lipids in VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,40080,-0.00142989794797383,0.00675224245918725,-0.0146642931679808,0.0118044972720332,0.832293262283076
NMR metabolomics,X23424.Total Lipids in VLDL,TFRC,Transferrin receptor protein 1,42673,-0.000806057602149953,0.00385578170451093,-0.00836338974299137,0.00675127453869146,0.834411062328132
NMR metabolomics,X23424.Total Lipids in VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,40302,0.00134422275429616,0.00643613193115614,-0.0112705958307699,0.0139590413393622,0.834564727709076
NMR metabolomics,X23424.Total Lipids in VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,40199,-0.00116676065479419,0.00560828748295338,-0.0121590041213828,0.00982548281179443,0.83519984086658
NMR metabolomics,X23424.Total Lipids in VLDL,ANK2,Ankyrin-2,40116,0.00154925662694233,0.00753406304248459,-0.0132175069363275,0.0163160201902121,0.837080949243323
NMR metabolomics,X23424.Total Lipids in VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,40302,-0.000904523952088985,0.00448897114434854,-0.00970290739501213,0.00789385949083416,0.840311969309317
NMR metabolomics,X23424.Total Lipids in VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,40080,-0.000976746066117154,0.00487999915467484,-0.0105415444092798,0.00858805227704554,0.841364727509107
NMR metabolomics,X23424.Total Lipids in VLDL,BTNL10,Butyrophilin-like protein 10,40080,-0.000865736234247377,0.00436344836472352,-0.00941809502910547,0.00768662256061071,0.842730788092844
NMR metabolomics,X23424.Total Lipids in VLDL,PDIA2,Protein disulfide-isomerase A2,40080,-0.000855237810720584,0.0043117311824986,-0.00930623092841785,0.00759575530697668,0.842773862166725
NMR metabolomics,X23424.Total Lipids in VLDL,REST,RE1-silencing transcription factor,40080,-0.000684828953854879,0.00350974035838435,-0.00756392005628821,0.00619426214857845,0.845300770224574
NMR metabolomics,X23424.Total Lipids in VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,40136,0.000631015847968569,0.00323818598934726,-0.00571582869115206,0.00697786038708919,0.84550062443576
NMR metabolomics,X23424.Total Lipids in VLDL,KHDC3L,KH domain-containing protein 3,40080,-0.00132440295171814,0.00706182737619249,-0.0151655846090554,0.0125167787056191,0.851237668532066
NMR metabolomics,X23424.Total Lipids in VLDL,IL18RAP,Interleukin-18 receptor accessory protein,42425,0.00325609575003278,0.0175792749726668,-0.0311992831963942,0.0377114746964598,0.853056536057162
NMR metabolomics,X23424.Total Lipids in VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,40527,-0.000553344492886574,0.00300455335195361,-0.00644226906271565,0.0053355800769425,0.853884458458373
NMR metabolomics,X23424.Total Lipids in VLDL,TPT1,Translationally-controlled tumor protein,42370,-0.00120701958937623,0.00667013921174169,-0.0142804924443899,0.0118664532656375,0.856402792088021
NMR metabolomics,X23424.Total Lipids in VLDL,CLEC7A,C-type lectin domain family 7 member A,42754,-0.00110704521371219,0.00619954438341923,-0.0132581522052139,0.0110440617777895,0.858278960728175
NMR metabolomics,X23424.Total Lipids in VLDL,CLSTN1,Calsyntenin-1,42311,0.000959585331296576,0.00542072326505666,-0.00966503226821448,0.0115842029308076,0.859494123604258
NMR metabolomics,X23424.Total Lipids in VLDL,MORC3,MORC family CW-type zinc finger protein 3,40483,-0.000505993656218884,0.00289073668780554,-0.00617183756431775,0.00515985025187998,0.861051585326661
NMR metabolomics,X23424.Total Lipids in VLDL,COL5A1,Collagen alpha-1(V) chain,40283,0.000736772582577104,0.00421862921318641,-0.00753174067526825,0.00900528584042246,0.861359897140314
NMR metabolomics,X23424.Total Lipids in VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",40080,-0.000861602432078605,0.00500907760875422,-0.0106793945452369,0.00895618968107967,0.863434278392321
NMR metabolomics,X23424.Total Lipids in VLDL,HMMR,Hyaluronan mediated motility receptor,40059,0.000852629516754552,0.00508401866431684,-0.00911204706530645,0.0108173060988156,0.866816291522772
NMR metabolomics,X23424.Total Lipids in VLDL,TEX33,Testis-expressed protein 33,40302,0.000643249374202618,0.0039020064059888,-0.00700468318153544,0.00829118192994067,0.869064317872393
NMR metabolomics,X23424.Total Lipids in VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",40199,0.000702657639622371,0.00434363755539919,-0.00781087196896004,0.00921618724820479,0.871492233861839
NMR metabolomics,X23424.Total Lipids in VLDL,FOLR3,Folate receptor gamma,42629,-0.00292438541430499,0.0189031576948225,-0.039974574496157,0.034125803667547,0.877057362884625
NMR metabolomics,X23424.Total Lipids in VLDL,CHIT1,Chitotriosidase-1,42699,-0.00242286684240069,0.0157230654607818,-0.033240075145533,0.0283943414607316,0.877536076556554
NMR metabolomics,X23424.Total Lipids in VLDL,GAD1,Glutamate decarboxylase 1,40080,-0.000410338570686474,0.00267775199898275,-0.00565873248869266,0.00483805534731972,0.878211897889012
NMR metabolomics,X23424.Total Lipids in VLDL,EVPL,Envoplakin,40302,-0.000547902308594555,0.00359980042221038,-0.00760351113612689,0.00650770651893778,0.879029179161267
NMR metabolomics,X23424.Total Lipids in VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,40116,0.000402343551144348,0.00264671266525296,-0.00478521327275145,0.00558990037504015,0.87917686211581
NMR metabolomics,X23424.Total Lipids in VLDL,PAEP,Glycodelin,42495,0.00134205817659433,0.00919236472890509,-0.0166749766920596,0.0193590930452483,0.883925925902354
NMR metabolomics,X23424.Total Lipids in VLDL,CRX,Cone-rod homeobox protein,42357,0.00156557963841287,0.0108343743258276,-0.0196697940402092,0.022800953317035,0.885106954186493
NMR metabolomics,X23424.Total Lipids in VLDL,NLGN1,Neuroligin-1,40182,0.000991564239423713,0.00714838577526121,-0.0130192718800883,0.0150024003589357,0.889680569863345
NMR metabolomics,X23424.Total Lipids in VLDL,NRN1,Neuritin,40482,0.000491944814200457,0.00371705375831747,-0.00679348055210178,0.00777737018050269,0.894711362647691
NMR metabolomics,X23424.Total Lipids in VLDL,FOS,Proto-oncogene c-Fos,40065,-0.00046188197201833,0.00365557786260023,-0.00762681458271479,0.00670305063867813,0.899457278717272
NMR metabolomics,X23424.Total Lipids in VLDL,ICAM2,Intercellular adhesion molecule 2,42794,-0.000409227715650064,0.00330467709386963,-0.00688639481963453,0.00606793938833441,0.901449419639598
NMR metabolomics,X23424.Total Lipids in VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42653,0.000618109669115163,0.00501295068913753,-0.00920727368159439,0.0104434930198247,0.901869352332084
NMR metabolomics,X23424.Total Lipids in VLDL,CASQ2,Calsequestrin-2,40116,-0.000596401340880323,0.00502493459422447,-0.0104452731455603,0.00925247046379963,0.905524426504827
NMR metabolomics,X23424.Total Lipids in VLDL,NCLN,Nicalin,42370,-0.00061878678818992,0.00529111286336442,-0.0109893680003842,0.00975179442400434,0.906902785280149
NMR metabolomics,X23424.Total Lipids in VLDL,CD70,CD70 antigen,42594,0.000514036989211393,0.0044156845308571,-0.00814070469126852,0.0091687786696913,0.907328071155883
NMR metabolomics,X23424.Total Lipids in VLDL,MAMDC2,MAM domain-containing protein 2,40511,-0.000432770606335995,0.00373137616677539,-0.00774626789321577,0.00688072668054378,0.90766926124533
NMR metabolomics,X23424.Total Lipids in VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,42594,0.000790222278174462,0.00707540204483824,-0.0130775657297085,0.0146580102860574,0.911074173484857
NMR metabolomics,X23424.Total Lipids in VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,40116,-0.0006843441979614,0.00627161041951476,-0.0129767006202103,0.0116080122242875,0.913111078291569
NMR metabolomics,X23424.Total Lipids in VLDL,DCN,Decorin,42357,-0.000262520171902162,0.00244995780110702,-0.00506443746207193,0.00453939711826761,0.914669284886269
NMR metabolomics,X23424.Total Lipids in VLDL,GAMT,Guanidinoacetate N-methyltransferase,40116,-0.000408067902587868,0.00387727811428996,-0.0080075330065962,0.00719139720142046,0.916182565800134
NMR metabolomics,X23424.Total Lipids in VLDL,HK2,Hexokinase-2,42357,0.000292944096382043,0.00281287101381998,-0.00522028309070513,0.00580617128346921,0.917056531319135
NMR metabolomics,X23424.Total Lipids in VLDL,BEX3,Protein BEX3,40080,0.00050632702752176,0.00489140646287719,-0.00908082963971752,0.010093483694761,0.917557273509411
NMR metabolomics,X23424.Total Lipids in VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,42611,-0.000347850853058407,0.00351260015026452,-0.00723254714757686,0.00653684544146005,0.921116368519239
NMR metabolomics,X23424.Total Lipids in VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",40136,0.000571233206944026,0.00582699116787293,-0.0108496694820869,0.011992135895975,0.921908459802537
NMR metabolomics,X23424.Total Lipids in VLDL,SSB,Lupus La protein,42311,0.000582318280710534,0.00594106724346128,-0.0110621735164736,0.0122268100778946,0.921921268613101
NMR metabolomics,X23424.Total Lipids in VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,40449,0.000295692136883471,0.00303487080932417,-0.00565265464939189,0.00624403892315884,0.922385433402027
NMR metabolomics,X23424.Total Lipids in VLDL,ANKRA2,Ankyrin repeat family A protein 2,40080,0.000557603016839264,0.00587353699240913,-0.0109545294882826,0.0120697355219612,0.92436836804319
NMR metabolomics,X23424.Total Lipids in VLDL,HBQ1,Hemoglobin subunit theta-1,42721,-0.000578340601598352,0.00614296518925945,-0.0126185523725469,0.0114618711693502,0.924993927639323
NMR metabolomics,X23424.Total Lipids in VLDL,TP53BP1,TP53-binding protein 1,40199,-0.000835408663050408,0.00888070581230346,-0.0182415920551652,0.0165707747290644,0.925055204065045
NMR metabolomics,X23424.Total Lipids in VLDL,CA8,Carbonic anhydrase-related protein,40199,0.000268027183010663,0.00292984550615789,-0.00547447000905881,0.00601052437508013,0.927111529096546
NMR metabolomics,X23424.Total Lipids in VLDL,CDAN1,Codanin-1,40483,0.00020929648126675,0.00231143579348988,-0.00432111767397342,0.00473971063650692,0.927853154665881
NMR metabolomics,X23424.Total Lipids in VLDL,CDSN,Corneodesmosin,42710,0.000397906125910325,0.00454172372358151,-0.00850387237230944,0.00929968462413009,0.930186952426648
NMR metabolomics,X23424.Total Lipids in VLDL,RANGAP1,Ran GTPase-activating protein 1,42346,0.000424536154104406,0.00492771201575227,-0.00923377939677005,0.0100828517049789,0.931346268163034
NMR metabolomics,X23424.Total Lipids in VLDL,TAP1,Antigen peptide transporter 1,40302,0.000526301483911965,0.00630130997612112,-0.0118242660692854,0.0128768690371094,0.933437551962103
NMR metabolomics,X23424.Total Lipids in VLDL,PALLD,Palladin,40199,-0.000319329744492007,0.00398717872196178,-0.00813420003953709,0.00749554055055308,0.936167810389877
NMR metabolomics,X23424.Total Lipids in VLDL,SHC1,SHC-transforming protein 1,40080,0.000964671948358917,0.0120869956035987,-0.0227258394346946,0.0246551833314124,0.936389256908622
NMR metabolomics,X23424.Total Lipids in VLDL,PRRT3,Proline-rich transmembrane protein 3,40223,-0.000315134004413737,0.00409092895707897,-0.00833335476028852,0.00770308675146105,0.93859918125667
NMR metabolomics,X23424.Total Lipids in VLDL,UBQLN3,Ubiquilin-3,40116,-0.00040401443416726,0.00555119873768598,-0.0112843639600318,0.0104763350916973,0.941982778575636
NMR metabolomics,X23424.Total Lipids in VLDL,SPINT3,Kunitz-type protease inhibitor 3,40449,0.000907263931575695,0.0151843945536879,-0.0288541493936526,0.030668677256804,0.952356000495357
NMR metabolomics,X23424.Total Lipids in VLDL,RLN1,Prorelaxin H1,40482,0.000289007028166399,0.00494731233123484,-0.00940772514105388,0.00998573919738668,0.953417526612738
NMR metabolomics,X23424.Total Lipids in VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,40136,-0.000430128707186723,0.00750365466828712,-0.0151372918570295,0.014277034442656,0.954289294999573
NMR metabolomics,X23424.Total Lipids in VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,40080,-0.000202253705378811,0.00353900615350053,-0.00713870576623984,0.00673419835548222,0.954426867832928
NMR metabolomics,X23424.Total Lipids in VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,42521,0.000336162540201849,0.00589303077461584,-0.0112141777780452,0.0118865028584489,0.954510933833111
NMR metabolomics,X23424.Total Lipids in VLDL,PLXDC2,Plexin domain-containing protein 2,40483,0.000158345062326703,0.00278905710862662,-0.00530820687058147,0.00562489699523488,0.954726477613272
NMR metabolomics,X23424.Total Lipids in VLDL,COL3A1,Collagen alpha-1(III) chain,40527,0.000114813417866522,0.00238637387867669,-0.00456247938433979,0.00479210622007283,0.961627764387163
NMR metabolomics,X23424.Total Lipids in VLDL,ENPEP,Glutamyl aminopeptidase,40116,-0.000225334588877807,0.00488107345801655,-0.00979223856659025,0.00934156938883464,0.963179610000963
NMR metabolomics,X23424.Total Lipids in VLDL,PSMC3,26S proteasome regulatory subunit 6A,40080,0.000137806775971419,0.00313343517485181,-0.00600372616673813,0.00627933971868097,0.964921585990406
NMR metabolomics,X23424.Total Lipids in VLDL,ITGB5,Integrin beta-5,42679,0.000156000819180351,0.00378994696958039,-0.00727229524119721,0.00758429687955791,0.967167562683093
NMR metabolomics,X23424.Total Lipids in VLDL,ARG2,"Arginase-2, mitochondrial",40451,-0.000166912899728305,0.00436547860052042,-0.00872325095674833,0.00838942515729172,0.969501207840559
NMR metabolomics,X23424.Total Lipids in VLDL,IL36A,Interleukin-36 alpha,40199,-0.000200642505057918,0.005889517335938,-0.0117440964834964,0.0113428114733806,0.972823756593474
NMR metabolomics,X23424.Total Lipids in VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,40080,0.000324264110588242,0.00985034224207105,-0.018982406683871,0.0196309349050475,0.973739728504261
NMR metabolomics,X23424.Total Lipids in VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42737,-0.000110490659657899,0.00353494278060053,-0.00703897850963493,0.00681799719031913,0.975065279427859
NMR metabolomics,X23424.Total Lipids in VLDL,CRYBB2,Beta-crystallin B2,40483,0.000247011157206689,0.00834417064025201,-0.0161075632976872,0.0166015856121006,0.976384322764086
NMR metabolomics,X23424.Total Lipids in VLDL,FGF20,Fibroblast growth factor 20,40199,-0.000136455224898314,0.00461687228077803,-0.00918552489522325,0.00891261444542662,0.976421874589546
NMR metabolomics,X23424.Total Lipids in VLDL,NPTN,Neuroplastin,42346,-0.000221997868691279,0.00802433619472835,-0.0159496968103589,0.0155057010729763,0.977929300716564
NMR metabolomics,X23424.Total Lipids in VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,40199,-0.000238641612270411,0.00926569281782719,-0.0183993995352117,0.0179221163106709,0.979452903737749
NMR metabolomics,X23424.Total Lipids in VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,40136,-0.000166236011775546,0.00652540316055444,-0.0129560262064623,0.0126235541829112,0.979676386675905
NMR metabolomics,X23424.Total Lipids in VLDL,MBL2,Mannose-binding protein C,40379,0.000276119227666228,0.0111273906563965,-0.021533566458871,0.0220858049142034,0.980203468871586
NMR metabolomics,X23424.Total Lipids in VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,40511,-6.9825887948121e-05,0.00302319452191111,-0.00599528715089389,0.00585563537499765,0.981573526463701
NMR metabolomics,X23424.Total Lipids in VLDL,NXPE4,NXPE family member 4,40116,-7.46281038397495e-05,0.00344950375179535,-0.00683565545735864,0.00668639924967914,0.982739950948677
NMR metabolomics,X23424.Total Lipids in VLDL,DUSP29,Dual specificity phosphatase 29,40182,-0.000128143012614696,0.00688909827635506,-0.0136307756342706,0.0133744896090412,0.985159870706378
NMR metabolomics,X23424.Total Lipids in VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,40116,-5.44593257024992e-05,0.00344387331392323,-0.00680445102099203,0.00669553236958704,0.987383551719171
NMR metabolomics,X23424.Total Lipids in VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,40136,7.1516129727036e-05,0.00550926543222271,-0.0107266441174295,0.0108696763768835,0.989643136617901
NMR metabolomics,X23424.Total Lipids in VLDL,ZNF75D,Zinc finger protein 75D,40302,7.48039309664702e-05,0.00627472721565695,-0.0122236614117211,0.0123732692736541,0.990488487791024
NMR metabolomics,X23424.Total Lipids in VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,40302,6.79341676060818e-05,0.00685567625109624,-0.0133691912845426,0.0135050596197547,0.992093921229282
NMR metabolomics,X23424.Total Lipids in VLDL,LRP2BP,LRP2-binding protein,40182,6.54656680237128e-05,0.00882776454550711,-0.0172369528411702,0.0173678841772177,0.994083170400718
NMR metabolomics,X23424.Total Lipids in VLDL,FGF7,Fibroblast growth factor 7,40080,2.22237833604479e-05,0.00811201190174187,-0.0158773195440536,0.0159217671107745,0.997814157025156
